Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'hyperaldostéronisme secondaire'
(id=1836023 ; fe=hyperaldostéronisme secondaire ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2906 creation date=2015-07-30 touchdate=2025-12-28 16:52:43.000)
≈ 5137 relations sortantes

  1. hyperaldostéronisme secondaire -- r_associated #0: 60 / 1 -> hyperaldostéronisme primaire
    n1=hyperaldostéronisme secondaire | n2=hyperaldostéronisme primaire | rel=r_associated | relid=0 | w=60
  2. hyperaldostéronisme secondaire -- r_associated #0: 44 / 0.733 -> aldostéronisme secondaire
    n1=hyperaldostéronisme secondaire | n2=aldostéronisme secondaire | rel=r_associated | relid=0 | w=44
  3. hyperaldostéronisme secondaire -- r_associated #0: 44 / 0.733 -> processus pathologique
    n1=hyperaldostéronisme secondaire | n2=processus pathologique | rel=r_associated | relid=0 | w=44
  4. hyperaldostéronisme secondaire -- r_associated #0: 42 / 0.7 -> hyperaldostéronisme
    n1=hyperaldostéronisme secondaire | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=42
  5. hyperaldostéronisme secondaire -- r_associated #0: 40 / 0.667 -> aldostérone
    n1=hyperaldostéronisme secondaire | n2=aldostérone | rel=r_associated | relid=0 | w=40
  6. hyperaldostéronisme secondaire -- r_associated #0: 40 / 0.667 -> antialdostérones
    n1=hyperaldostéronisme secondaire | n2=antialdostérones | rel=r_associated | relid=0 | w=40
  7. hyperaldostéronisme secondaire -- r_associated #0: 40 / 0.667 -> hypertension rénovasculaire
    n1=hyperaldostéronisme secondaire | n2=hypertension rénovasculaire | rel=r_associated | relid=0 | w=40
  8. hyperaldostéronisme secondaire -- r_associated #0: 40 / 0.667 -> rénine angio tensine (système)
    n1=hyperaldostéronisme secondaire | n2=rénine angio tensine (système) | rel=r_associated | relid=0 | w=40
  9. hyperaldostéronisme secondaire -- r_associated #0: 35 / 0.583 -> angiotensine (test à l')
    n1=hyperaldostéronisme secondaire | n2=angiotensine (test à l') | rel=r_associated | relid=0 | w=35
  10. hyperaldostéronisme secondaire -- r_associated #0: 34 / 0.567 -> en:secondary hyperaldosteronism
    n1=hyperaldostéronisme secondaire | n2=en:secondary hyperaldosteronism | rel=r_associated | relid=0 | w=34
  11. hyperaldostéronisme secondaire -- r_associated #0: 22 / 0.367 -> secondaire
    n1=hyperaldostéronisme secondaire | n2=secondaire | rel=r_associated | relid=0 | w=22
  12. hyperaldostéronisme secondaire -- r_associated #0: 20 / 0.333 -> en:aldosterone
    n1=hyperaldostéronisme secondaire | n2=en:aldosterone | rel=r_associated | relid=0 | w=20
  13. hyperaldostéronisme secondaire -- r_associated #0: 20 / 0.333 -> en:hyperaldosteronism
    n1=hyperaldostéronisme secondaire | n2=en:hyperaldosteronism | rel=r_associated | relid=0 | w=20
  14. hyperaldostéronisme secondaire -- r_associated #0: 20 / 0.333 -> en:primary hyperaldosteronism
    n1=hyperaldostéronisme secondaire | n2=en:primary hyperaldosteronism | rel=r_associated | relid=0 | w=20
  15. hyperaldostéronisme secondaire -- r_associated #0: 20 / 0.333 -> en:renovascular hypertension
    n1=hyperaldostéronisme secondaire | n2=en:renovascular hypertension | rel=r_associated | relid=0 | w=20
  16. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> acide
    n1=hyperaldostéronisme secondaire | n2=acide | rel=r_associated | relid=0 | w=15
  17. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> bêta
    n1=hyperaldostéronisme secondaire | n2=bêta | rel=r_associated | relid=0 | w=15
  18. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> en:hyodeoxycholic acid
    n1=hyperaldostéronisme secondaire | n2=en:hyodeoxycholic acid | rel=r_associated | relid=0 | w=15
  19. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyodésoxycholique
    n1=hyperaldostéronisme secondaire | n2=hyodésoxycholique | rel=r_associated | relid=0 | w=15
  20. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyodésoxycholique (acide)
    n1=hyperaldostéronisme secondaire | n2=hyodésoxycholique (acide) | rel=r_associated | relid=0 | w=15
  21. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyoïdien
    n1=hyperaldostéronisme secondaire | n2=hyoïdien | rel=r_associated | relid=0 | w=15
  22. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper
    n1=hyperaldostéronisme secondaire | n2=hyper | rel=r_associated | relid=0 | w=15
  23. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper-alpha-globulinémie
    n1=hyperaldostéronisme secondaire | n2=hyper-alpha-globulinémie | rel=r_associated | relid=0 | w=15
  24. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper-bêta-alaninémie
    n1=hyperaldostéronisme secondaire | n2=hyper-bêta-alaninémie | rel=r_associated | relid=0 | w=15
  25. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper-bêta-globulinémie
    n1=hyperaldostéronisme secondaire | n2=hyper-bêta-globulinémie | rel=r_associated | relid=0 | w=15
  26. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper-bêta-lipoprotéinémie
    n1=hyperaldostéronisme secondaire | n2=hyper-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=15
  27. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> Hyper-HDLémie
    n1=hyperaldostéronisme secondaire | n2=Hyper-HDLémie | rel=r_associated | relid=0 | w=15
  28. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyper-LDLémie
    n1=hyperaldostéronisme secondaire | n2=hyper-LDLémie | rel=r_associated | relid=0 | w=15
  29. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperabsorbant
    n1=hyperaldostéronisme secondaire | n2=hyperabsorbant | rel=r_associated | relid=0 | w=15
  30. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperacanthose
    n1=hyperaldostéronisme secondaire | n2=hyperacanthose | rel=r_associated | relid=0 | w=15
  31. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperaction d'un muscle oculomoteur
    n1=hyperaldostéronisme secondaire | n2=hyperaction d'un muscle oculomoteur | rel=r_associated | relid=0 | w=15
  32. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperactivité
    n1=hyperaldostéronisme secondaire | n2=hyperactivité | rel=r_associated | relid=0 | w=15
  33. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperactivité avec déficit de l'attention
    n1=hyperaldostéronisme secondaire | n2=hyperactivité avec déficit de l'attention | rel=r_associated | relid=0 | w=15
  34. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperactivité détrusorienne
    n1=hyperaldostéronisme secondaire | n2=hyperactivité détrusorienne | rel=r_associated | relid=0 | w=15
  35. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperactivité vésicale
    n1=hyperaldostéronisme secondaire | n2=hyperactivité vésicale | rel=r_associated | relid=0 | w=15
  36. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperalaninémie
    n1=hyperaldostéronisme secondaire | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
  37. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperaminoacidémie
    n1=hyperaldostéronisme secondaire | n2=hyperaminoacidémie | rel=r_associated | relid=0 | w=15
  38. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperaminoacidurie
    n1=hyperaldostéronisme secondaire | n2=hyperaminoacidurie | rel=r_associated | relid=0 | w=15
  39. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperammoniémie
    n1=hyperaldostéronisme secondaire | n2=hyperammoniémie | rel=r_associated | relid=0 | w=15
  40. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> hyperammoniémie congénitale
    n1=hyperaldostéronisme secondaire | n2=hyperammoniémie congénitale | rel=r_associated | relid=0 | w=15
  41. hyperaldostéronisme secondaire -- r_associated #0: 15 / 0.25 -> médecine
    n1=hyperaldostéronisme secondaire | n2=médecine | rel=r_associated | relid=0 | w=15
  42. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> citrullinémie
    n1=hyperaldostéronisme secondaire | n2=citrullinémie | rel=r_associated | relid=0 | w=10
  43. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:3,6-dihydroxy-5alpha-cholanoic acid
    n1=hyperaldostéronisme secondaire | n2=en:3,6-dihydroxy-5alpha-cholanoic acid | rel=r_associated | relid=0 | w=10
  44. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:abnormal ocular motility
    n1=hyperaldostéronisme secondaire | n2=en:abnormal ocular motility | rel=r_associated | relid=0 | w=10
  45. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:abnormal visual evoked potential
    n1=hyperaldostéronisme secondaire | n2=en:abnormal visual evoked potential | rel=r_associated | relid=0 | w=10
  46. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:abnormal visual evoked potential (vep)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal visual evoked potential (vep) | rel=r_associated | relid=0 | w=10
  47. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:abnormality of ocular smooth pursuit
    n1=hyperaldostéronisme secondaire | n2=en:abnormality of ocular smooth pursuit | rel=r_associated | relid=0 | w=10
  48. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:adrenoleukodystrophy
    n1=hyperaldostéronisme secondaire | n2=en:adrenoleukodystrophy | rel=r_associated | relid=0 | w=10
  49. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:amino acid metabolism disorder
    n1=hyperaldostéronisme secondaire | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=10
  50. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:anisocoria
    n1=hyperaldostéronisme secondaire | n2=en:anisocoria | rel=r_associated | relid=0 | w=10
  51. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:anterior pituitary hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:anterior pituitary hypoplasia | rel=r_associated | relid=0 | w=10
  52. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:aspects of mortality statistics
    n1=hyperaldostéronisme secondaire | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=10
  53. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:aspects of radionuclide imaging
    n1=hyperaldostéronisme secondaire | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=10
  54. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:blindness
    n1=hyperaldostéronisme secondaire | n2=en:blindness | rel=r_associated | relid=0 | w=10
  55. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:chemically induced
    n1=hyperaldostéronisme secondaire | n2=en:chemically induced | rel=r_associated | relid=0 | w=10
  56. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:complication aspects
    n1=hyperaldostéronisme secondaire | n2=en:complication aspects | rel=r_associated | relid=0 | w=10
  57. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:cortical blindness (in 1 moroccan patient)
    n1=hyperaldostéronisme secondaire | n2=en:cortical blindness (in 1 moroccan patient) | rel=r_associated | relid=0 | w=10
  58. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:deoxycholic acid
    n1=hyperaldostéronisme secondaire | n2=en:deoxycholic acid | rel=r_associated | relid=0 | w=10
  59. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:dermoid cyst
    n1=hyperaldostéronisme secondaire | n2=en:dermoid cyst | rel=r_associated | relid=0 | w=10
  60. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:diagnosis aspect
    n1=hyperaldostéronisme secondaire | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=10
  61. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:difficulty reading
    n1=hyperaldostéronisme secondaire | n2=en:difficulty reading | rel=r_associated | relid=0 | w=10
  62. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:dysmetric saccades
    n1=hyperaldostéronisme secondaire | n2=en:dysmetric saccades | rel=r_associated | relid=0 | w=10
  63. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:ectopic posterior pituitary
    n1=hyperaldostéronisme secondaire | n2=en:ectopic posterior pituitary | rel=r_associated | relid=0 | w=10
  64. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:end-position nystagmus
    n1=hyperaldostéronisme secondaire | n2=en:end-position nystagmus | rel=r_associated | relid=0 | w=10
  65. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:enzymology
    n1=hyperaldostéronisme secondaire | n2=en:enzymology | rel=r_associated | relid=0 | w=10
  66. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:epidemiologic
    n1=hyperaldostéronisme secondaire | n2=en:epidemiologic | rel=r_associated | relid=0 | w=10
  67. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:ethnologic
    n1=hyperaldostéronisme secondaire | n2=en:ethnologic | rel=r_associated | relid=0 | w=10
  68. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:etiology aspects
    n1=hyperaldostéronisme secondaire | n2=en:etiology aspects | rel=r_associated | relid=0 | w=10
  69. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:exposure as collected domain
    n1=hyperaldostéronisme secondaire | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=10
  70. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:eye
    n1=hyperaldostéronisme secondaire | n2=en:eye | rel=r_associated | relid=0 | w=10
  71. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:fatigue
    n1=hyperaldostéronisme secondaire | n2=en:fatigue | rel=r_associated | relid=0 | w=10
  72. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:genetic aspects
    n1=hyperaldostéronisme secondaire | n2=en:genetic aspects | rel=r_associated | relid=0 | w=10
  73. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:gliosis
    n1=hyperaldostéronisme secondaire | n2=en:gliosis | rel=r_associated | relid=0 | w=10
  74. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:hallucinations, visual, precipitated by infectious illness (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hallucinations, visual, precipitated by infectious illness (in some patients) | rel=r_associated | relid=0 | w=10
  75. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:herpes zoster
    n1=hyperaldostéronisme secondaire | n2=en:herpes zoster | rel=r_associated | relid=0 | w=10
  76. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:historical aspects qualifier
    n1=hyperaldostéronisme secondaire | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=10
  77. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:horner syndrome
    n1=hyperaldostéronisme secondaire | n2=en:horner syndrome | rel=r_associated | relid=0 | w=10
  78. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:hyodeoxycholic acid, (3alpha,6beta)-isomer
    n1=hyperaldostéronisme secondaire | n2=en:hyodeoxycholic acid, (3alpha,6beta)-isomer | rel=r_associated | relid=0 | w=10
  79. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:hyodeoxycholic acid, sodium salt
    n1=hyperaldostéronisme secondaire | n2=en:hyodeoxycholic acid, sodium salt | rel=r_associated | relid=0 | w=10
  80. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:hyper-beta-alaninemia
    n1=hyperaldostéronisme secondaire | n2=en:hyper-beta-alaninemia | rel=r_associated | relid=0 | w=10
  81. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:hypermetric saccades
    n1=hyperaldostéronisme secondaire | n2=en:hypermetric saccades | rel=r_associated | relid=0 | w=10
  82. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:immunology aspects
    n1=hyperaldostéronisme secondaire | n2=en:immunology aspects | rel=r_associated | relid=0 | w=10
  83. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:impaired horizontal smooth pursuit
    n1=hyperaldostéronisme secondaire | n2=en:impaired horizontal smooth pursuit | rel=r_associated | relid=0 | w=10
  84. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:in blood
    n1=hyperaldostéronisme secondaire | n2=en:in blood | rel=r_associated | relid=0 | w=10
  85. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:in cerebrospinal fluid
    n1=hyperaldostéronisme secondaire | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=10
  86. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:in urine
    n1=hyperaldostéronisme secondaire | n2=en:in urine | rel=r_associated | relid=0 | w=10
  87. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:infantile nystagmus
    n1=hyperaldostéronisme secondaire | n2=en:infantile nystagmus | rel=r_associated | relid=0 | w=10
  88. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:interictal downbeat nystagmus
    n1=hyperaldostéronisme secondaire | n2=en:interictal downbeat nystagmus | rel=r_associated | relid=0 | w=10
  89. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:lack of visual attention
    n1=hyperaldostéronisme secondaire | n2=en:lack of visual attention | rel=r_associated | relid=0 | w=10
  90. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:metabolic aspects
    n1=hyperaldostéronisme secondaire | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=10
  91. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:microbiological
    n1=hyperaldostéronisme secondaire | n2=en:microbiological | rel=r_associated | relid=0 | w=10
  92. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:mobius syndrome
    n1=hyperaldostéronisme secondaire | n2=en:mobius syndrome | rel=r_associated | relid=0 | w=10
  93. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:movement of visual image - finding
    n1=hyperaldostéronisme secondaire | n2=en:movement of visual image - finding | rel=r_associated | relid=0 | w=10
  94. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:murideoxycholic acid
    n1=hyperaldostéronisme secondaire | n2=en:murideoxycholic acid | rel=r_associated | relid=0 | w=10
  95. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nahdc compound
    n1=hyperaldostéronisme secondaire | n2=en:nahdc compound | rel=r_associated | relid=0 | w=10
  96. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nursing therapy
    n1=hyperaldostéronisme secondaire | n2=en:nursing therapy | rel=r_associated | relid=0 | w=10
  97. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nutritional management
    n1=hyperaldostéronisme secondaire | n2=en:nutritional management | rel=r_associated | relid=0 | w=10
  98. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nystagmus
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus | rel=r_associated | relid=0 | w=10
  99. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nystagmus, horizontal
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus, horizontal | rel=r_associated | relid=0 | w=10
  100. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nystagmus, jerky, horizontal, congenital
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus, jerky, horizontal, congenital | rel=r_associated | relid=0 | w=10
  101. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:nystagmus, mild
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus, mild | rel=r_associated | relid=0 | w=10
  102. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:oculomotor apraxia
    n1=hyperaldostéronisme secondaire | n2=en:oculomotor apraxia | rel=r_associated | relid=0 | w=10
  103. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:optic nerve hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:optic nerve hypoplasia | rel=r_associated | relid=0 | w=10
  104. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pain
    n1=hyperaldostéronisme secondaire | n2=en:pain | rel=r_associated | relid=0 | w=10
  105. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:parasitology
    n1=hyperaldostéronisme secondaire | n2=en:parasitology | rel=r_associated | relid=0 | w=10
  106. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pathological aspects
    n1=hyperaldostéronisme secondaire | n2=en:pathological aspects | rel=r_associated | relid=0 | w=10
  107. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pediatric adverse events terminology
    n1=hyperaldostéronisme secondaire | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=10
  108. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pediatric terminology
    n1=hyperaldostéronisme secondaire | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=10
  109. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pharmacotherapeutic
    n1=hyperaldostéronisme secondaire | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=10
  110. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:photophobia
    n1=hyperaldostéronisme secondaire | n2=en:photophobia | rel=r_associated | relid=0 | w=10
  111. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:physiopathological
    n1=hyperaldostéronisme secondaire | n2=en:physiopathological | rel=r_associated | relid=0 | w=10
  112. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pituitary agenesis
    n1=hyperaldostéronisme secondaire | n2=en:pituitary agenesis | rel=r_associated | relid=0 | w=10
  113. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pituitary gland adenoma
    n1=hyperaldostéronisme secondaire | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=10
  114. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:pituitary hypoplasia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:pituitary hypoplasia (in some patients) | rel=r_associated | relid=0 | w=10
  115. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:poor eye contact
    n1=hyperaldostéronisme secondaire | n2=en:poor eye contact | rel=r_associated | relid=0 | w=10
  116. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:psychology qualifier
    n1=hyperaldostéronisme secondaire | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=10
  117. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:rehabilitation aspects
    n1=hyperaldostéronisme secondaire | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=10
  118. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:roentgenographic
    n1=hyperaldostéronisme secondaire | n2=en:roentgenographic | rel=r_associated | relid=0 | w=10
  119. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:secondary
    n1=hyperaldostéronisme secondaire | n2=en:secondary | rel=r_associated | relid=0 | w=10
  120. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:seizure
    n1=hyperaldostéronisme secondaire | n2=en:seizure | rel=r_associated | relid=0 | w=10
  121. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:self-injury
    n1=hyperaldostéronisme secondaire | n2=en:self-injury | rel=r_associated | relid=0 | w=10
  122. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:sensorineural hearing loss
    n1=hyperaldostéronisme secondaire | n2=en:sensorineural hearing loss | rel=r_associated | relid=0 | w=10
  123. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:skin photosensitivity
    n1=hyperaldostéronisme secondaire | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=10
  124. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:spongiosis, mild
    n1=hyperaldostéronisme secondaire | n2=en:spongiosis, mild | rel=r_associated | relid=0 | w=10
  125. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:staring
    n1=hyperaldostéronisme secondaire | n2=en:staring | rel=r_associated | relid=0 | w=10
  126. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:supranuclear gaze palsy
    n1=hyperaldostéronisme secondaire | n2=en:supranuclear gaze palsy | rel=r_associated | relid=0 | w=10
  127. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:surgical aspects
    n1=hyperaldostéronisme secondaire | n2=en:surgical aspects | rel=r_associated | relid=0 | w=10
  128. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:taxonomic
    n1=hyperaldostéronisme secondaire | n2=en:taxonomic | rel=r_associated | relid=0 | w=10
  129. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:therapeutic aspects
    n1=hyperaldostéronisme secondaire | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=10
  130. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:thin pituitary stalk
    n1=hyperaldostéronisme secondaire | n2=en:thin pituitary stalk | rel=r_associated | relid=0 | w=10
  131. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:type 1 diabetes mellitus
    n1=hyperaldostéronisme secondaire | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=10
  132. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:type 2 diabetes mellitus
    n1=hyperaldostéronisme secondaire | n2=en:type 2 diabetes mellitus | rel=r_associated | relid=0 | w=10
  133. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:use of ultrasonography
    n1=hyperaldostéronisme secondaire | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=10
  134. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:viruses
    n1=hyperaldostéronisme secondaire | n2=en:viruses | rel=r_associated | relid=0 | w=10
  135. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:visual impairment
    n1=hyperaldostéronisme secondaire | n2=en:visual impairment | rel=r_associated | relid=0 | w=10
  136. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> en:visual inattention
    n1=hyperaldostéronisme secondaire | n2=en:visual inattention | rel=r_associated | relid=0 | w=10
  137. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> excès
    n1=hyperaldostéronisme secondaire | n2=excès | rel=r_associated | relid=0 | w=10
  138. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> globulinémie
    n1=hyperaldostéronisme secondaire | n2=globulinémie | rel=r_associated | relid=0 | w=10
  139. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> maladie
    n1=hyperaldostéronisme secondaire | n2=maladie | rel=r_associated | relid=0 | w=10
  140. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> maladie
    (médecine)
    n1=hyperaldostéronisme secondaire | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=10
  141. hyperaldostéronisme secondaire -- r_associated #0: 10 / 0.167 -> maladies
    n1=hyperaldostéronisme secondaire | n2=maladies | rel=r_associated | relid=0 | w=10
  142. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ?-alaninémie
    n1=hyperaldostéronisme secondaire | n2=?-alaninémie | rel=r_associated | relid=0 | w=5
  143. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ?-globulinémie
    n1=hyperaldostéronisme secondaire | n2=?-globulinémie | rel=r_associated | relid=0 | w=5
  144. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ?-lipoprotéinémie
    n1=hyperaldostéronisme secondaire | n2=?-lipoprotéinémie | rel=r_associated | relid=0 | w=5
  145. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> 6-a0 anomalies du métabolisme des acides aminés termes généraux
    n1=hyperaldostéronisme secondaire | n2=6-a0 anomalies du métabolisme des acides aminés termes généraux | rel=r_associated | relid=0 | w=5
  146. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> 6-a5 anomalies du cycle de l'uréogenèse
    n1=hyperaldostéronisme secondaire | n2=6-a5 anomalies du cycle de l'uréogenèse | rel=r_associated | relid=0 | w=5
  147. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> acanthose
    n1=hyperaldostéronisme secondaire | n2=acanthose | rel=r_associated | relid=0 | w=5
  148. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> acidose lactiqu e
    n1=hyperaldostéronisme secondaire | n2=acidose lactiqu e | rel=r_associated | relid=0 | w=5
  149. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> affection non précisée du transport et du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=affection non précisée du transport et du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  150. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> alanine
    n1=hyperaldostéronisme secondaire | n2=alanine | rel=r_associated | relid=0 | w=5
  151. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> alaninémie
    n1=hyperaldostéronisme secondaire | n2=alaninémie | rel=r_associated | relid=0 | w=5
  152. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> aldostéronisme dû à une tumeur corticosurrénalienne
    n1=hyperaldostéronisme secondaire | n2=aldostéronisme dû à une tumeur corticosurrénalienne | rel=r_associated | relid=0 | w=5
  153. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> aldostéronisme primaire
    n1=hyperaldostéronisme secondaire | n2=aldostéronisme primaire | rel=r_associated | relid=0 | w=5
  154. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> alpha
    n1=hyperaldostéronisme secondaire | n2=alpha | rel=r_associated | relid=0 | w=5
  155. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> amino-acidopathie
    n1=hyperaldostéronisme secondaire | n2=amino-acidopathie | rel=r_associated | relid=0 | w=5
  156. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> aminoacidopathies congénitales
    n1=hyperaldostéronisme secondaire | n2=aminoacidopathies congénitales | rel=r_associated | relid=0 | w=5
  157. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> aminoacidopathies héréditaires
    n1=hyperaldostéronisme secondaire | n2=aminoacidopathies héréditaires | rel=r_associated | relid=0 | w=5
  158. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ammoniaque
    n1=hyperaldostéronisme secondaire | n2=ammoniaque | rel=r_associated | relid=0 | w=5
  159. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ammoniémie
    n1=hyperaldostéronisme secondaire | n2=ammoniémie | rel=r_associated | relid=0 | w=5
  160. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> anatomie
    n1=hyperaldostéronisme secondaire | n2=anatomie | rel=r_associated | relid=0 | w=5
  161. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> anomalies congénitales du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=anomalies congénitales du cycle de l'urée | rel=r_associated | relid=0 | w=5
  162. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> anomalies du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=anomalies du cycle de l'urée | rel=r_associated | relid=0 | w=5
  163. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> anomalies du cycle de l'uréogenèse
    n1=hyperaldostéronisme secondaire | n2=anomalies du cycle de l'uréogenèse | rel=r_associated | relid=0 | w=5
  164. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> anomalies du métabolisme de l'ornithine
    n1=hyperaldostéronisme secondaire | n2=anomalies du métabolisme de l'ornithine | rel=r_associated | relid=0 | w=5
  165. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> argininémie
    n1=hyperaldostéronisme secondaire | n2=argininémie | rel=r_associated | relid=0 | w=5
  166. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ataxie cérébelleuse
    n1=hyperaldostéronisme secondaire | n2=ataxie cérébelleuse | rel=r_associated | relid=0 | w=5
  167. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> attention
    n1=hyperaldostéronisme secondaire | n2=attention | rel=r_associated | relid=0 | w=5
  168. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> biochimie
    n1=hyperaldostéronisme secondaire | n2=biochimie | rel=r_associated | relid=0 | w=5
  169. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> carbamylphosphate-synthétase
    n1=hyperaldostéronisme secondaire | n2=carbamylphosphate-synthétase | rel=r_associated | relid=0 | w=5
  170. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> carbamyltransférase
    n1=hyperaldostéronisme secondaire | n2=carbamyltransférase | rel=r_associated | relid=0 | w=5
  171. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> choréo-athétose
    n1=hyperaldostéronisme secondaire | n2=choréo-athétose | rel=r_associated | relid=0 | w=5
  172. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> condylome acuminé
    n1=hyperaldostéronisme secondaire | n2=condylome acuminé | rel=r_associated | relid=0 | w=5
  173. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> congénitale
    n1=hyperaldostéronisme secondaire | n2=congénitale | rel=r_associated | relid=0 | w=5
  174. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=cycle de l'urée | rel=r_associated | relid=0 | w=5
  175. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> déficit
    n1=hyperaldostéronisme secondaire | n2=déficit | rel=r_associated | relid=0 | w=5
  176. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> déficit d'attention et hyperactivité
    n1=hyperaldostéronisme secondaire | n2=déficit d'attention et hyperactivité | rel=r_associated | relid=0 | w=5
  177. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> déficit de l'attention
    n1=hyperaldostéronisme secondaire | n2=déficit de l'attention | rel=r_associated | relid=0 | w=5
  178. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> déficit de l'attention avec hyperactivité
    n1=hyperaldostéronisme secondaire | n2=déficit de l'attention avec hyperactivité | rel=r_associated | relid=0 | w=5
  179. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> détrusorienne
    n1=hyperaldostéronisme secondaire | n2=détrusorienne | rel=r_associated | relid=0 | w=5
  180. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> dysfonction cérébrale mineure
    n1=hyperaldostéronisme secondaire | n2=dysfonction cérébrale mineure | rel=r_associated | relid=0 | w=5
  181. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> dysfonction cérébrale minimale
    n1=hyperaldostéronisme secondaire | n2=dysfonction cérébrale minimale | rel=r_associated | relid=0 | w=5
  182. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> dysfonctionnement cérébral a minima
    n1=hyperaldostéronisme secondaire | n2=dysfonctionnement cérébral a minima | rel=r_associated | relid=0 | w=5
  183. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> dysfonctionnement cérébral minime
    n1=hyperaldostéronisme secondaire | n2=dysfonctionnement cérébral minime | rel=r_associated | relid=0 | w=5
  184. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> dysfonctionnement cérébral minime de l'enfant
    n1=hyperaldostéronisme secondaire | n2=dysfonctionnement cérébral minime de l'enfant | rel=r_associated | relid=0 | w=5
  185. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'ballooned' neurons with autofluorescent fine granular material
    n1=hyperaldostéronisme secondaire | n2=en:'ballooned' neurons with autofluorescent fine granular material | rel=r_associated | relid=0 | w=5
  186. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'double contour' convolutional calcification on ct scan
    n1=hyperaldostéronisme secondaire | n2=en:'double contour' convolutional calcification on ct scan | rel=r_associated | relid=0 | w=5
  187. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'dragonfly-like' pattern
    n1=hyperaldostéronisme secondaire | n2=en:'dragonfly-like' pattern | rel=r_associated | relid=0 | w=5
  188. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'dragonfly' pattern on imaging
    n1=hyperaldostéronisme secondaire | n2=en:'dragonfly' pattern on imaging | rel=r_associated | relid=0 | w=5
  189. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'eye of the tiger' sign on mri
    n1=hyperaldostéronisme secondaire | n2=en:'eye of the tiger' sign on mri | rel=r_associated | relid=0 | w=5
  190. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'globoid multinucleated cells' in brain tissue
    n1=hyperaldostéronisme secondaire | n2=en:'globoid multinucleated cells' in brain tissue | rel=r_associated | relid=0 | w=5
  191. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'morning larks'
    n1=hyperaldostéronisme secondaire | n2=en:'morning larks' | rel=r_associated | relid=0 | w=5
  192. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'neurotic' signs and symptoms
    n1=hyperaldostéronisme secondaire | n2=en:'neurotic' signs and symptoms | rel=r_associated | relid=0 | w=5
  193. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:'spheroid' inclusions in axons
    n1=hyperaldostéronisme secondaire | n2=en:'spheroid' inclusions in axons | rel=r_associated | relid=0 | w=5
  194. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:15q11.2 microdeletion
    n1=hyperaldostéronisme secondaire | n2=en:15q11.2 microdeletion | rel=r_associated | relid=0 | w=5
  195. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:2-aminoadipic 2-oxoadipic aciduria
    n1=hyperaldostéronisme secondaire | n2=en:2-aminoadipic 2-oxoadipic aciduria | rel=r_associated | relid=0 | w=5
  196. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:3-4 hz slow sharp waves seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:3-4 hz slow sharp waves seen on eeg | rel=r_associated | relid=0 | w=5
  197. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:3-6 hz polyspike eeg
    n1=hyperaldostéronisme secondaire | n2=en:3-6 hz polyspike eeg | rel=r_associated | relid=0 | w=5
  198. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:a subset of patients develop frontotemporal dementia
    n1=hyperaldostéronisme secondaire | n2=en:a subset of patients develop frontotemporal dementia | rel=r_associated | relid=0 | w=5
  199. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:a subset of patients have neurologic abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:a subset of patients have neurologic abnormalities | rel=r_associated | relid=0 | w=5
  200. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abducens nerve palsy (cn vi)
    n1=hyperaldostéronisme secondaire | n2=en:abducens nerve palsy (cn vi) | rel=r_associated | relid=0 | w=5
  201. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle
    n1=hyperaldostéronisme secondaire | n2=en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle | rel=r_associated | relid=0 | w=5
  202. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal 'hobby horse' ataxic gait
    n1=hyperaldostéronisme secondaire | n2=en:abnormal 'hobby horse' ataxic gait | rel=r_associated | relid=0 | w=5
  203. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal behavior
    n1=hyperaldostéronisme secondaire | n2=en:abnormal behavior | rel=r_associated | relid=0 | w=5
  204. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal brain myelination
    n1=hyperaldostéronisme secondaire | n2=en:abnormal brain myelination | rel=r_associated | relid=0 | w=5
  205. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal cell orientation
    n1=hyperaldostéronisme secondaire | n2=en:abnormal cell orientation | rel=r_associated | relid=0 | w=5
  206. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal coordination
    n1=hyperaldostéronisme secondaire | n2=en:abnormal coordination | rel=r_associated | relid=0 | w=5
  207. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal cortical eeg discharges triggered by intermittent light
    n1=hyperaldostéronisme secondaire | n2=en:abnormal cortical eeg discharges triggered by intermittent light | rel=r_associated | relid=0 | w=5
  208. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal cortical gyration
    n1=hyperaldostéronisme secondaire | n2=en:abnormal cortical gyration | rel=r_associated | relid=0 | w=5
  209. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal cortical lamination
    n1=hyperaldostéronisme secondaire | n2=en:abnormal cortical lamination | rel=r_associated | relid=0 | w=5
  210. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal cortical layering
    n1=hyperaldostéronisme secondaire | n2=en:abnormal cortical layering | rel=r_associated | relid=0 | w=5
  211. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal corticospinal tract decussation
    n1=hyperaldostéronisme secondaire | n2=en:abnormal corticospinal tract decussation | rel=r_associated | relid=0 | w=5
  212. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal eeg (abnormal slowing of background activity)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal eeg (abnormal slowing of background activity) | rel=r_associated | relid=0 | w=5
  213. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal eeg (poor alpha rhythms)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal eeg (poor alpha rhythms) | rel=r_associated | relid=0 | w=5
  214. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal eeg activity during sleep
    n1=hyperaldostéronisme secondaire | n2=en:abnormal eeg activity during sleep | rel=r_associated | relid=0 | w=5
  215. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal eeg with epileptiform changes
    n1=hyperaldostéronisme secondaire | n2=en:abnormal eeg with epileptiform changes | rel=r_associated | relid=0 | w=5
  216. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gait (67%)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gait (67%) | rel=r_associated | relid=0 | w=5
  217. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gait due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gait due to muscle weakness | rel=r_associated | relid=0 | w=5
  218. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan | rel=r_associated | relid=0 | w=5
  219. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gyral pattern
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gyral pattern | rel=r_associated | relid=0 | w=5
  220. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gyri
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gyri | rel=r_associated | relid=0 | w=5
  221. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal gyri (in 1 of 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal gyri (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
  222. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal hippocampus
    n1=hyperaldostéronisme secondaire | n2=en:abnormal hippocampus | rel=r_associated | relid=0 | w=5
  223. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal hypothalamo-pituitary axis
    n1=hyperaldostéronisme secondaire | n2=en:abnormal hypothalamo-pituitary axis | rel=r_associated | relid=0 | w=5
  224. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal interictal eeg (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:abnormal interictal eeg (in some patients) | rel=r_associated | relid=0 | w=5
  225. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal involuntary movement
    n1=hyperaldostéronisme secondaire | n2=en:abnormal involuntary movement | rel=r_associated | relid=0 | w=5
  226. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal lipid peak on brain mrs
    n1=hyperaldostéronisme secondaire | n2=en:abnormal lipid peak on brain mrs | rel=r_associated | relid=0 | w=5
  227. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal lower motor neuron morphology
    n1=hyperaldostéronisme secondaire | n2=en:abnormal lower motor neuron morphology | rel=r_associated | relid=0 | w=5
  228. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal movement
    n1=hyperaldostéronisme secondaire | n2=en:abnormal movement | rel=r_associated | relid=0 | w=5
  229. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal myelination
    n1=hyperaldostéronisme secondaire | n2=en:abnormal myelination | rel=r_associated | relid=0 | w=5
  230. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal posture
    n1=hyperaldostéronisme secondaire | n2=en:abnormal posture | rel=r_associated | relid=0 | w=5
  231. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal primitive reflexes
    n1=hyperaldostéronisme secondaire | n2=en:abnormal primitive reflexes | rel=r_associated | relid=0 | w=5
  232. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal purkinje cells
    n1=hyperaldostéronisme secondaire | n2=en:abnormal purkinje cells | rel=r_associated | relid=0 | w=5
  233. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal rapid eye movement sleep
    n1=hyperaldostéronisme secondaire | n2=en:abnormal rapid eye movement sleep | rel=r_associated | relid=0 | w=5
  234. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:abnormal septum pellucidum | rel=r_associated | relid=0 | w=5
  235. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal signals in the thalami seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:abnormal signals in the thalami seen on mri | rel=r_associated | relid=0 | w=5
  236. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal sleep pattern
    n1=hyperaldostéronisme secondaire | n2=en:abnormal sleep pattern | rel=r_associated | relid=0 | w=5
  237. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal sleep-wake cycles
    n1=hyperaldostéronisme secondaire | n2=en:abnormal sleep-wake cycles | rel=r_associated | relid=0 | w=5
  238. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal spike waves
    n1=hyperaldostéronisme secondaire | n2=en:abnormal spike waves | rel=r_associated | relid=0 | w=5
  239. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal sulci
    n1=hyperaldostéronisme secondaire | n2=en:abnormal sulci | rel=r_associated | relid=0 | w=5
  240. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal t2-weighted signals in the occipital white and gray matter
    n1=hyperaldostéronisme secondaire | n2=en:abnormal t2-weighted signals in the occipital white and gray matter | rel=r_associated | relid=0 | w=5
  241. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation
    n1=hyperaldostéronisme secondaire | n2=en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation | rel=r_associated | relid=0 | w=5
  242. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri | rel=r_associated | relid=0 | w=5
  243. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormality of brainstem morphology
    n1=hyperaldostéronisme secondaire | n2=en:abnormality of brainstem morphology | rel=r_associated | relid=0 | w=5
  244. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormality of the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:abnormality of the cerebellum | rel=r_associated | relid=0 | w=5
  245. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormality of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:abnormality of the corpus callosum | rel=r_associated | relid=0 | w=5
  246. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormality of the posterior cranial fossa
    n1=hyperaldostéronisme secondaire | n2=en:abnormality of the posterior cranial fossa | rel=r_associated | relid=0 | w=5
  247. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abnormally marked pontobulbar sulcus
    n1=hyperaldostéronisme secondaire | n2=en:abnormally marked pontobulbar sulcus | rel=r_associated | relid=0 | w=5
  248. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of anterior pituitary
    n1=hyperaldostéronisme secondaire | n2=en:absence of anterior pituitary | rel=r_associated | relid=0 | w=5
  249. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of balloon cells (in type iia)
    n1=hyperaldostéronisme secondaire | n2=en:absence of balloon cells (in type iia) | rel=r_associated | relid=0 | w=5
  250. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of cerebral aneurysms
    n1=hyperaldostéronisme secondaire | n2=en:absence of cerebral aneurysms | rel=r_associated | relid=0 | w=5
  251. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of fear
    n1=hyperaldostéronisme secondaire | n2=en:absence of fear | rel=r_associated | relid=0 | w=5
  252. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of language development
    n1=hyperaldostéronisme secondaire | n2=en:absence of language development | rel=r_associated | relid=0 | w=5
  253. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of lower motor neuron involvement
    n1=hyperaldostéronisme secondaire | n2=en:absence of lower motor neuron involvement | rel=r_associated | relid=0 | w=5
  254. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of myelin in the posterior column of the spinal cord (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:absence of myelin in the posterior column of the spinal cord (1 patient) | rel=r_associated | relid=0 | w=5
  255. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of neurologic manifestations
    n1=hyperaldostéronisme secondaire | n2=en:absence of neurologic manifestations | rel=r_associated | relid=0 | w=5
  256. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of neuropathologic findings in the brainstem and anterior horn cells
    n1=hyperaldostéronisme secondaire | n2=en:absence of neuropathologic findings in the brainstem and anterior horn cells | rel=r_associated | relid=0 | w=5
  257. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of olfactory bulbs
    n1=hyperaldostéronisme secondaire | n2=en:absence of olfactory bulbs | rel=r_associated | relid=0 | w=5
  258. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of primitive reflexes
    n1=hyperaldostéronisme secondaire | n2=en:absence of primitive reflexes | rel=r_associated | relid=0 | w=5
  259. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:absence of septum pellucidum | rel=r_associated | relid=0 | w=5
  260. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of spontaneous movements
    n1=hyperaldostéronisme secondaire | n2=en:absence of spontaneous movements | rel=r_associated | relid=0 | w=5
  261. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:absence of the basal ganglia | rel=r_associated | relid=0 | w=5
  262. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:absence of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  263. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of the inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:absence of the inferior olives | rel=r_associated | relid=0 | w=5
  264. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of the olfactory bulbs and tracts
    n1=hyperaldostéronisme secondaire | n2=en:absence of the olfactory bulbs and tracts | rel=r_associated | relid=0 | w=5
  265. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of transverse pontine fibers
    n1=hyperaldostéronisme secondaire | n2=en:absence of transverse pontine fibers | rel=r_associated | relid=0 | w=5
  266. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence of vestibular schwannomas at age greater than 18 years
    n1=hyperaldostéronisme secondaire | n2=en:absence of vestibular schwannomas at age greater than 18 years | rel=r_associated | relid=0 | w=5
  267. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence or atrophy of the putamen
    n1=hyperaldostéronisme secondaire | n2=en:absence or atrophy of the putamen | rel=r_associated | relid=0 | w=5
  268. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence or hypoplasia of the anterior limb of the internal capsule
    n1=hyperaldostéronisme secondaire | n2=en:absence or hypoplasia of the anterior limb of the internal capsule | rel=r_associated | relid=0 | w=5
  269. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence seizures (in some)
    n1=hyperaldostéronisme secondaire | n2=en:absence seizures (in some) | rel=r_associated | relid=0 | w=5
  270. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence seizures (stage 2 and 3)
    n1=hyperaldostéronisme secondaire | n2=en:absence seizures (stage 2 and 3) | rel=r_associated | relid=0 | w=5
  271. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absence seizures may occur
    n1=hyperaldostéronisme secondaire | n2=en:absence seizures may occur | rel=r_associated | relid=0 | w=5
  272. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent cisterna magna
    n1=hyperaldostéronisme secondaire | n2=en:absent cisterna magna | rel=r_associated | relid=0 | w=5
  273. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent corpus callosum (variable)
    n1=hyperaldostéronisme secondaire | n2=en:absent corpus callosum (variable) | rel=r_associated | relid=0 | w=5
  274. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent cortical responses of somatosensory evoked potentials
    n1=hyperaldostéronisme secondaire | n2=en:absent cortical responses of somatosensory evoked potentials | rel=r_associated | relid=0 | w=5
  275. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent development
    n1=hyperaldostéronisme secondaire | n2=en:absent development | rel=r_associated | relid=0 | w=5
  276. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent myelination of the brain (severe connatal form)
    n1=hyperaldostéronisme secondaire | n2=en:absent myelination of the brain (severe connatal form) | rel=r_associated | relid=0 | w=5
  277. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent olfactory bulbs
    n1=hyperaldostéronisme secondaire | n2=en:absent olfactory bulbs | rel=r_associated | relid=0 | w=5
  278. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent olfactory tract or bulbs
    n1=hyperaldostéronisme secondaire | n2=en:absent olfactory tract or bulbs | rel=r_associated | relid=0 | w=5
  279. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent olfactory tracts and bulbs
    n1=hyperaldostéronisme secondaire | n2=en:absent olfactory tracts and bulbs | rel=r_associated | relid=0 | w=5
  280. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent optic nerves, chiasm, and tracts
    n1=hyperaldostéronisme secondaire | n2=en:absent optic nerves, chiasm, and tracts | rel=r_associated | relid=0 | w=5
  281. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent or delayed psychomotor development, severe
    n1=hyperaldostéronisme secondaire | n2=en:absent or delayed psychomotor development, severe | rel=r_associated | relid=0 | w=5
  282. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent or delayed speech development
    n1=hyperaldostéronisme secondaire | n2=en:absent or delayed speech development | rel=r_associated | relid=0 | w=5
  283. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent or immature dentate nuclei
    n1=hyperaldostéronisme secondaire | n2=en:absent or immature dentate nuclei | rel=r_associated | relid=0 | w=5
  284. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent or limited speech development
    n1=hyperaldostéronisme secondaire | n2=en:absent or limited speech development | rel=r_associated | relid=0 | w=5
  285. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent or poor expressive speech
    n1=hyperaldostéronisme secondaire | n2=en:absent or poor expressive speech | rel=r_associated | relid=0 | w=5
  286. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent pituitary
    n1=hyperaldostéronisme secondaire | n2=en:absent pituitary | rel=r_associated | relid=0 | w=5
  287. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent posterior pituitary bright spot
    n1=hyperaldostéronisme secondaire | n2=en:absent posterior pituitary bright spot | rel=r_associated | relid=0 | w=5
  288. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent primitive reflexes
    n1=hyperaldostéronisme secondaire | n2=en:absent primitive reflexes | rel=r_associated | relid=0 | w=5
  289. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent rem sleep
    n1=hyperaldostéronisme secondaire | n2=en:absent rem sleep | rel=r_associated | relid=0 | w=5
  290. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent speech
    n1=hyperaldostéronisme secondaire | n2=en:absent speech | rel=r_associated | relid=0 | w=5
  291. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:absent superior division of oculomotor nerve and corresponding alpha motor neurons
    n1=hyperaldostéronisme secondaire | n2=en:absent superior division of oculomotor nerve and corresponding alpha motor neurons | rel=r_associated | relid=0 | w=5
  292. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:abuse dwarfism syndrome
    n1=hyperaldostéronisme secondaire | n2=en:abuse dwarfism syndrome | rel=r_associated | relid=0 | w=5
  293. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acanthosis
    n1=hyperaldostéronisme secondaire | n2=en:acanthosis | rel=r_associated | relid=0 | w=5
  294. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:accumulation of autofluorescent material in neurons
    n1=hyperaldostéronisme secondaire | n2=en:accumulation of autofluorescent material in neurons | rel=r_associated | relid=0 | w=5
  295. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies)
    n1=hyperaldostéronisme secondaire | n2=en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies) | rel=r_associated | relid=0 | w=5
  296. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acoustic schwannoma
    n1=hyperaldostéronisme secondaire | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=5
  297. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons
    n1=hyperaldostéronisme secondaire | n2=en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons | rel=r_associated | relid=0 | w=5
  298. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum
    n1=hyperaldostéronisme secondaire | n2=en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum | rel=r_associated | relid=0 | w=5
  299. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:action and postural tremor
    n1=hyperaldostéronisme secondaire | n2=en:action and postural tremor | rel=r_associated | relid=0 | w=5
  300. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:action dystonia
    n1=hyperaldostéronisme secondaire | n2=en:action dystonia | rel=r_associated | relid=0 | w=5
  301. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:action myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:action myoclonus | rel=r_associated | relid=0 | w=5
  302. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:action myoclonus (triggered by voluntary movements)
    n1=hyperaldostéronisme secondaire | n2=en:action myoclonus (triggered by voluntary movements) | rel=r_associated | relid=0 | w=5
  303. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:active state
    n1=hyperaldostéronisme secondaire | n2=en:active state | rel=r_associated | relid=0 | w=5
  304. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:actual effective cognition
    n1=hyperaldostéronisme secondaire | n2=en:actual effective cognition | rel=r_associated | relid=0 | w=5
  305. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute cerebrovascular accidents
    n1=hyperaldostéronisme secondaire | n2=en:acute cerebrovascular accidents | rel=r_associated | relid=0 | w=5
  306. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:acute encephalopathy | rel=r_associated | relid=0 | w=5
  307. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute episodes of neuropathic symptoms
    n1=hyperaldostéronisme secondaire | n2=en:acute episodes of neuropathic symptoms | rel=r_associated | relid=0 | w=5
  308. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute episodes of neuropathic symptoms (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:acute episodes of neuropathic symptoms (hcp) | rel=r_associated | relid=0 | w=5
  309. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute necrotizing encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:acute necrotizing encephalopathy | rel=r_associated | relid=0 | w=5
  310. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute neurologic decompensation (in later-onset cases)
    n1=hyperaldostéronisme secondaire | n2=en:acute neurologic decompensation (in later-onset cases) | rel=r_associated | relid=0 | w=5
  311. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute neurologic deficits due to cerebrovascular disease
    n1=hyperaldostéronisme secondaire | n2=en:acute neurologic deficits due to cerebrovascular disease | rel=r_associated | relid=0 | w=5
  312. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute poliomyelitis
    n1=hyperaldostéronisme secondaire | n2=en:acute poliomyelitis | rel=r_associated | relid=0 | w=5
  313. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:acute stress disorder
    n1=hyperaldostéronisme secondaire | n2=en:acute stress disorder | rel=r_associated | relid=0 | w=5
  314. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ADHD
    n1=hyperaldostéronisme secondaire | n2=en:ADHD | rel=r_associated | relid=0 | w=5
  315. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adipose tissue in subarachnoid space
    n1=hyperaldostéronisme secondaire | n2=en:adipose tissue in subarachnoid space | rel=r_associated | relid=0 | w=5
  316. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adjustment reaction
    n1=hyperaldostéronisme secondaire | n2=en:adjustment reaction | rel=r_associated | relid=0 | w=5
  317. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adjustment stress reaction syndrome
    n1=hyperaldostéronisme secondaire | n2=en:adjustment stress reaction syndrome | rel=r_associated | relid=0 | w=5
  318. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adoption
    n1=hyperaldostéronisme secondaire | n2=en:adoption | rel=r_associated | relid=0 | w=5
  319. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adrenal gland hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:adrenal gland hyperplasia | rel=r_associated | relid=0 | w=5
  320. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:adrenal hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=5
  321. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:advanced word recognition
    n1=hyperaldostéronisme secondaire | n2=en:advanced word recognition | rel=r_associated | relid=0 | w=5
  322. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:afebrile seizure
    n1=hyperaldostéronisme secondaire | n2=en:afebrile seizure | rel=r_associated | relid=0 | w=5
  323. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:affable demeanor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:affable demeanor (in some patients) | rel=r_associated | relid=0 | w=5
  324. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes
    n1=hyperaldostéronisme secondaire | n2=en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes | rel=r_associated | relid=0 | w=5
  325. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:affected arteries show loss of smooth muscle cells
    n1=hyperaldostéronisme secondaire | n2=en:affected arteries show loss of smooth muscle cells | rel=r_associated | relid=0 | w=5
  326. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:affected children are unable to sit without support
    n1=hyperaldostéronisme secondaire | n2=en:affected children are unable to sit without support | rel=r_associated | relid=0 | w=5
  327. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:affectionate behavior
    n1=hyperaldostéronisme secondaire | n2=en:affectionate behavior | rel=r_associated | relid=0 | w=5
  328. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of corpus callosum, partial or complete (rare)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of corpus callosum, partial or complete (rare) | rel=r_associated | relid=0 | w=5
  329. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of pineal gland
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of pineal gland | rel=r_associated | relid=0 | w=5
  330. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the anterior commissure
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the anterior commissure | rel=r_associated | relid=0 | w=5
  331. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (1 patient) | rel=r_associated | relid=0 | w=5
  332. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (in 1 of 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
  333. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (in 2 patients) | rel=r_associated | relid=0 | w=5
  334. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (less common)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (less common) | rel=r_associated | relid=0 | w=5
  335. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (patient a) | rel=r_associated | relid=0 | w=5
  336. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (rare)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (rare) | rel=r_associated | relid=0 | w=5
  337. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the corpus callosum (variable)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the corpus callosum (variable) | rel=r_associated | relid=0 | w=5
  338. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the occipital lobes (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the occipital lobes (1 patient) | rel=r_associated | relid=0 | w=5
  339. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis of the rostrum of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:agenesis of the rostrum of corpus callosum | rel=r_associated | relid=0 | w=5
  340. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis or hypogenesis of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:agenesis or hypogenesis of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  341. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis or hypoplasia of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:agenesis or hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=5
  342. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agenesis or severe hypoplasia of cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:agenesis or severe hypoplasia of cerebellar vermis | rel=r_associated | relid=0 | w=5
  343. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agents for cocaine-related cognitive impairment
    n1=hyperaldostéronisme secondaire | n2=en:agents for cocaine-related cognitive impairment | rel=r_associated | relid=0 | w=5
  344. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggregation of snca-immunopositive inclusions
    n1=hyperaldostéronisme secondaire | n2=en:aggregation of snca-immunopositive inclusions | rel=r_associated | relid=0 | w=5
  345. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggression
    n1=hyperaldostéronisme secondaire | n2=en:aggression | rel=r_associated | relid=0 | w=5
  346. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggression (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:aggression (if left untreated) | rel=r_associated | relid=0 | w=5
  347. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggression (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:aggression (in some patients) | rel=r_associated | relid=0 | w=5
  348. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggression (rare)
    n1=hyperaldostéronisme secondaire | n2=en:aggression (rare) | rel=r_associated | relid=0 | w=5
  349. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggressive behavior (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:aggressive behavior (2 patients) | rel=r_associated | relid=0 | w=5
  350. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggressive behavior (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:aggressive behavior (in 1 family) | rel=r_associated | relid=0 | w=5
  351. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggressive behavior (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:aggressive behavior (in some patients) | rel=r_associated | relid=0 | w=5
  352. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggressive outburst
    n1=hyperaldostéronisme secondaire | n2=en:aggressive outburst | rel=r_associated | relid=0 | w=5
  353. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aggressive type unsocialized behavior disorder
    n1=hyperaldostéronisme secondaire | n2=en:aggressive type unsocialized behavior disorder | rel=r_associated | relid=0 | w=5
  354. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agitated delirium
    n1=hyperaldostéronisme secondaire | n2=en:agitated delirium | rel=r_associated | relid=0 | w=5
  355. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agitation
    n1=hyperaldostéronisme secondaire | n2=en:agitation | rel=r_associated | relid=0 | w=5
  356. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agnosia
    n1=hyperaldostéronisme secondaire | n2=en:agnosia | rel=r_associated | relid=0 | w=5
  357. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agoraphobia
    n1=hyperaldostéronisme secondaire | n2=en:agoraphobia | rel=r_associated | relid=0 | w=5
  358. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agyria (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:agyria (1 patient) | rel=r_associated | relid=0 | w=5
  359. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agyria (posterior-to-anterior gradient)
    n1=hyperaldostéronisme secondaire | n2=en:agyria (posterior-to-anterior gradient) | rel=r_associated | relid=0 | w=5
  360. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:agyria (wws)
    n1=hyperaldostéronisme secondaire | n2=en:agyria (wws) | rel=r_associated | relid=0 | w=5
  361. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:akinesia
    n1=hyperaldostéronisme secondaire | n2=en:akinesia | rel=r_associated | relid=0 | w=5
  362. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:akinetic mutism (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:akinetic mutism (in some patients) | rel=r_associated | relid=0 | w=5
  363. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alcohol dependence
    n1=hyperaldostéronisme secondaire | n2=en:alcohol dependence | rel=r_associated | relid=0 | w=5
  364. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alert affect
    n1=hyperaldostéronisme secondaire | n2=en:alert affect | rel=r_associated | relid=0 | w=5
  365. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alobar holoprosencephaly (rare)
    n1=hyperaldostéronisme secondaire | n2=en:alobar holoprosencephaly (rare) | rel=r_associated | relid=0 | w=5
  366. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alobar hpe shows absence of interhemispheric cleavage and single ventricle
    n1=hyperaldostéronisme secondaire | n2=en:alobar hpe shows absence of interhemispheric cleavage and single ventricle | rel=r_associated | relid=0 | w=5
  367. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha ketoadipic aciduria
    n1=hyperaldostéronisme secondaire | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=5
  368. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha-b-crystallin expression in oligodendrocytes
    n1=hyperaldostéronisme secondaire | n2=en:alpha-b-crystallin expression in oligodendrocytes | rel=r_associated | relid=0 | w=5
  369. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha-synuclein immunoreactive neuronal and glial inclusions
    n1=hyperaldostéronisme secondaire | n2=en:alpha-synuclein immunoreactive neuronal and glial inclusions | rel=r_associated | relid=0 | w=5
  370. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha-synuclein-containing inclusions
    n1=hyperaldostéronisme secondaire | n2=en:alpha-synuclein-containing inclusions | rel=r_associated | relid=0 | w=5
  371. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha-synuclein-immunoreactive lewy neurites
    n1=hyperaldostéronisme secondaire | n2=en:alpha-synuclein-immunoreactive lewy neurites | rel=r_associated | relid=0 | w=5
  372. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alpha-synuclein-immunreactive lewy bodies
    n1=hyperaldostéronisme secondaire | n2=en:alpha-synuclein-immunreactive lewy bodies | rel=r_associated | relid=0 | w=5
  373. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alteration of cognitive function
    n1=hyperaldostéronisme secondaire | n2=en:alteration of cognitive function | rel=r_associated | relid=0 | w=5
  374. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:altered breathing patterns
    n1=hyperaldostéronisme secondaire | n2=en:altered breathing patterns | rel=r_associated | relid=0 | w=5
  375. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:altered mental status
    n1=hyperaldostéronisme secondaire | n2=en:altered mental status | rel=r_associated | relid=0 | w=5
  376. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alzheimer disease, early onset
    n1=hyperaldostéronisme secondaire | n2=en:alzheimer disease, early onset | rel=r_associated | relid=0 | w=5
  377. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alzheimer's caregivers
    n1=hyperaldostéronisme secondaire | n2=en:alzheimer's caregivers | rel=r_associated | relid=0 | w=5
  378. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:alzheimer's disease
    n1=hyperaldostéronisme secondaire | n2=en:alzheimer's disease | rel=r_associated | relid=0 | w=5
  379. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ambulation difficulty
    n1=hyperaldostéronisme secondaire | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=5
  380. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amicable behavior
    n1=hyperaldostéronisme secondaire | n2=en:amicable behavior | rel=r_associated | relid=0 | w=5
  381. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amicable character
    n1=hyperaldostéronisme secondaire | n2=en:amicable character | rel=r_associated | relid=0 | w=5
  382. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amino acid metabolism, inborn errors
    n1=hyperaldostéronisme secondaire | n2=en:amino acid metabolism, inborn errors | rel=r_associated | relid=0 | w=5
  383. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amotivation
    n1=hyperaldostéronisme secondaire | n2=en:amotivation | rel=r_associated | relid=0 | w=5
  384. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord | rel=r_associated | relid=0 | w=5
  385. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyloid plaques may be present
    n1=hyperaldostéronisme secondaire | n2=en:amyloid plaques may be present | rel=r_associated | relid=0 | w=5
  386. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyloid-like plaques are not immunoreactive to app (104760)
    n1=hyperaldostéronisme secondaire | n2=en:amyloid-like plaques are not immunoreactive to app (104760) | rel=r_associated | relid=0 | w=5
  387. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum | rel=r_associated | relid=0 | w=5
  388. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyotrophic lateral sclerosis
    n1=hyperaldostéronisme secondaire | n2=en:amyotrophic lateral sclerosis | rel=r_associated | relid=0 | w=5
  389. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:amyotrophy, distal, severe
    n1=hyperaldostéronisme secondaire | n2=en:amyotrophy, distal, severe | rel=r_associated | relid=0 | w=5
  390. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anarthria speech disorder
    n1=hyperaldostéronisme secondaire | n2=en:anarthria speech disorder | rel=r_associated | relid=0 | w=5
  391. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anatomic structures
    n1=hyperaldostéronisme secondaire | n2=en:anatomic structures | rel=r_associated | relid=0 | w=5
  392. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anencephaly
    n1=hyperaldostéronisme secondaire | n2=en:anencephaly | rel=r_associated | relid=0 | w=5
  393. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anencephaly (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:anencephaly (1 patient) | rel=r_associated | relid=0 | w=5
  394. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:angiitis, cerebral
    n1=hyperaldostéronisme secondaire | n2=en:angiitis, cerebral | rel=r_associated | relid=0 | w=5
  395. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:angiographically 'silent'
    n1=hyperaldostéronisme secondaire | n2=en:angiographically 'silent' | rel=r_associated | relid=0 | w=5
  396. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:angry outbursts
    n1=hyperaldostéronisme secondaire | n2=en:angry outbursts | rel=r_associated | relid=0 | w=5
  397. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:angulation of the frontal horns
    n1=hyperaldostéronisme secondaire | n2=en:angulation of the frontal horns | rel=r_associated | relid=0 | w=5
  398. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ankle clonus
    n1=hyperaldostéronisme secondaire | n2=en:ankle clonus | rel=r_associated | relid=0 | w=5
  399. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ankle clonus (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ankle clonus (in some patients) | rel=r_associated | relid=0 | w=5
  400. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ankle clonus (in some)
    n1=hyperaldostéronisme secondaire | n2=en:ankle clonus (in some) | rel=r_associated | relid=0 | w=5
  401. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ankle or knee clonus
    n1=hyperaldostéronisme secondaire | n2=en:ankle or knee clonus | rel=r_associated | relid=0 | w=5
  402. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ankle reflex absent
    n1=hyperaldostéronisme secondaire | n2=en:ankle reflex absent | rel=r_associated | relid=0 | w=5
  403. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anomalies of the folding of the right sylvian area
    n1=hyperaldostéronisme secondaire | n2=en:anomalies of the folding of the right sylvian area | rel=r_associated | relid=0 | w=5
  404. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anomalies of the temporal area
    n1=hyperaldostéronisme secondaire | n2=en:anomalies of the temporal area | rel=r_associated | relid=0 | w=5
  405. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anomia
    n1=hyperaldostéronisme secondaire | n2=en:anomia | rel=r_associated | relid=0 | w=5
  406. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anosmia
    n1=hyperaldostéronisme secondaire | n2=en:anosmia | rel=r_associated | relid=0 | w=5
  407. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anosmia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:anosmia (1 patient) | rel=r_associated | relid=0 | w=5
  408. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anosmia (in contiguous gene syndrome patients)
    n1=hyperaldostéronisme secondaire | n2=en:anosmia (in contiguous gene syndrome patients) | rel=r_associated | relid=0 | w=5
  409. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anosmia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:anosmia (in some patients) | rel=r_associated | relid=0 | w=5
  410. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:antenatal intracerebral hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:antenatal intracerebral hemorrhage | rel=r_associated | relid=0 | w=5
  411. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior basal encephalocele
    n1=hyperaldostéronisme secondaire | n2=en:anterior basal encephalocele | rel=r_associated | relid=0 | w=5
  412. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior commissure not evident
    n1=hyperaldostéronisme secondaire | n2=en:anterior commissure not evident | rel=r_associated | relid=0 | w=5
  413. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior horn atrophy
    n1=hyperaldostéronisme secondaire | n2=en:anterior horn atrophy | rel=r_associated | relid=0 | w=5
  414. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior horn cell impairment
    n1=hyperaldostéronisme secondaire | n2=en:anterior horn cell impairment | rel=r_associated | relid=0 | w=5
  415. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior pachygyria and posterior agyria
    n1=hyperaldostéronisme secondaire | n2=en:anterior pachygyria and posterior agyria | rel=r_associated | relid=0 | w=5
  416. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior pituitary adenoma
    n1=hyperaldostéronisme secondaire | n2=en:anterior pituitary adenoma | rel=r_associated | relid=0 | w=5
  417. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior sacral meningocele
    n1=hyperaldostéronisme secondaire | n2=en:anterior sacral meningocele | rel=r_associated | relid=0 | w=5
  418. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anterior temporal lobe subcortical cysts
    n1=hyperaldostéronisme secondaire | n2=en:anterior temporal lobe subcortical cysts | rel=r_associated | relid=0 | w=5
  419. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:antidepressant agent
    n1=hyperaldostéronisme secondaire | n2=en:antidepressant agent | rel=r_associated | relid=0 | w=5
  420. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:antisocial behavior
    n1=hyperaldostéronisme secondaire | n2=en:antisocial behavior | rel=r_associated | relid=0 | w=5
  421. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety
    n1=hyperaldostéronisme secondaire | n2=en:anxiety | rel=r_associated | relid=0 | w=5
  422. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:anxiety (hcp) | rel=r_associated | relid=0 | w=5
  423. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:anxiety (in some patients) | rel=r_associated | relid=0 | w=5
  424. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety (with pheochromocytoma)
    n1=hyperaldostéronisme secondaire | n2=en:anxiety (with pheochromocytoma) | rel=r_associated | relid=0 | w=5
  425. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety attack
    n1=hyperaldostéronisme secondaire | n2=en:anxiety attack | rel=r_associated | relid=0 | w=5
  426. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety disorder
    n1=hyperaldostéronisme secondaire | n2=en:anxiety disorder | rel=r_associated | relid=0 | w=5
  427. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety disorder of childhood or adolescence
    n1=hyperaldostéronisme secondaire | n2=en:anxiety disorder of childhood or adolescence | rel=r_associated | relid=0 | w=5
  428. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxiety, dissociative and somatoform disorders
    n1=hyperaldostéronisme secondaire | n2=en:anxiety, dissociative and somatoform disorders | rel=r_associated | relid=0 | w=5
  429. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:anxious affect
    n1=hyperaldostéronisme secondaire | n2=en:anxious affect | rel=r_associated | relid=0 | w=5
  430. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:apathy
    n1=hyperaldostéronisme secondaire | n2=en:apathy | rel=r_associated | relid=0 | w=5
  431. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aphasia
    n1=hyperaldostéronisme secondaire | n2=en:aphasia | rel=r_associated | relid=0 | w=5
  432. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:aplasia of corpus callosum | rel=r_associated | relid=0 | w=5
  433. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia of olfactory bulbs, bilateral
    n1=hyperaldostéronisme secondaire | n2=en:aplasia of olfactory bulbs, bilateral | rel=r_associated | relid=0 | w=5
  434. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb)
    n1=hyperaldostéronisme secondaire | n2=en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb) | rel=r_associated | relid=0 | w=5
  435. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia of the inferior half of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:aplasia of the inferior half of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  436. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia of the vermis
    n1=hyperaldostéronisme secondaire | n2=en:aplasia of the vermis | rel=r_associated | relid=0 | w=5
  437. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia/hypoplasia of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:aplasia/hypoplasia of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  438. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia/hypoplasia of the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:aplasia/hypoplasia of the cerebellum | rel=r_associated | relid=0 | w=5
  439. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aplasia/hypoplasia of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:aplasia/hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=5
  440. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:apoptotic neurons
    n1=hyperaldostéronisme secondaire | n2=en:apoptotic neurons | rel=r_associated | relid=0 | w=5
  441. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:appendicular hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:appendicular hypertonia | rel=r_associated | relid=0 | w=5
  442. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:approximately 30% of patients show normal early development
    n1=hyperaldostéronisme secondaire | n2=en:approximately 30% of patients show normal early development | rel=r_associated | relid=0 | w=5
  443. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:apraxia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:apraxia (in some patients) | rel=r_associated | relid=0 | w=5
  444. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:apraxia, verbal
    n1=hyperaldostéronisme secondaire | n2=en:apraxia, verbal | rel=r_associated | relid=0 | w=5
  445. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:apraxias
    n1=hyperaldostéronisme secondaire | n2=en:apraxias | rel=r_associated | relid=0 | w=5
  446. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aqueductal stenosis
    n1=hyperaldostéronisme secondaire | n2=en:aqueductal stenosis | rel=r_associated | relid=0 | w=5
  447. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid cyst
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid cyst | rel=r_associated | relid=0 | w=5
  448. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid cyst (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid cyst (in some patients) | rel=r_associated | relid=0 | w=5
  449. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid cysts (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid cysts (1 patient) | rel=r_associated | relid=0 | w=5
  450. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid cysts (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid cysts (in one family) | rel=r_associated | relid=0 | w=5
  451. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid cysts of the cerebellopontine angle (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid cysts of the cerebellopontine angle (reported in 1 family) | rel=r_associated | relid=0 | w=5
  452. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoid hemangiomata
    n1=hyperaldostéronisme secondaire | n2=en:arachnoid hemangiomata | rel=r_associated | relid=0 | w=5
  453. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arachnoidal cysts
    n1=hyperaldostéronisme secondaire | n2=en:arachnoidal cysts | rel=r_associated | relid=0 | w=5
  454. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:areflexia
    n1=hyperaldostéronisme secondaire | n2=en:areflexia | rel=r_associated | relid=0 | w=5
  455. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:areflexia (30%)
    n1=hyperaldostéronisme secondaire | n2=en:areflexia (30%) | rel=r_associated | relid=0 | w=5
  456. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:areflexia of lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:areflexia of lower limbs | rel=r_associated | relid=0 | w=5
  457. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:areflexia of upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:areflexia of upper limbs | rel=r_associated | relid=0 | w=5
  458. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies)
    n1=hyperaldostéronisme secondaire | n2=en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies) | rel=r_associated | relid=0 | w=5
  459. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arhinencephaly
    n1=hyperaldostéronisme secondaire | n2=en:arhinencephaly | rel=r_associated | relid=0 | w=5
  460. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arhinencephaly (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:arhinencephaly (1 patient) | rel=r_associated | relid=0 | w=5
  461. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arm flexion
    n1=hyperaldostéronisme secondaire | n2=en:arm flexion | rel=r_associated | relid=0 | w=5
  462. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arm pain
    n1=hyperaldostéronisme secondaire | n2=en:arm pain | rel=r_associated | relid=0 | w=5
  463. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arnold-chiari i malformation
    n1=hyperaldostéronisme secondaire | n2=en:arnold-chiari i malformation | rel=r_associated | relid=0 | w=5
  464. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arnold-chiari malformation
    n1=hyperaldostéronisme secondaire | n2=en:arnold-chiari malformation | rel=r_associated | relid=0 | w=5
  465. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arrest of psychomotor development after seizure onset
    n1=hyperaldostéronisme secondaire | n2=en:arrest of psychomotor development after seizure onset | rel=r_associated | relid=0 | w=5
  466. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arrested hydrocephalus (rare)
    n1=hyperaldostéronisme secondaire | n2=en:arrested hydrocephalus (rare) | rel=r_associated | relid=0 | w=5
  467. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:arteriovenous hemangioma
    n1=hyperaldostéronisme secondaire | n2=en:arteriovenous hemangioma | rel=r_associated | relid=0 | w=5
  468. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:articulation difficulties
    n1=hyperaldostéronisme secondaire | n2=en:articulation difficulties | rel=r_associated | relid=0 | w=5
  469. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:articulation, unintelligible
    n1=hyperaldostéronisme secondaire | n2=en:articulation, unintelligible | rel=r_associated | relid=0 | w=5
  470. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:articulatory defect
    n1=hyperaldostéronisme secondaire | n2=en:articulatory defect | rel=r_associated | relid=0 | w=5
  471. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:asperger syndrome (rare)
    n1=hyperaldostéronisme secondaire | n2=en:asperger syndrome (rare) | rel=r_associated | relid=0 | w=5
  472. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:asperger-like features
    n1=hyperaldostéronisme secondaire | n2=en:asperger-like features | rel=r_associated | relid=0 | w=5
  473. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:associated with paresthesias and dysesthesias
    n1=hyperaldostéronisme secondaire | n2=en:associated with paresthesias and dysesthesias | rel=r_associated | relid=0 | w=5
  474. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:associated with syringomyelia (186700)
    n1=hyperaldostéronisme secondaire | n2=en:associated with syringomyelia (186700) | rel=r_associated | relid=0 | w=5
  475. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:association between poor metabolizers (pm) and parkinson disease
    n1=hyperaldostéronisme secondaire | n2=en:association between poor metabolizers (pm) and parkinson disease | rel=r_associated | relid=0 | w=5
  476. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:astrocyte
    n1=hyperaldostéronisme secondaire | n2=en:astrocyte | rel=r_associated | relid=0 | w=5
  477. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:astrocytes show reactive changes
    n1=hyperaldostéronisme secondaire | n2=en:astrocytes show reactive changes | rel=r_associated | relid=0 | w=5
  478. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:astrocytic gliosis
    n1=hyperaldostéronisme secondaire | n2=en:astrocytic gliosis | rel=r_associated | relid=0 | w=5
  479. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:astrocytosis
    n1=hyperaldostéronisme secondaire | n2=en:astrocytosis | rel=r_associated | relid=0 | w=5
  480. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:astrogliosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:astrogliosis (in some patients) | rel=r_associated | relid=0 | w=5
  481. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:asymmetric brain development
    n1=hyperaldostéronisme secondaire | n2=en:asymmetric brain development | rel=r_associated | relid=0 | w=5
  482. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:asymmetry at onset (74%)
    n1=hyperaldostéronisme secondaire | n2=en:asymmetry at onset (74%) | rel=r_associated | relid=0 | w=5
  483. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:asymmetry of symptoms
    n1=hyperaldostéronisme secondaire | n2=en:asymmetry of symptoms | rel=r_associated | relid=0 | w=5
  484. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia
    n1=hyperaldostéronisme secondaire | n2=en:ataxia | rel=r_associated | relid=0 | w=5
  485. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (1 patient) | rel=r_associated | relid=0 | w=5
  486. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (cvs+) | rel=r_associated | relid=0 | w=5
  487. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (deletion patients)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (deletion patients) | rel=r_associated | relid=0 | w=5
  488. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (early-onset form)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (early-onset form) | rel=r_associated | relid=0 | w=5
  489. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (if untreated)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (if untreated) | rel=r_associated | relid=0 | w=5
  490. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (in some patients) | rel=r_associated | relid=0 | w=5
  491. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (less common) | rel=r_associated | relid=0 | w=5
  492. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (type i and type ii, infantile and juvenile)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (type i and type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=5
  493. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia (uncommon) | rel=r_associated | relid=0 | w=5
  494. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia in those who survive
    n1=hyperaldostéronisme secondaire | n2=en:ataxia in those who survive | rel=r_associated | relid=0 | w=5
  495. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia may develop in middle age (less common)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia may develop in middle age (less common) | rel=r_associated | relid=0 | w=5
  496. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia telangiectasia syndrome
    n1=hyperaldostéronisme secondaire | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=5
  497. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia with febrile episodes (rare)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia with febrile episodes (rare) | rel=r_associated | relid=0 | w=5
  498. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia with jerky arm movements
    n1=hyperaldostéronisme secondaire | n2=en:ataxia with jerky arm movements | rel=r_associated | relid=0 | w=5
  499. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia worsens in the dark
    n1=hyperaldostéronisme secondaire | n2=en:ataxia worsens in the dark | rel=r_associated | relid=0 | w=5
  500. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, (1 family) | rel=r_associated | relid=0 | w=5
  501. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, cerebellar (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, cerebellar (in some patients) | rel=r_associated | relid=0 | w=5
  502. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, cerebellar (upper and lower limbs affected)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, cerebellar (upper and lower limbs affected) | rel=r_associated | relid=0 | w=5
  503. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, cerebellar, limb and gait
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, cerebellar, limb and gait | rel=r_associated | relid=0 | w=5
  504. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, episodic (episodes last from hours to days)
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, episodic (episodes last from hours to days) | rel=r_associated | relid=0 | w=5
  505. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, episodic, occurring after febrile illness or stress
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, episodic, occurring after febrile illness or stress | rel=r_associated | relid=0 | w=5
  506. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, gait and appendicular
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, gait and appendicular | rel=r_associated | relid=0 | w=5
  507. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxia, mild
    n1=hyperaldostéronisme secondaire | n2=en:ataxia, mild | rel=r_associated | relid=0 | w=5
  508. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxias, appendicular
    n1=hyperaldostéronisme secondaire | n2=en:ataxias, appendicular | rel=r_associated | relid=0 | w=5
  509. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxias, sensory
    n1=hyperaldostéronisme secondaire | n2=en:ataxias, sensory | rel=r_associated | relid=0 | w=5
  510. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxias, truncal
    n1=hyperaldostéronisme secondaire | n2=en:ataxias, truncal | rel=r_associated | relid=0 | w=5
  511. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxic gait
    n1=hyperaldostéronisme secondaire | n2=en:ataxic gait | rel=r_associated | relid=0 | w=5
  512. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxic gait (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ataxic gait (in some patients) | rel=r_associated | relid=0 | w=5
  513. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxic gait (juvenile form)
    n1=hyperaldostéronisme secondaire | n2=en:ataxic gait (juvenile form) | rel=r_associated | relid=0 | w=5
  514. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ataxic movements
    n1=hyperaldostéronisme secondaire | n2=en:ataxic movements | rel=r_associated | relid=0 | w=5
  515. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atelencephaly
    n1=hyperaldostéronisme secondaire | n2=en:atelencephaly | rel=r_associated | relid=0 | w=5
  516. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:athetoid and dystonic hand movements (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:athetoid and dystonic hand movements (in some patients) | rel=r_associated | relid=0 | w=5
  517. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:athetosis
    n1=hyperaldostéronisme secondaire | n2=en:athetosis | rel=r_associated | relid=0 | w=5
  518. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:athetosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:athetosis (in some patients) | rel=r_associated | relid=0 | w=5
  519. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:athetosis (later)
    n1=hyperaldostéronisme secondaire | n2=en:athetosis (later) | rel=r_associated | relid=0 | w=5
  520. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:athetosis, mild (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:athetosis, mild (in one patient) | rel=r_associated | relid=0 | w=5
  521. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atlantoaxial instability
    n1=hyperaldostéronisme secondaire | n2=en:atlantoaxial instability | rel=r_associated | relid=0 | w=5
  522. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atretic occipital cephalocele
    n1=hyperaldostéronisme secondaire | n2=en:atretic occipital cephalocele | rel=r_associated | relid=0 | w=5
  523. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophic pons (in some)
    n1=hyperaldostéronisme secondaire | n2=en:atrophic pons (in some) | rel=r_associated | relid=0 | w=5
  524. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy and weakness of limb musculature
    n1=hyperaldostéronisme secondaire | n2=en:atrophy and weakness of limb musculature | rel=r_associated | relid=0 | w=5
  525. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy and weakness of the tongue, jaw, and throat muscles
    n1=hyperaldostéronisme secondaire | n2=en:atrophy and weakness of the tongue, jaw, and throat muscles | rel=r_associated | relid=0 | w=5
  526. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy may be more severe in the left hemisphere
    n1=hyperaldostéronisme secondaire | n2=en:atrophy may be more severe in the left hemisphere | rel=r_associated | relid=0 | w=5
  527. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of cerebellum, brainstem, cervical spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of cerebellum, brainstem, cervical spinal cord | rel=r_associated | relid=0 | w=5
  528. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of corpus callosum | rel=r_associated | relid=0 | w=5
  529. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of hippocampal dentate gyrus
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of hippocampal dentate gyrus | rel=r_associated | relid=0 | w=5
  530. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of pyramids
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of pyramids | rel=r_associated | relid=0 | w=5
  531. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the cerebellar vermis seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the cerebellar vermis seen on mri | rel=r_associated | relid=0 | w=5
  532. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the dentate nucleus
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the dentate nucleus | rel=r_associated | relid=0 | w=5
  533. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the frontal and parietal cortex
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the frontal and parietal cortex | rel=r_associated | relid=0 | w=5
  534. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the granular cell layer of the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the granular cell layer of the cerebellum | rel=r_associated | relid=0 | w=5
  535. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the motor cortex in older patients seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the motor cortex in older patients seen on mri | rel=r_associated | relid=0 | w=5
  536. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the pituitary (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the pituitary (1 patient) | rel=r_associated | relid=0 | w=5
  537. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the pons (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the pons (in some patients) | rel=r_associated | relid=0 | w=5
  538. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the posterior columns and spinocerebellar tracts
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the posterior columns and spinocerebellar tracts | rel=r_associated | relid=0 | w=5
  539. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the spinal cord | rel=r_associated | relid=0 | w=5
  540. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy of the spinal cord and cerebellar tracts
    n1=hyperaldostéronisme secondaire | n2=en:atrophy of the spinal cord and cerebellar tracts | rel=r_associated | relid=0 | w=5
  541. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy, thin hemisphere
    n1=hyperaldostéronisme secondaire | n2=en:atrophy, thin hemisphere | rel=r_associated | relid=0 | w=5
  542. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atrophy/degeneration involving the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:atrophy/degeneration involving the spinal cord | rel=r_associated | relid=0 | w=5
  543. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attacks characterized by lethargy, incoordination, loss of motor skills
    n1=hyperaldostéronisme secondaire | n2=en:attacks characterized by lethargy, incoordination, loss of motor skills | rel=r_associated | relid=0 | w=5
  544. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attacks of disabling daytime drowsiness and low alertness
    n1=hyperaldostéronisme secondaire | n2=en:attacks of disabling daytime drowsiness and low alertness | rel=r_associated | relid=0 | w=5
  545. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit and disruptive behavior disorders
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit and disruptive behavior disorders | rel=r_associated | relid=0 | w=5
  546. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder | rel=r_associated | relid=0 | w=5
  547. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder (in those who stop treatment)
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder (in those who stop treatment) | rel=r_associated | relid=0 | w=5
  548. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder of childhood, combined type
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder of childhood, combined type | rel=r_associated | relid=0 | w=5
  549. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder of childhood, overactivity nos
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder of childhood, overactivity nos | rel=r_associated | relid=0 | w=5
  550. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder of childhood, predominantly hyperactive/impulsive type
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder of childhood, predominantly hyperactive/impulsive type | rel=r_associated | relid=0 | w=5
  551. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit disorder of childhood, simple disturbance of attention with overactivity
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit disorder of childhood, simple disturbance of attention with overactivity | rel=r_associated | relid=0 | w=5
  552. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=5
  553. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit hyperactivity disorder (adhd) survey
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit hyperactivity disorder (adhd) survey | rel=r_associated | relid=0 | w=5
  554. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit hyperactivity disorder, combined type
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit hyperactivity disorder, combined type | rel=r_associated | relid=0 | w=5
  555. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit-hyperactivity
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit-hyperactivity | rel=r_associated | relid=0 | w=5
  556. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit-hyperactivity disorder (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit-hyperactivity disorder (3 patients) | rel=r_associated | relid=0 | w=5
  557. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficit-hyperactivity disorder (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:attention deficit-hyperactivity disorder (cvs+) | rel=r_associated | relid=0 | w=5
  558. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention deficits (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:attention deficits (in some patients) | rel=r_associated | relid=0 | w=5
  559. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention difficulties (73%)
    n1=hyperaldostéronisme secondaire | n2=en:attention difficulties (73%) | rel=r_associated | relid=0 | w=5
  560. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit disorder (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit disorder (in some patients) | rel=r_associated | relid=0 | w=5
  561. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit hyperactivity disorder (33%)
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit hyperactivity disorder (33%) | rel=r_associated | relid=0 | w=5
  562. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit hyperactivity disorder of childhood or adolescence nos
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit hyperactivity disorder of childhood or adolescence nos | rel=r_associated | relid=0 | w=5
  563. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit hyperactivity disorder, other type
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit hyperactivity disorder, other type | rel=r_associated | relid=0 | w=5
  564. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit hyperactivity disorder, predominantly hyperactive type
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit hyperactivity disorder, predominantly hyperactive type | rel=r_associated | relid=0 | w=5
  565. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit/hyperactivity disorder (1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit/hyperactivity disorder (1/4 patients) | rel=r_associated | relid=0 | w=5
  566. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attention-deficit/hyperactivity disorder, predominantly inattentive type
    n1=hyperaldostéronisme secondaire | n2=en:attention-deficit/hyperactivity disorder, predominantly inattentive type | rel=r_associated | relid=0 | w=5
  567. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attenuated gyri
    n1=hyperaldostéronisme secondaire | n2=en:attenuated gyri | rel=r_associated | relid=0 | w=5
  568. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:attraction to/fascination with water, crinkly items (paper, plastic)
    n1=hyperaldostéronisme secondaire | n2=en:attraction to/fascination with water, crinkly items (paper, plastic) | rel=r_associated | relid=0 | w=5
  569. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atypical absence seizure
    n1=hyperaldostéronisme secondaire | n2=en:atypical absence seizure | rel=r_associated | relid=0 | w=5
  570. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atypical absence, atonic/tonic, or tonic-clonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:atypical absence, atonic/tonic, or tonic-clonic seizures | rel=r_associated | relid=0 | w=5
  571. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:atypical attention deficit syndrome
    n1=hyperaldostéronisme secondaire | n2=en:atypical attention deficit syndrome | rel=r_associated | relid=0 | w=5
  572. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:auditory and visual hallucinations
    n1=hyperaldostéronisme secondaire | n2=en:auditory and visual hallucinations | rel=r_associated | relid=0 | w=5
  573. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:auditory auras
    n1=hyperaldostéronisme secondaire | n2=en:auditory auras | rel=r_associated | relid=0 | w=5
  574. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:auditory hallucination
    n1=hyperaldostéronisme secondaire | n2=en:auditory hallucination | rel=r_associated | relid=0 | w=5
  575. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:auditory, olfactory, and visual auras
    n1=hyperaldostéronisme secondaire | n2=en:auditory, olfactory, and visual auras | rel=r_associated | relid=0 | w=5
  576. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aura
    n1=hyperaldostéronisme secondaire | n2=en:aura | rel=r_associated | relid=0 | w=5
  577. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aura (in some instances)
    n1=hyperaldostéronisme secondaire | n2=en:aura (in some instances) | rel=r_associated | relid=0 | w=5
  578. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:aura may occur
    n1=hyperaldostéronisme secondaire | n2=en:aura may occur | rel=r_associated | relid=0 | w=5
  579. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism
    n1=hyperaldostéronisme secondaire | n2=en:autism | rel=r_associated | relid=0 | w=5
  580. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:autism (cvs+) | rel=r_associated | relid=0 | w=5
  581. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:autism (in some patients) | rel=r_associated | relid=0 | w=5
  582. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism (rare)
    n1=hyperaldostéronisme secondaire | n2=en:autism (rare) | rel=r_associated | relid=0 | w=5
  583. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism or autistic features
    n1=hyperaldostéronisme secondaire | n2=en:autism or autistic features | rel=r_associated | relid=0 | w=5
  584. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism or autistic-like condition
    n1=hyperaldostéronisme secondaire | n2=en:autism or autistic-like condition | rel=r_associated | relid=0 | w=5
  585. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism spectrum disorder
    n1=hyperaldostéronisme secondaire | n2=en:autism spectrum disorder | rel=r_associated | relid=0 | w=5
  586. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism spectrum disorder (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:autism spectrum disorder (in some patients) | rel=r_associated | relid=0 | w=5
  587. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism spectrum disorder (less common)
    n1=hyperaldostéronisme secondaire | n2=en:autism spectrum disorder (less common) | rel=r_associated | relid=0 | w=5
  588. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism spectrum disorder (rare)
    n1=hyperaldostéronisme secondaire | n2=en:autism spectrum disorder (rare) | rel=r_associated | relid=0 | w=5
  589. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autism, mild
    n1=hyperaldostéronisme secondaire | n2=en:autism, mild | rel=r_associated | relid=0 | w=5
  590. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic behavior
    n1=hyperaldostéronisme secondaire | n2=en:autistic behavior | rel=r_associated | relid=0 | w=5
  591. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic behavior (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:autistic behavior (in some patients) | rel=r_associated | relid=0 | w=5
  592. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features
    n1=hyperaldostéronisme secondaire | n2=en:autistic features | rel=r_associated | relid=0 | w=5
  593. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (1 patient) | rel=r_associated | relid=0 | w=5
  594. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (if left untreated) | rel=r_associated | relid=0 | w=5
  595. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (in 1 family) | rel=r_associated | relid=0 | w=5
  596. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (in some patients) | rel=r_associated | relid=0 | w=5
  597. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (rare)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (rare) | rel=r_associated | relid=0 | w=5
  598. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic features (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:autistic features (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  599. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic-like behavior
    n1=hyperaldostéronisme secondaire | n2=en:autistic-like behavior | rel=r_associated | relid=0 | w=5
  600. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autistic-like features
    n1=hyperaldostéronisme secondaire | n2=en:autistic-like features | rel=r_associated | relid=0 | w=5
  601. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:auto- and hetero-aggressive behavior
    n1=hyperaldostéronisme secondaire | n2=en:auto- and hetero-aggressive behavior | rel=r_associated | relid=0 | w=5
  602. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autofluorescent lipopigment in neurons
    n1=hyperaldostéronisme secondaire | n2=en:autofluorescent lipopigment in neurons | rel=r_associated | relid=0 | w=5
  603. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autofluorescent pigment in microglia and macrophages
    n1=hyperaldostéronisme secondaire | n2=en:autofluorescent pigment in microglia and macrophages | rel=r_associated | relid=0 | w=5
  604. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:automatism
    n1=hyperaldostéronisme secondaire | n2=en:automatism | rel=r_associated | relid=0 | w=5
  605. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:automutilation
    n1=hyperaldostéronisme secondaire | n2=en:automutilation | rel=r_associated | relid=0 | w=5
  606. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:autonomic abnormalities | rel=r_associated | relid=0 | w=5
  607. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic disturbances
    n1=hyperaldostéronisme secondaire | n2=en:autonomic disturbances | rel=r_associated | relid=0 | w=5
  608. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic dysfunction (in patients with hsan2d)
    n1=hyperaldostéronisme secondaire | n2=en:autonomic dysfunction (in patients with hsan2d) | rel=r_associated | relid=0 | w=5
  609. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic dysfunction may occur
    n1=hyperaldostéronisme secondaire | n2=en:autonomic dysfunction may occur | rel=r_associated | relid=0 | w=5
  610. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic dysregulation
    n1=hyperaldostéronisme secondaire | n2=en:autonomic dysregulation | rel=r_associated | relid=0 | w=5
  611. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic features may occur
    n1=hyperaldostéronisme secondaire | n2=en:autonomic features may occur | rel=r_associated | relid=0 | w=5
  612. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension)
    n1=hyperaldostéronisme secondaire | n2=en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension) | rel=r_associated | relid=0 | w=5
  613. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic instability (22%)
    n1=hyperaldostéronisme secondaire | n2=en:autonomic instability (22%) | rel=r_associated | relid=0 | w=5
  614. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic involvement
    n1=hyperaldostéronisme secondaire | n2=en:autonomic involvement | rel=r_associated | relid=0 | w=5
  615. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic involvement affecting limbs during episodes
    n1=hyperaldostéronisme secondaire | n2=en:autonomic involvement affecting limbs during episodes | rel=r_associated | relid=0 | w=5
  616. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic involvement may occur
    n1=hyperaldostéronisme secondaire | n2=en:autonomic involvement may occur | rel=r_associated | relid=0 | w=5
  617. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic manifestations
    n1=hyperaldostéronisme secondaire | n2=en:autonomic manifestations | rel=r_associated | relid=0 | w=5
  618. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic nervous system disorders
    n1=hyperaldostéronisme secondaire | n2=en:autonomic nervous system disorders | rel=r_associated | relid=0 | w=5
  619. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic signs
    n1=hyperaldostéronisme secondaire | n2=en:autonomic signs | rel=r_associated | relid=0 | w=5
  620. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:autonomic symptoms
    n1=hyperaldostéronisme secondaire | n2=en:autonomic symptoms | rel=r_associated | relid=0 | w=5
  621. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:average intellect
    n1=hyperaldostéronisme secondaire | n2=en:average intellect | rel=r_associated | relid=0 | w=5
  622. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:avoidant personality disorder
    n1=hyperaldostéronisme secondaire | n2=en:avoidant personality disorder | rel=r_associated | relid=0 | w=5
  623. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial dystonia
    n1=hyperaldostéronisme secondaire | n2=en:axial dystonia | rel=r_associated | relid=0 | w=5
  624. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial hypotonia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:axial hypotonia (1 patient) | rel=r_associated | relid=0 | w=5
  625. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial hypotonia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:axial hypotonia (rare) | rel=r_associated | relid=0 | w=5
  626. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial imbalance (34%)
    n1=hyperaldostéronisme secondaire | n2=en:axial imbalance (34%) | rel=r_associated | relid=0 | w=5
  627. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial muscle stiffness, symmetric
    n1=hyperaldostéronisme secondaire | n2=en:axial muscle stiffness, symmetric | rel=r_associated | relid=0 | w=5
  628. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axial rigidity
    n1=hyperaldostéronisme secondaire | n2=en:axial rigidity | rel=r_associated | relid=0 | w=5
  629. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal 'spheroid' inclusions
    n1=hyperaldostéronisme secondaire | n2=en:axonal 'spheroid' inclusions | rel=r_associated | relid=0 | w=5
  630. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal 'spheroid' inclusions in the cns
    n1=hyperaldostéronisme secondaire | n2=en:axonal 'spheroid' inclusions in the cns | rel=r_associated | relid=0 | w=5
  631. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal dystrophy
    n1=hyperaldostéronisme secondaire | n2=en:axonal dystrophy | rel=r_associated | relid=0 | w=5
  632. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal dystrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:axonal dystrophy (in some patients) | rel=r_associated | relid=0 | w=5
  633. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal loss
    n1=hyperaldostéronisme secondaire | n2=en:axonal loss | rel=r_associated | relid=0 | w=5
  634. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal loss and gliosis in the corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:axonal loss and gliosis in the corticospinal tracts | rel=r_associated | relid=0 | w=5
  635. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal spheroids
    n1=hyperaldostéronisme secondaire | n2=en:axonal spheroids | rel=r_associated | relid=0 | w=5
  636. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal spheroids in the dorsal column
    n1=hyperaldostéronisme secondaire | n2=en:axonal spheroids in the dorsal column | rel=r_associated | relid=0 | w=5
  637. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal swelling of spinal nerve roots and cranial nerves
    n1=hyperaldostéronisme secondaire | n2=en:axonal swelling of spinal nerve roots and cranial nerves | rel=r_associated | relid=0 | w=5
  638. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal swelling or thickening
    n1=hyperaldostéronisme secondaire | n2=en:axonal swelling or thickening | rel=r_associated | relid=0 | w=5
  639. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal swelling or thickening in the cns
    n1=hyperaldostéronisme secondaire | n2=en:axonal swelling or thickening in the cns | rel=r_associated | relid=0 | w=5
  640. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:axonal swellings or spheroids
    n1=hyperaldostéronisme secondaire | n2=en:axonal swellings or spheroids | rel=r_associated | relid=0 | w=5
  641. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:babinski sign
    n1=hyperaldostéronisme secondaire | n2=en:babinski sign | rel=r_associated | relid=0 | w=5
  642. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:baby health checkup
    n1=hyperaldostéronisme secondaire | n2=en:baby health checkup | rel=r_associated | relid=0 | w=5
  643. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:back pain
    n1=hyperaldostéronisme secondaire | n2=en:back pain | rel=r_associated | relid=0 | w=5
  644. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:background slowing
    n1=hyperaldostéronisme secondaire | n2=en:background slowing | rel=r_associated | relid=0 | w=5
  645. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:balloon cells (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:balloon cells (in type iib) | rel=r_associated | relid=0 | w=5
  646. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ballooned neurons
    n1=hyperaldostéronisme secondaire | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=5
  647. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:band heterotopia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:band heterotopia (1 patient) | rel=r_associated | relid=0 | w=5
  648. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia atrophy
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia atrophy | rel=r_associated | relid=0 | w=5
  649. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia atrophy, progressive | rel=r_associated | relid=0 | w=5
  650. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia calcification
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia calcification | rel=r_associated | relid=0 | w=5
  651. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia calcifications (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia calcifications (in some patients) | rel=r_associated | relid=0 | w=5
  652. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia calcifications (rare)
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia calcifications (rare) | rel=r_associated | relid=0 | w=5
  653. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia cysts
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia cysts | rel=r_associated | relid=0 | w=5
  654. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia dysfunction | rel=r_associated | relid=0 | w=5
  655. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia gliosis
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia gliosis | rel=r_associated | relid=0 | w=5
  656. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia lesions may be present before onset of clinical symptoms
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia lesions may be present before onset of clinical symptoms | rel=r_associated | relid=0 | w=5
  657. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia lesions seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia lesions seen on mri | rel=r_associated | relid=0 | w=5
  658. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglia lucencies
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglia lucencies | rel=r_associated | relid=0 | w=5
  659. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:basal ganglion degeneration
    n1=hyperaldostéronisme secondaire | n2=en:basal ganglion degeneration | rel=r_associated | relid=0 | w=5
  660. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:begins in limbs, later generalized (childhood onset)
    n1=hyperaldostéronisme secondaire | n2=en:begins in limbs, later generalized (childhood onset) | rel=r_associated | relid=0 | w=5
  661. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavior disorders
    n1=hyperaldostéronisme secondaire | n2=en:behavior disorders | rel=r_associated | relid=0 | w=5
  662. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral change
    n1=hyperaldostéronisme secondaire | n2=en:behavioral change | rel=r_associated | relid=0 | w=5
  663. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral changes consistent with an autistic disorder
    n1=hyperaldostéronisme secondaire | n2=en:behavioral changes consistent with an autistic disorder | rel=r_associated | relid=0 | w=5
  664. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral difficulties
    n1=hyperaldostéronisme secondaire | n2=en:behavioral difficulties | rel=r_associated | relid=0 | w=5
  665. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral difficulties (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:behavioral difficulties (in some patients) | rel=r_associated | relid=0 | w=5
  666. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral disorders (rare)
    n1=hyperaldostéronisme secondaire | n2=en:behavioral disorders (rare) | rel=r_associated | relid=0 | w=5
  667. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral disturbances (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:behavioral disturbances (in some patients) | rel=r_associated | relid=0 | w=5
  668. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral disturbances (in some)
    n1=hyperaldostéronisme secondaire | n2=en:behavioral disturbances (in some) | rel=r_associated | relid=0 | w=5
  669. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral problems (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:behavioral problems (in some patients) | rel=r_associated | relid=0 | w=5
  670. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral syndrome associated with physiological disturbance and physical factors
    n1=hyperaldostéronisme secondaire | n2=en:behavioral syndrome associated with physiological disturbance and physical factors | rel=r_associated | relid=0 | w=5
  671. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral variant of frontotemporal dementia
    n1=hyperaldostéronisme secondaire | n2=en:behavioral variant of frontotemporal dementia | rel=r_associated | relid=0 | w=5
  672. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:behavioral/psychiatric manifestations
    n1=hyperaldostéronisme secondaire | n2=en:behavioral/psychiatric manifestations | rel=r_associated | relid=0 | w=5
  673. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:benzphetamine
    n1=hyperaldostéronisme secondaire | n2=en:benzphetamine | rel=r_associated | relid=0 | w=5
  674. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:benzphetamine 50mg tablet
    n1=hyperaldostéronisme secondaire | n2=en:benzphetamine 50mg tablet | rel=r_associated | relid=0 | w=5
  675. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:benzphetamine hydrochloride
    n1=hyperaldostéronisme secondaire | n2=en:benzphetamine hydrochloride | rel=r_associated | relid=0 | w=5
  676. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:benzphetamine hydrochloride 25 mg oral tablet
    n1=hyperaldostéronisme secondaire | n2=en:benzphetamine hydrochloride 25 mg oral tablet | rel=r_associated | relid=0 | w=5
  677. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bereavement
    n1=hyperaldostéronisme secondaire | n2=en:bereavement | rel=r_associated | relid=0 | w=5
  678. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:beta-amyloid-positive senile plaques
    n1=hyperaldostéronisme secondaire | n2=en:beta-amyloid-positive senile plaques | rel=r_associated | relid=0 | w=5
  679. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:between 2 and 7% of children will develop afebrile seizure disorders later in life
    n1=hyperaldostéronisme secondaire | n2=en:between 2 and 7% of children will develop afebrile seizure disorders later in life | rel=r_associated | relid=0 | w=5
  680. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral calcification of basal ganglia and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:bilateral calcification of basal ganglia and cerebellum | rel=r_associated | relid=0 | w=5
  681. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral convulsive seizures
    n1=hyperaldostéronisme secondaire | n2=en:bilateral convulsive seizures | rel=r_associated | relid=0 | w=5
  682. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral perisylvian cortical malformations on mri
    n1=hyperaldostéronisme secondaire | n2=en:bilateral perisylvian cortical malformations on mri | rel=r_associated | relid=0 | w=5
  683. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral schizencephaly
    n1=hyperaldostéronisme secondaire | n2=en:bilateral schizencephaly | rel=r_associated | relid=0 | w=5
  684. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral signals in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:bilateral signals in the basal ganglia | rel=r_associated | relid=0 | w=5
  685. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral striatal lucencies on imaging
    n1=hyperaldostéronisme secondaire | n2=en:bilateral striatal lucencies on imaging | rel=r_associated | relid=0 | w=5
  686. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral striatal necrosis
    n1=hyperaldostéronisme secondaire | n2=en:bilateral striatal necrosis | rel=r_associated | relid=0 | w=5
  687. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral thalamic lesions on mri
    n1=hyperaldostéronisme secondaire | n2=en:bilateral thalamic lesions on mri | rel=r_associated | relid=0 | w=5
  688. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas
    n1=hyperaldostéronisme secondaire | n2=en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas | rel=r_associated | relid=0 | w=5
  689. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex
    n1=hyperaldostéronisme secondaire | n2=en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex | rel=r_associated | relid=0 | w=5
  690. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:biopsy shows foamy lipid-laden macrophages
    n1=hyperaldostéronisme secondaire | n2=en:biopsy shows foamy lipid-laden macrophages | rel=r_associated | relid=0 | w=5
  691. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:biopsy shows white matter hypomyelination, demyelination, gliosis
    n1=hyperaldostéronisme secondaire | n2=en:biopsy shows white matter hypomyelination, demyelination, gliosis | rel=r_associated | relid=0 | w=5
  692. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bipolar disorder
    n1=hyperaldostéronisme secondaire | n2=en:bipolar disorder | rel=r_associated | relid=0 | w=5
  693. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:birth weight
    n1=hyperaldostéronisme secondaire | n2=en:birth weight | rel=r_associated | relid=0 | w=5
  694. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:blake's pouch (rare)
    n1=hyperaldostéronisme secondaire | n2=en:blake's pouch (rare) | rel=r_associated | relid=0 | w=5
  695. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:blunt or inappropriate affect
    n1=hyperaldostéronisme secondaire | n2=en:blunt or inappropriate affect | rel=r_associated | relid=0 | w=5
  696. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:blunted affect
    n1=hyperaldostéronisme secondaire | n2=en:blunted affect | rel=r_associated | relid=0 | w=5
  697. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:blurring of the gray-white junction (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:blurring of the gray-white junction (in type iib) | rel=r_associated | relid=0 | w=5
  698. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib) | rel=r_associated | relid=0 | w=5
  699. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:board and poorly defined gyri
    n1=hyperaldostéronisme secondaire | n2=en:board and poorly defined gyri | rel=r_associated | relid=0 | w=5
  700. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:borderline intelligence
    n1=hyperaldostéronisme secondaire | n2=en:borderline intelligence | rel=r_associated | relid=0 | w=5
  701. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brachial plexus injury
    n1=hyperaldostéronisme secondaire | n2=en:brachial plexus injury | rel=r_associated | relid=0 | w=5
  702. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bradykinesia
    n1=hyperaldostéronisme secondaire | n2=en:bradykinesia | rel=r_associated | relid=0 | w=5
  703. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bradykinesia (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:bradykinesia (in severe cases) | rel=r_associated | relid=0 | w=5
  704. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain
    n1=hyperaldostéronisme secondaire | n2=en:brain | rel=r_associated | relid=0 | w=5
  705. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain abscess
    n1=hyperaldostéronisme secondaire | n2=en:brain abscess | rel=r_associated | relid=0 | w=5
  706. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain and nerves
    n1=hyperaldostéronisme secondaire | n2=en:brain and nerves | rel=r_associated | relid=0 | w=5
  707. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain and spinal cord structure
    n1=hyperaldostéronisme secondaire | n2=en:brain and spinal cord structure | rel=r_associated | relid=0 | w=5
  708. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain aneurysm
    n1=hyperaldostéronisme secondaire | n2=en:brain aneurysm | rel=r_associated | relid=0 | w=5
  709. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain atrophy (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:brain atrophy (1 family) | rel=r_associated | relid=0 | w=5
  710. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:brain atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  711. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:brain atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  712. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain atrophy seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:brain atrophy seen on mri | rel=r_associated | relid=0 | w=5
  713. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain atrophy, particularly of the frontal and temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:brain atrophy, particularly of the frontal and temporal lobes | rel=r_associated | relid=0 | w=5
  714. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain calcification (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:brain calcification (if left untreated) | rel=r_associated | relid=0 | w=5
  715. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain circuit
    n1=hyperaldostéronisme secondaire | n2=en:brain circuit | rel=r_associated | relid=0 | w=5
  716. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain disorder
    n1=hyperaldostéronisme secondaire | n2=en:brain disorder | rel=r_associated | relid=0 | w=5
  717. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain edema
    n1=hyperaldostéronisme secondaire | n2=en:brain edema | rel=r_associated | relid=0 | w=5
  718. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain edema following head injury (less common)
    n1=hyperaldostéronisme secondaire | n2=en:brain edema following head injury (less common) | rel=r_associated | relid=0 | w=5
  719. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows calcification of the dentate nucleus
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows calcification of the dentate nucleus | rel=r_associated | relid=0 | w=5
  720. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows cortical atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows cortical atrophy | rel=r_associated | relid=0 | w=5
  721. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows decreased white matter density
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows decreased white matter density | rel=r_associated | relid=0 | w=5
  722. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows diffuse white matter abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows diffuse white matter abnormalities | rel=r_associated | relid=0 | w=5
  723. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe | rel=r_associated | relid=0 | w=5
  724. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows generalized atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows generalized atrophy | rel=r_associated | relid=0 | w=5
  725. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows hypomyelination
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows hypomyelination | rel=r_associated | relid=0 | w=5
  726. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows lesions in the thalami, brainstem, and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows lesions in the thalami, brainstem, and cerebellum | rel=r_associated | relid=0 | w=5
  727. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain imaging shows white-matter hypodensities and demyelination
    n1=hyperaldostéronisme secondaire | n2=en:brain imaging shows white-matter hypodensities and demyelination | rel=r_associated | relid=0 | w=5
  728. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain injury
    n1=hyperaldostéronisme secondaire | n2=en:brain injury | rel=r_associated | relid=0 | w=5
  729. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain iron accumulation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:brain iron accumulation (in some patients) | rel=r_associated | relid=0 | w=5
  730. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain iron accumulation in the basal ganglia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:brain iron accumulation in the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=5
  731. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family) | rel=r_associated | relid=0 | w=5
  732. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows abnormal gyral pattern in frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows abnormal gyral pattern in frontal lobes | rel=r_associated | relid=0 | w=5
  733. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows arrest in myelination
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows arrest in myelination | rel=r_associated | relid=0 | w=5
  734. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows cerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows cerebellar atrophy | rel=r_associated | relid=0 | w=5
  735. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows cerebellar atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows cerebellar atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  736. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows cerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows cerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  737. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows cortical atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows cortical atrophy | rel=r_associated | relid=0 | w=5
  738. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows diffusion abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows diffusion abnormalities | rel=r_associated | relid=0 | w=5
  739. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows flattening of the ventral pons
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows flattening of the ventral pons | rel=r_associated | relid=0 | w=5
  740. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows hyperintensities in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows hyperintensities in the basal ganglia | rel=r_associated | relid=0 | w=5
  741. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows hypoplasia of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=5
  742. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows hypoplastic pituitary
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows hypoplastic pituitary | rel=r_associated | relid=0 | w=5
  743. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows lesions consistent with epileptic episodes
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows lesions consistent with epileptic episodes | rel=r_associated | relid=0 | w=5
  744. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows lesions in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows lesions in the basal ganglia | rel=r_associated | relid=0 | w=5
  745. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows molar tooth sign
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows molar tooth sign | rel=r_associated | relid=0 | w=5
  746. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows proportionate pontocerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows proportionate pontocerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  747. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows signal abnormalities in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows signal abnormalities in the basal ganglia | rel=r_associated | relid=0 | w=5
  748. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mri shows t2-weighted hyperintensities (17%)
    n1=hyperaldostéronisme secondaire | n2=en:brain mri shows t2-weighted hyperintensities (17%) | rel=r_associated | relid=0 | w=5
  749. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mrs shows decreased creatine content
    n1=hyperaldostéronisme secondaire | n2=en:brain mrs shows decreased creatine content | rel=r_associated | relid=0 | w=5
  750. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter
    n1=hyperaldostéronisme secondaire | n2=en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter | rel=r_associated | relid=0 | w=5
  751. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain neoplasm
    n1=hyperaldostéronisme secondaire | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=5
  752. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd)
    n1=hyperaldostéronisme secondaire | n2=en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd) | rel=r_associated | relid=0 | w=5
  753. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain small vessel disease with hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:brain small vessel disease with hemorrhage | rel=r_associated | relid=0 | w=5
  754. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain stem
    n1=hyperaldostéronisme secondaire | n2=en:brain stem | rel=r_associated | relid=0 | w=5
  755. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain stem atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brain stem atrophy | rel=r_associated | relid=0 | w=5
  756. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain stem atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:brain stem atrophy, progressive | rel=r_associated | relid=0 | w=5
  757. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum | rel=r_associated | relid=0 | w=5
  758. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain tissue shows cavitation of the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:brain tissue shows cavitation of the basal ganglia | rel=r_associated | relid=0 | w=5
  759. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain vascular anomalies (rare)
    n1=hyperaldostéronisme secondaire | n2=en:brain vascular anomalies (rare) | rel=r_associated | relid=0 | w=5
  760. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brain white matter hyperintensities on mri
    n1=hyperaldostéronisme secondaire | n2=en:brain white matter hyperintensities on mri | rel=r_associated | relid=0 | w=5
  761. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem atrophy
    n1=hyperaldostéronisme secondaire | n2=en:brainstem atrophy | rel=r_associated | relid=0 | w=5
  762. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem concavity
    n1=hyperaldostéronisme secondaire | n2=en:brainstem concavity | rel=r_associated | relid=0 | w=5
  763. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem damage
    n1=hyperaldostéronisme secondaire | n2=en:brainstem damage | rel=r_associated | relid=0 | w=5
  764. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:brainstem dysplasia | rel=r_associated | relid=0 | w=5
  765. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem hypoplasia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:brainstem hypoplasia (1 patient) | rel=r_associated | relid=0 | w=5
  766. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem hypoplasia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:brainstem hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
  767. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem lesions, hyperintense on t2-weighted imaging
    n1=hyperaldostéronisme secondaire | n2=en:brainstem lesions, hyperintense on t2-weighted imaging | rel=r_associated | relid=0 | w=5
  768. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem may show neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:brainstem may show neuronal loss | rel=r_associated | relid=0 | w=5
  769. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brainstem white matter lesions
    n1=hyperaldostéronisme secondaire | n2=en:brainstem white matter lesions | rel=r_associated | relid=0 | w=5
  770. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:breath holding
    n1=hyperaldostéronisme secondaire | n2=en:breath holding | rel=r_associated | relid=0 | w=5
  771. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:breath-holding episodes
    n1=hyperaldostéronisme secondaire | n2=en:breath-holding episodes | rel=r_associated | relid=0 | w=5
  772. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:breathing difficulty due to vocal cord paralysis
    n1=hyperaldostéronisme secondaire | n2=en:breathing difficulty due to vocal cord paralysis | rel=r_associated | relid=0 | w=5
  773. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brief involuntary movements of upper extremities
    n1=hyperaldostéronisme secondaire | n2=en:brief involuntary movements of upper extremities | rel=r_associated | relid=0 | w=5
  774. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brisk knee reflexes (early-on)
    n1=hyperaldostéronisme secondaire | n2=en:brisk knee reflexes (early-on) | rel=r_associated | relid=0 | w=5
  775. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brisk lower limb reflexes (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:brisk lower limb reflexes (in some patients) | rel=r_associated | relid=0 | w=5
  776. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brisk reflexes
    n1=hyperaldostéronisme secondaire | n2=en:brisk reflexes | rel=r_associated | relid=0 | w=5
  777. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brisk reflexes (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:brisk reflexes (1 patient) | rel=r_associated | relid=0 | w=5
  778. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:brisk tendon reflex
    n1=hyperaldostéronisme secondaire | n2=en:brisk tendon reflex | rel=r_associated | relid=0 | w=5
  779. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:broad gait
    n1=hyperaldostéronisme secondaire | n2=en:broad gait | rel=r_associated | relid=0 | w=5
  780. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:broad-based gait
    n1=hyperaldostéronisme secondaire | n2=en:broad-based gait | rel=r_associated | relid=0 | w=5
  781. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:broad-based gait (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:broad-based gait (1 patient) | rel=r_associated | relid=0 | w=5
  782. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:broca's aphasia
    n1=hyperaldostéronisme secondaire | n2=en:broca's aphasia | rel=r_associated | relid=0 | w=5
  783. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bruxism
    n1=hyperaldostéronisme secondaire | n2=en:bruxism | rel=r_associated | relid=0 | w=5
  784. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:buccolingofacial dyspraxia
    n1=hyperaldostéronisme secondaire | n2=en:buccolingofacial dyspraxia | rel=r_associated | relid=0 | w=5
  785. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar and upper limb symptoms more severe than lower limb symptoms
    n1=hyperaldostéronisme secondaire | n2=en:bulbar and upper limb symptoms more severe than lower limb symptoms | rel=r_associated | relid=0 | w=5
  786. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:bulbar dysfunction | rel=r_associated | relid=0 | w=5
  787. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar dysfunction (e.g. dysarthria and dysphagia)
    n1=hyperaldostéronisme secondaire | n2=en:bulbar dysfunction (e.g. dysarthria and dysphagia) | rel=r_associated | relid=0 | w=5
  788. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar dysfunction (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:bulbar dysfunction (in some patients) | rel=r_associated | relid=0 | w=5
  789. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar dysfunction (juvenile-onset, less common)
    n1=hyperaldostéronisme secondaire | n2=en:bulbar dysfunction (juvenile-onset, less common) | rel=r_associated | relid=0 | w=5
  790. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar involvement
    n1=hyperaldostéronisme secondaire | n2=en:bulbar involvement | rel=r_associated | relid=0 | w=5
  791. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar paresis
    n1=hyperaldostéronisme secondaire | n2=en:bulbar paresis | rel=r_associated | relid=0 | w=5
  792. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar signs
    n1=hyperaldostéronisme secondaire | n2=en:bulbar signs | rel=r_associated | relid=0 | w=5
  793. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar spasticity
    n1=hyperaldostéronisme secondaire | n2=en:bulbar spasticity | rel=r_associated | relid=0 | w=5
  794. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar symptoms may occur (less common)
    n1=hyperaldostéronisme secondaire | n2=en:bulbar symptoms may occur (less common) | rel=r_associated | relid=0 | w=5
  795. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulbar weakness
    n1=hyperaldostéronisme secondaire | n2=en:bulbar weakness | rel=r_associated | relid=0 | w=5
  796. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bulging of the caudate nuclei
    n1=hyperaldostéronisme secondaire | n2=en:bulging of the caudate nuclei | rel=r_associated | relid=0 | w=5
  797. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:bullying
    n1=hyperaldostéronisme secondaire | n2=en:bullying | rel=r_associated | relid=0 | w=5
  798. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:burning or tingling of plantar surface of foot (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:burning or tingling of plantar surface of foot (in some patients) | rel=r_associated | relid=0 | w=5
  799. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:burning pain in the limbs
    n1=hyperaldostéronisme secondaire | n2=en:burning pain in the limbs | rel=r_associated | relid=0 | w=5
  800. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:burst suppression pattern on neonatal eeg
    n1=hyperaldostéronisme secondaire | n2=en:burst suppression pattern on neonatal eeg | rel=r_associated | relid=0 | w=5
  801. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:burst suppression pattern seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:burst suppression pattern seen on eeg | rel=r_associated | relid=0 | w=5
  802. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:by 10-15 years after onset, postural dystonia spreads to all limbs
    n1=hyperaldostéronisme secondaire | n2=en:by 10-15 years after onset, postural dystonia spreads to all limbs | rel=r_associated | relid=0 | w=5
  803. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:c-cell hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  804. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:c3hex, decreased ability to smell
    n1=hyperaldostéronisme secondaire | n2=en:c3hex, decreased ability to smell | rel=r_associated | relid=0 | w=5
  805. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcification in the pons and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:calcification in the pons and cerebellum | rel=r_associated | relid=0 | w=5
  806. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter
    n1=hyperaldostéronisme secondaire | n2=en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter | rel=r_associated | relid=0 | w=5
  807. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcification of the amygdala and the amygdala-hippocampal transition area
    n1=hyperaldostéronisme secondaire | n2=en:calcification of the amygdala and the amygdala-hippocampal transition area | rel=r_associated | relid=0 | w=5
  808. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcification of the falx
    n1=hyperaldostéronisme secondaire | n2=en:calcification of the falx | rel=r_associated | relid=0 | w=5
  809. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord | rel=r_associated | relid=0 | w=5
  810. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex
    n1=hyperaldostéronisme secondaire | n2=en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex | rel=r_associated | relid=0 | w=5
  811. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calcifications of cerebral ventricles
    n1=hyperaldostéronisme secondaire | n2=en:calcifications of cerebral ventricles | rel=r_associated | relid=0 | w=5
  812. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:calicification of the falx cerebri
    n1=hyperaldostéronisme secondaire | n2=en:calicification of the falx cerebri | rel=r_associated | relid=0 | w=5
  813. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:canavan disease
    n1=hyperaldostéronisme secondaire | n2=en:canavan disease | rel=r_associated | relid=0 | w=5
  814. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cancer--living with cancer
    n1=hyperaldostéronisme secondaire | n2=en:cancer--living with cancer | rel=r_associated | relid=0 | w=5
  815. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:candidal meningitis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:candidal meningitis (in some patients) | rel=r_associated | relid=0 | w=5
  816. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:carpal tunnel syndrome
    n1=hyperaldostéronisme secondaire | n2=en:carpal tunnel syndrome | rel=r_associated | relid=0 | w=5
  817. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:carrier males show controlling and inflexible traits
    n1=hyperaldostéronisme secondaire | n2=en:carrier males show controlling and inflexible traits | rel=r_associated | relid=0 | w=5
  818. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:carrier males show obsessive features
    n1=hyperaldostéronisme secondaire | n2=en:carrier males show obsessive features | rel=r_associated | relid=0 | w=5
  819. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:carrier males show rigid personality
    n1=hyperaldostéronisme secondaire | n2=en:carrier males show rigid personality | rel=r_associated | relid=0 | w=5
  820. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cataplexy
    n1=hyperaldostéronisme secondaire | n2=en:cataplexy | rel=r_associated | relid=0 | w=5
  821. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cataplexy often triggered by strong emotions
    n1=hyperaldostéronisme secondaire | n2=en:cataplexy often triggered by strong emotions | rel=r_associated | relid=0 | w=5
  822. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cataplexy, paroxysmal weakness or paralysis
    n1=hyperaldostéronisme secondaire | n2=en:cataplexy, paroxysmal weakness or paralysis | rel=r_associated | relid=0 | w=5
  823. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:catatonia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:catatonia (in some patients) | rel=r_associated | relid=0 | w=5
  824. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:catatonic behavior
    n1=hyperaldostéronisme secondaire | n2=en:catatonic behavior | rel=r_associated | relid=0 | w=5
  825. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cauda equina syndrome
    n1=hyperaldostéronisme secondaire | n2=en:cauda equina syndrome | rel=r_associated | relid=0 | w=5
  826. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:caudate atrophy
    n1=hyperaldostéronisme secondaire | n2=en:caudate atrophy | rel=r_associated | relid=0 | w=5
  827. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:caudate nuclei atrophy
    n1=hyperaldostéronisme secondaire | n2=en:caudate nuclei atrophy | rel=r_associated | relid=0 | w=5
  828. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cavitating leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:cavitating leukoencephalopathy | rel=r_associated | relid=0 | w=5
  829. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cavitating white matter degeneration
    n1=hyperaldostéronisme secondaire | n2=en:cavitating white matter degeneration | rel=r_associated | relid=0 | w=5
  830. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cavum septum pellucidum atrophy
    n1=hyperaldostéronisme secondaire | n2=en:cavum septum pellucidum atrophy | rel=r_associated | relid=0 | w=5
  831. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cavum vergae
    n1=hyperaldostéronisme secondaire | n2=en:cavum vergae | rel=r_associated | relid=0 | w=5
  832. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ccerebellar ataxia
    n1=hyperaldostéronisme secondaire | n2=en:ccerebellar ataxia | rel=r_associated | relid=0 | w=5
  833. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cell loss and gliosis in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:cell loss and gliosis in the basal ganglia | rel=r_associated | relid=0 | w=5
  834. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central canal malformation
    n1=hyperaldostéronisme secondaire | n2=en:central canal malformation | rel=r_associated | relid=0 | w=5
  835. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central facial nerve paralysis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:central facial nerve paralysis (rare) | rel=r_associated | relid=0 | w=5
  836. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central facial palsy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:central facial palsy (in some patients) | rel=r_associated | relid=0 | w=5
  837. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:central hypotonia | rel=r_associated | relid=0 | w=5
  838. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system | rel=r_associated | relid=0 | w=5
  839. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system degeneration
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system degeneration | rel=r_associated | relid=0 | w=5
  840. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system demyelination
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system demyelination | rel=r_associated | relid=0 | w=5
  841. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system involvement (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system involvement (in some patients) | rel=r_associated | relid=0 | w=5
  842. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system involvement in approximately 50% of patients
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system involvement in approximately 50% of patients | rel=r_associated | relid=0 | w=5
  843. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system malformations (40%)
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system malformations (40%) | rel=r_associated | relid=0 | w=5
  844. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system neoplasm
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=5
  845. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system part
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system part | rel=r_associated | relid=0 | w=5
  846. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central nervous system space
    n1=hyperaldostéronisme secondaire | n2=en:central nervous system space | rel=r_associated | relid=0 | w=5
  847. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:central neural pathway/tract
    n1=hyperaldostéronisme secondaire | n2=en:central neural pathway/tract | rel=r_associated | relid=0 | w=5
  848. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar and brainstem atrophy, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar and brainstem atrophy, mild (1 patient) | rel=r_associated | relid=0 | w=5
  849. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia | rel=r_associated | relid=0 | w=5
  850. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia (1 patient) | rel=r_associated | relid=0 | w=5
  851. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia (in 1 of 3 families)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia (in 1 of 3 families) | rel=r_associated | relid=0 | w=5
  852. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia (may be permanent in 50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia (may be permanent in 50% of patients) | rel=r_associated | relid=0 | w=5
  853. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia (rare) | rel=r_associated | relid=0 | w=5
  854. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia (seen in hhs variant)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia (seen in hhs variant) | rel=r_associated | relid=0 | w=5
  855. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia during episodes
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia during episodes | rel=r_associated | relid=0 | w=5
  856. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, adult-onset (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, adult-onset (in 1 family) | rel=r_associated | relid=0 | w=5
  857. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, gait and stance
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, gait and stance | rel=r_associated | relid=0 | w=5
  858. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, limb and trunk
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, limb and trunk | rel=r_associated | relid=0 | w=5
  859. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, mild, late-onset
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, mild, late-onset | rel=r_associated | relid=0 | w=5
  860. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, severe
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, severe | rel=r_associated | relid=0 | w=5
  861. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar ataxia, slowly progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar ataxia, slowly progressive | rel=r_associated | relid=0 | w=5
  862. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy | rel=r_associated | relid=0 | w=5
  863. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  864. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (96% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (96% of patients) | rel=r_associated | relid=0 | w=5
  865. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (especially in the superior cerebellar vermis)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (especially in the superior cerebellar vermis) | rel=r_associated | relid=0 | w=5
  866. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (especially of the vermis)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (especially of the vermis) | rel=r_associated | relid=0 | w=5
  867. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (in 1 family) | rel=r_associated | relid=0 | w=5
  868. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (in adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (in adulthood) | rel=r_associated | relid=0 | w=5
  869. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  870. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (juvenile form)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (juvenile form) | rel=r_associated | relid=0 | w=5
  871. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  872. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy in most cases
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy in most cases | rel=r_associated | relid=0 | w=5
  873. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy in older patients
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy in older patients | rel=r_associated | relid=0 | w=5
  874. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy seen on mri | rel=r_associated | relid=0 | w=5
  875. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri | rel=r_associated | relid=0 | w=5
  876. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, diffuse, severe
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, diffuse, severe | rel=r_associated | relid=0 | w=5
  877. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, mild
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, mild | rel=r_associated | relid=0 | w=5
  878. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, mild (1 patient) | rel=r_associated | relid=0 | w=5
  879. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, mild (in 1 of 3 families)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, mild (in 1 of 3 families) | rel=r_associated | relid=0 | w=5
  880. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, particularly of the hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, particularly of the hemispheres | rel=r_associated | relid=0 | w=5
  881. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, progressive | rel=r_associated | relid=0 | w=5
  882. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, progressive (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, progressive (1 patient) | rel=r_associated | relid=0 | w=5
  883. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy) | rel=r_associated | relid=0 | w=5
  884. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, progressive (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, progressive (in some patients) | rel=r_associated | relid=0 | w=5
  885. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar atrophy, severe
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar atrophy, severe | rel=r_associated | relid=0 | w=5
  886. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar calcifications
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar calcifications | rel=r_associated | relid=0 | w=5
  887. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cell paucity, more marked in vermis than hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cell paucity, more marked in vermis than hemispheres | rel=r_associated | relid=0 | w=5
  888. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cortex shows normal layers
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cortex shows normal layers | rel=r_associated | relid=0 | w=5
  889. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cortical degeneration
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cortical degeneration | rel=r_associated | relid=0 | w=5
  890. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cyst
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cyst | rel=r_associated | relid=0 | w=5
  891. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cyst (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cyst (rare) | rel=r_associated | relid=0 | w=5
  892. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar cysts (meb)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar cysts (meb) | rel=r_associated | relid=0 | w=5
  893. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar degeneration
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar degeneration | rel=r_associated | relid=0 | w=5
  894. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar diseases
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar diseases | rel=r_associated | relid=0 | w=5
  895. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar dysarthria
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar dysarthria | rel=r_associated | relid=0 | w=5
  896. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar dysfunction, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar dysfunction, progressive | rel=r_associated | relid=0 | w=5
  897. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar dysplasia | rel=r_associated | relid=0 | w=5
  898. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar enlargement
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar enlargement | rel=r_associated | relid=0 | w=5
  899. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar gangliocytoma manifesting as seizure and tremor
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar gangliocytoma manifesting as seizure and tremor | rel=r_associated | relid=0 | w=5
  900. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hemangioblastoma
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hemangioblastoma | rel=r_associated | relid=0 | w=5
  901. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hemorrhage (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hemorrhage (rare) | rel=r_associated | relid=0 | w=5
  902. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar herniation (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar herniation (rare) | rel=r_associated | relid=0 | w=5
  903. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar heterotopias
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar heterotopias | rel=r_associated | relid=0 | w=5
  904. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (1 patient) | rel=r_associated | relid=0 | w=5
  905. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (in 1 of 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
  906. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (in 1 of 2 sibs)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=5
  907. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (in most patients) | rel=r_associated | relid=0 | w=5
  908. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
  909. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (in some)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (in some) | rel=r_associated | relid=0 | w=5
  910. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (male)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (male) | rel=r_associated | relid=0 | w=5
  911. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (reported in 1 family) | rel=r_associated | relid=0 | w=5
  912. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (seen in hhs variant)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (seen in hhs variant) | rel=r_associated | relid=0 | w=5
  913. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (seen in recessive form)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (seen in recessive form) | rel=r_associated | relid=0 | w=5
  914. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia (variable)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia (variable) | rel=r_associated | relid=0 | w=5
  915. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia due to enlarged foramen magnum
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia due to enlarged foramen magnum | rel=r_associated | relid=0 | w=5
  916. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia or agenesis
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia or agenesis | rel=r_associated | relid=0 | w=5
  917. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia predominantly affecting the vermis
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia predominantly affecting the vermis | rel=r_associated | relid=0 | w=5
  918. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia, mild (in some patients) | rel=r_associated | relid=0 | w=5
  919. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia, mild asymmetric (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia, mild asymmetric (rare) | rel=r_associated | relid=0 | w=5
  920. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia, particularly of the hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia, particularly of the hemispheres | rel=r_associated | relid=0 | w=5
  921. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia, severe (wws)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia, severe (wws) | rel=r_associated | relid=0 | w=5
  922. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar hypoplasia/atrophy (27%)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar hypoplasia/atrophy (27%) | rel=r_associated | relid=0 | w=5
  923. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar lesion nos
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar lesion nos | rel=r_associated | relid=0 | w=5
  924. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar medulloblastoma (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar medulloblastoma (rare) | rel=r_associated | relid=0 | w=5
  925. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar neuronal loss | rel=r_associated | relid=0 | w=5
  926. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar origin most likely
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar origin most likely | rel=r_associated | relid=0 | w=5
  927. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs | rel=r_associated | relid=0 | w=5
  928. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs (in some patients) | rel=r_associated | relid=0 | w=5
  929. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs (less common)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs (less common) | rel=r_associated | relid=0 | w=5
  930. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs (may be permanent in 50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs (may be permanent in 50% of patients) | rel=r_associated | relid=0 | w=5
  931. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs (more common in variant cjd)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs (more common in variant cjd) | rel=r_associated | relid=0 | w=5
  932. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs during episodes
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs during episodes | rel=r_associated | relid=0 | w=5
  933. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs may develop
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs may develop | rel=r_associated | relid=0 | w=5
  934. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar signs, mild (in 1 of 3 families)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar signs, mild (in 1 of 3 families) | rel=r_associated | relid=0 | w=5
  935. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar stroke
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar stroke | rel=r_associated | relid=0 | w=5
  936. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar tonsil herniation
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar tonsil herniation | rel=r_associated | relid=0 | w=5
  937. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar tonsillar herniation
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar tonsillar herniation | rel=r_associated | relid=0 | w=5
  938. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar vermis aplasia or hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar vermis aplasia or hypoplasia | rel=r_associated | relid=0 | w=5
  939. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar vermis atrophy
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar vermis atrophy | rel=r_associated | relid=0 | w=5
  940. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar vermis hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar vermis hypoplasia | rel=r_associated | relid=0 | w=5
  941. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar vermis hypoplasia (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar vermis hypoplasia (in 1 patient) | rel=r_associated | relid=0 | w=5
  942. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar vermis hypoplasia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar vermis hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
  943. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellar white matter lesions on mri
    n1=hyperaldostéronisme secondaire | n2=en:cerebellar white matter lesions on mri | rel=r_associated | relid=0 | w=5
  944. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:cerebellum | rel=r_associated | relid=0 | w=5
  945. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral and cerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:cerebral and cerebellar atrophy | rel=r_associated | relid=0 | w=5
  946. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral arterial hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:cerebral arterial hemorrhage | rel=r_associated | relid=0 | w=5
  947. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=5
  948. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  949. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (in 1 family) | rel=r_associated | relid=0 | w=5
  950. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (in severe cases) | rel=r_associated | relid=0 | w=5
  951. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  952. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (rare) | rel=r_associated | relid=0 | w=5
  953. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  954. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy diffuse
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy diffuse | rel=r_associated | relid=0 | w=5
  955. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, diffuse, severe
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, diffuse, severe | rel=r_associated | relid=0 | w=5
  956. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, frontotemporal, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, frontotemporal, progressive | rel=r_associated | relid=0 | w=5
  957. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, generalized mild
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, generalized mild | rel=r_associated | relid=0 | w=5
  958. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, mild
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, mild | rel=r_associated | relid=0 | w=5
  959. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, mild, diffuse
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, mild, diffuse | rel=r_associated | relid=0 | w=5
  960. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, progressive | rel=r_associated | relid=0 | w=5
  961. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, progressive, from anterior to posterior
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, progressive, from anterior to posterior | rel=r_associated | relid=0 | w=5
  962. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral atrophy, severe
    n1=hyperaldostéronisme secondaire | n2=en:cerebral atrophy, severe | rel=r_associated | relid=0 | w=5
  963. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral calcification
    n1=hyperaldostéronisme secondaire | n2=en:cerebral calcification | rel=r_associated | relid=0 | w=5
  964. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cavernous malformation
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cavernous malformation | rel=r_associated | relid=0 | w=5
  965. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortex myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortex myoclonus | rel=r_associated | relid=0 | w=5
  966. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortex with spongiform changes
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortex with spongiform changes | rel=r_associated | relid=0 | w=5
  967. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortical and cerebellar atrophy (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortical and cerebellar atrophy (patient a) | rel=r_associated | relid=0 | w=5
  968. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortical atrophy, diffuse
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortical atrophy, diffuse | rel=r_associated | relid=0 | w=5
  969. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortical atrophy, especially frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortical atrophy, especially frontal lobes | rel=r_associated | relid=0 | w=5
  970. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cortical neurodegeneration
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cortical neurodegeneration | rel=r_associated | relid=0 | w=5
  971. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral cyst
    n1=hyperaldostéronisme secondaire | n2=en:cerebral cyst | rel=r_associated | relid=0 | w=5
  972. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral degeneration
    n1=hyperaldostéronisme secondaire | n2=en:cerebral degeneration | rel=r_associated | relid=0 | w=5
  973. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral demyelination and inflammation
    n1=hyperaldostéronisme secondaire | n2=en:cerebral demyelination and inflammation | rel=r_associated | relid=0 | w=5
  974. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral dysmyelination
    n1=hyperaldostéronisme secondaire | n2=en:cerebral dysmyelination | rel=r_associated | relid=0 | w=5
  975. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral edema
    n1=hyperaldostéronisme secondaire | n2=en:cerebral edema | rel=r_associated | relid=0 | w=5
  976. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:cerebral hemorrhage | rel=r_associated | relid=0 | w=5
  977. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral hypomyelination
    n1=hyperaldostéronisme secondaire | n2=en:cerebral hypomyelination | rel=r_associated | relid=0 | w=5
  978. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:cerebral hypoplasia | rel=r_associated | relid=0 | w=5
  979. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral infarction
    n1=hyperaldostéronisme secondaire | n2=en:cerebral infarction | rel=r_associated | relid=0 | w=5
  980. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral infarction dandy-walker malformation
    n1=hyperaldostéronisme secondaire | n2=en:cerebral infarction dandy-walker malformation | rel=r_associated | relid=0 | w=5
  981. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral malformations
    n1=hyperaldostéronisme secondaire | n2=en:cerebral malformations | rel=r_associated | relid=0 | w=5
  982. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral oligogyria
    n1=hyperaldostéronisme secondaire | n2=en:cerebral oligogyria | rel=r_associated | relid=0 | w=5
  983. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral palsy
    n1=hyperaldostéronisme secondaire | n2=en:cerebral palsy | rel=r_associated | relid=0 | w=5
  984. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral spongiosis
    n1=hyperaldostéronisme secondaire | n2=en:cerebral spongiosis | rel=r_associated | relid=0 | w=5
  985. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral thrombosis
    n1=hyperaldostéronisme secondaire | n2=en:cerebral thrombosis | rel=r_associated | relid=0 | w=5
  986. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency) | rel=r_associated | relid=0 | w=5
  987. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral vasculitis or vasculopathy (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral vasculitis or vasculopathy (rare) | rel=r_associated | relid=0 | w=5
  988. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral white matter atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cerebral white matter atrophy, progressive | rel=r_associated | relid=0 | w=5
  989. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral white matter lesion
    n1=hyperaldostéronisme secondaire | n2=en:cerebral white matter lesion | rel=r_associated | relid=0 | w=5
  990. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebral white matter lesions (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cerebral white matter lesions (1 patient) | rel=r_associated | relid=0 | w=5
  991. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrospinal fluid
    n1=hyperaldostéronisme secondaire | n2=en:cerebrospinal fluid | rel=r_associated | relid=0 | w=5
  992. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrospinal fluid glucose decreased
    n1=hyperaldostéronisme secondaire | n2=en:cerebrospinal fluid glucose decreased | rel=r_associated | relid=0 | w=5
  993. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva)
    n1=hyperaldostéronisme secondaire | n2=en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
  994. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrovascular accident
    n1=hyperaldostéronisme secondaire | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=5
  995. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrovascular accident (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cerebrovascular accident (in some patients) | rel=r_associated | relid=0 | w=5
  996. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrovascular ischemia
    n1=hyperaldostéronisme secondaire | n2=en:cerebrovascular ischemia | rel=r_associated | relid=0 | w=5
  997. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings)
    n1=hyperaldostéronisme secondaire | n2=en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings) | rel=r_associated | relid=0 | w=5
  998. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cervical cord compression
    n1=hyperaldostéronisme secondaire | n2=en:cervical cord compression | rel=r_associated | relid=0 | w=5
  999. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cervical myelopathy
    n1=hyperaldostéronisme secondaire | n2=en:cervical myelopathy | rel=r_associated | relid=0 | w=5
  1000. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:characteristic arm position with wrist and elbow flexion
    n1=hyperaldostéronisme secondaire | n2=en:characteristic arm position with wrist and elbow flexion | rel=r_associated | relid=0 | w=5
  1001. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:characteristic electroencephalogram (eeg) discharges
    n1=hyperaldostéronisme secondaire | n2=en:characteristic electroencephalogram (eeg) discharges | rel=r_associated | relid=0 | w=5
  1002. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:characteristic findings on mri
    n1=hyperaldostéronisme secondaire | n2=en:characteristic findings on mri | rel=r_associated | relid=0 | w=5
  1003. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd)
    n1=hyperaldostéronisme secondaire | n2=en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd) | rel=r_associated | relid=0 | w=5
  1004. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:charcot-marie-tooth disease
    n1=hyperaldostéronisme secondaire | n2=en:charcot-marie-tooth disease | rel=r_associated | relid=0 | w=5
  1005. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cheerful personality
    n1=hyperaldostéronisme secondaire | n2=en:cheerful personality | rel=r_associated | relid=0 | w=5
  1006. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari i malformation of the cerebellum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:chiari i malformation of the cerebellum (in some patients) | rel=r_associated | relid=0 | w=5
  1007. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari i malformation on mri
    n1=hyperaldostéronisme secondaire | n2=en:chiari i malformation on mri | rel=r_associated | relid=0 | w=5
  1008. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari i malformation on mri (some)
    n1=hyperaldostéronisme secondaire | n2=en:chiari i malformation on mri (some) | rel=r_associated | relid=0 | w=5
  1009. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari malformation (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:chiari malformation (uncommon) | rel=r_associated | relid=0 | w=5
  1010. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari malformation type ii
    n1=hyperaldostéronisme secondaire | n2=en:chiari malformation type ii | rel=r_associated | relid=0 | w=5
  1011. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari type i
    n1=hyperaldostéronisme secondaire | n2=en:chiari type i | rel=r_associated | relid=0 | w=5
  1012. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chiari type i malformation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:chiari type i malformation (in some patients) | rel=r_associated | relid=0 | w=5
  1013. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chicken pox
    n1=hyperaldostéronisme secondaire | n2=en:chicken pox | rel=r_associated | relid=0 | w=5
  1014. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child abuse and neglect
    n1=hyperaldostéronisme secondaire | n2=en:child abuse and neglect | rel=r_associated | relid=0 | w=5
  1015. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child attention deficit disorder
    n1=hyperaldostéronisme secondaire | n2=en:child attention deficit disorder | rel=r_associated | relid=0 | w=5
  1016. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child behavior disorders
    n1=hyperaldostéronisme secondaire | n2=en:child behavior disorders | rel=r_associated | relid=0 | w=5
  1017. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child care
    n1=hyperaldostéronisme secondaire | n2=en:child care | rel=r_associated | relid=0 | w=5
  1018. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child dental health
    n1=hyperaldostéronisme secondaire | n2=en:child dental health | rel=r_associated | relid=0 | w=5
  1019. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child development
    n1=hyperaldostéronisme secondaire | n2=en:child development | rel=r_associated | relid=0 | w=5
  1020. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child health care
    n1=hyperaldostéronisme secondaire | n2=en:child health care | rel=r_associated | relid=0 | w=5
  1021. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child mental health
    n1=hyperaldostéronisme secondaire | n2=en:child mental health | rel=r_associated | relid=0 | w=5
  1022. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child nutritional physiological phenomena
    n1=hyperaldostéronisme secondaire | n2=en:child nutritional physiological phenomena | rel=r_associated | relid=0 | w=5
  1023. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child safety
    n1=hyperaldostéronisme secondaire | n2=en:child safety | rel=r_associated | relid=0 | w=5
  1024. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:child sexual abuse
    n1=hyperaldostéronisme secondaire | n2=en:child sexual abuse | rel=r_associated | relid=0 | w=5
  1025. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childbirth problems
    n1=hyperaldostéronisme secondaire | n2=en:childbirth problems | rel=r_associated | relid=0 | w=5
  1026. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood asthma
    n1=hyperaldostéronisme secondaire | n2=en:childhood asthma | rel=r_associated | relid=0 | w=5
  1027. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood brain neoplasm
    n1=hyperaldostéronisme secondaire | n2=en:childhood brain neoplasm | rel=r_associated | relid=0 | w=5
  1028. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood depression
    n1=hyperaldostéronisme secondaire | n2=en:childhood depression | rel=r_associated | relid=0 | w=5
  1029. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood emotional disorder
    n1=hyperaldostéronisme secondaire | n2=en:childhood emotional disorder | rel=r_associated | relid=0 | w=5
  1030. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood immunization
    n1=hyperaldostéronisme secondaire | n2=en:childhood immunization | rel=r_associated | relid=0 | w=5
  1031. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood leukemia
    n1=hyperaldostéronisme secondaire | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=5
  1032. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood malignant neoplasm
    n1=hyperaldostéronisme secondaire | n2=en:childhood malignant neoplasm | rel=r_associated | relid=0 | w=5
  1033. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood obesity
    n1=hyperaldostéronisme secondaire | n2=en:childhood obesity | rel=r_associated | relid=0 | w=5
  1034. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:childhood polyphagia
    n1=hyperaldostéronisme secondaire | n2=en:childhood polyphagia | rel=r_associated | relid=0 | w=5
  1035. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:children's page
    n1=hyperaldostéronisme secondaire | n2=en:children's page | rel=r_associated | relid=0 | w=5
  1036. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea
    n1=hyperaldostéronisme secondaire | n2=en:chorea | rel=r_associated | relid=0 | w=5
  1037. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:chorea (in some patients) | rel=r_associated | relid=0 | w=5
  1038. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea of all limbs
    n1=hyperaldostéronisme secondaire | n2=en:chorea of all limbs | rel=r_associated | relid=0 | w=5
  1039. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea of hands
    n1=hyperaldostéronisme secondaire | n2=en:chorea of hands | rel=r_associated | relid=0 | w=5
  1040. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea-ballism
    n1=hyperaldostéronisme secondaire | n2=en:chorea-ballism | rel=r_associated | relid=0 | w=5
  1041. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea, mild (in some)
    n1=hyperaldostéronisme secondaire | n2=en:chorea, mild (in some) | rel=r_associated | relid=0 | w=5
  1042. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chorea, prominent (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:chorea, prominent (in some patients) | rel=r_associated | relid=0 | w=5
  1043. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreic movements (10 to 22% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:choreic movements (10 to 22% of patients) | rel=r_associated | relid=0 | w=5
  1044. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreic movements, episodic
    n1=hyperaldostéronisme secondaire | n2=en:choreic movements, episodic | rel=r_associated | relid=0 | w=5
  1045. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetoid movements
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetoid movements | rel=r_associated | relid=0 | w=5
  1046. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis | rel=r_associated | relid=0 | w=5
  1047. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis (2 patients) | rel=r_associated | relid=0 | w=5
  1048. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis (described in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis (described in 1 patient) | rel=r_associated | relid=0 | w=5
  1049. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis (in 79%), more frequent at disease onset
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis (in 79%), more frequent at disease onset | rel=r_associated | relid=0 | w=5
  1050. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis (in a subset of patients) | rel=r_associated | relid=0 | w=5
  1051. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis (in some patients) | rel=r_associated | relid=0 | w=5
  1052. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreoathetosis of the face, trunk, extremities
    n1=hyperaldostéronisme secondaire | n2=en:choreoathetosis of the face, trunk, extremities | rel=r_associated | relid=0 | w=5
  1053. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choreodystonia of the upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:choreodystonia of the upper limbs | rel=r_associated | relid=0 | w=5
  1054. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choristoma
    n1=hyperaldostéronisme secondaire | n2=en:choristoma | rel=r_associated | relid=0 | w=5
  1055. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choroid plexus calcification
    n1=hyperaldostéronisme secondaire | n2=en:choroid plexus calcification | rel=r_associated | relid=0 | w=5
  1056. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choroid plexus cyst
    n1=hyperaldostéronisme secondaire | n2=en:choroid plexus cyst | rel=r_associated | relid=0 | w=5
  1057. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:choroid plexus papilloma (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:choroid plexus papilloma (in some patients) | rel=r_associated | relid=0 | w=5
  1058. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic denervation
    n1=hyperaldostéronisme secondaire | n2=en:chronic denervation | rel=r_associated | relid=0 | w=5
  1059. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic headaches
    n1=hyperaldostéronisme secondaire | n2=en:chronic headaches | rel=r_associated | relid=0 | w=5
  1060. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic lymphocytic meningitis
    n1=hyperaldostéronisme secondaire | n2=en:chronic lymphocytic meningitis | rel=r_associated | relid=0 | w=5
  1061. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic pain
    n1=hyperaldostéronisme secondaire | n2=en:chronic pain | rel=r_associated | relid=0 | w=5
  1062. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic subtype, headaches occur without remission for 1 year
    n1=hyperaldostéronisme secondaire | n2=en:chronic subtype, headaches occur without remission for 1 year | rel=r_associated | relid=0 | w=5
  1063. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma
    n1=hyperaldostéronisme secondaire | n2=en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma | rel=r_associated | relid=0 | w=5
  1064. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clonic convulsion
    n1=hyperaldostéronisme secondaire | n2=en:clonic convulsion | rel=r_associated | relid=0 | w=5
  1065. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clonus
    n1=hyperaldostéronisme secondaire | n2=en:clonus | rel=r_associated | relid=0 | w=5
  1066. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clonus may occur
    n1=hyperaldostéronisme secondaire | n2=en:clonus may occur | rel=r_associated | relid=0 | w=5
  1067. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:closed-lip schizencephaly
    n1=hyperaldostéronisme secondaire | n2=en:closed-lip schizencephaly | rel=r_associated | relid=0 | w=5
  1068. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsiness
    n1=hyperaldostéronisme secondaire | n2=en:clumsiness | rel=r_associated | relid=0 | w=5
  1069. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsiness (82%)
    n1=hyperaldostéronisme secondaire | n2=en:clumsiness (82%) | rel=r_associated | relid=0 | w=5
  1070. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsiness (mild)
    n1=hyperaldostéronisme secondaire | n2=en:clumsiness (mild) | rel=r_associated | relid=0 | w=5
  1071. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsiness in childhood
    n1=hyperaldostéronisme secondaire | n2=en:clumsiness in childhood | rel=r_associated | relid=0 | w=5
  1072. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsiness, unsteadiness
    n1=hyperaldostéronisme secondaire | n2=en:clumsiness, unsteadiness | rel=r_associated | relid=0 | w=5
  1073. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:clumsy gait
    n1=hyperaldostéronisme secondaire | n2=en:clumsy gait | rel=r_associated | relid=0 | w=5
  1074. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cns component
    n1=hyperaldostéronisme secondaire | n2=en:cns component | rel=r_associated | relid=0 | w=5
  1075. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cns infarctions
    n1=hyperaldostéronisme secondaire | n2=en:cns infarctions | rel=r_associated | relid=0 | w=5
  1076. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cns venous malformations
    n1=hyperaldostéronisme secondaire | n2=en:cns venous malformations | rel=r_associated | relid=0 | w=5
  1077. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coarse tremors
    n1=hyperaldostéronisme secondaire | n2=en:coarse tremors | rel=r_associated | relid=0 | w=5
  1078. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coarsened pattern of sulci and gyri
    n1=hyperaldostéronisme secondaire | n2=en:coarsened pattern of sulci and gyri | rel=r_associated | relid=0 | w=5
  1079. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly | rel=r_associated | relid=0 | w=5
  1080. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly (1 patient) | rel=r_associated | relid=0 | w=5
  1081. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions)
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions) | rel=r_associated | relid=0 | w=5
  1082. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly, posterior frontal and parietal regions
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly, posterior frontal and parietal regions | rel=r_associated | relid=0 | w=5
  1083. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly, type ii
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly, type ii | rel=r_associated | relid=0 | w=5
  1084. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cobblestone lissencephaly, type ii (wws)
    n1=hyperaldostéronisme secondaire | n2=en:cobblestone lissencephaly, type ii (wws) | rel=r_associated | relid=0 | w=5
  1085. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cocktail party personality
    n1=hyperaldostéronisme secondaire | n2=en:cocktail party personality | rel=r_associated | relid=0 | w=5
  1086. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognition is preserved
    n1=hyperaldostéronisme secondaire | n2=en:cognition is preserved | rel=r_associated | relid=0 | w=5
  1087. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognition is spared
    n1=hyperaldostéronisme secondaire | n2=en:cognition is spared | rel=r_associated | relid=0 | w=5
  1088. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline (1 family) | rel=r_associated | relid=0 | w=5
  1089. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline (1 patient) | rel=r_associated | relid=0 | w=5
  1090. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline (in some patients) | rel=r_associated | relid=0 | w=5
  1091. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline (later in life)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline (later in life) | rel=r_associated | relid=0 | w=5
  1092. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline (rare) | rel=r_associated | relid=0 | w=5
  1093. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline in adulthood
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline in adulthood | rel=r_associated | relid=0 | w=5
  1094. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline in older patients
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline in older patients | rel=r_associated | relid=0 | w=5
  1095. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive decline, rapid
    n1=hyperaldostéronisme secondaire | n2=en:cognitive decline, rapid | rel=r_associated | relid=0 | w=5
  1096. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive defects (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive defects (rare) | rel=r_associated | relid=0 | w=5
  1097. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive defects (variable from mild to severe)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive defects (variable from mild to severe) | rel=r_associated | relid=0 | w=5
  1098. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive defects develop later in the disease
    n1=hyperaldostéronisme secondaire | n2=en:cognitive defects develop later in the disease | rel=r_associated | relid=0 | w=5
  1099. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive defects in executive function and attention
    n1=hyperaldostéronisme secondaire | n2=en:cognitive defects in executive function and attention | rel=r_associated | relid=0 | w=5
  1100. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive deficits (less common)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive deficits (less common) | rel=r_associated | relid=0 | w=5
  1101. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive deficits may occur
    n1=hyperaldostéronisme secondaire | n2=en:cognitive deficits may occur | rel=r_associated | relid=0 | w=5
  1102. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive deficits, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive deficits, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1103. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive delay
    n1=hyperaldostéronisme secondaire | n2=en:cognitive delay | rel=r_associated | relid=0 | w=5
  1104. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive delay, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive delay, mild (1 patient) | rel=r_associated | relid=0 | w=5
  1105. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive delay, mild to severe
    n1=hyperaldostéronisme secondaire | n2=en:cognitive delay, mild to severe | rel=r_associated | relid=0 | w=5
  1106. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive deterioration
    n1=hyperaldostéronisme secondaire | n2=en:cognitive deterioration | rel=r_associated | relid=0 | w=5
  1107. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:cognitive dysfunction | rel=r_associated | relid=0 | w=5
  1108. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive dysfunction (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive dysfunction (in some patients) | rel=r_associated | relid=0 | w=5
  1109. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive dysfunction (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive dysfunction (rare) | rel=r_associated | relid=0 | w=5
  1110. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive function, variable
    n1=hyperaldostéronisme secondaire | n2=en:cognitive function, variable | rel=r_associated | relid=0 | w=5
  1111. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive function: distractibility
    n1=hyperaldostéronisme secondaire | n2=en:cognitive function: distractibility | rel=r_associated | relid=0 | w=5
  1112. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment | rel=r_associated | relid=0 | w=5
  1113. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (1 family) | rel=r_associated | relid=0 | w=5
  1114. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (1 patient) | rel=r_associated | relid=0 | w=5
  1115. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (3 patients) | rel=r_associated | relid=0 | w=5
  1116. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (cvs+) | rel=r_associated | relid=0 | w=5
  1117. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (in 1 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (in 1 of 3 patients) | rel=r_associated | relid=0 | w=5
  1118. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (in some patients) | rel=r_associated | relid=0 | w=5
  1119. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment (rare) | rel=r_associated | relid=0 | w=5
  1120. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, gradual onset
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, gradual onset | rel=r_associated | relid=0 | w=5
  1121. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, mild (1 patient) | rel=r_associated | relid=0 | w=5
  1122. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, mild (44%)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, mild (44%) | rel=r_associated | relid=0 | w=5
  1123. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, mild (in 2 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, mild (in 2 of 3 patients) | rel=r_associated | relid=0 | w=5
  1124. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, mild to moderate | rel=r_associated | relid=0 | w=5
  1125. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive impairment, mild to severe
    n1=hyperaldostéronisme secondaire | n2=en:cognitive impairment, mild to severe | rel=r_associated | relid=0 | w=5
  1126. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive regression
    n1=hyperaldostéronisme secondaire | n2=en:cognitive regression | rel=r_associated | relid=0 | w=5
  1127. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cognitive regression, mild
    n1=hyperaldostéronisme secondaire | n2=en:cognitive regression, mild | rel=r_associated | relid=0 | w=5
  1128. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cogwheel rigidities
    n1=hyperaldostéronisme secondaire | n2=en:cogwheel rigidities | rel=r_associated | relid=0 | w=5
  1129. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cogwheel rigidity (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cogwheel rigidity (in some patients) | rel=r_associated | relid=0 | w=5
  1130. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:college health
    n1=hyperaldostéronisme secondaire | n2=en:college health | rel=r_associated | relid=0 | w=5
  1131. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:colpocephaly
    n1=hyperaldostéronisme secondaire | n2=en:colpocephaly | rel=r_associated | relid=0 | w=5
  1132. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma
    n1=hyperaldostéronisme secondaire | n2=en:coma | rel=r_associated | relid=0 | w=5
  1133. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma (if untreated)
    n1=hyperaldostéronisme secondaire | n2=en:coma (if untreated) | rel=r_associated | relid=0 | w=5
  1134. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma (in up to 33% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:coma (in up to 33% of patients) | rel=r_associated | relid=0 | w=5
  1135. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma (less common)
    n1=hyperaldostéronisme secondaire | n2=en:coma (less common) | rel=r_associated | relid=0 | w=5
  1136. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma during episodes (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:coma during episodes (in some patients) | rel=r_associated | relid=0 | w=5
  1137. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coma may occur after force feeding of high protein diet
    n1=hyperaldostéronisme secondaire | n2=en:coma may occur after force feeding of high protein diet | rel=r_associated | relid=0 | w=5
  1138. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:common infant and newborn problems
    n1=hyperaldostéronisme secondaire | n2=en:common infant and newborn problems | rel=r_associated | relid=0 | w=5
  1139. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:communicating hydrocephalus
    n1=hyperaldostéronisme secondaire | n2=en:communicating hydrocephalus | rel=r_associated | relid=0 | w=5
  1140. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:communication defects
    n1=hyperaldostéronisme secondaire | n2=en:communication defects | rel=r_associated | relid=0 | w=5
  1141. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:communication disorder, developmental
    n1=hyperaldostéronisme secondaire | n2=en:communication disorder, developmental | rel=r_associated | relid=0 | w=5
  1142. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complete or partial absence of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:complete or partial absence of the corpus callosum | rel=r_associated | relid=0 | w=5
  1143. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complete or partial absence of the corpus callosum (wws)
    n1=hyperaldostéronisme secondaire | n2=en:complete or partial absence of the corpus callosum (wws) | rel=r_associated | relid=0 | w=5
  1144. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex motor behavior such as sleep walking
    n1=hyperaldostéronisme secondaire | n2=en:complex motor behavior such as sleep walking | rel=r_associated | relid=0 | w=5
  1145. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex partial seizure with impairment of consciousness
    n1=hyperaldostéronisme secondaire | n2=en:complex partial seizure with impairment of consciousness | rel=r_associated | relid=0 | w=5
  1146. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex partial seizures
    n1=hyperaldostéronisme secondaire | n2=en:complex partial seizures | rel=r_associated | relid=0 | w=5
  1147. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex partial seizures (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:complex partial seizures (in some patients) | rel=r_associated | relid=0 | w=5
  1148. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex partial seizures, often with secondary generalization, are the most common type
    n1=hyperaldostéronisme secondaire | n2=en:complex partial seizures, often with secondary generalization, are the most common type | rel=r_associated | relid=0 | w=5
  1149. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:complex regional pain syndromes
    n1=hyperaldostéronisme secondaire | n2=en:complex regional pain syndromes | rel=r_associated | relid=0 | w=5
  1150. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:compromised expressive language development, severe
    n1=hyperaldostéronisme secondaire | n2=en:compromised expressive language development, severe | rel=r_associated | relid=0 | w=5
  1151. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:compulsion
    n1=hyperaldostéronisme secondaire | n2=en:compulsion | rel=r_associated | relid=0 | w=5
  1152. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:concentration impairment
    n1=hyperaldostéronisme secondaire | n2=en:concentration impairment | rel=r_associated | relid=0 | w=5
  1153. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:concussion
    n1=hyperaldostéronisme secondaire | n2=en:concussion | rel=r_associated | relid=0 | w=5
  1154. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:conduct disorder
    n1=hyperaldostéronisme secondaire | n2=en:conduct disorder | rel=r_associated | relid=0 | w=5
  1155. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:confusion
    n1=hyperaldostéronisme secondaire | n2=en:confusion | rel=r_associated | relid=0 | w=5
  1156. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:confusion (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:confusion (later-onset) | rel=r_associated | relid=0 | w=5
  1157. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:confusion, paroxysmal
    n1=hyperaldostéronisme secondaire | n2=en:confusion, paroxysmal | rel=r_associated | relid=0 | w=5
  1158. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital absence of the vermis
    n1=hyperaldostéronisme secondaire | n2=en:congenital absence of the vermis | rel=r_associated | relid=0 | w=5
  1159. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital anomaly of brain
    n1=hyperaldostéronisme secondaire | n2=en:congenital anomaly of brain | rel=r_associated | relid=0 | w=5
  1160. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital cerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:congenital cerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  1161. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital hyperammonaemia
    n1=hyperaldostéronisme secondaire | n2=en:congenital hyperammonaemia | rel=r_associated | relid=0 | w=5
  1162. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital hyperextension of limb
    n1=hyperaldostéronisme secondaire | n2=en:congenital hyperextension of limb | rel=r_associated | relid=0 | w=5
  1163. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital hypotonia, axial or generalized
    n1=hyperaldostéronisme secondaire | n2=en:congenital hypotonia, axial or generalized | rel=r_associated | relid=0 | w=5
  1164. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital hypotonia, mild
    n1=hyperaldostéronisme secondaire | n2=en:congenital hypotonia, mild | rel=r_associated | relid=0 | w=5
  1165. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:congenital porencephaly
    n1=hyperaldostéronisme secondaire | n2=en:congenital porencephaly | rel=r_associated | relid=0 | w=5
  1166. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:conn syndrome
    n1=hyperaldostéronisme secondaire | n2=en:conn syndrome | rel=r_associated | relid=0 | w=5
  1167. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:consciousness fluctuating
    n1=hyperaldostéronisme secondaire | n2=en:consciousness fluctuating | rel=r_associated | relid=0 | w=5
  1168. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:constructional apraxia (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:constructional apraxia (in a subset of patients) | rel=r_associated | relid=0 | w=5
  1169. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:continuous spike-wave discharges during sleep
    n1=hyperaldostéronisme secondaire | n2=en:continuous spike-wave discharges during sleep | rel=r_associated | relid=0 | w=5
  1170. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:continuous spike-waves during slow-wave sleep
    n1=hyperaldostéronisme secondaire | n2=en:continuous spike-waves during slow-wave sleep | rel=r_associated | relid=0 | w=5
  1171. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:contractures (older children and adolescents)
    n1=hyperaldostéronisme secondaire | n2=en:contractures (older children and adolescents) | rel=r_associated | relid=0 | w=5
  1172. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:contralateral hemiparesis, congenital
    n1=hyperaldostéronisme secondaire | n2=en:contralateral hemiparesis, congenital | rel=r_associated | relid=0 | w=5
  1173. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:convulsions, febrile (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:convulsions, febrile (in some patients) | rel=r_associated | relid=0 | w=5
  1174. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:convulsive seizures
    n1=hyperaldostéronisme secondaire | n2=en:convulsive seizures | rel=r_associated | relid=0 | w=5
  1175. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coping with chronic illness
    n1=hyperaldostéronisme secondaire | n2=en:coping with chronic illness | rel=r_associated | relid=0 | w=5
  1176. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:coping with disasters
    n1=hyperaldostéronisme secondaire | n2=en:coping with disasters | rel=r_associated | relid=0 | w=5
  1177. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corprolalia
    n1=hyperaldostéronisme secondaire | n2=en:corprolalia | rel=r_associated | relid=0 | w=5
  1178. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corpus callosum abnormalities (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:corpus callosum abnormalities (in some patients) | rel=r_associated | relid=0 | w=5
  1179. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corpus callosum agenesis
    n1=hyperaldostéronisme secondaire | n2=en:corpus callosum agenesis | rel=r_associated | relid=0 | w=5
  1180. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corpus callosum lipoma
    n1=hyperaldostéronisme secondaire | n2=en:corpus callosum lipoma | rel=r_associated | relid=0 | w=5
  1181. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corpus callosum, agenesis of (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:corpus callosum, agenesis of (in some patients) | rel=r_associated | relid=0 | w=5
  1182. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corpus callosum, thin (rare)
    n1=hyperaldostéronisme secondaire | n2=en:corpus callosum, thin (rare) | rel=r_associated | relid=0 | w=5
  1183. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical and brainstem neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:cortical and brainstem neuronal loss | rel=r_associated | relid=0 | w=5
  1184. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical and subcortical atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cortical and subcortical atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  1185. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical and subcortical hyperintensities
    n1=hyperaldostéronisme secondaire | n2=en:cortical and subcortical hyperintensities | rel=r_associated | relid=0 | w=5
  1186. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical and subcortical neuronal loss in the frontal and temporal regions
    n1=hyperaldostéronisme secondaire | n2=en:cortical and subcortical neuronal loss in the frontal and temporal regions | rel=r_associated | relid=0 | w=5
  1187. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical and subcortical regions involved
    n1=hyperaldostéronisme secondaire | n2=en:cortical and subcortical regions involved | rel=r_associated | relid=0 | w=5
  1188. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy (43%)
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy (43%) | rel=r_associated | relid=0 | w=5
  1189. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy (frontal area)
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy (frontal area) | rel=r_associated | relid=0 | w=5
  1190. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy (in 2 siblings)
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy (in 2 siblings) | rel=r_associated | relid=0 | w=5
  1191. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  1192. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy (rare)
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy (rare) | rel=r_associated | relid=0 | w=5
  1193. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy with loss of pyramidal neurons in the motor cortex
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy with loss of pyramidal neurons in the motor cortex | rel=r_associated | relid=0 | w=5
  1194. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:cortical atrophy, progressive | rel=r_associated | relid=0 | w=5
  1195. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical cytotoxic edema
    n1=hyperaldostéronisme secondaire | n2=en:cortical cytotoxic edema | rel=r_associated | relid=0 | w=5
  1196. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical degeneration
    n1=hyperaldostéronisme secondaire | n2=en:cortical degeneration | rel=r_associated | relid=0 | w=5
  1197. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysgenesis
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysgenesis | rel=r_associated | relid=0 | w=5
  1198. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysgenesis, complex
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysgenesis, complex | rel=r_associated | relid=0 | w=5
  1199. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysplasia | rel=r_associated | relid=0 | w=5
  1200. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysplasia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysplasia (1 patient) | rel=r_associated | relid=0 | w=5
  1201. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysplasia (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysplasia (2 patients) | rel=r_associated | relid=0 | w=5
  1202. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysplasia, focal (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysplasia, focal (1 patient) | rel=r_associated | relid=0 | w=5
  1203. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical dysplasia, focal (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cortical dysplasia, focal (in some patients) | rel=r_associated | relid=0 | w=5
  1204. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical gyral simplification
    n1=hyperaldostéronisme secondaire | n2=en:cortical gyral simplification | rel=r_associated | relid=0 | w=5
  1205. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical hypergyria (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cortical hypergyria (in some patients) | rel=r_associated | relid=0 | w=5
  1206. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical malformations
    n1=hyperaldostéronisme secondaire | n2=en:cortical malformations | rel=r_associated | relid=0 | w=5
  1207. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical myoclonic tremors characterized by 8 to 10-hz discharges
    n1=hyperaldostéronisme secondaire | n2=en:cortical myoclonic tremors characterized by 8 to 10-hz discharges | rel=r_associated | relid=0 | w=5
  1208. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:cortical neuronal loss | rel=r_associated | relid=0 | w=5
  1209. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical origin of the tremor
    n1=hyperaldostéronisme secondaire | n2=en:cortical origin of the tremor | rel=r_associated | relid=0 | w=5
  1210. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical reflex myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:cortical reflex myoclonus | rel=r_associated | relid=0 | w=5
  1211. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical simplification
    n1=hyperaldostéronisme secondaire | n2=en:cortical simplification | rel=r_associated | relid=0 | w=5
  1212. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical thinning
    n1=hyperaldostéronisme secondaire | n2=en:cortical thinning | rel=r_associated | relid=0 | w=5
  1213. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical tubers
    n1=hyperaldostéronisme secondaire | n2=en:cortical tubers | rel=r_associated | relid=0 | w=5
  1214. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cortical venous thromboses
    n1=hyperaldostéronisme secondaire | n2=en:cortical venous thromboses | rel=r_associated | relid=0 | w=5
  1215. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticobasal degeneration (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:corticobasal degeneration (in some patients) | rel=r_associated | relid=0 | w=5
  1216. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticospinal signs (87% of patients in 1 report)
    n1=hyperaldostéronisme secondaire | n2=en:corticospinal signs (87% of patients in 1 report) | rel=r_associated | relid=0 | w=5
  1217. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticospinal tract atrophy
    n1=hyperaldostéronisme secondaire | n2=en:corticospinal tract atrophy | rel=r_associated | relid=0 | w=5
  1218. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticospinal tract disease in lower limbs (in adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:corticospinal tract disease in lower limbs (in adulthood) | rel=r_associated | relid=0 | w=5
  1219. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticospinal tract hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:corticospinal tract hypoplasia | rel=r_associated | relid=0 | w=5
  1220. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:corticospinal tracts with decreased myelin staining
    n1=hyperaldostéronisme secondaire | n2=en:corticospinal tracts with decreased myelin staining | rel=r_associated | relid=0 | w=5
  1221. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cranial nerve anomalies
    n1=hyperaldostéronisme secondaire | n2=en:cranial nerve anomalies | rel=r_associated | relid=0 | w=5
  1222. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cranial nerve dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:cranial nerve dysfunction | rel=r_associated | relid=0 | w=5
  1223. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cranial nerve palsies can arise with head and neck paragangliomas
    n1=hyperaldostéronisme secondaire | n2=en:cranial nerve palsies can arise with head and neck paragangliomas | rel=r_associated | relid=0 | w=5
  1224. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cranial nerve palsy
    n1=hyperaldostéronisme secondaire | n2=en:cranial nerve palsy | rel=r_associated | relid=0 | w=5
  1225. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cranial nerve palsy, intermittent, transient
    n1=hyperaldostéronisme secondaire | n2=en:cranial nerve palsy, intermittent, transient | rel=r_associated | relid=0 | w=5
  1226. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:craniofacial abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:craniofacial abnormalities | rel=r_associated | relid=0 | w=5
  1227. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:crawling and standing not achieved
    n1=hyperaldostéronisme secondaire | n2=en:crawling and standing not achieved | rel=r_associated | relid=0 | w=5
  1228. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:creutzfeldt-jakob disease
    n1=hyperaldostéronisme secondaire | n2=en:creutzfeldt-jakob disease | rel=r_associated | relid=0 | w=5
  1229. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:croup
    n1=hyperaldostéronisme secondaire | n2=en:croup | rel=r_associated | relid=0 | w=5
  1230. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:crowding of the posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:crowding of the posterior fossa | rel=r_associated | relid=0 | w=5
  1231. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ct scan shows dense calcifications in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:ct scan shows dense calcifications in the basal ganglia | rel=r_associated | relid=0 | w=5
  1232. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cyst of septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:cyst of septum pellucidum | rel=r_associated | relid=0 | w=5
  1233. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cyst of septum pellucidum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:cyst of septum pellucidum (in some patients) | rel=r_associated | relid=0 | w=5
  1234. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic cavitation of the white matter
    n1=hyperaldostéronisme secondaire | n2=en:cystic cavitation of the white matter | rel=r_associated | relid=0 | w=5
  1235. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic degeneration of cerebral white matter with preserved cortex
    n1=hyperaldostéronisme secondaire | n2=en:cystic degeneration of cerebral white matter with preserved cortex | rel=r_associated | relid=0 | w=5
  1236. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic degeneration of the white matter
    n1=hyperaldostéronisme secondaire | n2=en:cystic degeneration of the white matter | rel=r_associated | relid=0 | w=5
  1237. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic destruction of brain tissue, including basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:cystic destruction of brain tissue, including basal ganglia | rel=r_associated | relid=0 | w=5
  1238. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic lesions consistent with leigh syndrome (256000)
    n1=hyperaldostéronisme secondaire | n2=en:cystic lesions consistent with leigh syndrome (256000) | rel=r_associated | relid=0 | w=5
  1239. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000)
    n1=hyperaldostéronisme secondaire | n2=en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000) | rel=r_associated | relid=0 | w=5
  1240. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cystic lysis of the deep white matter
    n1=hyperaldostéronisme secondaire | n2=en:cystic lysis of the deep white matter | rel=r_associated | relid=0 | w=5
  1241. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cysts tend to enlarge with age
    n1=hyperaldostéronisme secondaire | n2=en:cysts tend to enlarge with age | rel=r_associated | relid=0 | w=5
  1242. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:cytopathic effect
    n1=hyperaldostéronisme secondaire | n2=en:cytopathic effect | rel=r_associated | relid=0 | w=5
  1243. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy walker variant
    n1=hyperaldostéronisme secondaire | n2=en:dandy walker variant | rel=r_associated | relid=0 | w=5
  1244. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation | rel=r_associated | relid=0 | w=5
  1245. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (1 patient) | rel=r_associated | relid=0 | w=5
  1246. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (in 1 of 4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (in 1 of 4 patients) | rel=r_associated | relid=0 | w=5
  1247. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (in some patients) | rel=r_associated | relid=0 | w=5
  1248. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (rare)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (rare) | rel=r_associated | relid=0 | w=5
  1249. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (variable)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (variable) | rel=r_associated | relid=0 | w=5
  1250. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dandy-walker malformation (wws)
    n1=hyperaldostéronisme secondaire | n2=en:dandy-walker malformation (wws) | rel=r_associated | relid=0 | w=5
  1251. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deafness
    n1=hyperaldostéronisme secondaire | n2=en:deafness | rel=r_associated | relid=0 | w=5
  1252. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decerebrate or decorticate posturing late
    n1=hyperaldostéronisme secondaire | n2=en:decerebrate or decorticate posturing late | rel=r_associated | relid=0 | w=5
  1253. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decerebrate posturings
    n1=hyperaldostéronisme secondaire | n2=en:decerebrate posturings | rel=r_associated | relid=0 | w=5
  1254. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decorticate posture
    n1=hyperaldostéronisme secondaire | n2=en:decorticate posture | rel=r_associated | relid=0 | w=5
  1255. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decrease in abstract thinking
    n1=hyperaldostéronisme secondaire | n2=en:decrease in abstract thinking | rel=r_associated | relid=0 | w=5
  1256. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased active movements
    n1=hyperaldostéronisme secondaire | n2=en:decreased active movements | rel=r_associated | relid=0 | w=5
  1257. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased amount of myelin-specific lipids
    n1=hyperaldostéronisme secondaire | n2=en:decreased amount of myelin-specific lipids | rel=r_associated | relid=0 | w=5
  1258. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased amount of myelin-specific proteins
    n1=hyperaldostéronisme secondaire | n2=en:decreased amount of myelin-specific proteins | rel=r_associated | relid=0 | w=5
  1259. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased attention span
    n1=hyperaldostéronisme secondaire | n2=en:decreased attention span | rel=r_associated | relid=0 | w=5
  1260. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased brain volume (female)
    n1=hyperaldostéronisme secondaire | n2=en:decreased brain volume (female) | rel=r_associated | relid=0 | w=5
  1261. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased brain weight
    n1=hyperaldostéronisme secondaire | n2=en:decreased brain weight | rel=r_associated | relid=0 | w=5
  1262. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased cerebellar folia
    n1=hyperaldostéronisme secondaire | n2=en:decreased cerebellar folia | rel=r_associated | relid=0 | w=5
  1263. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased cerebral volume, especially of the frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:decreased cerebral volume, especially of the frontal lobes | rel=r_associated | relid=0 | w=5
  1264. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased cognition (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:decreased cognition (later-onset) | rel=r_associated | relid=0 | w=5
  1265. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased core body temperature
    n1=hyperaldostéronisme secondaire | n2=en:decreased core body temperature | rel=r_associated | relid=0 | w=5
  1266. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased creatine signal seen on magnetic resonance spectroscopy
    n1=hyperaldostéronisme secondaire | n2=en:decreased creatine signal seen on magnetic resonance spectroscopy | rel=r_associated | relid=0 | w=5
  1267. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased csf volume in posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:decreased csf volume in posterior fossa | rel=r_associated | relid=0 | w=5
  1268. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased delineation of the basal ganglia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:decreased delineation of the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=5
  1269. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased fine motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:decreased fine motor coordination | rel=r_associated | relid=0 | w=5
  1270. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased iq
    n1=hyperaldostéronisme secondaire | n2=en:decreased iq | rel=r_associated | relid=0 | w=5
  1271. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased iq (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:decreased iq (1 patient) | rel=r_associated | relid=0 | w=5
  1272. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased iq (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:decreased iq (some patients) | rel=r_associated | relid=0 | w=5
  1273. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased iron content in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:decreased iron content in the substantia nigra | rel=r_associated | relid=0 | w=5
  1274. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased mental processing speed
    n1=hyperaldostéronisme secondaire | n2=en:decreased mental processing speed | rel=r_associated | relid=0 | w=5
  1275. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased mitochondrial respiratory chain complex activity
    n1=hyperaldostéronisme secondaire | n2=en:decreased mitochondrial respiratory chain complex activity | rel=r_associated | relid=0 | w=5
  1276. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased motor nerve conduction velocity
    n1=hyperaldostéronisme secondaire | n2=en:decreased motor nerve conduction velocity | rel=r_associated | relid=0 | w=5
  1277. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased myelin
    n1=hyperaldostéronisme secondaire | n2=en:decreased myelin | rel=r_associated | relid=0 | w=5
  1278. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased myelination seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:decreased myelination seen on mri | rel=r_associated | relid=0 | w=5
  1279. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased n-acetylaspartate
    n1=hyperaldostéronisme secondaire | n2=en:decreased n-acetylaspartate | rel=r_associated | relid=0 | w=5
  1280. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased need for sleep
    n1=hyperaldostéronisme secondaire | n2=en:decreased need for sleep | rel=r_associated | relid=0 | w=5
  1281. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased nonverbal iq
    n1=hyperaldostéronisme secondaire | n2=en:decreased nonverbal iq | rel=r_associated | relid=0 | w=5
  1282. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased numbers of astrocytes
    n1=hyperaldostéronisme secondaire | n2=en:decreased numbers of astrocytes | rel=r_associated | relid=0 | w=5
  1283. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased or absent gyri (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:decreased or absent gyri (in some patients) | rel=r_associated | relid=0 | w=5
  1284. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts | rel=r_associated | relid=0 | w=5
  1285. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased pain response
    n1=hyperaldostéronisme secondaire | n2=en:decreased pain response | rel=r_associated | relid=0 | w=5
  1286. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased pyramidal cells
    n1=hyperaldostéronisme secondaire | n2=en:decreased pyramidal cells | rel=r_associated | relid=0 | w=5
  1287. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased rapid automatized naming (ran) speed
    n1=hyperaldostéronisme secondaire | n2=en:decreased rapid automatized naming (ran) speed | rel=r_associated | relid=0 | w=5
  1288. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased reflexes (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:decreased reflexes (in some patients) | rel=r_associated | relid=0 | w=5
  1289. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased sleep latency
    n1=hyperaldostéronisme secondaire | n2=en:decreased sleep latency | rel=r_associated | relid=0 | w=5
  1290. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased somatosensory-evoked potentials
    n1=hyperaldostéronisme secondaire | n2=en:decreased somatosensory-evoked potentials | rel=r_associated | relid=0 | w=5
  1291. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased speech
    n1=hyperaldostéronisme secondaire | n2=en:decreased speech | rel=r_associated | relid=0 | w=5
  1292. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased spontaneous movements at birth
    n1=hyperaldostéronisme secondaire | n2=en:decreased spontaneous movements at birth | rel=r_associated | relid=0 | w=5
  1293. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased supratentorial volume
    n1=hyperaldostéronisme secondaire | n2=en:decreased supratentorial volume | rel=r_associated | relid=0 | w=5
  1294. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased tendon reflex
    n1=hyperaldostéronisme secondaire | n2=en:decreased tendon reflex | rel=r_associated | relid=0 | w=5
  1295. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased upper extremity reflexes
    n1=hyperaldostéronisme secondaire | n2=en:decreased upper extremity reflexes | rel=r_associated | relid=0 | w=5
  1296. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased vibration sense, suggesting posterior column involvement
    n1=hyperaldostéronisme secondaire | n2=en:decreased vibration sense, suggesting posterior column involvement | rel=r_associated | relid=0 | w=5
  1297. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased vibratory sense
    n1=hyperaldostéronisme secondaire | n2=en:decreased vibratory sense | rel=r_associated | relid=0 | w=5
  1298. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased volume of the cerebral white matter
    n1=hyperaldostéronisme secondaire | n2=en:decreased volume of the cerebral white matter | rel=r_associated | relid=0 | w=5
  1299. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased volume of the posterior cranial fossa with normal hindbrain volume
    n1=hyperaldostéronisme secondaire | n2=en:decreased volume of the posterior cranial fossa with normal hindbrain volume | rel=r_associated | relid=0 | w=5
  1300. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased white matter
    n1=hyperaldostéronisme secondaire | n2=en:decreased white matter | rel=r_associated | relid=0 | w=5
  1301. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreased white matter volume
    n1=hyperaldostéronisme secondaire | n2=en:decreased white matter volume | rel=r_associated | relid=0 | w=5
  1302. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:decreasing responsiveness
    n1=hyperaldostéronisme secondaire | n2=en:decreasing responsiveness | rel=r_associated | relid=0 | w=5
  1303. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep hypointensities (mri, t2) suggestive of past microbleeds
    n1=hyperaldostéronisme secondaire | n2=en:deep hypointensities (mri, t2) suggestive of past microbleeds | rel=r_associated | relid=0 | w=5
  1304. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep interpeduncular fossa
    n1=hyperaldostéronisme secondaire | n2=en:deep interpeduncular fossa | rel=r_associated | relid=0 | w=5
  1305. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep posterior interpeduncular fossa
    n1=hyperaldostéronisme secondaire | n2=en:deep posterior interpeduncular fossa | rel=r_associated | relid=0 | w=5
  1306. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep white matter changes
    n1=hyperaldostéronisme secondaire | n2=en:deep white matter changes | rel=r_associated | relid=0 | w=5
  1307. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep white matter hypodensities
    n1=hyperaldostéronisme secondaire | n2=en:deep white matter hypodensities | rel=r_associated | relid=0 | w=5
  1308. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deep white matter lesions, particularly affecting the frontal and parietal lobes
    n1=hyperaldostéronisme secondaire | n2=en:deep white matter lesions, particularly affecting the frontal and parietal lobes | rel=r_associated | relid=0 | w=5
  1309. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defect in axonal guidance
    n1=hyperaldostéronisme secondaire | n2=en:defect in axonal guidance | rel=r_associated | relid=0 | w=5
  1310. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defect in morphosyntactic rules
    n1=hyperaldostéronisme secondaire | n2=en:defect in morphosyntactic rules | rel=r_associated | relid=0 | w=5
  1311. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defective myelination of the deep white matter
    n1=hyperaldostéronisme secondaire | n2=en:defective myelination of the deep white matter | rel=r_associated | relid=0 | w=5
  1312. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defective opercularization
    n1=hyperaldostéronisme secondaire | n2=en:defective opercularization | rel=r_associated | relid=0 | w=5
  1313. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defects in auditory cue processing
    n1=hyperaldostéronisme secondaire | n2=en:defects in auditory cue processing | rel=r_associated | relid=0 | w=5
  1314. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defects in executive function
    n1=hyperaldostéronisme secondaire | n2=en:defects in executive function | rel=r_associated | relid=0 | w=5
  1315. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defects in fine motor skills
    n1=hyperaldostéronisme secondaire | n2=en:defects in fine motor skills | rel=r_associated | relid=0 | w=5
  1316. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:defects in visual cue processing
    n1=hyperaldostéronisme secondaire | n2=en:defects in visual cue processing | rel=r_associated | relid=0 | w=5
  1317. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficient myelination
    n1=hyperaldostéronisme secondaire | n2=en:deficient myelination | rel=r_associated | relid=0 | w=5
  1318. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in basic reading
    n1=hyperaldostéronisme secondaire | n2=en:deficit in basic reading | rel=r_associated | relid=0 | w=5
  1319. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in expressive language
    n1=hyperaldostéronisme secondaire | n2=en:deficit in expressive language | rel=r_associated | relid=0 | w=5
  1320. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in nonword repetition (nwr)
    n1=hyperaldostéronisme secondaire | n2=en:deficit in nonword repetition (nwr) | rel=r_associated | relid=0 | w=5
  1321. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in phonologic short-term memory
    n1=hyperaldostéronisme secondaire | n2=en:deficit in phonologic short-term memory | rel=r_associated | relid=0 | w=5
  1322. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in reading comprehension
    n1=hyperaldostéronisme secondaire | n2=en:deficit in reading comprehension | rel=r_associated | relid=0 | w=5
  1323. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficit in spelling
    n1=hyperaldostéronisme secondaire | n2=en:deficit in spelling | rel=r_associated | relid=0 | w=5
  1324. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficits in abstraction
    n1=hyperaldostéronisme secondaire | n2=en:deficits in abstraction | rel=r_associated | relid=0 | w=5
  1325. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deficits in language expression
    n1=hyperaldostéronisme secondaire | n2=en:deficits in language expression | rel=r_associated | relid=0 | w=5
  1326. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deformed temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:deformed temporal lobes | rel=r_associated | relid=0 | w=5
  1327. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:degeneration of anterior horn cells
    n1=hyperaldostéronisme secondaire | n2=en:degeneration of anterior horn cells | rel=r_associated | relid=0 | w=5
  1328. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:degeneration of purkinje cells in the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:degeneration of purkinje cells in the cerebellum | rel=r_associated | relid=0 | w=5
  1329. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:degeneration of the dentatorubral and pallidoluysian systems
    n1=hyperaldostéronisme secondaire | n2=en:degeneration of the dentatorubral and pallidoluysian systems | rel=r_associated | relid=0 | w=5
  1330. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:degeneration of the lateral corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:degeneration of the lateral corticospinal tracts | rel=r_associated | relid=0 | w=5
  1331. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:degenerative nerve diseases
    n1=hyperaldostéronisme secondaire | n2=en:degenerative nerve diseases | rel=r_associated | relid=0 | w=5
  1332. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deja vu feeling
    n1=hyperaldostéronisme secondaire | n2=en:deja vu feeling | rel=r_associated | relid=0 | w=5
  1333. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delay in gross motor development due to weakness
    n1=hyperaldostéronisme secondaire | n2=en:delay in gross motor development due to weakness | rel=r_associated | relid=0 | w=5
  1334. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delay of gross motor function
    n1=hyperaldostéronisme secondaire | n2=en:delay of gross motor function | rel=r_associated | relid=0 | w=5
  1335. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed adaptive hand use
    n1=hyperaldostéronisme secondaire | n2=en:delayed adaptive hand use | rel=r_associated | relid=0 | w=5
  1336. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed ambulation
    n1=hyperaldostéronisme secondaire | n2=en:delayed ambulation | rel=r_associated | relid=0 | w=5
  1337. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed brainstem development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed brainstem development (in some patients) | rel=r_associated | relid=0 | w=5
  1338. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed cerebellar development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed cerebellar development (in some patients) | rel=r_associated | relid=0 | w=5
  1339. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed cerebral myelination
    n1=hyperaldostéronisme secondaire | n2=en:delayed cerebral myelination | rel=r_associated | relid=0 | w=5
  1340. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed cognitive development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed cognitive development (in some patients) | rel=r_associated | relid=0 | w=5
  1341. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed cognitive development, mild (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:delayed cognitive development, mild (reported in 1 family) | rel=r_associated | relid=0 | w=5
  1342. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed cognitive development/learning disabilities (93%)
    n1=hyperaldostéronisme secondaire | n2=en:delayed cognitive development/learning disabilities (93%) | rel=r_associated | relid=0 | w=5
  1343. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development (1 family) | rel=r_associated | relid=0 | w=5
  1344. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development (about 25%)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development (about 25%) | rel=r_associated | relid=0 | w=5
  1345. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development (in some patients) | rel=r_associated | relid=0 | w=5
  1346. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development (in some)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development (in some) | rel=r_associated | relid=0 | w=5
  1347. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development if untreated
    n1=hyperaldostéronisme secondaire | n2=en:delayed development if untreated | rel=r_associated | relid=0 | w=5
  1348. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development in early childhood (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development in early childhood (in some patients) | rel=r_associated | relid=0 | w=5
  1349. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development may occur
    n1=hyperaldostéronisme secondaire | n2=en:delayed development may occur | rel=r_associated | relid=0 | w=5
  1350. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development, after 8-15 months
    n1=hyperaldostéronisme secondaire | n2=en:delayed development, after 8-15 months | rel=r_associated | relid=0 | w=5
  1351. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development, ranging from mild to severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed development, ranging from mild to severe | rel=r_associated | relid=0 | w=5
  1352. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development, severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed development, severe | rel=r_associated | relid=0 | w=5
  1353. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development, variable (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed development, variable (in some patients) | rel=r_associated | relid=0 | w=5
  1354. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed development, variable severity, from birth in some patients
    n1=hyperaldostéronisme secondaire | n2=en:delayed development, variable severity, from birth in some patients | rel=r_associated | relid=0 | w=5
  1355. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed developmental milestones
    n1=hyperaldostéronisme secondaire | n2=en:delayed developmental milestones | rel=r_associated | relid=0 | w=5
  1356. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed gross motor development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed gross motor development (in some patients) | rel=r_associated | relid=0 | w=5
  1357. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed gyration
    n1=hyperaldostéronisme secondaire | n2=en:delayed gyration | rel=r_associated | relid=0 | w=5
  1358. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed independent walking
    n1=hyperaldostéronisme secondaire | n2=en:delayed independent walking | rel=r_associated | relid=0 | w=5
  1359. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed intellectual development
    n1=hyperaldostéronisme secondaire | n2=en:delayed intellectual development | rel=r_associated | relid=0 | w=5
  1360. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor and speech development, mild (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor and speech development, mild (1 family) | rel=r_associated | relid=0 | w=5
  1361. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor development (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor development (1 patient) | rel=r_associated | relid=0 | w=5
  1362. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor development (secondary to skeletal abnormalities)
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor development (secondary to skeletal abnormalities) | rel=r_associated | relid=0 | w=5
  1363. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor development due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor development due to muscle weakness | rel=r_associated | relid=0 | w=5
  1364. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor development, mild, transient
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor development, mild, transient | rel=r_associated | relid=0 | w=5
  1365. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor development, severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor development, severe | rel=r_associated | relid=0 | w=5
  1366. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed motor milestones due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:delayed motor milestones due to muscle weakness | rel=r_associated | relid=0 | w=5
  1367. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination | rel=r_associated | relid=0 | w=5
  1368. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination (1 patient) | rel=r_associated | relid=0 | w=5
  1369. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination (1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination (1/4 patients) | rel=r_associated | relid=0 | w=5
  1370. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination (in some patients) | rel=r_associated | relid=0 | w=5
  1371. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  1372. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination on brain mri (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination on brain mri (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  1373. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination seen on mri | rel=r_associated | relid=0 | w=5
  1374. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelination, mild
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelination, mild | rel=r_associated | relid=0 | w=5
  1375. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed myelinization (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed myelinization (in some patients) | rel=r_associated | relid=0 | w=5
  1376. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed onset of phrase speech (> 36 months)
    n1=hyperaldostéronisme secondaire | n2=en:delayed onset of phrase speech (> 36 months) | rel=r_associated | relid=0 | w=5
  1377. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed opercularization
    n1=hyperaldostéronisme secondaire | n2=en:delayed opercularization | rel=r_associated | relid=0 | w=5
  1378. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed or absent independent walking
    n1=hyperaldostéronisme secondaire | n2=en:delayed or absent independent walking | rel=r_associated | relid=0 | w=5
  1379. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (1 patient) | rel=r_associated | relid=0 | w=5
  1380. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (in 1 family) | rel=r_associated | relid=0 | w=5
  1381. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (in most patients) | rel=r_associated | relid=0 | w=5
  1382. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (in severe cases) | rel=r_associated | relid=0 | w=5
  1383. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (in some patients) | rel=r_associated | relid=0 | w=5
  1384. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (in some)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (in some) | rel=r_associated | relid=0 | w=5
  1385. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (mild to severe)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (mild to severe) | rel=r_associated | relid=0 | w=5
  1386. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development (stops at development levels of 1-2 years)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development (stops at development levels of 1-2 years) | rel=r_associated | relid=0 | w=5
  1387. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development after onset of seizures
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development after onset of seizures | rel=r_associated | relid=0 | w=5
  1388. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, mild
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, mild | rel=r_associated | relid=0 | w=5
  1389. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, mild (in 3 of 5 patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, mild (in 3 of 5 patients) | rel=r_associated | relid=0 | w=5
  1390. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1391. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, moderate to severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, moderate to severe | rel=r_associated | relid=0 | w=5
  1392. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, profound
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, profound | rel=r_associated | relid=0 | w=5
  1393. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, profound (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, profound (1 patient) | rel=r_associated | relid=0 | w=5
  1394. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, profound (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, profound (patient a) | rel=r_associated | relid=0 | w=5
  1395. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, severe | rel=r_associated | relid=0 | w=5
  1396. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, severe (> 90%)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, severe (> 90%) | rel=r_associated | relid=0 | w=5
  1397. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, severe (in 2 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, severe (in 2 of 6 patients) | rel=r_associated | relid=0 | w=5
  1398. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, severe to profound
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, severe to profound | rel=r_associated | relid=0 | w=5
  1399. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed psychomotor development, variable
    n1=hyperaldostéronisme secondaire | n2=en:delayed psychomotor development, variable | rel=r_associated | relid=0 | w=5
  1400. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed speech and language development
    n1=hyperaldostéronisme secondaire | n2=en:delayed speech and language development | rel=r_associated | relid=0 | w=5
  1401. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed speech development, severe
    n1=hyperaldostéronisme secondaire | n2=en:delayed speech development, severe | rel=r_associated | relid=0 | w=5
  1402. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed walking (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:delayed walking (1 family) | rel=r_associated | relid=0 | w=5
  1403. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed walking (less common)
    n1=hyperaldostéronisme secondaire | n2=en:delayed walking (less common) | rel=r_associated | relid=0 | w=5
  1404. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed walking (rare)
    n1=hyperaldostéronisme secondaire | n2=en:delayed walking (rare) | rel=r_associated | relid=0 | w=5
  1405. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed walking and running in early childhood
    n1=hyperaldostéronisme secondaire | n2=en:delayed walking and running in early childhood | rel=r_associated | relid=0 | w=5
  1406. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delayed walking, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:delayed walking, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1407. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delirium
    n1=hyperaldostéronisme secondaire | n2=en:delirium | rel=r_associated | relid=0 | w=5
  1408. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delirium (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:delirium (later-onset) | rel=r_associated | relid=0 | w=5
  1409. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:delusion
    n1=hyperaldostéronisme secondaire | n2=en:delusion | rel=r_associated | relid=0 | w=5
  1410. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia
    n1=hyperaldostéronisme secondaire | n2=en:dementia | rel=r_associated | relid=0 | w=5
  1411. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (<20%)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (<20%) | rel=r_associated | relid=0 | w=5
  1412. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (1 family) | rel=r_associated | relid=0 | w=5
  1413. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (5%)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (5%) | rel=r_associated | relid=0 | w=5
  1414. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (in some patients) | rel=r_associated | relid=0 | w=5
  1415. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (later-onset) | rel=r_associated | relid=0 | w=5
  1416. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (onset in fifth decade)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (onset in fifth decade) | rel=r_associated | relid=0 | w=5
  1417. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia (subtype 3a)
    n1=hyperaldostéronisme secondaire | n2=en:dementia (subtype 3a) | rel=r_associated | relid=0 | w=5
  1418. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia in a subset of patients
    n1=hyperaldostéronisme secondaire | n2=en:dementia in a subset of patients | rel=r_associated | relid=0 | w=5
  1419. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia may occur
    n1=hyperaldostéronisme secondaire | n2=en:dementia may occur | rel=r_associated | relid=0 | w=5
  1420. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia of frontal lobe type
    n1=hyperaldostéronisme secondaire | n2=en:dementia of frontal lobe type | rel=r_associated | relid=0 | w=5
  1421. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia, presenile, progressive, beginning around age 30 years
    n1=hyperaldostéronisme secondaire | n2=en:dementia, presenile, progressive, beginning around age 30 years | rel=r_associated | relid=0 | w=5
  1422. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia, progressive (more common in males)
    n1=hyperaldostéronisme secondaire | n2=en:dementia, progressive (more common in males) | rel=r_associated | relid=0 | w=5
  1423. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia, progressive, with onset of disease
    n1=hyperaldostéronisme secondaire | n2=en:dementia, progressive, with onset of disease | rel=r_associated | relid=0 | w=5
  1424. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dementia, rapidly progressive
    n1=hyperaldostéronisme secondaire | n2=en:dementia, rapidly progressive | rel=r_associated | relid=0 | w=5
  1425. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:demyelination
    n1=hyperaldostéronisme secondaire | n2=en:demyelination | rel=r_associated | relid=0 | w=5
  1426. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:demyelination of the posterior and lateral columns of the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:demyelination of the posterior and lateral columns of the spinal cord | rel=r_associated | relid=0 | w=5
  1427. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa | rel=r_associated | relid=0 | w=5
  1428. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:demyelination, symmetric
    n1=hyperaldostéronisme secondaire | n2=en:demyelination, symmetric | rel=r_associated | relid=0 | w=5
  1429. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:demyelinization
    n1=hyperaldostéronisme secondaire | n2=en:demyelinization | rel=r_associated | relid=0 | w=5
  1430. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:denervation seen on emg
    n1=hyperaldostéronisme secondaire | n2=en:denervation seen on emg | rel=r_associated | relid=0 | w=5
  1431. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dense calcifications in the cerebellar dentate nucleus
    n1=hyperaldostéronisme secondaire | n2=en:dense calcifications in the cerebellar dentate nucleus | rel=r_associated | relid=0 | w=5
  1432. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression
    n1=hyperaldostéronisme secondaire | n2=en:depression | rel=r_associated | relid=0 | w=5
  1433. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:depression (1 family) | rel=r_associated | relid=0 | w=5
  1434. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:depression (1 patient) | rel=r_associated | relid=0 | w=5
  1435. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:depression (hcp) | rel=r_associated | relid=0 | w=5
  1436. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:depression (in some patients) | rel=r_associated | relid=0 | w=5
  1437. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression with hypomania (bipolar 2)
    n1=hyperaldostéronisme secondaire | n2=en:depression with hypomania (bipolar 2) | rel=r_associated | relid=0 | w=5
  1438. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depression with mania (bipolar 1)
    n1=hyperaldostéronisme secondaire | n2=en:depression with mania (bipolar 1) | rel=r_associated | relid=0 | w=5
  1439. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depressive disorder, nec in icd9cm_2014
    n1=hyperaldostéronisme secondaire | n2=en:depressive disorder, nec in icd9cm_2014 | rel=r_associated | relid=0 | w=5
  1440. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:depressive symptom
    n1=hyperaldostéronisme secondaire | n2=en:depressive symptom | rel=r_associated | relid=0 | w=5
  1441. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:deterioration of motor development
    n1=hyperaldostéronisme secondaire | n2=en:deterioration of motor development | rel=r_associated | relid=0 | w=5
  1442. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:detrusor overactivity (DOA)
    n1=hyperaldostéronisme secondaire | n2=en:detrusor overactivity (DOA) | rel=r_associated | relid=0 | w=5
  1443. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:development varies from normal to retarded
    n1=hyperaldostéronisme secondaire | n2=en:development varies from normal to retarded | rel=r_associated | relid=0 | w=5
  1444. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental arrest, 2nd year of life
    n1=hyperaldostéronisme secondaire | n2=en:developmental arrest, 2nd year of life | rel=r_associated | relid=0 | w=5
  1445. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay | rel=r_associated | relid=0 | w=5
  1446. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (1 family) | rel=r_associated | relid=0 | w=5
  1447. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (1 patient) | rel=r_associated | relid=0 | w=5
  1448. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (100%)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (100%) | rel=r_associated | relid=0 | w=5
  1449. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (20%)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (20%) | rel=r_associated | relid=0 | w=5
  1450. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (apparent after the first year of life)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (apparent after the first year of life) | rel=r_associated | relid=0 | w=5
  1451. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (female)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (female) | rel=r_associated | relid=0 | w=5
  1452. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (homozygote)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (homozygote) | rel=r_associated | relid=0 | w=5
  1453. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (in most patients) | rel=r_associated | relid=0 | w=5
  1454. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (in some patients who survive infancy)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (in some patients who survive infancy) | rel=r_associated | relid=0 | w=5
  1455. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (in some patients) | rel=r_associated | relid=0 | w=5
  1456. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (in some)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (in some) | rel=r_associated | relid=0 | w=5
  1457. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (microdeletion patients only)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (microdeletion patients only) | rel=r_associated | relid=0 | w=5
  1458. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (mild-severe)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (mild-severe) | rel=r_associated | relid=0 | w=5
  1459. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (rare)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (rare) | rel=r_associated | relid=0 | w=5
  1460. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (seen in recessive form)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (seen in recessive form) | rel=r_associated | relid=0 | w=5
  1461. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (type ii)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (type ii) | rel=r_associated | relid=0 | w=5
  1462. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay (uncommon) | rel=r_associated | relid=0 | w=5
  1463. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay evident by 12-24 months of age
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay evident by 12-24 months of age | rel=r_associated | relid=0 | w=5
  1464. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay if undiagnosed or untreated
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay if undiagnosed or untreated | rel=r_associated | relid=0 | w=5
  1465. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay or regression
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay or regression | rel=r_associated | relid=0 | w=5
  1466. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, mild
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, mild | rel=r_associated | relid=0 | w=5
  1467. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1468. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, mild (in some)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, mild (in some) | rel=r_associated | relid=0 | w=5
  1469. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, mild to moderate | rel=r_associated | relid=0 | w=5
  1470. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, moderate (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, moderate (in some patients) | rel=r_associated | relid=0 | w=5
  1471. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, primarily motor, resolves in childhood
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, primarily motor, resolves in childhood | rel=r_associated | relid=0 | w=5
  1472. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, profound
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, profound | rel=r_associated | relid=0 | w=5
  1473. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, progressive
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, progressive | rel=r_associated | relid=0 | w=5
  1474. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, severe
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, severe | rel=r_associated | relid=0 | w=5
  1475. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, severe (2p21del)
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, severe (2p21del) | rel=r_associated | relid=0 | w=5
  1476. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, significant
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, significant | rel=r_associated | relid=0 | w=5
  1477. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, variable
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, variable | rel=r_associated | relid=0 | w=5
  1478. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental delay, variable severity
    n1=hyperaldostéronisme secondaire | n2=en:developmental delay, variable severity | rel=r_associated | relid=0 | w=5
  1479. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental disorder
    n1=hyperaldostéronisme secondaire | n2=en:developmental disorder | rel=r_associated | relid=0 | w=5
  1480. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental mental disorder
    n1=hyperaldostéronisme secondaire | n2=en:developmental mental disorder | rel=r_associated | relid=0 | w=5
  1481. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression | rel=r_associated | relid=0 | w=5
  1482. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression (in some patients) | rel=r_associated | relid=0 | w=5
  1483. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression after age 2 years
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression after age 2 years | rel=r_associated | relid=0 | w=5
  1484. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression after onset of seizures
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression after onset of seizures | rel=r_associated | relid=0 | w=5
  1485. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression after the first year
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression after the first year | rel=r_associated | relid=0 | w=5
  1486. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression before age 6 months
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression before age 6 months | rel=r_associated | relid=0 | w=5
  1487. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression in about 50% of patients
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression in about 50% of patients | rel=r_associated | relid=0 | w=5
  1488. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression in affected children
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression in affected children | rel=r_associated | relid=0 | w=5
  1489. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression, after age 2 years (some)
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression, after age 2 years (some) | rel=r_associated | relid=0 | w=5
  1490. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental regression, severe
    n1=hyperaldostéronisme secondaire | n2=en:developmental regression, severe | rel=r_associated | relid=0 | w=5
  1491. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental retardation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:developmental retardation (in some patients) | rel=r_associated | relid=0 | w=5
  1492. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental retardation, profound
    n1=hyperaldostéronisme secondaire | n2=en:developmental retardation, profound | rel=r_associated | relid=0 | w=5
  1493. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental retardation, severe
    n1=hyperaldostéronisme secondaire | n2=en:developmental retardation, severe | rel=r_associated | relid=0 | w=5
  1494. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental stagnation
    n1=hyperaldostéronisme secondaire | n2=en:developmental stagnation | rel=r_associated | relid=0 | w=5
  1495. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:developmental stagnation at onset of seizures
    n1=hyperaldostéronisme secondaire | n2=en:developmental stagnation at onset of seizures | rel=r_associated | relid=0 | w=5
  1496. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diabetes in children and teens
    n1=hyperaldostéronisme secondaire | n2=en:diabetes in children and teens | rel=r_associated | relid=0 | w=5
  1497. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diabetic foot
    n1=hyperaldostéronisme secondaire | n2=en:diabetic foot | rel=r_associated | relid=0 | w=5
  1498. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diabetic nerve problems
    n1=hyperaldostéronisme secondaire | n2=en:diabetic nerve problems | rel=r_associated | relid=0 | w=5
  1499. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulties in fine bimanual activities
    n1=hyperaldostéronisme secondaire | n2=en:difficulties in fine bimanual activities | rel=r_associated | relid=0 | w=5
  1500. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulties in fine movement of the hands
    n1=hyperaldostéronisme secondaire | n2=en:difficulties in fine movement of the hands | rel=r_associated | relid=0 | w=5
  1501. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulties with equilibrium
    n1=hyperaldostéronisme secondaire | n2=en:difficulties with equilibrium | rel=r_associated | relid=0 | w=5
  1502. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulties with fine motor skills and coordination
    n1=hyperaldostéronisme secondaire | n2=en:difficulties with fine motor skills and coordination | rel=r_associated | relid=0 | w=5
  1503. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty concentrating
    n1=hyperaldostéronisme secondaire | n2=en:difficulty concentrating | rel=r_associated | relid=0 | w=5
  1504. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty in phonologic coding
    n1=hyperaldostéronisme secondaire | n2=en:difficulty in phonologic coding | rel=r_associated | relid=0 | w=5
  1505. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty in spelling
    n1=hyperaldostéronisme secondaire | n2=en:difficulty in spelling | rel=r_associated | relid=0 | w=5
  1506. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty running
    n1=hyperaldostéronisme secondaire | n2=en:difficulty running | rel=r_associated | relid=0 | w=5
  1507. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty running and climbing stairs
    n1=hyperaldostéronisme secondaire | n2=en:difficulty running and climbing stairs | rel=r_associated | relid=0 | w=5
  1508. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty sleeping
    n1=hyperaldostéronisme secondaire | n2=en:difficulty sleeping | rel=r_associated | relid=0 | w=5
  1509. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty speaking during seizures
    n1=hyperaldostéronisme secondaire | n2=en:difficulty speaking during seizures | rel=r_associated | relid=0 | w=5
  1510. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty standing
    n1=hyperaldostéronisme secondaire | n2=en:difficulty standing | rel=r_associated | relid=0 | w=5
  1511. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty standing alone
    n1=hyperaldostéronisme secondaire | n2=en:difficulty standing alone | rel=r_associated | relid=0 | w=5
  1512. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty walking and climbing stairs
    n1=hyperaldostéronisme secondaire | n2=en:difficulty walking and climbing stairs | rel=r_associated | relid=0 | w=5
  1513. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty walking in childhood
    n1=hyperaldostéronisme secondaire | n2=en:difficulty walking in childhood | rel=r_associated | relid=0 | w=5
  1514. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty walking, running
    n1=hyperaldostéronisme secondaire | n2=en:difficulty walking, running | rel=r_associated | relid=0 | w=5
  1515. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty with writing and drawing
    n1=hyperaldostéronisme secondaire | n2=en:difficulty with writing and drawing | rel=r_associated | relid=0 | w=5
  1516. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:difficulty writing
    n1=hyperaldostéronisme secondaire | n2=en:difficulty writing | rel=r_associated | relid=0 | w=5
  1517. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem
    n1=hyperaldostéronisme secondaire | n2=en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem | rel=r_associated | relid=0 | w=5
  1518. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse axonal swelling
    n1=hyperaldostéronisme secondaire | n2=en:diffuse axonal swelling | rel=r_associated | relid=0 | w=5
  1519. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse brain and spinal cord atrophy on brain ct/mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse brain and spinal cord atrophy on brain ct/mri | rel=r_associated | relid=0 | w=5
  1520. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse brain swelling occurs during coma
    n1=hyperaldostéronisme secondaire | n2=en:diffuse brain swelling occurs during coma | rel=r_associated | relid=0 | w=5
  1521. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse cerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:diffuse cerebellar atrophy | rel=r_associated | relid=0 | w=5
  1522. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse cerebral atrophy on ct and mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse cerebral atrophy on ct and mri | rel=r_associated | relid=0 | w=5
  1523. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse cerebral atrophy seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse cerebral atrophy seen on mri | rel=r_associated | relid=0 | w=5
  1524. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse cerebral gliosis
    n1=hyperaldostéronisme secondaire | n2=en:diffuse cerebral gliosis | rel=r_associated | relid=0 | w=5
  1525. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes) | rel=r_associated | relid=0 | w=5
  1526. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare) | rel=r_associated | relid=0 | w=5
  1527. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse fibrillar astrocytosis (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse fibrillar astrocytosis (in type iib) | rel=r_associated | relid=0 | w=5
  1528. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse hyperintense signal abnormalities in the white matter (in children)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse hyperintense signal abnormalities in the white matter (in children) | rel=r_associated | relid=0 | w=5
  1529. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse hypomyelination
    n1=hyperaldostéronisme secondaire | n2=en:diffuse hypomyelination | rel=r_associated | relid=0 | w=5
  1530. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse hyporeflexia (later)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse hyporeflexia (later) | rel=r_associated | relid=0 | w=5
  1531. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:diffuse hypotonia | rel=r_associated | relid=0 | w=5
  1532. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse leptomeningeal enhancement seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse leptomeningeal enhancement seen on mri | rel=r_associated | relid=0 | w=5
  1533. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:diffuse leukoencephalopathy | rel=r_associated | relid=0 | w=5
  1534. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse lewy bodies throughout the brain (cortical and subcortical regions)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse lewy bodies throughout the brain (cortical and subcortical regions) | rel=r_associated | relid=0 | w=5
  1535. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse lewy body pathology
    n1=hyperaldostéronisme secondaire | n2=en:diffuse lewy body pathology | rel=r_associated | relid=0 | w=5
  1536. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse paroxysmal discharges
    n1=hyperaldostéronisme secondaire | n2=en:diffuse paroxysmal discharges | rel=r_associated | relid=0 | w=5
  1537. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse periventricular leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:diffuse periventricular leukoencephalopathy | rel=r_associated | relid=0 | w=5
  1538. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse signal abnormality of central white matter
    n1=hyperaldostéronisme secondaire | n2=en:diffuse signal abnormality of central white matter | rel=r_associated | relid=0 | w=5
  1539. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse slowing
    n1=hyperaldostéronisme secondaire | n2=en:diffuse slowing | rel=r_associated | relid=0 | w=5
  1540. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse slowing of background
    n1=hyperaldostéronisme secondaire | n2=en:diffuse slowing of background | rel=r_associated | relid=0 | w=5
  1541. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse spongiform leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:diffuse spongiform leukoencephalopathy | rel=r_associated | relid=0 | w=5
  1542. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse swelling of cerebral white matter
    n1=hyperaldostéronisme secondaire | n2=en:diffuse swelling of cerebral white matter | rel=r_associated | relid=0 | w=5
  1543. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter abnormalities on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter abnormalities on brain mri | rel=r_associated | relid=0 | w=5
  1544. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter abnormalities seen on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter abnormalities seen on brain mri | rel=r_associated | relid=0 | w=5
  1545. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter changes (meb)
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter changes (meb) | rel=r_associated | relid=0 | w=5
  1546. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter dysmyelination
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter dysmyelination | rel=r_associated | relid=0 | w=5
  1547. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter hyperintensities on t2-weighed imaging
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter hyperintensities on t2-weighed imaging | rel=r_associated | relid=0 | w=5
  1548. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse white matter loss
    n1=hyperaldostéronisme secondaire | n2=en:diffuse white matter loss | rel=r_associated | relid=0 | w=5
  1549. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diffuse, severe neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:diffuse, severe neuronal loss | rel=r_associated | relid=0 | w=5
  1550. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilatation of the 3rd ventricle (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:dilatation of the 3rd ventricle (in one family) | rel=r_associated | relid=0 | w=5
  1551. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilatation of the lateral and third ventricles
    n1=hyperaldostéronisme secondaire | n2=en:dilatation of the lateral and third ventricles | rel=r_associated | relid=0 | w=5
  1552. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilatation of the lateral ventricles (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:dilatation of the lateral ventricles (in one family) | rel=r_associated | relid=0 | w=5
  1553. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilated fourth ventricle
    n1=hyperaldostéronisme secondaire | n2=en:dilated fourth ventricle | rel=r_associated | relid=0 | w=5
  1554. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilated lateral ventricles (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dilated lateral ventricles (1 patient) | rel=r_associated | relid=0 | w=5
  1555. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilated perivascular spaces
    n1=hyperaldostéronisme secondaire | n2=en:dilated perivascular spaces | rel=r_associated | relid=0 | w=5
  1556. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilated venous sinuses
    n1=hyperaldostéronisme secondaire | n2=en:dilated venous sinuses | rel=r_associated | relid=0 | w=5
  1557. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilated ventricles (finding)
    n1=hyperaldostéronisme secondaire | n2=en:dilated ventricles (finding) | rel=r_associated | relid=0 | w=5
  1558. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilation of cerebral ventricles
    n1=hyperaldostéronisme secondaire | n2=en:dilation of cerebral ventricles | rel=r_associated | relid=0 | w=5
  1559. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilation of lateral ventricles
    n1=hyperaldostéronisme secondaire | n2=en:dilation of lateral ventricles | rel=r_associated | relid=0 | w=5
  1560. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dilation of lateral ventricles (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dilation of lateral ventricles (in some patients) | rel=r_associated | relid=0 | w=5
  1561. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diminished incentive
    n1=hyperaldostéronisme secondaire | n2=en:diminished incentive | rel=r_associated | relid=0 | w=5
  1562. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diminished social interaction
    n1=hyperaldostéronisme secondaire | n2=en:diminished social interaction | rel=r_associated | relid=0 | w=5
  1563. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diminished visual activity
    n1=hyperaldostéronisme secondaire | n2=en:diminished visual activity | rel=r_associated | relid=0 | w=5
  1564. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diplegia
    n1=hyperaldostéronisme secondaire | n2=en:diplegia | rel=r_associated | relid=0 | w=5
  1565. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:discrepancy between verbal and nonverbal abilities
    n1=hyperaldostéronisme secondaire | n2=en:discrepancy between verbal and nonverbal abilities | rel=r_associated | relid=0 | w=5
  1566. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disdiadochokinesia
    n1=hyperaldostéronisme secondaire | n2=en:disdiadochokinesia | rel=r_associated | relid=0 | w=5
  1567. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disinhibition
    n1=hyperaldostéronisme secondaire | n2=en:disinhibition | rel=r_associated | relid=0 | w=5
  1568. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorder of branched-chain amino acid metabolism
    n1=hyperaldostéronisme secondaire | n2=en:disorder of branched-chain amino acid metabolism | rel=r_associated | relid=0 | w=5
  1569. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorder of psychological development
    n1=hyperaldostéronisme secondaire | n2=en:disorder of psychological development | rel=r_associated | relid=0 | w=5
  1570. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disordered myelination
    n1=hyperaldostéronisme secondaire | n2=en:disordered myelination | rel=r_associated | relid=0 | w=5
  1571. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disordered sleep pattern (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:disordered sleep pattern (in some patients) | rel=r_associated | relid=0 | w=5
  1572. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorders of social functioning with onset specific to childhood and adolescence
    n1=hyperaldostéronisme secondaire | n2=en:disorders of social functioning with onset specific to childhood and adolescence | rel=r_associated | relid=0 | w=5
  1573. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganised speech
    n1=hyperaldostéronisme secondaire | n2=en:disorganised speech | rel=r_associated | relid=0 | w=5
  1574. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganization of the anterior cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:disorganization of the anterior cerebellar vermis | rel=r_associated | relid=0 | w=5
  1575. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganized brain cytoarchitecture
    n1=hyperaldostéronisme secondaire | n2=en:disorganized brain cytoarchitecture | rel=r_associated | relid=0 | w=5
  1576. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganized cortical architecture
    n1=hyperaldostéronisme secondaire | n2=en:disorganized cortical architecture | rel=r_associated | relid=0 | w=5
  1577. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganized eeg
    n1=hyperaldostéronisme secondaire | n2=en:disorganized eeg | rel=r_associated | relid=0 | w=5
  1578. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganized slow background activity seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:disorganized slow background activity seen on eeg | rel=r_associated | relid=0 | w=5
  1579. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorganized thinking
    n1=hyperaldostéronisme secondaire | n2=en:disorganized thinking | rel=r_associated | relid=0 | w=5
  1580. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorientation
    n1=hyperaldostéronisme secondaire | n2=en:disorientation | rel=r_associated | relid=0 | w=5
  1581. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disorientation (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:disorientation (hcp) | rel=r_associated | relid=0 | w=5
  1582. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disproportionately small cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:disproportionately small cerebral cortex | rel=r_associated | relid=0 | w=5
  1583. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disruptive behavior disorder
    n1=hyperaldostéronisme secondaire | n2=en:disruptive behavior disorder | rel=r_associated | relid=0 | w=5
  1584. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disruptive mood dysregulation disorder
    n1=hyperaldostéronisme secondaire | n2=en:disruptive mood dysregulation disorder | rel=r_associated | relid=0 | w=5
  1585. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal amyotrophy
    n1=hyperaldostéronisme secondaire | n2=en:distal amyotrophy | rel=r_associated | relid=0 | w=5
  1586. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:distal muscle weakness | rel=r_associated | relid=0 | w=5
  1587. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal muscle weakness and atrophy due to motor neuronopathy
    n1=hyperaldostéronisme secondaire | n2=en:distal muscle weakness and atrophy due to motor neuronopathy | rel=r_associated | relid=0 | w=5
  1588. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal muscle weakness, upper and lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:distal muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=5
  1589. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal sensory impairment
    n1=hyperaldostéronisme secondaire | n2=en:distal sensory impairment | rel=r_associated | relid=0 | w=5
  1590. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal sensory loss to all modalities, lower limbs more affected than upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:distal sensory loss to all modalities, lower limbs more affected than upper limbs | rel=r_associated | relid=0 | w=5
  1591. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal tapering of the carotid, cerebellar, and meningeal arteries
    n1=hyperaldostéronisme secondaire | n2=en:distal tapering of the carotid, cerebellar, and meningeal arteries | rel=r_associated | relid=0 | w=5
  1592. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distal weakness occurs later
    n1=hyperaldostéronisme secondaire | n2=en:distal weakness occurs later | rel=r_associated | relid=0 | w=5
  1593. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:distress and functional impairment resulting from hair pulling behavior
    n1=hyperaldostéronisme secondaire | n2=en:distress and functional impairment resulting from hair pulling behavior | rel=r_associated | relid=0 | w=5
  1594. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbance of activity and attention
    n1=hyperaldostéronisme secondaire | n2=en:disturbance of activity and attention | rel=r_associated | relid=0 | w=5
  1595. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbance of attention
    n1=hyperaldostéronisme secondaire | n2=en:disturbance of attention | rel=r_associated | relid=0 | w=5
  1596. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbance of conduct, nec in icd9cm_2014
    n1=hyperaldostéronisme secondaire | n2=en:disturbance of conduct, nec in icd9cm_2014 | rel=r_associated | relid=0 | w=5
  1597. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbance of consciousness
    n1=hyperaldostéronisme secondaire | n2=en:disturbance of consciousness | rel=r_associated | relid=0 | w=5
  1598. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbance of emotions specific to childhood and adolescence
    n1=hyperaldostéronisme secondaire | n2=en:disturbance of emotions specific to childhood and adolescence | rel=r_associated | relid=0 | w=5
  1599. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbed equilibrium
    n1=hyperaldostéronisme secondaire | n2=en:disturbed equilibrium | rel=r_associated | relid=0 | w=5
  1600. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbed gait
    n1=hyperaldostéronisme secondaire | n2=en:disturbed gait | rel=r_associated | relid=0 | w=5
  1601. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbed myelination affecting the periventricular and subcortical white matter
    n1=hyperaldostéronisme secondaire | n2=en:disturbed myelination affecting the periventricular and subcortical white matter | rel=r_associated | relid=0 | w=5
  1602. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:disturbed sleep-wake cycle
    n1=hyperaldostéronisme secondaire | n2=en:disturbed sleep-wake cycle | rel=r_associated | relid=0 | w=5
  1603. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:diurnal fluctuations of symptoms (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:diurnal fluctuations of symptoms (in a subset of patients) | rel=r_associated | relid=0 | w=5
  1604. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dizziness
    n1=hyperaldostéronisme secondaire | n2=en:dizziness | rel=r_associated | relid=0 | w=5
  1605. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dizziness and vertigo
    n1=hyperaldostéronisme secondaire | n2=en:dizziness and vertigo | rel=r_associated | relid=0 | w=5
  1606. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dizziness may occur
    n1=hyperaldostéronisme secondaire | n2=en:dizziness may occur | rel=r_associated | relid=0 | w=5
  1607. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dizziness, episodic
    n1=hyperaldostéronisme secondaire | n2=en:dizziness, episodic | rel=r_associated | relid=0 | w=5
  1608. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dopamine-responsive parkinsonism
    n1=hyperaldostéronisme secondaire | n2=en:dopamine-responsive parkinsonism | rel=r_associated | relid=0 | w=5
  1609. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:double cortex syndrome
    n1=hyperaldostéronisme secondaire | n2=en:double cortex syndrome | rel=r_associated | relid=0 | w=5
  1610. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dream enactment
    n1=hyperaldostéronisme secondaire | n2=en:dream enactment | rel=r_associated | relid=0 | w=5
  1611. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drooling
    n1=hyperaldostéronisme secondaire | n2=en:drooling | rel=r_associated | relid=0 | w=5
  1612. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drop attack
    n1=hyperaldostéronisme secondaire | n2=en:drop attack | rel=r_associated | relid=0 | w=5
  1613. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drug abuse
    n1=hyperaldostéronisme secondaire | n2=en:drug abuse | rel=r_associated | relid=0 | w=5
  1614. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drug dependence
    n1=hyperaldostéronisme secondaire | n2=en:drug dependence | rel=r_associated | relid=0 | w=5
  1615. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drug therapy for attention deficit hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:drug therapy for attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=5
  1616. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drug-resistent seizures (rare)
    n1=hyperaldostéronisme secondaire | n2=en:drug-resistent seizures (rare) | rel=r_associated | relid=0 | w=5
  1617. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:drugs and young people
    n1=hyperaldostéronisme secondaire | n2=en:drugs and young people | rel=r_associated | relid=0 | w=5
  1618. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dual diagnosis (psychiatry)
    n1=hyperaldostéronisme secondaire | n2=en:dual diagnosis (psychiatry) | rel=r_associated | relid=0 | w=5
  1619. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dural and choroid plexus calcifications
    n1=hyperaldostéronisme secondaire | n2=en:dural and choroid plexus calcifications | rel=r_associated | relid=0 | w=5
  1620. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dural ectasia
    n1=hyperaldostéronisme secondaire | n2=en:dural ectasia | rel=r_associated | relid=0 | w=5
  1621. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria | rel=r_associated | relid=0 | w=5
  1622. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (1 family) | rel=r_associated | relid=0 | w=5
  1623. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (1 patient) | rel=r_associated | relid=0 | w=5
  1624. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (74%)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (74%) | rel=r_associated | relid=0 | w=5
  1625. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (in some patients) | rel=r_associated | relid=0 | w=5
  1626. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (less common)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (less common) | rel=r_associated | relid=0 | w=5
  1627. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (mild)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (mild) | rel=r_associated | relid=0 | w=5
  1628. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (most common presenting symptom)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (most common presenting symptom) | rel=r_associated | relid=0 | w=5
  1629. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria (onset in third decade)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria (onset in third decade) | rel=r_associated | relid=0 | w=5
  1630. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria may occur
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria may occur | rel=r_associated | relid=0 | w=5
  1631. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria, mild (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria, mild (1 family) | rel=r_associated | relid=0 | w=5
  1632. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1633. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthria, slowly progressive
    n1=hyperaldostéronisme secondaire | n2=en:dysarthria, slowly progressive | rel=r_associated | relid=0 | w=5
  1634. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysarthrias, spastic
    n1=hyperaldostéronisme secondaire | n2=en:dysarthrias, spastic | rel=r_associated | relid=0 | w=5
  1635. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysautonomia
    n1=hyperaldostéronisme secondaire | n2=en:dysautonomia | rel=r_associated | relid=0 | w=5
  1636. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysautonomia may occur
    n1=hyperaldostéronisme secondaire | n2=en:dysautonomia may occur | rel=r_associated | relid=0 | w=5
  1637. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyscalculia
    n1=hyperaldostéronisme secondaire | n2=en:dyscalculia | rel=r_associated | relid=0 | w=5
  1638. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysdiadochokinesis
    n1=hyperaldostéronisme secondaire | n2=en:dysdiadochokinesis | rel=r_associated | relid=0 | w=5
  1639. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysdiadochokinesis (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dysdiadochokinesis (1 family) | rel=r_associated | relid=0 | w=5
  1640. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysdiadochokinesis (63%)
    n1=hyperaldostéronisme secondaire | n2=en:dysdiadochokinesis (63%) | rel=r_associated | relid=0 | w=5
  1641. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysexecutive behavior
    n1=hyperaldostéronisme secondaire | n2=en:dysexecutive behavior | rel=r_associated | relid=0 | w=5
  1642. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysfunction of lateral corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:dysfunction of lateral corticospinal tracts | rel=r_associated | relid=0 | w=5
  1643. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysfunction of the autonomic nervous system
    n1=hyperaldostéronisme secondaire | n2=en:dysfunction of the autonomic nervous system | rel=r_associated | relid=0 | w=5
  1644. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgenesis of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:dysgenesis of corpus callosum | rel=r_associated | relid=0 | w=5
  1645. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgenesis of the anterior commissure (in some)
    n1=hyperaldostéronisme secondaire | n2=en:dysgenesis of the anterior commissure (in some) | rel=r_associated | relid=0 | w=5
  1646. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgenesis of the corpus callosum (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dysgenesis of the corpus callosum (1 patient) | rel=r_associated | relid=0 | w=5
  1647. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgenesis or agenesis of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:dysgenesis or agenesis of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  1648. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgenesis or agenesis of the corpus callosum (in some)
    n1=hyperaldostéronisme secondaire | n2=en:dysgenesis or agenesis of the corpus callosum (in some) | rel=r_associated | relid=0 | w=5
  1649. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysgraphias
    n1=hyperaldostéronisme secondaire | n2=en:dysgraphias | rel=r_associated | relid=0 | w=5
  1650. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyskinesia
    n1=hyperaldostéronisme secondaire | n2=en:dyskinesia | rel=r_associated | relid=0 | w=5
  1651. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyskinesia, episodic
    n1=hyperaldostéronisme secondaire | n2=en:dyskinesia, episodic | rel=r_associated | relid=0 | w=5
  1652. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyskinesia, limb, exertion-induced
    n1=hyperaldostéronisme secondaire | n2=en:dyskinesia, limb, exertion-induced | rel=r_associated | relid=0 | w=5
  1653. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyskinetic movements
    n1=hyperaldostéronisme secondaire | n2=en:dyskinetic movements | rel=r_associated | relid=0 | w=5
  1654. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dyslexia
    n1=hyperaldostéronisme secondaire | n2=en:dyslexia | rel=r_associated | relid=0 | w=5
  1655. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria (1 family) | rel=r_associated | relid=0 | w=5
  1656. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria (1 patient) | rel=r_associated | relid=0 | w=5
  1657. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria (in 1 of 3 families)
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria (in 1 of 3 families) | rel=r_associated | relid=0 | w=5
  1658. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria (in some patients) | rel=r_associated | relid=0 | w=5
  1659. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria (type i)
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria (type i) | rel=r_associated | relid=0 | w=5
  1660. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetria, mild
    n1=hyperaldostéronisme secondaire | n2=en:dysmetria, mild | rel=r_associated | relid=0 | w=5
  1661. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmetrias, cerebellar
    n1=hyperaldostéronisme secondaire | n2=en:dysmetrias, cerebellar | rel=r_associated | relid=0 | w=5
  1662. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmorphic basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:dysmorphic basal ganglia | rel=r_associated | relid=0 | w=5
  1663. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmorphic basal ganglia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dysmorphic basal ganglia (1 patient) | rel=r_associated | relid=0 | w=5
  1664. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmorphic basal ganglia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dysmorphic basal ganglia (in some patients) | rel=r_associated | relid=0 | w=5
  1665. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmorphic basal ganglia (in some)
    n1=hyperaldostéronisme secondaire | n2=en:dysmorphic basal ganglia (in some) | rel=r_associated | relid=0 | w=5
  1666. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmorphic corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:dysmorphic corpus callosum | rel=r_associated | relid=0 | w=5
  1667. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmyelinating leukodystrophy
    n1=hyperaldostéronisme secondaire | n2=en:dysmyelinating leukodystrophy | rel=r_associated | relid=0 | w=5
  1668. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmyelination of the brain and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:dysmyelination of the brain and spinal cord | rel=r_associated | relid=0 | w=5
  1669. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysmyelination of the brain, myelin is not formed properly
    n1=hyperaldostéronisme secondaire | n2=en:dysmyelination of the brain, myelin is not formed properly | rel=r_associated | relid=0 | w=5
  1670. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysphagia
    n1=hyperaldostéronisme secondaire | n2=en:dysphagia | rel=r_associated | relid=0 | w=5
  1671. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysphasia
    n1=hyperaldostéronisme secondaire | n2=en:dysphasia | rel=r_associated | relid=0 | w=5
  1672. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysphonia
    n1=hyperaldostéronisme secondaire | n2=en:dysphonia | rel=r_associated | relid=0 | w=5
  1673. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplasia of the cerebellar hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:dysplasia of the cerebellar hemispheres | rel=r_associated | relid=0 | w=5
  1674. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic basal ganglia | rel=r_associated | relid=0 | w=5
  1675. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic c-shaped inferior olivary nuclei
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic c-shaped inferior olivary nuclei | rel=r_associated | relid=0 | w=5
  1676. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic cerebellar gangliocytoma
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic cerebellar gangliocytoma | rel=r_associated | relid=0 | w=5
  1677. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic cerebellar vermis | rel=r_associated | relid=0 | w=5
  1678. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic cerebellum | rel=r_associated | relid=0 | w=5
  1679. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic pons
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic pons | rel=r_associated | relid=0 | w=5
  1680. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dysplastic superior cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:dysplastic superior cerebellar vermis | rel=r_associated | relid=0 | w=5
  1681. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia
    n1=hyperaldostéronisme secondaire | n2=en:dystonia | rel=r_associated | relid=0 | w=5
  1682. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (<20%) (finding)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (<20%) (finding) | rel=r_associated | relid=0 | w=5
  1683. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (1 family) | rel=r_associated | relid=0 | w=5
  1684. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (1 patient) | rel=r_associated | relid=0 | w=5
  1685. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (14% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (14% of patients) | rel=r_associated | relid=0 | w=5
  1686. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (57%)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (57%) | rel=r_associated | relid=0 | w=5
  1687. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (in 2 patients) | rel=r_associated | relid=0 | w=5
  1688. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (in severe cases) | rel=r_associated | relid=0 | w=5
  1689. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (in some patients) | rel=r_associated | relid=0 | w=5
  1690. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (less common) | rel=r_associated | relid=0 | w=5
  1691. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia (may spontaneously remit in childhood or adolescence)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia (may spontaneously remit in childhood or adolescence) | rel=r_associated | relid=0 | w=5
  1692. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia 18 (disorder)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia 18 (disorder) | rel=r_associated | relid=0 | w=5
  1693. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia at onset (16%)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia at onset (16%) | rel=r_associated | relid=0 | w=5
  1694. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia disorders
    n1=hyperaldostéronisme secondaire | n2=en:dystonia disorders | rel=r_associated | relid=0 | w=5
  1695. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia may become generalized
    n1=hyperaldostéronisme secondaire | n2=en:dystonia may become generalized | rel=r_associated | relid=0 | w=5
  1696. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia with diurnal variation
    n1=hyperaldostéronisme secondaire | n2=en:dystonia with diurnal variation | rel=r_associated | relid=0 | w=5
  1697. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, episodic, primary affects hands and feet
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, episodic, primary affects hands and feet | rel=r_associated | relid=0 | w=5
  1698. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, focal (at onset)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, focal (at onset) | rel=r_associated | relid=0 | w=5
  1699. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm) | rel=r_associated | relid=0 | w=5
  1700. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, generalized, dopa-unresponsive
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, generalized, dopa-unresponsive | rel=r_associated | relid=0 | w=5
  1701. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, limb, exercise-induced
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, limb, exercise-induced | rel=r_associated | relid=0 | w=5
  1702. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, progressive
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, progressive | rel=r_associated | relid=0 | w=5
  1703. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, severe (in all limbs)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, severe (in all limbs) | rel=r_associated | relid=0 | w=5
  1704. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonia, trunk and limbs (upper and lower)
    n1=hyperaldostéronisme secondaire | n2=en:dystonia, trunk and limbs (upper and lower) | rel=r_associated | relid=0 | w=5
  1705. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic hand posturing (44% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:dystonic hand posturing (44% of patients) | rel=r_associated | relid=0 | w=5
  1706. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic movements (in 1 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:dystonic movements (in 1 of 6 patients) | rel=r_associated | relid=0 | w=5
  1707. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic posture
    n1=hyperaldostéronisme secondaire | n2=en:dystonic posture | rel=r_associated | relid=0 | w=5
  1708. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic posturing (rare)
    n1=hyperaldostéronisme secondaire | n2=en:dystonic posturing (rare) | rel=r_associated | relid=0 | w=5
  1709. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic posturing of the hands
    n1=hyperaldostéronisme secondaire | n2=en:dystonic posturing of the hands | rel=r_associated | relid=0 | w=5
  1710. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic tongue protrusion
    n1=hyperaldostéronisme secondaire | n2=en:dystonic tongue protrusion | rel=r_associated | relid=0 | w=5
  1711. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic tremor
    n1=hyperaldostéronisme secondaire | n2=en:dystonic tremor | rel=r_associated | relid=0 | w=5
  1712. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic vocal tremor
    n1=hyperaldostéronisme secondaire | n2=en:dystonic vocal tremor | rel=r_associated | relid=0 | w=5
  1713. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystonic writer's cramp
    n1=hyperaldostéronisme secondaire | n2=en:dystonic writer's cramp | rel=r_associated | relid=0 | w=5
  1714. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:dystrophic neurites
    n1=hyperaldostéronisme secondaire | n2=en:dystrophic neurites | rel=r_associated | relid=0 | w=5
  1715. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ear infection
    n1=hyperaldostéronisme secondaire | n2=en:ear infection | rel=r_associated | relid=0 | w=5
  1716. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:earlier sleep-offset time (earlier awakening)
    n1=hyperaldostéronisme secondaire | n2=en:earlier sleep-offset time (earlier awakening) | rel=r_associated | relid=0 | w=5
  1717. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early and severe foot extensor muscle involvement
    n1=hyperaldostéronisme secondaire | n2=en:early and severe foot extensor muscle involvement | rel=r_associated | relid=0 | w=5
  1718. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early involvement of the corticospinal pathways
    n1=hyperaldostéronisme secondaire | n2=en:early involvement of the corticospinal pathways | rel=r_associated | relid=0 | w=5
  1719. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early severe fetal akinesia sequence
    n1=hyperaldostéronisme secondaire | n2=en:early severe fetal akinesia sequence | rel=r_associated | relid=0 | w=5
  1720. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early sleep offset (almost 4 hours advanced over controls)
    n1=hyperaldostéronisme secondaire | n2=en:early sleep offset (almost 4 hours advanced over controls) | rel=r_associated | relid=0 | w=5
  1721. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early sleep onset (almost 4 hours advanced over controls)
    n1=hyperaldostéronisme secondaire | n2=en:early sleep onset (almost 4 hours advanced over controls) | rel=r_associated | relid=0 | w=5
  1722. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early speech delay
    n1=hyperaldostéronisme secondaire | n2=en:early speech delay | rel=r_associated | relid=0 | w=5
  1723. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:early-onset myoclonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:early-onset myoclonic seizures | rel=r_associated | relid=0 | w=5
  1724. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:easily excitable
    n1=hyperaldostéronisme secondaire | n2=en:easily excitable | rel=r_associated | relid=0 | w=5
  1725. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:easily frustrated
    n1=hyperaldostéronisme secondaire | n2=en:easily frustrated | rel=r_associated | relid=0 | w=5
  1726. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:easily provoked laughter
    n1=hyperaldostéronisme secondaire | n2=en:easily provoked laughter | rel=r_associated | relid=0 | w=5
  1727. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eating disorder
    n1=hyperaldostéronisme secondaire | n2=en:eating disorder | rel=r_associated | relid=0 | w=5
  1728. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:echolalia
    n1=hyperaldostéronisme secondaire | n2=en:echolalia | rel=r_associated | relid=0 | w=5
  1729. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap'
    n1=hyperaldostéronisme secondaire | n2=en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap' | rel=r_associated | relid=0 | w=5
  1730. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ectopic posterior pituitary (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ectopic posterior pituitary (in some patients) | rel=r_associated | relid=0 | w=5
  1731. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3)
    n1=hyperaldostéronisme secondaire | n2=en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3) | rel=r_associated | relid=0 | w=5
  1732. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2)
    n1=hyperaldostéronisme secondaire | n2=en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2) | rel=r_associated | relid=0 | w=5
  1733. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg - polyspike on photic stimulation (stage 1)
    n1=hyperaldostéronisme secondaire | n2=en:eeg - polyspike on photic stimulation (stage 1) | rel=r_associated | relid=0 | w=5
  1734. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges | rel=r_associated | relid=0 | w=5
  1735. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg abnormalities in 20-50%
    n1=hyperaldostéronisme secondaire | n2=en:eeg abnormalities in 20-50% | rel=r_associated | relid=0 | w=5
  1736. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg abnormalities in 20-50% impaired language development
    n1=hyperaldostéronisme secondaire | n2=en:eeg abnormalities in 20-50% impaired language development | rel=r_associated | relid=0 | w=5
  1737. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg and symptomatology suggest mesial temporal origin
    n1=hyperaldostéronisme secondaire | n2=en:eeg and symptomatology suggest mesial temporal origin | rel=r_associated | relid=0 | w=5
  1738. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg during episodes shows desynchronization
    n1=hyperaldostéronisme secondaire | n2=en:eeg during episodes shows desynchronization | rel=r_associated | relid=0 | w=5
  1739. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg is slowed with polyspike wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg is slowed with polyspike wave discharges | rel=r_associated | relid=0 | w=5
  1740. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg is usually normal
    n1=hyperaldostéronisme secondaire | n2=en:eeg is usually normal | rel=r_associated | relid=0 | w=5
  1741. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg later shows generalized spike or polyspike waves and focal spikes
    n1=hyperaldostéronisme secondaire | n2=en:eeg later shows generalized spike or polyspike waves and focal spikes | rel=r_associated | relid=0 | w=5
  1742. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg may be normal at first
    n1=hyperaldostéronisme secondaire | n2=en:eeg may be normal at first | rel=r_associated | relid=0 | w=5
  1743. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg may show migrating focal or multifocal origin (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:eeg may show migrating focal or multifocal origin (in severe cases) | rel=r_associated | relid=0 | w=5
  1744. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows 3-4-hz spike and multispike slow wave complexes
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows 3-4-hz spike and multispike slow wave complexes | rel=r_associated | relid=0 | w=5
  1745. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows 3-4-hz spike waves
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows 3-4-hz spike waves | rel=r_associated | relid=0 | w=5
  1746. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows 3-hz spike-wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows 3-hz spike-wave discharges | rel=r_associated | relid=0 | w=5
  1747. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows abundant slow waves and fast spike activity
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows abundant slow waves and fast spike activity | rel=r_associated | relid=0 | w=5
  1748. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows active generalized spike and wave and polyspike pattern
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows active generalized spike and wave and polyspike pattern | rel=r_associated | relid=0 | w=5
  1749. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows burst suppression
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows burst suppression | rel=r_associated | relid=0 | w=5
  1750. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows centrotemporal spike-wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows centrotemporal spike-wave discharges | rel=r_associated | relid=0 | w=5
  1751. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows epileptiform activity
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows epileptiform activity | rel=r_associated | relid=0 | w=5
  1752. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows epileptiform discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows epileptiform discharges | rel=r_associated | relid=0 | w=5
  1753. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows frontal lobe origin
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows frontal lobe origin | rel=r_associated | relid=0 | w=5
  1754. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows generalized polyspike and wave discharges (4-5 hz)
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows generalized polyspike and wave discharges (4-5 hz) | rel=r_associated | relid=0 | w=5
  1755. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows generalized polyspike and wave discharges (4-6 hz)
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows generalized polyspike and wave discharges (4-6 hz) | rel=r_associated | relid=0 | w=5
  1756. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows generalized, bilateral, synchronous, symmetrical discharge
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows generalized, bilateral, synchronous, symmetrical discharge | rel=r_associated | relid=0 | w=5
  1757. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows hypsarrhythmia
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows hypsarrhythmia | rel=r_associated | relid=0 | w=5
  1758. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows hypsarrhythmia (in 1 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows hypsarrhythmia (in 1 of 6 patients) | rel=r_associated | relid=0 | w=5
  1759. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows multifocal discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows multifocal discharges | rel=r_associated | relid=0 | w=5
  1760. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows multifocal epileptic activity
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows multifocal epileptic activity | rel=r_associated | relid=0 | w=5
  1761. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows nonspecific slow-wave paroxysms
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows nonspecific slow-wave paroxysms | rel=r_associated | relid=0 | w=5
  1762. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows photosensitivity
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows photosensitivity | rel=r_associated | relid=0 | w=5
  1763. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows rolandic sharp waves and spikes
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows rolandic sharp waves and spikes | rel=r_associated | relid=0 | w=5
  1764. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows slow frequency high amplitude waves with high frequency polyspikes
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows slow frequency high amplitude waves with high frequency polyspikes | rel=r_associated | relid=0 | w=5
  1765. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows slowed dysrhythmia and multifocal discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows slowed dysrhythmia and multifocal discharges | rel=r_associated | relid=0 | w=5
  1766. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows spike and multispike waves, 3-4 hz
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows spike and multispike waves, 3-4 hz | rel=r_associated | relid=0 | w=5
  1767. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows spike and wave or polyspike and wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows spike and wave or polyspike and wave discharges | rel=r_associated | relid=0 | w=5
  1768. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows suppression with ictal burst activities
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows suppression with ictal burst activities | rel=r_associated | relid=0 | w=5
  1769. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows suppression-burst pattern
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows suppression-burst pattern | rel=r_associated | relid=0 | w=5
  1770. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows unilateral centrotemporal spikes
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows unilateral centrotemporal spikes | rel=r_associated | relid=0 | w=5
  1771. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg shows with a multifocal pattern with spikes and sharp waves
    n1=hyperaldostéronisme secondaire | n2=en:eeg shows with a multifocal pattern with spikes and sharp waves | rel=r_associated | relid=0 | w=5
  1772. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg with burst suppression
    n1=hyperaldostéronisme secondaire | n2=en:eeg with burst suppression | rel=r_associated | relid=0 | w=5
  1773. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg with focal discharge
    n1=hyperaldostéronisme secondaire | n2=en:eeg with focal discharge | rel=r_associated | relid=0 | w=5
  1774. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg with paroxysmal activity
    n1=hyperaldostéronisme secondaire | n2=en:eeg with paroxysmal activity | rel=r_associated | relid=0 | w=5
  1775. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eeg with photoparoxysmal response
    n1=hyperaldostéronisme secondaire | n2=en:eeg with photoparoxysmal response | rel=r_associated | relid=0 | w=5
  1776. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:effaced gyral pattern
    n1=hyperaldostéronisme secondaire | n2=en:effaced gyral pattern | rel=r_associated | relid=0 | w=5
  1777. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:electroencephalogram (eeg) abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:electroencephalogram (eeg) abnormalities | rel=r_associated | relid=0 | w=5
  1778. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:electroencephalogram abnormal
    n1=hyperaldostéronisme secondaire | n2=en:electroencephalogram abnormal | rel=r_associated | relid=0 | w=5
  1779. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:electrophysiologic studies indicate cortical origin
    n1=hyperaldostéronisme secondaire | n2=en:electrophysiologic studies indicate cortical origin | rel=r_associated | relid=0 | w=5
  1780. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elevated interferon levels in cerebrospinal fluid
    n1=hyperaldostéronisme secondaire | n2=en:elevated interferon levels in cerebrospinal fluid | rel=r_associated | relid=0 | w=5
  1781. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid
    n1=hyperaldostéronisme secondaire | n2=en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid | rel=r_associated | relid=0 | w=5
  1782. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elevated white cell count in cerebrospinal fluid
    n1=hyperaldostéronisme secondaire | n2=en:elevated white cell count in cerebrospinal fluid | rel=r_associated | relid=0 | w=5
  1783. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elevation and splaying of the superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:elevation and splaying of the superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  1784. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elimination disorders
    n1=hyperaldostéronisme secondaire | n2=en:elimination disorders | rel=r_associated | relid=0 | w=5
  1785. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:elongated superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:elongated superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  1786. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles
    n1=hyperaldostéronisme secondaire | n2=en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles | rel=r_associated | relid=0 | w=5
  1787. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows continuous motor unit firing at rest
    n1=hyperaldostéronisme secondaire | n2=en:emg shows continuous motor unit firing at rest | rel=r_associated | relid=0 | w=5
  1788. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows evidence of denervation
    n1=hyperaldostéronisme secondaire | n2=en:emg shows evidence of denervation | rel=r_associated | relid=0 | w=5
  1789. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials
    n1=hyperaldostéronisme secondaire | n2=en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials | rel=r_associated | relid=0 | w=5
  1790. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows fibrillations and fasiculations
    n1=hyperaldostéronisme secondaire | n2=en:emg shows fibrillations and fasiculations | rel=r_associated | relid=0 | w=5
  1791. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows involuntary continuous motor activity at rest
    n1=hyperaldostéronisme secondaire | n2=en:emg shows involuntary continuous motor activity at rest | rel=r_associated | relid=0 | w=5
  1792. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows neurogenic abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:emg shows neurogenic abnormalities | rel=r_associated | relid=0 | w=5
  1793. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows neurogenic changes
    n1=hyperaldostéronisme secondaire | n2=en:emg shows neurogenic changes | rel=r_associated | relid=0 | w=5
  1794. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows neurogenic changes and denervation
    n1=hyperaldostéronisme secondaire | n2=en:emg shows neurogenic changes and denervation | rel=r_associated | relid=0 | w=5
  1795. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg shows neurogenic findings
    n1=hyperaldostéronisme secondaire | n2=en:emg shows neurogenic findings | rel=r_associated | relid=0 | w=5
  1796. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emg with spontaneous discharge of normal motor unit potentials
    n1=hyperaldostéronisme secondaire | n2=en:emg with spontaneous discharge of normal motor unit potentials | rel=r_associated | relid=0 | w=5
  1797. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional fragility
    n1=hyperaldostéronisme secondaire | n2=en:emotional fragility | rel=r_associated | relid=0 | w=5
  1798. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional lability (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:emotional lability (2 patients) | rel=r_associated | relid=0 | w=5
  1799. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional lability (in some)
    n1=hyperaldostéronisme secondaire | n2=en:emotional lability (in some) | rel=r_associated | relid=0 | w=5
  1800. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional lability (variable)
    n1=hyperaldostéronisme secondaire | n2=en:emotional lability (variable) | rel=r_associated | relid=0 | w=5
  1801. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional lability in 50% of patients
    n1=hyperaldostéronisme secondaire | n2=en:emotional lability in 50% of patients | rel=r_associated | relid=0 | w=5
  1802. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:emotional lability, extreme
    n1=hyperaldostéronisme secondaire | n2=en:emotional lability, extreme | rel=r_associated | relid=0 | w=5
  1803. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:empty sella syndrome
    n1=hyperaldostéronisme secondaire | n2=en:empty sella syndrome | rel=r_associated | relid=0 | w=5
  1804. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalitis
    n1=hyperaldostéronisme secondaire | n2=en:encephalitis | rel=r_associated | relid=0 | w=5
  1805. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele | rel=r_associated | relid=0 | w=5
  1806. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele (1 patient) | rel=r_associated | relid=0 | w=5
  1807. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele (rare)
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele (rare) | rel=r_associated | relid=0 | w=5
  1808. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele (single case)
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele (single case) | rel=r_associated | relid=0 | w=5
  1809. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele (uncommon) | rel=r_associated | relid=0 | w=5
  1810. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalocele of orbit
    n1=hyperaldostéronisme secondaire | n2=en:encephalocele of orbit | rel=r_associated | relid=0 | w=5
  1811. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephaloceles, frontal
    n1=hyperaldostéronisme secondaire | n2=en:encephaloceles, frontal | rel=r_associated | relid=0 | w=5
  1812. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalomyelopathy
    n1=hyperaldostéronisme secondaire | n2=en:encephalomyelopathy | rel=r_associated | relid=0 | w=5
  1813. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalomyopathy
    n1=hyperaldostéronisme secondaire | n2=en:encephalomyopathy | rel=r_associated | relid=0 | w=5
  1814. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathic attacks, episodic, associated with infection
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathic attacks, episodic, associated with infection | rel=r_associated | relid=0 | w=5
  1815. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathic episodes, often associated with infection
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathic episodes, often associated with infection | rel=r_associated | relid=0 | w=5
  1816. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy | rel=r_associated | relid=0 | w=5
  1817. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy (in 1 patient) | rel=r_associated | relid=0 | w=5
  1818. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy (in some patients) | rel=r_associated | relid=0 | w=5
  1819. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy associated with hypoglycemia
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy associated with hypoglycemia | rel=r_associated | relid=0 | w=5
  1820. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy during episodes
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy during episodes | rel=r_associated | relid=0 | w=5
  1821. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, acute-onset
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, acute-onset | rel=r_associated | relid=0 | w=5
  1822. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, acute, episodic
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, acute, episodic | rel=r_associated | relid=0 | w=5
  1823. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, acute, sudden-onset after febrile illness
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, acute, sudden-onset after febrile illness | rel=r_associated | relid=0 | w=5
  1824. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, acute, sudden-onset during febrile illness
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, acute, sudden-onset during febrile illness | rel=r_associated | relid=0 | w=5
  1825. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, episodic
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, episodic | rel=r_associated | relid=0 | w=5
  1826. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, episodic, associated with febrile illnesses
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, episodic, associated with febrile illnesses | rel=r_associated | relid=0 | w=5
  1827. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encephalopathy, severe, neonatal
    n1=hyperaldostéronisme secondaire | n2=en:encephalopathy, severe, neonatal | rel=r_associated | relid=0 | w=5
  1828. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:encopresis
    n1=hyperaldostéronisme secondaire | n2=en:encopresis | rel=r_associated | relid=0 | w=5
  1829. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:endothelial intracytoplasmic globular inclusions
    n1=hyperaldostéronisme secondaire | n2=en:endothelial intracytoplasmic globular inclusions | rel=r_associated | relid=0 | w=5
  1830. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enhancement of the c-reflex
    n1=hyperaldostéronisme secondaire | n2=en:enhancement of the c-reflex | rel=r_associated | relid=0 | w=5
  1831. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged cerebellar cistern
    n1=hyperaldostéronisme secondaire | n2=en:enlarged cerebellar cistern | rel=r_associated | relid=0 | w=5
  1832. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:enlarged cerebellum | rel=r_associated | relid=0 | w=5
  1833. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged cisterna magna
    n1=hyperaldostéronisme secondaire | n2=en:enlarged cisterna magna | rel=r_associated | relid=0 | w=5
  1834. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged cisterna magna (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged cisterna magna (in some patients) | rel=r_associated | relid=0 | w=5
  1835. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:enlarged corpus callosum | rel=r_associated | relid=0 | w=5
  1836. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged extraaxial space on brain imaging
    n1=hyperaldostéronisme secondaire | n2=en:enlarged extraaxial space on brain imaging | rel=r_associated | relid=0 | w=5
  1837. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged fourth ventricle, mild
    n1=hyperaldostéronisme secondaire | n2=en:enlarged fourth ventricle, mild | rel=r_associated | relid=0 | w=5
  1838. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged lateral and third ventricles
    n1=hyperaldostéronisme secondaire | n2=en:enlarged lateral and third ventricles | rel=r_associated | relid=0 | w=5
  1839. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged lateral ventricles (occipital>frontal)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged lateral ventricles (occipital>frontal) | rel=r_associated | relid=0 | w=5
  1840. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged motor unit action potentials
    n1=hyperaldostéronisme secondaire | n2=en:enlarged motor unit action potentials | rel=r_associated | relid=0 | w=5
  1841. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged or prominent ventricles (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged or prominent ventricles (in some patients) | rel=r_associated | relid=0 | w=5
  1842. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged ventricles (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged ventricles (1 patient) | rel=r_associated | relid=0 | w=5
  1843. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged ventricles (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged ventricles (in some patients) | rel=r_associated | relid=0 | w=5
  1844. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged ventricles (in some)
    n1=hyperaldostéronisme secondaire | n2=en:enlarged ventricles (in some) | rel=r_associated | relid=0 | w=5
  1845. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enlarged white matter
    n1=hyperaldostéronisme secondaire | n2=en:enlarged white matter | rel=r_associated | relid=0 | w=5
  1846. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enterobiasis
    n1=hyperaldostéronisme secondaire | n2=en:enterobiasis | rel=r_associated | relid=0 | w=5
  1847. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:entire central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:entire central nervous system | rel=r_associated | relid=0 | w=5
  1848. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:enuresis
    n1=hyperaldostéronisme secondaire | n2=en:enuresis | rel=r_associated | relid=0 | w=5
  1849. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions
    n1=hyperaldostéronisme secondaire | n2=en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions | rel=r_associated | relid=0 | w=5
  1850. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsia partialis continua
    n1=hyperaldostéronisme secondaire | n2=en:epilepsia partialis continua | rel=r_associated | relid=0 | w=5
  1851. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsies, myoclonic
    n1=hyperaldostéronisme secondaire | n2=en:epilepsies, myoclonic | rel=r_associated | relid=0 | w=5
  1852. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy (in 2 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy (in 2 of 3 patients) | rel=r_associated | relid=0 | w=5
  1853. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy (in some patients) | rel=r_associated | relid=0 | w=5
  1854. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, frontal lobe
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, frontal lobe | rel=r_associated | relid=0 | w=5
  1855. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, multifocal, intractable
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, multifocal, intractable | rel=r_associated | relid=0 | w=5
  1856. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, myoclonic astatic
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, myoclonic astatic | rel=r_associated | relid=0 | w=5
  1857. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, refractory (onset in adolescence or young adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, refractory (onset in adolescence or young adulthood) | rel=r_associated | relid=0 | w=5
  1858. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, rolandic
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, rolandic | rel=r_associated | relid=0 | w=5
  1859. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epilepsy, temporal lobe
    n1=hyperaldostéronisme secondaire | n2=en:epilepsy, temporal lobe | rel=r_associated | relid=0 | w=5
  1860. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epileptic drop attack
    n1=hyperaldostéronisme secondaire | n2=en:epileptic drop attack | rel=r_associated | relid=0 | w=5
  1861. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epileptic encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:epileptic encephalopathy | rel=r_associated | relid=0 | w=5
  1862. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epileptic encephalopathy (in 2 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:epileptic encephalopathy (in 2 of 3 patients) | rel=r_associated | relid=0 | w=5
  1863. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epileptic encephalopathy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:epileptic encephalopathy (in some patients) | rel=r_associated | relid=0 | w=5
  1864. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:epileptic encephalopathy with psychomotor retardation (rare)
    n1=hyperaldostéronisme secondaire | n2=en:epileptic encephalopathy with psychomotor retardation (rare) | rel=r_associated | relid=0 | w=5
  1865. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes begin with muscle tightening
    n1=hyperaldostéronisme secondaire | n2=en:episodes begin with muscle tightening | rel=r_associated | relid=0 | w=5
  1866. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes last up to 2 minutes
    n1=hyperaldostéronisme secondaire | n2=en:episodes last up to 2 minutes | rel=r_associated | relid=0 | w=5
  1867. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes may last less than 30 minutes or greater than several hours
    n1=hyperaldostéronisme secondaire | n2=en:episodes may last less than 30 minutes or greater than several hours | rel=r_associated | relid=0 | w=5
  1868. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation
    n1=hyperaldostéronisme secondaire | n2=en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation | rel=r_associated | relid=0 | w=5
  1869. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month
    n1=hyperaldostéronisme secondaire | n2=en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month | rel=r_associated | relid=0 | w=5
  1870. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodes typically occur several times a week
    n1=hyperaldostéronisme secondaire | n2=en:episodes typically occur several times a week | rel=r_associated | relid=0 | w=5
  1871. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic absence-like spells
    n1=hyperaldostéronisme secondaire | n2=en:episodic absence-like spells | rel=r_associated | relid=0 | w=5
  1872. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic acute neurologic deterioration/encephalopathy, recurrent
    n1=hyperaldostéronisme secondaire | n2=en:episodic acute neurologic deterioration/encephalopathy, recurrent | rel=r_associated | relid=0 | w=5
  1873. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic aggression or exaggerated affection-seeking (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:episodic aggression or exaggerated affection-seeking (in some patients) | rel=r_associated | relid=0 | w=5
  1874. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic ataxia
    n1=hyperaldostéronisme secondaire | n2=en:episodic ataxia | rel=r_associated | relid=0 | w=5
  1875. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic confusion
    n1=hyperaldostéronisme secondaire | n2=en:episodic confusion | rel=r_associated | relid=0 | w=5
  1876. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic generalized skeletal muscle contractions
    n1=hyperaldostéronisme secondaire | n2=en:episodic generalized skeletal muscle contractions | rel=r_associated | relid=0 | w=5
  1877. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic hemiplegia
    n1=hyperaldostéronisme secondaire | n2=en:episodic hemiplegia | rel=r_associated | relid=0 | w=5
  1878. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic subtype, headaches occur in clusters
    n1=hyperaldostéronisme secondaire | n2=en:episodic subtype, headaches occur in clusters | rel=r_associated | relid=0 | w=5
  1879. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic sudden headache
    n1=hyperaldostéronisme secondaire | n2=en:episodic sudden headache | rel=r_associated | relid=0 | w=5
  1880. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:episodic vomiting
    n1=hyperaldostéronisme secondaire | n2=en:episodic vomiting | rel=r_associated | relid=0 | w=5
  1881. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:equivocal plantar response
    n1=hyperaldostéronisme secondaire | n2=en:equivocal plantar response | rel=r_associated | relid=0 | w=5
  1882. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:erythema infectiosum
    n1=hyperaldostéronisme secondaire | n2=en:erythema infectiosum | rel=r_associated | relid=0 | w=5
  1883. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:essential tremor
    n1=hyperaldostéronisme secondaire | n2=en:essential tremor | rel=r_associated | relid=0 | w=5
  1884. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:essential tremor (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:essential tremor (1 family) | rel=r_associated | relid=0 | w=5
  1885. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:euphoria
    n1=hyperaldostéronisme secondaire | n2=en:euphoria | rel=r_associated | relid=0 | w=5
  1886. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:evolution to severe encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:evolution to severe encephalopathy | rel=r_associated | relid=0 | w=5
  1887. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exaggerated acoustic startle response
    n1=hyperaldostéronisme secondaire | n2=en:exaggerated acoustic startle response | rel=r_associated | relid=0 | w=5
  1888. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exaggerated moro reflex
    n1=hyperaldostéronisme secondaire | n2=en:exaggerated moro reflex | rel=r_associated | relid=0 | w=5
  1889. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exaggerated startle response
    n1=hyperaldostéronisme secondaire | n2=en:exaggerated startle response | rel=r_associated | relid=0 | w=5
  1890. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exaggerated startle response to tactile or acoustic stimuli
    n1=hyperaldostéronisme secondaire | n2=en:exaggerated startle response to tactile or acoustic stimuli | rel=r_associated | relid=0 | w=5
  1891. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:excessive daytime somnolence
    n1=hyperaldostéronisme secondaire | n2=en:excessive daytime somnolence | rel=r_associated | relid=0 | w=5
  1892. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:excited catatonia
    n1=hyperaldostéronisme secondaire | n2=en:excited catatonia | rel=r_associated | relid=0 | w=5
  1893. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:executive dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:executive dysfunction | rel=r_associated | relid=0 | w=5
  1894. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exercise for children
    n1=hyperaldostéronisme secondaire | n2=en:exercise for children | rel=r_associated | relid=0 | w=5
  1895. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:exhaustion
    n1=hyperaldostéronisme secondaire | n2=en:exhaustion | rel=r_associated | relid=0 | w=5
  1896. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressionless face
    n1=hyperaldostéronisme secondaire | n2=en:expressionless face | rel=r_associated | relid=0 | w=5
  1897. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressive aphasia
    n1=hyperaldostéronisme secondaire | n2=en:expressive aphasia | rel=r_associated | relid=0 | w=5
  1898. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressive language delay
    n1=hyperaldostéronisme secondaire | n2=en:expressive language delay | rel=r_associated | relid=0 | w=5
  1899. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressive language disorder
    n1=hyperaldostéronisme secondaire | n2=en:expressive language disorder | rel=r_associated | relid=0 | w=5
  1900. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressive speech absent
    n1=hyperaldostéronisme secondaire | n2=en:expressive speech absent | rel=r_associated | relid=0 | w=5
  1901. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:expressive speech deficit
    n1=hyperaldostéronisme secondaire | n2=en:expressive speech deficit | rel=r_associated | relid=0 | w=5
  1902. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres | rel=r_associated | relid=0 | w=5
  1903. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (1 family) | rel=r_associated | relid=0 | w=5
  1904. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (1 patient) | rel=r_associated | relid=0 | w=5
  1905. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (early-on)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (early-on) | rel=r_associated | relid=0 | w=5
  1906. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (in some patients) | rel=r_associated | relid=0 | w=5
  1907. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (later)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (later) | rel=r_associated | relid=0 | w=5
  1908. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (reported in 1 family) | rel=r_associated | relid=0 | w=5
  1909. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  1910. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor plantar responses (variable)
    n1=hyperaldostéronisme secondaire | n2=en:extensor plantar responses (variable) | rel=r_associated | relid=0 | w=5
  1911. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extensor posturing
    n1=hyperaldostéronisme secondaire | n2=en:extensor posturing | rel=r_associated | relid=0 | w=5
  1912. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:external capsule and claustrum may be involved
    n1=hyperaldostéronisme secondaire | n2=en:external capsule and claustrum may be involved | rel=r_associated | relid=0 | w=5
  1913. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extra superior temporal gyrus (female)
    n1=hyperaldostéronisme secondaire | n2=en:extra superior temporal gyrus (female) | rel=r_associated | relid=0 | w=5
  1914. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions
    n1=hyperaldostéronisme secondaire | n2=en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions | rel=r_associated | relid=0 | w=5
  1915. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal disorder
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal disorder | rel=r_associated | relid=0 | w=5
  1916. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal dyskinesia
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal dyskinesia | rel=r_associated | relid=0 | w=5
  1917. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal dyskinesias (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal dyskinesias (1 patient) | rel=r_associated | relid=0 | w=5
  1918. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal features
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal features | rel=r_associated | relid=0 | w=5
  1919. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal muscular rigidity
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal muscular rigidity | rel=r_associated | relid=0 | w=5
  1920. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal sign
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal sign | rel=r_associated | relid=0 | w=5
  1921. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal signs (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal signs (in 1 patient) | rel=r_associated | relid=0 | w=5
  1922. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal signs (in some patients) thinning of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal signs (in some patients) thinning of the corpus callosum | rel=r_associated | relid=0 | w=5
  1923. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal signs (less common)
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal signs (less common) | rel=r_associated | relid=0 | w=5
  1924. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal signs may develop
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal signs may develop | rel=r_associated | relid=0 | w=5
  1925. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal signs, mild
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal signs, mild | rel=r_associated | relid=0 | w=5
  1926. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal symptoms (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal symptoms (later-onset) | rel=r_associated | relid=0 | w=5
  1927. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extrapyramidal symptoms may occur
    n1=hyperaldostéronisme secondaire | n2=en:extrapyramidal symptoms may occur | rel=r_associated | relid=0 | w=5
  1928. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:extremity ataxia
    n1=hyperaldostéronisme secondaire | n2=en:extremity ataxia | rel=r_associated | relid=0 | w=5
  1929. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial injuries and disorders
    n1=hyperaldostéronisme secondaire | n2=en:facial injuries and disorders | rel=r_associated | relid=0 | w=5
  1930. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial muscle sparing
    n1=hyperaldostéronisme secondaire | n2=en:facial muscle sparing | rel=r_associated | relid=0 | w=5
  1931. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:facial muscle weakness | rel=r_associated | relid=0 | w=5
  1932. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial muscle weakness of muscles innervated by cn vii
    n1=hyperaldostéronisme secondaire | n2=en:facial muscle weakness of muscles innervated by cn vii | rel=r_associated | relid=0 | w=5
  1933. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial myokymia, mild
    n1=hyperaldostéronisme secondaire | n2=en:facial myokymia, mild | rel=r_associated | relid=0 | w=5
  1934. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial myokymias
    n1=hyperaldostéronisme secondaire | n2=en:facial myokymias | rel=r_associated | relid=0 | w=5
  1935. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial nerve palsy
    n1=hyperaldostéronisme secondaire | n2=en:facial nerve palsy | rel=r_associated | relid=0 | w=5
  1936. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial nerve weakness
    n1=hyperaldostéronisme secondaire | n2=en:facial nerve weakness | rel=r_associated | relid=0 | w=5
  1937. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial palsy secondary to cranial hyperostosis
    n1=hyperaldostéronisme secondaire | n2=en:facial palsy secondary to cranial hyperostosis | rel=r_associated | relid=0 | w=5
  1938. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial paralysis
    n1=hyperaldostéronisme secondaire | n2=en:facial paralysis | rel=r_associated | relid=0 | w=5
  1939. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial paresis, congenital bilateral
    n1=hyperaldostéronisme secondaire | n2=en:facial paresis, congenital bilateral | rel=r_associated | relid=0 | w=5
  1940. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial-faucial-finger mini-myoclonus (fff)
    n1=hyperaldostéronisme secondaire | n2=en:facial-faucial-finger mini-myoclonus (fff) | rel=r_associated | relid=0 | w=5
  1941. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial-lingual fasciculations
    n1=hyperaldostéronisme secondaire | n2=en:facial-lingual fasciculations | rel=r_associated | relid=0 | w=5
  1942. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:facial, pharyngeal, and masticatory muscle diplegia
    n1=hyperaldostéronisme secondaire | n2=en:facial, pharyngeal, and masticatory muscle diplegia | rel=r_associated | relid=0 | w=5
  1943. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:faciogenital dysplasia with attention deficit-hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:faciogenital dysplasia with attention deficit-hyperactivity disorder | rel=r_associated | relid=0 | w=5
  1944. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:faciomandibular myoclonus, nocturnal
    n1=hyperaldostéronisme secondaire | n2=en:faciomandibular myoclonus, nocturnal | rel=r_associated | relid=0 | w=5
  1945. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:failure of opercularization of the frontal and temporal lobes on ct
    n1=hyperaldostéronisme secondaire | n2=en:failure of opercularization of the frontal and temporal lobes on ct | rel=r_associated | relid=0 | w=5
  1946. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:failure to achieve sitting or walking (severe form)
    n1=hyperaldostéronisme secondaire | n2=en:failure to achieve sitting or walking (severe form) | rel=r_associated | relid=0 | w=5
  1947. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fall
    n1=hyperaldostéronisme secondaire | n2=en:fall | rel=r_associated | relid=0 | w=5
  1948. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:falx cerebri, precocious calcification of
    n1=hyperaldostéronisme secondaire | n2=en:falx cerebri, precocious calcification of | rel=r_associated | relid=0 | w=5
  1949. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:family history of attention deficit hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:family history of attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=5
  1950. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fasciculation
    n1=hyperaldostéronisme secondaire | n2=en:fasciculation | rel=r_associated | relid=0 | w=5
  1951. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fasciculation-like movements
    n1=hyperaldostéronisme secondaire | n2=en:fasciculation-like movements | rel=r_associated | relid=0 | w=5
  1952. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fasciculations (after long disease duration)
    n1=hyperaldostéronisme secondaire | n2=en:fasciculations (after long disease duration) | rel=r_associated | relid=0 | w=5
  1953. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fasciculations, tongue
    n1=hyperaldostéronisme secondaire | n2=en:fasciculations, tongue | rel=r_associated | relid=0 | w=5
  1954. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fatal subacute encephalopathy (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:fatal subacute encephalopathy (1 family) | rel=r_associated | relid=0 | w=5
  1955. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:favorable response to levodopa
    n1=hyperaldostéronisme secondaire | n2=en:favorable response to levodopa | rel=r_associated | relid=0 | w=5
  1956. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fearful expression
    n1=hyperaldostéronisme secondaire | n2=en:fearful expression | rel=r_associated | relid=0 | w=5
  1957. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizure
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizure | rel=r_associated | relid=0 | w=5
  1958. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures (1 patient) | rel=r_associated | relid=0 | w=5
  1959. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures (in some)
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures (in some) | rel=r_associated | relid=0 | w=5
  1960. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  1961. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures (usually remit by age 6 years)
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures (usually remit by age 6 years) | rel=r_associated | relid=0 | w=5
  1962. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures in infancy
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures in infancy | rel=r_associated | relid=0 | w=5
  1963. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:febrile seizures may occur
    n1=hyperaldostéronisme secondaire | n2=en:febrile seizures may occur | rel=r_associated | relid=0 | w=5
  1964. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:feeding problem
    n1=hyperaldostéronisme secondaire | n2=en:feeding problem | rel=r_associated | relid=0 | w=5
  1965. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:feelings of guilt associated with episodes
    n1=hyperaldostéronisme secondaire | n2=en:feelings of guilt associated with episodes | rel=r_associated | relid=0 | w=5
  1966. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fenestrated basilar artery
    n1=hyperaldostéronisme secondaire | n2=en:fenestrated basilar artery | rel=r_associated | relid=0 | w=5
  1967. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:festinating (parkinsonian) gait
    n1=hyperaldostéronisme secondaire | n2=en:festinating (parkinsonian) gait | rel=r_associated | relid=0 | w=5
  1968. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fetal akinesia deformation sequence
    n1=hyperaldostéronisme secondaire | n2=en:fetal akinesia deformation sequence | rel=r_associated | relid=0 | w=5
  1969. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fibrillary plaques in the cerebellar cortex
    n1=hyperaldostéronisme secondaire | n2=en:fibrillary plaques in the cerebellar cortex | rel=r_associated | relid=0 | w=5
  1970. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fibrillation
    n1=hyperaldostéronisme secondaire | n2=en:fibrillation | rel=r_associated | relid=0 | w=5
  1971. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fibrous astrocyte
    n1=hyperaldostéronisme secondaire | n2=en:fibrous astrocyte | rel=r_associated | relid=0 | w=5
  1972. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fifth ventricle
    n1=hyperaldostéronisme secondaire | n2=en:fifth ventricle | rel=r_associated | relid=0 | w=5
  1973. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine motor delay
    n1=hyperaldostéronisme secondaire | n2=en:fine motor delay | rel=r_associated | relid=0 | w=5
  1974. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine motor impairment
    n1=hyperaldostéronisme secondaire | n2=en:fine motor impairment | rel=r_associated | relid=0 | w=5
  1975. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine motor skills delayed
    n1=hyperaldostéronisme secondaire | n2=en:fine motor skills delayed | rel=r_associated | relid=0 | w=5
  1976. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine motor task disruption
    n1=hyperaldostéronisme secondaire | n2=en:fine motor task disruption | rel=r_associated | relid=0 | w=5
  1977. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine motor/coordination problems (12%)
    n1=hyperaldostéronisme secondaire | n2=en:fine motor/coordination problems (12%) | rel=r_associated | relid=0 | w=5
  1978. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine rapid hand tremor, 4-12 hz
    n1=hyperaldostéronisme secondaire | n2=en:fine rapid hand tremor, 4-12 hz | rel=r_associated | relid=0 | w=5
  1979. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fine tremors
    n1=hyperaldostéronisme secondaire | n2=en:fine tremors | rel=r_associated | relid=0 | w=5
  1980. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:finger dysmetria
    n1=hyperaldostéronisme secondaire | n2=en:finger dysmetria | rel=r_associated | relid=0 | w=5
  1981. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:finger twitching
    n1=hyperaldostéronisme secondaire | n2=en:finger twitching | rel=r_associated | relid=0 | w=5
  1982. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fingers in mouth
    n1=hyperaldostéronisme secondaire | n2=en:fingers in mouth | rel=r_associated | relid=0 | w=5
  1983. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:first dorsal interossei muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:first dorsal interossei muscle atrophy | rel=r_associated | relid=0 | w=5
  1984. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:first dorsal interossei muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:first dorsal interossei muscle weakness | rel=r_associated | relid=0 | w=5
  1985. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flaccidity, episodic
    n1=hyperaldostéronisme secondaire | n2=en:flaccidity, episodic | rel=r_associated | relid=0 | w=5
  1986. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flat affect
    n1=hyperaldostéronisme secondaire | n2=en:flat affect | rel=r_associated | relid=0 | w=5
  1987. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flat pons
    n1=hyperaldostéronisme secondaire | n2=en:flat pons | rel=r_associated | relid=0 | w=5
  1988. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flattening of the caudate
    n1=hyperaldostéronisme secondaire | n2=en:flattening of the caudate | rel=r_associated | relid=0 | w=5
  1989. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flattening of the pons
    n1=hyperaldostéronisme secondaire | n2=en:flattening of the pons | rel=r_associated | relid=0 | w=5
  1990. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:flexor plantar response
    n1=hyperaldostéronisme secondaire | n2=en:flexor plantar response | rel=r_associated | relid=0 | w=5
  1991. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:floppiness
    n1=hyperaldostéronisme secondaire | n2=en:floppiness | rel=r_associated | relid=0 | w=5
  1992. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:floppy infant
    n1=hyperaldostéronisme secondaire | n2=en:floppy infant | rel=r_associated | relid=0 | w=5
  1993. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fluctuating neurologic signs
    n1=hyperaldostéronisme secondaire | n2=en:fluctuating neurologic signs | rel=r_associated | relid=0 | w=5
  1994. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fluctuations in consciousness
    n1=hyperaldostéronisme secondaire | n2=en:fluctuations in consciousness | rel=r_associated | relid=0 | w=5
  1995. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fluid filled posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:fluid filled posterior fossa | rel=r_associated | relid=0 | w=5
  1996. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces
    n1=hyperaldostéronisme secondaire | n2=en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces | rel=r_associated | relid=0 | w=5
  1997. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal cerebellar dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:focal cerebellar dysplasia | rel=r_associated | relid=0 | w=5
  1998. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal clonic seizure
    n1=hyperaldostéronisme secondaire | n2=en:focal clonic seizure | rel=r_associated | relid=0 | w=5
  1999. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal cortical dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:focal cortical dysplasia | rel=r_associated | relid=0 | w=5
  2000. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal discharges
    n1=hyperaldostéronisme secondaire | n2=en:focal discharges | rel=r_associated | relid=0 | w=5
  2001. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dyscognitive seizures
    n1=hyperaldostéronisme secondaire | n2=en:focal dyscognitive seizures | rel=r_associated | relid=0 | w=5
  2002. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonia (adult onset)
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonia (adult onset) | rel=r_associated | relid=0 | w=5
  2003. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonia (e.g., writer's cramp)
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonia (e.g., writer's cramp) | rel=r_associated | relid=0 | w=5
  2004. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonia (rare) | rel=r_associated | relid=0 | w=5
  2005. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonia, upper limb
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonia, upper limb | rel=r_associated | relid=0 | w=5
  2006. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonia, usually of the hands
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonia, usually of the hands | rel=r_associated | relid=0 | w=5
  2007. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal dystonias
    n1=hyperaldostéronisme secondaire | n2=en:focal dystonias | rel=r_associated | relid=0 | w=5
  2008. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal hyperplasia of the choroid plexus
    n1=hyperaldostéronisme secondaire | n2=en:focal hyperplasia of the choroid plexus | rel=r_associated | relid=0 | w=5
  2009. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal interhemispheric fusion
    n1=hyperaldostéronisme secondaire | n2=en:focal interhemispheric fusion | rel=r_associated | relid=0 | w=5
  2010. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal lissencephaly
    n1=hyperaldostéronisme secondaire | n2=en:focal lissencephaly | rel=r_associated | relid=0 | w=5
  2011. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal microgyria
    n1=hyperaldostéronisme secondaire | n2=en:focal microgyria | rel=r_associated | relid=0 | w=5
  2012. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal neurologic deficit
    n1=hyperaldostéronisme secondaire | n2=en:focal neurologic deficit | rel=r_associated | relid=0 | w=5
  2013. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal neurologic deficits (i.e., hemiparesis)
    n1=hyperaldostéronisme secondaire | n2=en:focal neurologic deficits (i.e., hemiparesis) | rel=r_associated | relid=0 | w=5
  2014. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal neurologic signs
    n1=hyperaldostéronisme secondaire | n2=en:focal neurologic signs | rel=r_associated | relid=0 | w=5
  2015. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal nodular heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:focal nodular heterotopia | rel=r_associated | relid=0 | w=5
  2016. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal pachygyria
    n1=hyperaldostéronisme secondaire | n2=en:focal pachygyria | rel=r_associated | relid=0 | w=5
  2017. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal parietal pachygyria
    n1=hyperaldostéronisme secondaire | n2=en:focal parietal pachygyria | rel=r_associated | relid=0 | w=5
  2018. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal paroxysmal discharges
    n1=hyperaldostéronisme secondaire | n2=en:focal paroxysmal discharges | rel=r_associated | relid=0 | w=5
  2019. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal thickening of the cortex on mri (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:focal thickening of the cortex on mri (in type iib) | rel=r_associated | relid=0 | w=5
  2020. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal tremor
    n1=hyperaldostéronisme secondaire | n2=en:focal tremor | rel=r_associated | relid=0 | w=5
  2021. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal white matter lesions (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:focal white matter lesions (in type iib) | rel=r_associated | relid=0 | w=5
  2022. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:focal, segmental or multifocal dystonia
    n1=hyperaldostéronisme secondaire | n2=en:focal, segmental or multifocal dystonia | rel=r_associated | relid=0 | w=5
  2023. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:foot-drop
    n1=hyperaldostéronisme secondaire | n2=en:foot-drop | rel=r_associated | relid=0 | w=5
  2024. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:forebrain defects
    n1=hyperaldostéronisme secondaire | n2=en:forebrain defects | rel=r_associated | relid=0 | w=5
  2025. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:forgetful
    n1=hyperaldostéronisme secondaire | n2=en:forgetful | rel=r_associated | relid=0 | w=5
  2026. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:four-repeat tau plaques in the striatum
    n1=hyperaldostéronisme secondaire | n2=en:four-repeat tau plaques in the striatum | rel=r_associated | relid=0 | w=5
  2027. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequency 3.5 hz in midline
    n1=hyperaldostéronisme secondaire | n2=en:frequency 3.5 hz in midline | rel=r_associated | relid=0 | w=5
  2028. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequency 6 hz in lateral gaze
    n1=hyperaldostéronisme secondaire | n2=en:frequency 6 hz in lateral gaze | rel=r_associated | relid=0 | w=5
  2029. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequency of 1 to 20 episodes per day
    n1=hyperaldostéronisme secondaire | n2=en:frequency of 1 to 20 episodes per day | rel=r_associated | relid=0 | w=5
  2030. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequent falls
    n1=hyperaldostéronisme secondaire | n2=en:frequent falls | rel=r_associated | relid=0 | w=5
  2031. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequent falls with preservation of consciousness
    n1=hyperaldostéronisme secondaire | n2=en:frequent falls with preservation of consciousness | rel=r_associated | relid=0 | w=5
  2032. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frequent headache
    n1=hyperaldostéronisme secondaire | n2=en:frequent headache | rel=r_associated | relid=0 | w=5
  2033. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:friedreich ataxia
    n1=hyperaldostéronisme secondaire | n2=en:friedreich ataxia | rel=r_associated | relid=0 | w=5
  2034. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:friendly behavior (89%)
    n1=hyperaldostéronisme secondaire | n2=en:friendly behavior (89%) | rel=r_associated | relid=0 | w=5
  2035. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:friendly personality
    n1=hyperaldostéronisme secondaire | n2=en:friendly personality | rel=r_associated | relid=0 | w=5
  2036. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:friendly, sociable personality
    n1=hyperaldostéronisme secondaire | n2=en:friendly, sociable personality | rel=r_associated | relid=0 | w=5
  2037. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frightened expression
    n1=hyperaldostéronisme secondaire | n2=en:frightened expression | rel=r_associated | relid=0 | w=5
  2038. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frightening sensation
    n1=hyperaldostéronisme secondaire | n2=en:frightening sensation | rel=r_associated | relid=0 | w=5
  2039. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal cortical atophy
    n1=hyperaldostéronisme secondaire | n2=en:frontal cortical atophy | rel=r_associated | relid=0 | w=5
  2040. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal lobe atrophy
    n1=hyperaldostéronisme secondaire | n2=en:frontal lobe atrophy | rel=r_associated | relid=0 | w=5
  2041. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal lobe hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:frontal lobe hypoplasia | rel=r_associated | relid=0 | w=5
  2042. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal lobe origin
    n1=hyperaldostéronisme secondaire | n2=en:frontal lobe origin | rel=r_associated | relid=0 | w=5
  2043. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal lobe syndrome
    n1=hyperaldostéronisme secondaire | n2=en:frontal lobe syndrome | rel=r_associated | relid=0 | w=5
  2044. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal release signs
    n1=hyperaldostéronisme secondaire | n2=en:frontal release signs | rel=r_associated | relid=0 | w=5
  2045. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontal release signs (45%)
    n1=hyperaldostéronisme secondaire | n2=en:frontal release signs (45%) | rel=r_associated | relid=0 | w=5
  2046. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontolimbic dementia
    n1=hyperaldostéronisme secondaire | n2=en:frontolimbic dementia | rel=r_associated | relid=0 | w=5
  2047. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontoparietal polymicrogyria
    n1=hyperaldostéronisme secondaire | n2=en:frontoparietal polymicrogyria | rel=r_associated | relid=0 | w=5
  2048. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal atrophy
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal atrophy | rel=r_associated | relid=0 | w=5
  2049. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal atrophy, mild, seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal atrophy, mild, seen on mri | rel=r_associated | relid=0 | w=5
  2050. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal dementia
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal dementia | rel=r_associated | relid=0 | w=5
  2051. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal dementia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal dementia (1 patient) | rel=r_associated | relid=0 | w=5
  2052. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal dementia (in 30% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal dementia (in 30% of patients) | rel=r_associated | relid=0 | w=5
  2053. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal dementia, variable severity
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal dementia, variable severity | rel=r_associated | relid=0 | w=5
  2054. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal hypoplasia | rel=r_associated | relid=0 | w=5
  2055. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal leukoencephalopathy | rel=r_associated | relid=0 | w=5
  2056. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal lobar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal lobar atrophy | rel=r_associated | relid=0 | w=5
  2057. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal lobar atrophy with 'knife-edge' distinction
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal lobar atrophy with 'knife-edge' distinction | rel=r_associated | relid=0 | w=5
  2058. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal pachygyria (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal pachygyria (1 patient) | rel=r_associated | relid=0 | w=5
  2059. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal polymicrogyria
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal polymicrogyria | rel=r_associated | relid=0 | w=5
  2060. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporal/subcortical dementia
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporal/subcortical dementia | rel=r_associated | relid=0 | w=5
  2061. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:frontotemporoparietal cortical dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:frontotemporoparietal cortical dysplasia | rel=r_associated | relid=0 | w=5
  2062. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:functional mri (fmri) shows increased activity in the left inferior frontal cortex
    n1=hyperaldostéronisme secondaire | n2=en:functional mri (fmri) shows increased activity in the left inferior frontal cortex | rel=r_associated | relid=0 | w=5
  2063. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients)
    n1=hyperaldostéronisme secondaire | n2=en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients) | rel=r_associated | relid=0 | w=5
  2064. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fused hemispheres (wws)
    n1=hyperaldostéronisme secondaire | n2=en:fused hemispheres (wws) | rel=r_associated | relid=0 | w=5
  2065. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fusion of the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:fusion of the basal ganglia | rel=r_associated | relid=0 | w=5
  2066. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fusion of the cerebellar hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:fusion of the cerebellar hemispheres | rel=r_associated | relid=0 | w=5
  2067. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fusion of the dentate nuclei and the superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:fusion of the dentate nuclei and the superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  2068. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:fusion of the left and right thalami
    n1=hyperaldostéronisme secondaire | n2=en:fusion of the left and right thalami | rel=r_associated | relid=0 | w=5
  2069. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait abnormalities (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:gait abnormalities (in some patients) | rel=r_associated | relid=0 | w=5
  2070. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait abnormalities (less common)
    n1=hyperaldostéronisme secondaire | n2=en:gait abnormalities (less common) | rel=r_associated | relid=0 | w=5
  2071. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait abnormalities due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:gait abnormalities due to muscle weakness | rel=r_associated | relid=0 | w=5
  2072. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait abnormalities may occur
    n1=hyperaldostéronisme secondaire | n2=en:gait abnormalities may occur | rel=r_associated | relid=0 | w=5
  2073. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait and limb ataxia
    n1=hyperaldostéronisme secondaire | n2=en:gait and limb ataxia | rel=r_associated | relid=0 | w=5
  2074. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait apraxia
    n1=hyperaldostéronisme secondaire | n2=en:gait apraxia | rel=r_associated | relid=0 | w=5
  2075. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait ataxia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:gait ataxia (in some patients) | rel=r_associated | relid=0 | w=5
  2076. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait ataxias, cerebellar
    n1=hyperaldostéronisme secondaire | n2=en:gait ataxias, cerebellar | rel=r_associated | relid=0 | w=5
  2077. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait difficulties due to contractures of the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:gait difficulties due to contractures of the lower limbs | rel=r_associated | relid=0 | w=5
  2078. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait difficulties, late-onset
    n1=hyperaldostéronisme secondaire | n2=en:gait difficulties, late-onset | rel=r_associated | relid=0 | w=5
  2079. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait disability
    n1=hyperaldostéronisme secondaire | n2=en:gait disability | rel=r_associated | relid=0 | w=5
  2080. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait disturbance
    n1=hyperaldostéronisme secondaire | n2=en:gait disturbance | rel=r_associated | relid=0 | w=5
  2081. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait disturbance (ataxia)
    n1=hyperaldostéronisme secondaire | n2=en:gait disturbance (ataxia) | rel=r_associated | relid=0 | w=5
  2082. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait imbalance
    n1=hyperaldostéronisme secondaire | n2=en:gait imbalance | rel=r_associated | relid=0 | w=5
  2083. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait impairment
    n1=hyperaldostéronisme secondaire | n2=en:gait impairment | rel=r_associated | relid=0 | w=5
  2084. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait impairment (55%)
    n1=hyperaldostéronisme secondaire | n2=en:gait impairment (55%) | rel=r_associated | relid=0 | w=5
  2085. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait instability, worse in the dark
    n1=hyperaldostéronisme secondaire | n2=en:gait instability, worse in the dark | rel=r_associated | relid=0 | w=5
  2086. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait unsteady
    n1=hyperaldostéronisme secondaire | n2=en:gait unsteady | rel=r_associated | relid=0 | w=5
  2087. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait, drop foot
    n1=hyperaldostéronisme secondaire | n2=en:gait, drop foot | rel=r_associated | relid=0 | w=5
  2088. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gait, rigid
    n1=hyperaldostéronisme secondaire | n2=en:gait, rigid | rel=r_associated | relid=0 | w=5
  2089. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gaze deviation
    n1=hyperaldostéronisme secondaire | n2=en:gaze deviation | rel=r_associated | relid=0 | w=5
  2090. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized amyotrophy
    n1=hyperaldostéronisme secondaire | n2=en:generalized amyotrophy | rel=r_associated | relid=0 | w=5
  2091. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized and focal spike and wave complexes seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:generalized and focal spike and wave complexes seen on eeg | rel=r_associated | relid=0 | w=5
  2092. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized cerebral hypoplasia/atrophy (45%)
    n1=hyperaldostéronisme secondaire | n2=en:generalized cerebral hypoplasia/atrophy (45%) | rel=r_associated | relid=0 | w=5
  2093. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized cerebral, cerebellar, and brainstem atrophy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:generalized cerebral, cerebellar, and brainstem atrophy, progressive | rel=r_associated | relid=0 | w=5
  2094. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized clonic or tonic-clonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:generalized clonic or tonic-clonic seizures | rel=r_associated | relid=0 | w=5
  2095. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized cortical atrophy (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:generalized cortical atrophy (in one patient) | rel=r_associated | relid=0 | w=5
  2096. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized cortical atrophy, most prominent in the frontal and parietal lobes
    n1=hyperaldostéronisme secondaire | n2=en:generalized cortical atrophy, most prominent in the frontal and parietal lobes | rel=r_associated | relid=0 | w=5
  2097. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized dystonia
    n1=hyperaldostéronisme secondaire | n2=en:generalized dystonia | rel=r_associated | relid=0 | w=5
  2098. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:generalized hypotonia | rel=r_associated | relid=0 | w=5
  2099. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized myelin loss
    n1=hyperaldostéronisme secondaire | n2=en:generalized myelin loss | rel=r_associated | relid=0 | w=5
  2100. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized seizures
    n1=hyperaldostéronisme secondaire | n2=en:generalized seizures | rel=r_associated | relid=0 | w=5
  2101. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized slowing
    n1=hyperaldostéronisme secondaire | n2=en:generalized slowing | rel=r_associated | relid=0 | w=5
  2102. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized slowing seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:generalized slowing seen on eeg | rel=r_associated | relid=0 | w=5
  2103. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized spike wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:generalized spike wave discharges | rel=r_associated | relid=0 | w=5
  2104. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized spike-wave activity seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:generalized spike-wave activity seen on eeg | rel=r_associated | relid=0 | w=5
  2105. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized spike-wave discharges see on eeg
    n1=hyperaldostéronisme secondaire | n2=en:generalized spike-wave discharges see on eeg | rel=r_associated | relid=0 | w=5
  2106. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized stiffening
    n1=hyperaldostéronisme secondaire | n2=en:generalized stiffening | rel=r_associated | relid=0 | w=5
  2107. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures (gtcs) (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures (gtcs) (in most patients) | rel=r_associated | relid=0 | w=5
  2108. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures (gtcs) on awakening
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures (gtcs) on awakening | rel=r_associated | relid=0 | w=5
  2109. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures (often develop in adolescence)
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures (often develop in adolescence) | rel=r_associated | relid=0 | w=5
  2110. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures (rare)
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures (rare) | rel=r_associated | relid=0 | w=5
  2111. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures (stage 2 and 3)
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures (stage 2 and 3) | rel=r_associated | relid=0 | w=5
  2112. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures in 50%
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures in 50% | rel=r_associated | relid=0 | w=5
  2113. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:generalized tonic-clonic seizures on awakening
    n1=hyperaldostéronisme secondaire | n2=en:generalized tonic-clonic seizures on awakening | rel=r_associated | relid=0 | w=5
  2114. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:genetic brain disorders
    n1=hyperaldostéronisme secondaire | n2=en:genetic brain disorders | rel=r_associated | relid=0 | w=5
  2115. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:germinal cysts over the caudate
    n1=hyperaldostéronisme secondaire | n2=en:germinal cysts over the caudate | rel=r_associated | relid=0 | w=5
  2116. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:giant axonal neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:giant axonal neuropathy | rel=r_associated | relid=0 | w=5
  2117. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:giant cortical somatosensory evoked potentials (seps)
    n1=hyperaldostéronisme secondaire | n2=en:giant cortical somatosensory evoked potentials (seps) | rel=r_associated | relid=0 | w=5
  2118. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:giant granules in schwann cells
    n1=hyperaldostéronisme secondaire | n2=en:giant granules in schwann cells | rel=r_associated | relid=0 | w=5
  2119. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gilles de la tourette syndrome (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:gilles de la tourette syndrome (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  2120. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:glial activation
    n1=hyperaldostéronisme secondaire | n2=en:glial activation | rel=r_associated | relid=0 | w=5
  2121. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:glial cell
    n1=hyperaldostéronisme secondaire | n2=en:glial cell | rel=r_associated | relid=0 | w=5
  2122. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:glial inclusions
    n1=hyperaldostéronisme secondaire | n2=en:glial inclusions | rel=r_associated | relid=0 | w=5
  2123. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis (27%)
    n1=hyperaldostéronisme secondaire | n2=en:gliosis (27%) | rel=r_associated | relid=0 | w=5
  2124. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:gliosis (patient a) | rel=r_associated | relid=0 | w=5
  2125. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis in the brainstem
    n1=hyperaldostéronisme secondaire | n2=en:gliosis in the brainstem | rel=r_associated | relid=0 | w=5
  2126. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis in the striatum, medial thalamic nuclei, and inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:gliosis in the striatum, medial thalamic nuclei, and inferior olives | rel=r_associated | relid=0 | w=5
  2127. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis of the white matter
    n1=hyperaldostéronisme secondaire | n2=en:gliosis of the white matter | rel=r_associated | relid=0 | w=5
  2128. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord | rel=r_associated | relid=0 | w=5
  2129. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global and focal neurologic abnormalities (less than 30%)
    n1=hyperaldostéronisme secondaire | n2=en:global and focal neurologic abnormalities (less than 30%) | rel=r_associated | relid=0 | w=5
  2130. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global brain atrophy
    n1=hyperaldostéronisme secondaire | n2=en:global brain atrophy | rel=r_associated | relid=0 | w=5
  2131. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global cerebral atrophy, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:global cerebral atrophy, mild (in some patients) | rel=r_associated | relid=0 | w=5
  2132. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:global developmental delay | rel=r_associated | relid=0 | w=5
  2133. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global developmental delay if untreated
    n1=hyperaldostéronisme secondaire | n2=en:global developmental delay if untreated | rel=r_associated | relid=0 | w=5
  2134. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global developmental delay, variable severity
    n1=hyperaldostéronisme secondaire | n2=en:global developmental delay, variable severity | rel=r_associated | relid=0 | w=5
  2135. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:global hypotonia | rel=r_associated | relid=0 | w=5
  2136. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:global reduction in cerebral blood flow on pet scan
    n1=hyperaldostéronisme secondaire | n2=en:global reduction in cerebral blood flow on pet scan | rel=r_associated | relid=0 | w=5
  2137. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:globally delayed development
    n1=hyperaldostéronisme secondaire | n2=en:globally delayed development | rel=r_associated | relid=0 | w=5
  2138. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:globular basal ganglia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:globular basal ganglia (1 patient) | rel=r_associated | relid=0 | w=5
  2139. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:globular thalamus (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:globular thalamus (1 patient) | rel=r_associated | relid=0 | w=5
  2140. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:glomeruloid vascular proliferation in brain and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:glomeruloid vascular proliferation in brain and spinal cord | rel=r_associated | relid=0 | w=5
  2141. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:good social contacts
    n1=hyperaldostéronisme secondaire | n2=en:good social contacts | rel=r_associated | relid=0 | w=5
  2142. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gowers sign
    n1=hyperaldostéronisme secondaire | n2=en:gowers sign | rel=r_associated | relid=0 | w=5
  2143. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:grand mal seizure
    n1=hyperaldostéronisme secondaire | n2=en:grand mal seizure | rel=r_associated | relid=0 | w=5
  2144. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:granular material in neurons
    n1=hyperaldostéronisme secondaire | n2=en:granular material in neurons | rel=r_associated | relid=0 | w=5
  2145. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:granular osmiophilic cytoplasmic deposits in schwann cells
    n1=hyperaldostéronisme secondaire | n2=en:granular osmiophilic cytoplasmic deposits in schwann cells | rel=r_associated | relid=0 | w=5
  2146. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:granulovacuolar degeneration
    n1=hyperaldostéronisme secondaire | n2=en:granulovacuolar degeneration | rel=r_associated | relid=0 | w=5
  2147. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gray matter
    n1=hyperaldostéronisme secondaire | n2=en:gray matter | rel=r_associated | relid=0 | w=5
  2148. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gray matter appears relatively unaffected
    n1=hyperaldostéronisme secondaire | n2=en:gray matter appears relatively unaffected | rel=r_associated | relid=0 | w=5
  2149. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gray matter heterotopia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:gray matter heterotopia (in some patients) | rel=r_associated | relid=0 | w=5
  2150. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gray matter structure of central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:gray matter structure of central nervous system | rel=r_associated | relid=0 | w=5
  2151. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gregarious character
    n1=hyperaldostéronisme secondaire | n2=en:gregarious character | rel=r_associated | relid=0 | w=5
  2152. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:grimaces
    n1=hyperaldostéronisme secondaire | n2=en:grimaces | rel=r_associated | relid=0 | w=5
  2153. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gross motor delay
    n1=hyperaldostéronisme secondaire | n2=en:gross motor delay | rel=r_associated | relid=0 | w=5
  2154. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gross motor delay (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:gross motor delay (in one family) | rel=r_associated | relid=0 | w=5
  2155. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gross motor delay, mild
    n1=hyperaldostéronisme secondaire | n2=en:gross motor delay, mild | rel=r_associated | relid=0 | w=5
  2156. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gross motor skill delay (infancy)
    n1=hyperaldostéronisme secondaire | n2=en:gross motor skill delay (infancy) | rel=r_associated | relid=0 | w=5
  2157. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:growth disorders
    n1=hyperaldostéronisme secondaire | n2=en:growth disorders | rel=r_associated | relid=0 | w=5
  2158. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gtcs during 'leisure' time (evening)
    n1=hyperaldostéronisme secondaire | n2=en:gtcs during 'leisure' time (evening) | rel=r_associated | relid=0 | w=5
  2159. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:guillain-barre syndrome
    n1=hyperaldostéronisme secondaire | n2=en:guillain-barre syndrome | rel=r_associated | relid=0 | w=5
  2160. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gurgling or drooling during seizures
    n1=hyperaldostéronisme secondaire | n2=en:gurgling or drooling during seizures | rel=r_associated | relid=0 | w=5
  2161. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gyral disorganization
    n1=hyperaldostéronisme secondaire | n2=en:gyral disorganization | rel=r_associated | relid=0 | w=5
  2162. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:gyral simplification
    n1=hyperaldostéronisme secondaire | n2=en:gyral simplification | rel=r_associated | relid=0 | w=5
  2163. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hallucination
    n1=hyperaldostéronisme secondaire | n2=en:hallucination | rel=r_associated | relid=0 | w=5
  2164. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hallucinations (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:hallucinations (hcp) | rel=r_associated | relid=0 | w=5
  2165. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hallucinations (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hallucinations (rare) | rel=r_associated | relid=0 | w=5
  2166. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hallucinatory psychosis develops during adolescence
    n1=hyperaldostéronisme secondaire | n2=en:hallucinatory psychosis develops during adolescence | rel=r_associated | relid=0 | w=5
  2167. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hamartomatous lesions of the brain
    n1=hyperaldostéronisme secondaire | n2=en:hamartomatous lesions of the brain | rel=r_associated | relid=0 | w=5
  2168. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand flap (substance)
    n1=hyperaldostéronisme secondaire | n2=en:hand flap (substance) | rel=r_associated | relid=0 | w=5
  2169. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:hand muscle atrophy | rel=r_associated | relid=0 | w=5
  2170. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:hand muscle weakness | rel=r_associated | relid=0 | w=5
  2171. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand stereotypies (e.g., hand wringing)
    n1=hyperaldostéronisme secondaire | n2=en:hand stereotypies (e.g., hand wringing) | rel=r_associated | relid=0 | w=5
  2172. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand tremor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hand tremor (in some patients) | rel=r_associated | relid=0 | w=5
  2173. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hand wringing
    n1=hyperaldostéronisme secondaire | n2=en:hand wringing | rel=r_associated | relid=0 | w=5
  2174. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:happy demeanor
    n1=hyperaldostéronisme secondaire | n2=en:happy demeanor | rel=r_associated | relid=0 | w=5
  2175. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:happy demeanor (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:happy demeanor (reported in 1 family) | rel=r_associated | relid=0 | w=5
  2176. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:happy disposition
    n1=hyperaldostéronisme secondaire | n2=en:happy disposition | rel=r_associated | relid=0 | w=5
  2177. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:happy personality
    n1=hyperaldostéronisme secondaire | n2=en:happy personality | rel=r_associated | relid=0 | w=5
  2178. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:has tingling sensation
    n1=hyperaldostéronisme secondaire | n2=en:has tingling sensation | rel=r_associated | relid=0 | w=5
  2179. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head 'tilt' in infancy
    n1=hyperaldostéronisme secondaire | n2=en:head 'tilt' in infancy | rel=r_associated | relid=0 | w=5
  2180. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head bobbing
    n1=hyperaldostéronisme secondaire | n2=en:head bobbing | rel=r_associated | relid=0 | w=5
  2181. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head lag
    n1=hyperaldostéronisme secondaire | n2=en:head lag | rel=r_associated | relid=0 | w=5
  2182. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head movements abnormal
    n1=hyperaldostéronisme secondaire | n2=en:head movements abnormal | rel=r_associated | relid=0 | w=5
  2183. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head oscillations
    n1=hyperaldostéronisme secondaire | n2=en:head oscillations | rel=r_associated | relid=0 | w=5
  2184. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head titubation
    n1=hyperaldostéronisme secondaire | n2=en:head titubation | rel=r_associated | relid=0 | w=5
  2185. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head titubations
    n1=hyperaldostéronisme secondaire | n2=en:head titubations | rel=r_associated | relid=0 | w=5
  2186. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head tremor
    n1=hyperaldostéronisme secondaire | n2=en:head tremor | rel=r_associated | relid=0 | w=5
  2187. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head tremor (14% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:head tremor (14% of patients) | rel=r_associated | relid=0 | w=5
  2188. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head tremor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:head tremor (in some patients) | rel=r_associated | relid=0 | w=5
  2189. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head tremor, mild
    n1=hyperaldostéronisme secondaire | n2=en:head tremor, mild | rel=r_associated | relid=0 | w=5
  2190. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head-banging
    n1=hyperaldostéronisme secondaire | n2=en:head-banging | rel=r_associated | relid=0 | w=5
  2191. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:head-rolling movements
    n1=hyperaldostéronisme secondaire | n2=en:head-rolling movements | rel=r_associated | relid=0 | w=5
  2192. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache
    n1=hyperaldostéronisme secondaire | n2=en:headache | rel=r_associated | relid=0 | w=5
  2193. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache (with pheochromocytoma)
    n1=hyperaldostéronisme secondaire | n2=en:headache (with pheochromocytoma) | rel=r_associated | relid=0 | w=5
  2194. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache is unilateral
    n1=hyperaldostéronisme secondaire | n2=en:headache is unilateral | rel=r_associated | relid=0 | w=5
  2195. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache is usually not a symptom
    n1=hyperaldostéronisme secondaire | n2=en:headache is usually not a symptom | rel=r_associated | relid=0 | w=5
  2196. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache recurrent
    n1=hyperaldostéronisme secondaire | n2=en:headache recurrent | rel=r_associated | relid=0 | w=5
  2197. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache, episodic
    n1=hyperaldostéronisme secondaire | n2=en:headache, episodic | rel=r_associated | relid=0 | w=5
  2198. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension
    n1=hyperaldostéronisme secondaire | n2=en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension | rel=r_associated | relid=0 | w=5
  2199. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:headaches, severe, unilateral
    n1=hyperaldostéronisme secondaire | n2=en:headaches, severe, unilateral | rel=r_associated | relid=0 | w=5
  2200. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:health, school
    n1=hyperaldostéronisme secondaire | n2=en:health, school | rel=r_associated | relid=0 | w=5
  2201. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:healthcare issues for children and teenagers
    n1=hyperaldostéronisme secondaire | n2=en:healthcare issues for children and teenagers | rel=r_associated | relid=0 | w=5
  2202. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hearing problems in children
    n1=hyperaldostéronisme secondaire | n2=en:hearing problems in children | rel=r_associated | relid=0 | w=5
  2203. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:heightened sensitivity to external stimuli
    n1=hyperaldostéronisme secondaire | n2=en:heightened sensitivity to external stimuli | rel=r_associated | relid=0 | w=5
  2204. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiclonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:hemiclonic seizures | rel=r_associated | relid=0 | w=5
  2205. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemihypoasthesia
    n1=hyperaldostéronisme secondaire | n2=en:hemihypoasthesia | rel=r_associated | relid=0 | w=5
  2206. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemimegalencephaly
    n1=hyperaldostéronisme secondaire | n2=en:hemimegalencephaly | rel=r_associated | relid=0 | w=5
  2207. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiparesis
    n1=hyperaldostéronisme secondaire | n2=en:hemiparesis | rel=r_associated | relid=0 | w=5
  2208. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiparesis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hemiparesis (in some patients) | rel=r_associated | relid=0 | w=5
  2209. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiparesis, paroxysmal
    n1=hyperaldostéronisme secondaire | n2=en:hemiparesis, paroxysmal | rel=r_associated | relid=0 | w=5
  2210. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiplegia
    n1=hyperaldostéronisme secondaire | n2=en:hemiplegia | rel=r_associated | relid=0 | w=5
  2211. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiplegia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hemiplegia (rare) | rel=r_associated | relid=0 | w=5
  2212. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiplegic migraine
    n1=hyperaldostéronisme secondaire | n2=en:hemiplegic migraine | rel=r_associated | relid=0 | w=5
  2213. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemiplegic migraine in some patients
    n1=hyperaldostéronisme secondaire | n2=en:hemiplegic migraine in some patients | rel=r_associated | relid=0 | w=5
  2214. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemisensory attacks
    n1=hyperaldostéronisme secondaire | n2=en:hemisensory attacks | rel=r_associated | relid=0 | w=5
  2215. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemispheric atrophy
    n1=hyperaldostéronisme secondaire | n2=en:hemispheric atrophy | rel=r_associated | relid=0 | w=5
  2216. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:hemorrhage | rel=r_associated | relid=0 | w=5
  2217. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemorrhagic cerebrovascular accident
    n1=hyperaldostéronisme secondaire | n2=en:hemorrhagic cerebrovascular accident | rel=r_associated | relid=0 | w=5
  2218. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hemosiderin deposition
    n1=hyperaldostéronisme secondaire | n2=en:hemosiderin deposition | rel=r_associated | relid=0 | w=5
  2219. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hepatic encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:hepatic encephalopathy | rel=r_associated | relid=0 | w=5
  2220. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hepatolenticular degeneration
    n1=hyperaldostéronisme secondaire | n2=en:hepatolenticular degeneration | rel=r_associated | relid=0 | w=5
  2221. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum
    n1=hyperaldostéronisme secondaire | n2=en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum | rel=r_associated | relid=0 | w=5
  2222. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater
    n1=hyperaldostéronisme secondaire | n2=en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater | rel=r_associated | relid=0 | w=5
  2223. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:heterotopic neurons in the white matter (36%)
    n1=hyperaldostéronisme secondaire | n2=en:heterotopic neurons in the white matter (36%) | rel=r_associated | relid=0 | w=5
  2224. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hiccough
    n1=hyperaldostéronisme secondaire | n2=en:hiccough | rel=r_associated | relid=0 | w=5
  2225. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high intensity area in white matter on head mri
    n1=hyperaldostéronisme secondaire | n2=en:high intensity area in white matter on head mri | rel=r_associated | relid=0 | w=5
  2226. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high pain threshold
    n1=hyperaldostéronisme secondaire | n2=en:high pain threshold | rel=r_associated | relid=0 | w=5
  2227. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high signal intensities at gray/white matter junction
    n1=hyperaldostéronisme secondaire | n2=en:high signal intensities at gray/white matter junction | rel=r_associated | relid=0 | w=5
  2228. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high signal intensities in periventricular white matter
    n1=hyperaldostéronisme secondaire | n2=en:high signal intensities in periventricular white matter | rel=r_associated | relid=0 | w=5
  2229. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high voltage spikes over the temporal and central regions seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:high voltage spikes over the temporal and central regions seen on eeg | rel=r_associated | relid=0 | w=5
  2230. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high voltage, fast rhythms seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:high voltage, fast rhythms seen on eeg | rel=r_associated | relid=0 | w=5
  2231. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high-steppage gait
    n1=hyperaldostéronisme secondaire | n2=en:high-steppage gait | rel=r_associated | relid=0 | w=5
  2232. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:high-stepping gait
    n1=hyperaldostéronisme secondaire | n2=en:high-stepping gait | rel=r_associated | relid=0 | w=5
  2233. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hippocampal atrophy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hippocampal atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  2234. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hippocampal atrophy (in 2 siblings)
    n1=hyperaldostéronisme secondaire | n2=en:hippocampal atrophy (in 2 siblings) | rel=r_associated | relid=0 | w=5
  2235. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hippocampal hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:hippocampal hypoplasia | rel=r_associated | relid=0 | w=5
  2236. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:holoprosencephaly
    n1=hyperaldostéronisme secondaire | n2=en:holoprosencephaly | rel=r_associated | relid=0 | w=5
  2237. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:holoprosencephaly (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:holoprosencephaly (1 patient) | rel=r_associated | relid=0 | w=5
  2238. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:holoprosencephaly (100%)
    n1=hyperaldostéronisme secondaire | n2=en:holoprosencephaly (100%) | rel=r_associated | relid=0 | w=5
  2239. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:holoprosencephaly (less common)
    n1=hyperaldostéronisme secondaire | n2=en:holoprosencephaly (less common) | rel=r_associated | relid=0 | w=5
  2240. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:holoprosencephaly (variable)
    n1=hyperaldostéronisme secondaire | n2=en:holoprosencephaly (variable) | rel=r_associated | relid=0 | w=5
  2241. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia | rel=r_associated | relid=0 | w=5
  2242. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hostility
    n1=hyperaldostéronisme secondaire | n2=en:hostility | rel=r_associated | relid=0 | w=5
  2243. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:human head louse
    n1=hyperaldostéronisme secondaire | n2=en:human head louse | rel=r_associated | relid=0 | w=5
  2244. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hunger and thirst disturbances (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hunger and thirst disturbances (in some patients) | rel=r_associated | relid=0 | w=5
  2245. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:huntington's disease
    n1=hyperaldostéronisme secondaire | n2=en:huntington's disease | rel=r_associated | relid=0 | w=5
  2246. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydranencephaly
    n1=hyperaldostéronisme secondaire | n2=en:hydranencephaly | rel=r_associated | relid=0 | w=5
  2247. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus | rel=r_associated | relid=0 | w=5
  2248. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (11%)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (11%) | rel=r_associated | relid=0 | w=5
  2249. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (12%)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (12%) | rel=r_associated | relid=0 | w=5
  2250. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (in 1 patient) | rel=r_associated | relid=0 | w=5
  2251. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (in 2 patients) | rel=r_associated | relid=0 | w=5
  2252. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (in some patients) | rel=r_associated | relid=0 | w=5
  2253. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (less common)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (less common) | rel=r_associated | relid=0 | w=5
  2254. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (rare) | rel=r_associated | relid=0 | w=5
  2255. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (uncommon) | rel=r_associated | relid=0 | w=5
  2256. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus (variable)
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus (variable) | rel=r_associated | relid=0 | w=5
  2257. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus, normal pressure
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus, normal pressure | rel=r_associated | relid=0 | w=5
  2258. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephalus, occasional
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephalus, occasional | rel=r_associated | relid=0 | w=5
  2259. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hydrocephaly, mild
    n1=hyperaldostéronisme secondaire | n2=en:hydrocephaly, mild | rel=r_associated | relid=0 | w=5
  2260. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyoid
    n1=hyperaldostéronisme secondaire | n2=en:hyoid | rel=r_associated | relid=0 | w=5
  2261. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyper attenuation
    n1=hyperaldostéronisme secondaire | n2=en:hyper attenuation | rel=r_associated | relid=0 | w=5
  2262. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyper-?-alaninemia
    n1=hyperaldostéronisme secondaire | n2=en:hyper-?-alaninemia | rel=r_associated | relid=0 | w=5
  2263. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyper-?-globulinaemia
    n1=hyperaldostéronisme secondaire | n2=en:hyper-?-globulinaemia | rel=r_associated | relid=0 | w=5
  2264. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyper-?-lipoproteinemia
    n1=hyperaldostéronisme secondaire | n2=en:hyper-?-lipoproteinemia | rel=r_associated | relid=0 | w=5
  2265. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperacanthosis
    n1=hyperaldostéronisme secondaire | n2=en:hyperacanthosis | rel=r_associated | relid=0 | w=5
  2266. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactive behavior, mild
    n1=hyperaldostéronisme secondaire | n2=en:hyperactive behavior, mild | rel=r_associated | relid=0 | w=5
  2267. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactive brainstem reflexes (head retraction, palmomental, snout)
    n1=hyperaldostéronisme secondaire | n2=en:hyperactive brainstem reflexes (head retraction, palmomental, snout) | rel=r_associated | relid=0 | w=5
  2268. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactive deep tendon reflexes
    n1=hyperaldostéronisme secondaire | n2=en:hyperactive deep tendon reflexes | rel=r_associated | relid=0 | w=5
  2269. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactive deep tendon reflexes in early stage
    n1=hyperaldostéronisme secondaire | n2=en:hyperactive deep tendon reflexes in early stage | rel=r_associated | relid=0 | w=5
  2270. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactive startle reflex
    n1=hyperaldostéronisme secondaire | n2=en:hyperactive startle reflex | rel=r_associated | relid=0 | w=5
  2271. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity | rel=r_associated | relid=0 | w=5
  2272. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity (if left untreated) | rel=r_associated | relid=0 | w=5
  2273. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity (in some patients) | rel=r_associated | relid=0 | w=5
  2274. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  2275. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity in 50% of patients
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity in 50% of patients | rel=r_associated | relid=0 | w=5
  2276. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperactivity syndrome aggravated
    n1=hyperaldostéronisme secondaire | n2=en:hyperactivity syndrome aggravated | rel=r_associated | relid=0 | w=5
  2277. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperalaninemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperalaninemia | rel=r_associated | relid=0 | w=5
  2278. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperalphaglobulinemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperalphaglobulinemia | rel=r_associated | relid=0 | w=5
  2279. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperaminoacidaemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperaminoacidaemia | rel=r_associated | relid=0 | w=5
  2280. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperaminoaciduria
    n1=hyperaldostéronisme secondaire | n2=en:hyperaminoaciduria | rel=r_associated | relid=0 | w=5
  2281. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperammonemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=5
  2282. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperammoniaemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperammoniaemia | rel=r_associated | relid=0 | w=5
  2283. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperekplexia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hyperekplexia (rare) | rel=r_associated | relid=0 | w=5
  2284. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperexcitability behavior
    n1=hyperaldostéronisme secondaire | n2=en:hyperexcitability behavior | rel=r_associated | relid=0 | w=5
  2285. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperexplexia
    n1=hyperaldostéronisme secondaire | n2=en:hyperexplexia | rel=r_associated | relid=0 | w=5
  2286. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperextension of the neck
    n1=hyperaldostéronisme secondaire | n2=en:hyperextension of the neck | rel=r_associated | relid=0 | w=5
  2287. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperglycinemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperglycinemia | rel=r_associated | relid=0 | w=5
  2288. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperHDLemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperHDLemia | rel=r_associated | relid=0 | w=5
  2289. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperintense lesions in the basal ganglia on mri
    n1=hyperaldostéronisme secondaire | n2=en:hyperintense lesions in the basal ganglia on mri | rel=r_associated | relid=0 | w=5
  2290. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperintense lesions of the globi pallidi
    n1=hyperaldostéronisme secondaire | n2=en:hyperintense lesions of the globi pallidi | rel=r_associated | relid=0 | w=5
  2291. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperintensities in the basal ganglia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hyperintensities in the basal ganglia (rare) | rel=r_associated | relid=0 | w=5
  2292. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperintensities in the basal ganglia and/or thalamus
    n1=hyperaldostéronisme secondaire | n2=en:hyperintensities in the basal ganglia and/or thalamus | rel=r_associated | relid=0 | w=5
  2293. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperirritability
    n1=hyperaldostéronisme secondaire | n2=en:hyperirritability | rel=r_associated | relid=0 | w=5
  2294. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinesia
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinesia | rel=r_associated | relid=0 | w=5
  2295. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinesis with developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinesis with developmental delay | rel=r_associated | relid=0 | w=5
  2296. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic conduct disorder
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic conduct disorder | rel=r_associated | relid=0 | w=5
  2297. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic conduct disorder of childhood
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic conduct disorder of childhood | rel=r_associated | relid=0 | w=5
  2298. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic disorder
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic disorder | rel=r_associated | relid=0 | w=5
  2299. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic involuntary movements
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic involuntary movements | rel=r_associated | relid=0 | w=5
  2300. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic reaction of childhood or adolescence nos
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic reaction of childhood or adolescence nos | rel=r_associated | relid=0 | w=5
  2301. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperkinetic syndrome
    n1=hyperaldostéronisme secondaire | n2=en:hyperkinetic syndrome | rel=r_associated | relid=0 | w=5
  2302. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperLDLemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperLDLemia | rel=r_associated | relid=0 | w=5
  2303. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperlexia
    n1=hyperaldostéronisme secondaire | n2=en:hyperlexia | rel=r_associated | relid=0 | w=5
  2304. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypermotor automatisms
    n1=hyperaldostéronisme secondaire | n2=en:hypermotor automatisms | rel=r_associated | relid=0 | w=5
  2305. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypermotor behavior
    n1=hyperaldostéronisme secondaire | n2=en:hypermotor behavior | rel=r_associated | relid=0 | w=5
  2306. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperorality
    n1=hyperaldostéronisme secondaire | n2=en:hyperorality | rel=r_associated | relid=0 | w=5
  2307. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperphagia
    n1=hyperaldostéronisme secondaire | n2=en:hyperphagia | rel=r_associated | relid=0 | w=5
  2308. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperphagia (deletion patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyperphagia (deletion patients) | rel=r_associated | relid=0 | w=5
  2309. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperphagia in late childhood (hcs)
    n1=hyperaldostéronisme secondaire | n2=en:hyperphagia in late childhood (hcs) | rel=r_associated | relid=0 | w=5
  2310. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia | rel=r_associated | relid=0 | w=5
  2311. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (2 patients) | rel=r_associated | relid=0 | w=5
  2312. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (33%)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (33%) | rel=r_associated | relid=0 | w=5
  2313. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (70%)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (70%) | rel=r_associated | relid=0 | w=5
  2314. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (early)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (early) | rel=r_associated | relid=0 | w=5
  2315. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (later)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (later) | rel=r_associated | relid=0 | w=5
  2316. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (less common) | rel=r_associated | relid=0 | w=5
  2317. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults) | rel=r_associated | relid=0 | w=5
  2318. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (some patients) | rel=r_associated | relid=0 | w=5
  2319. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia (type i)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia (type i) | rel=r_associated | relid=0 | w=5
  2320. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia in some
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia in some | rel=r_associated | relid=0 | w=5
  2321. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia in the lower limbs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia in the lower limbs (in some patients) | rel=r_associated | relid=0 | w=5
  2322. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia may occur
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia may occur | rel=r_associated | relid=0 | w=5
  2323. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia proximally
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia proximally | rel=r_associated | relid=0 | w=5
  2324. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia, especially of the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia, especially of the lower limbs | rel=r_associated | relid=0 | w=5
  2325. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia, lower limbs more than upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia, lower limbs more than upper limbs | rel=r_associated | relid=0 | w=5
  2326. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperreflexia, lower limbs, mild
    n1=hyperaldostéronisme secondaire | n2=en:hyperreflexia, lower limbs, mild | rel=r_associated | relid=0 | w=5
  2327. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypersensitive to stimuli
    n1=hyperaldostéronisme secondaire | n2=en:hypersensitive to stimuli | rel=r_associated | relid=0 | w=5
  2328. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypersensitivity to sound
    n1=hyperaldostéronisme secondaire | n2=en:hypersensitivity to sound | rel=r_associated | relid=0 | w=5
  2329. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypersexualism
    n1=hyperaldostéronisme secondaire | n2=en:hypersexualism | rel=r_associated | relid=0 | w=5
  2330. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypersomnolent
    n1=hyperaldostéronisme secondaire | n2=en:hypersomnolent | rel=r_associated | relid=0 | w=5
  2331. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperthermia
    n1=hyperaldostéronisme secondaire | n2=en:hyperthermia | rel=r_associated | relid=0 | w=5
  2332. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyperthreoninemia
    n1=hyperaldostéronisme secondaire | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=5
  2333. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia | rel=r_associated | relid=0 | w=5
  2334. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia (after age 2 years)
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia (after age 2 years) | rel=r_associated | relid=0 | w=5
  2335. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia (childhood)
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia (childhood) | rel=r_associated | relid=0 | w=5
  2336. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia (in some patients) | rel=r_associated | relid=0 | w=5
  2337. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia (older children and adolescents)
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia (older children and adolescents) | rel=r_associated | relid=0 | w=5
  2338. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia (type ii)
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia (type ii) | rel=r_associated | relid=0 | w=5
  2339. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia and rigidity during seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia and rigidity during seizures | rel=r_associated | relid=0 | w=5
  2340. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia in early stage
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia in early stage | rel=r_associated | relid=0 | w=5
  2341. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia in neonatal period
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia in neonatal period | rel=r_associated | relid=0 | w=5
  2342. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia late
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia late | rel=r_associated | relid=0 | w=5
  2343. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia of lower limbs, later
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia of lower limbs, later | rel=r_associated | relid=0 | w=5
  2344. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia of the extremities
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia of the extremities | rel=r_associated | relid=0 | w=5
  2345. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia, mild, transient
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia, mild, transient | rel=r_associated | relid=0 | w=5
  2346. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonia, peripheral dystonia
    n1=hyperaldostéronisme secondaire | n2=en:hypertonia, peripheral dystonia | rel=r_associated | relid=0 | w=5
  2347. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypertonic seizures | rel=r_associated | relid=0 | w=5
  2348. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypertonicity
    n1=hyperaldostéronisme secondaire | n2=en:hypertonicity | rel=r_associated | relid=0 | w=5
  2349. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypnagogic hallucinations
    n1=hyperaldostéronisme secondaire | n2=en:hypnagogic hallucinations | rel=r_associated | relid=0 | w=5
  2350. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypnapompic hallucinations
    n1=hyperaldostéronisme secondaire | n2=en:hypnapompic hallucinations | rel=r_associated | relid=0 | w=5
  2351. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypo- and demyelination of the brain
    n1=hyperaldostéronisme secondaire | n2=en:hypo- and demyelination of the brain | rel=r_associated | relid=0 | w=5
  2352. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypocalcemic seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypocalcemic seizures | rel=r_associated | relid=0 | w=5
  2353. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypocalcemic tetany
    n1=hyperaldostéronisme secondaire | n2=en:hypocalcemic tetany | rel=r_associated | relid=0 | w=5
  2354. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypodensity of caudate
    n1=hyperaldostéronisme secondaire | n2=en:hypodensity of caudate | rel=r_associated | relid=0 | w=5
  2355. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypodensity of cerebral white matter seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:hypodensity of cerebral white matter seen on mri | rel=r_associated | relid=0 | w=5
  2356. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypodensity of lenticular nuclei
    n1=hyperaldostéronisme secondaire | n2=en:hypodensity of lenticular nuclei | rel=r_associated | relid=0 | w=5
  2357. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypodensity of the white matter
    n1=hyperaldostéronisme secondaire | n2=en:hypodensity of the white matter | rel=r_associated | relid=0 | w=5
  2358. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypodysplasia of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:hypodysplasia of the corpus callosum | rel=r_associated | relid=0 | w=5
  2359. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypogenesis of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:hypogenesis of the corpus callosum | rel=r_associated | relid=0 | w=5
  2360. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoglycemia-related seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypoglycemia-related seizures | rel=r_associated | relid=0 | w=5
  2361. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoglycemic coma
    n1=hyperaldostéronisme secondaire | n2=en:hypoglycemic coma | rel=r_associated | relid=0 | w=5
  2362. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoglycemic encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:hypoglycemic encephalopathy | rel=r_associated | relid=0 | w=5
  2363. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoglycemic seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypoglycemic seizures | rel=r_associated | relid=0 | w=5
  2364. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypokinesia
    n1=hyperaldostéronisme secondaire | n2=en:hypokinesia | rel=r_associated | relid=0 | w=5
  2365. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypokinesia in infancy
    n1=hyperaldostéronisme secondaire | n2=en:hypokinesia in infancy | rel=r_associated | relid=0 | w=5
  2366. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypokinetic movements
    n1=hyperaldostéronisme secondaire | n2=en:hypokinetic movements | rel=r_associated | relid=0 | w=5
  2367. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypometabolism of the frontal lobe and thalamic regions
    n1=hyperaldostéronisme secondaire | n2=en:hypometabolism of the frontal lobe and thalamic regions | rel=r_associated | relid=0 | w=5
  2368. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomethioninemia
    n1=hyperaldostéronisme secondaire | n2=en:hypomethioninemia | rel=r_associated | relid=0 | w=5
  2369. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomimia
    n1=hyperaldostéronisme secondaire | n2=en:hypomimia | rel=r_associated | relid=0 | w=5
  2370. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomyelinating leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:hypomyelinating leukoencephalopathy | rel=r_associated | relid=0 | w=5
  2371. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomyelination
    n1=hyperaldostéronisme secondaire | n2=en:hypomyelination | rel=r_associated | relid=0 | w=5
  2372. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomyelination (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hypomyelination (1 patient) | rel=r_associated | relid=0 | w=5
  2373. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a) | rel=r_associated | relid=0 | w=5
  2374. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypomyelination of the brain white matter, diffuse
    n1=hyperaldostéronisme secondaire | n2=en:hypomyelination of the brain white matter, diffuse | rel=r_associated | relid=0 | w=5
  2375. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia and displacement of the corticospinal fibers within the brainstem
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia and displacement of the corticospinal fibers within the brainstem | rel=r_associated | relid=0 | w=5
  2376. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of anterior or entire pituitary gland (frequent)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of anterior or entire pituitary gland (frequent) | rel=r_associated | relid=0 | w=5
  2377. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of corpus callosum | rel=r_associated | relid=0 | w=5
  2378. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of corpus callosum and cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of corpus callosum and cerebellar vermis | rel=r_associated | relid=0 | w=5
  2379. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of dentate nucleus
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of dentate nucleus | rel=r_associated | relid=0 | w=5
  2380. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of olfactory tract
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of olfactory tract | rel=r_associated | relid=0 | w=5
  2381. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of septum pellucidum | rel=r_associated | relid=0 | w=5
  2382. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the brainstem
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the brainstem | rel=r_associated | relid=0 | w=5
  2383. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the corpus callosum (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the corpus callosum (2 patients) | rel=r_associated | relid=0 | w=5
  2384. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the hypothalamus
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the hypothalamus | rel=r_associated | relid=0 | w=5
  2385. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the medulla oblongata
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the medulla oblongata | rel=r_associated | relid=0 | w=5
  2386. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the mesencephalic tectum
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the mesencephalic tectum | rel=r_associated | relid=0 | w=5
  2387. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the optic chiasm
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the optic chiasm | rel=r_associated | relid=0 | w=5
  2388. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the optic tract
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the optic tract | rel=r_associated | relid=0 | w=5
  2389. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the pons
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the pons | rel=r_associated | relid=0 | w=5
  2390. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the posterior corpus callosum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the posterior corpus callosum (in some patients) | rel=r_associated | relid=0 | w=5
  2391. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the pyramidal tract
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the pyramidal tract | rel=r_associated | relid=0 | w=5
  2392. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia of the ventral pons
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia of the ventral pons | rel=r_associated | relid=0 | w=5
  2393. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplasia or dysgenesis of the corpus callosum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplasia or dysgenesis of the corpus callosum (in some patients) | rel=r_associated | relid=0 | w=5
  2394. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic anterior pituitary (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic anterior pituitary (in some patients) | rel=r_associated | relid=0 | w=5
  2395. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic anterior pituitary gland
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic anterior pituitary gland | rel=r_associated | relid=0 | w=5
  2396. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction | rel=r_associated | relid=0 | w=5
  2397. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic cerebellar vermis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic cerebellar vermis (rare) | rel=r_associated | relid=0 | w=5
  2398. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic cerebrum
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic cerebrum | rel=r_associated | relid=0 | w=5
  2399. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic corpus callosum (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic corpus callosum (1 patient) | rel=r_associated | relid=0 | w=5
  2400. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic corpus callosum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic corpus callosum (in some patients) | rel=r_associated | relid=0 | w=5
  2401. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic corpus callosum (in some)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic corpus callosum (in some) | rel=r_associated | relid=0 | w=5
  2402. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic corpus callosum (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic corpus callosum (rare) | rel=r_associated | relid=0 | w=5
  2403. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic internal capsule (in some)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic internal capsule (in some) | rel=r_associated | relid=0 | w=5
  2404. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic olfactory lobes
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic olfactory lobes | rel=r_associated | relid=0 | w=5
  2405. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic or absent middle cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic or absent middle cerebellar peduncles | rel=r_associated | relid=0 | w=5
  2406. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic or absent optic chiasm
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic or absent optic chiasm | rel=r_associated | relid=0 | w=5
  2407. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic pituitary gland (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic pituitary gland (in some patients) | rel=r_associated | relid=0 | w=5
  2408. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic pons
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic pons | rel=r_associated | relid=0 | w=5
  2409. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoplastic/atrophic corpus callosum (55%)
    n1=hyperaldostéronisme secondaire | n2=en:hypoplastic/atrophic corpus callosum (55%) | rel=r_associated | relid=0 | w=5
  2410. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia | rel=r_associated | relid=0 | w=5
  2411. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia (early)
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia (early) | rel=r_associated | relid=0 | w=5
  2412. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia (occurs later)
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia (occurs later) | rel=r_associated | relid=0 | w=5
  2413. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia of lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia of lower limbs | rel=r_associated | relid=0 | w=5
  2414. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia or areflexia
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia or areflexia | rel=r_associated | relid=0 | w=5
  2415. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyporeflexia to hyperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:hyporeflexia to hyperreflexia | rel=r_associated | relid=0 | w=5
  2416. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyposmia/anosmia
    n1=hyperaldostéronisme secondaire | n2=en:hyposmia/anosmia | rel=r_associated | relid=0 | w=5
  2417. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hyposmia/anosmia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hyposmia/anosmia (in some patients) | rel=r_associated | relid=0 | w=5
  2418. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypothalamic hamartoma
    n1=hyperaldostéronisme secondaire | n2=en:hypothalamic hamartoma | rel=r_associated | relid=0 | w=5
  2419. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypothalamus
    n1=hyperaldostéronisme secondaire | n2=en:hypothalamus | rel=r_associated | relid=0 | w=5
  2420. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia | rel=r_associated | relid=0 | w=5
  2421. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (1 patient) | rel=r_associated | relid=0 | w=5
  2422. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (93%)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (93%) | rel=r_associated | relid=0 | w=5
  2423. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (96%)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (96%) | rel=r_associated | relid=0 | w=5
  2424. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (congenital form)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (congenital form) | rel=r_associated | relid=0 | w=5
  2425. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (early infancy)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (early infancy) | rel=r_associated | relid=0 | w=5
  2426. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (early-onset form)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (early-onset form) | rel=r_associated | relid=0 | w=5
  2427. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (hcs and 2p21del)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (hcs and 2p21del) | rel=r_associated | relid=0 | w=5
  2428. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (in 1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (in 1/4 patients) | rel=r_associated | relid=0 | w=5
  2429. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (in males)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (in males) | rel=r_associated | relid=0 | w=5
  2430. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (in some patients) | rel=r_associated | relid=0 | w=5
  2431. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (less common) | rel=r_associated | relid=0 | w=5
  2432. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (newborn)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (newborn) | rel=r_associated | relid=0 | w=5
  2433. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (rare) | rel=r_associated | relid=0 | w=5
  2434. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia (type i and type ii, infantile)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia (type i and type ii, infantile) | rel=r_associated | relid=0 | w=5
  2435. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia at birth
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia at birth | rel=r_associated | relid=0 | w=5
  2436. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia changing to hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia changing to hypertonia | rel=r_associated | relid=0 | w=5
  2437. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia in infancy and early childhood
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia in infancy and early childhood | rel=r_associated | relid=0 | w=5
  2438. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia in later stages
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia in later stages | rel=r_associated | relid=0 | w=5
  2439. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia progressing to hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia progressing to hypertonia | rel=r_associated | relid=0 | w=5
  2440. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, axial, severe
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, axial, severe | rel=r_associated | relid=0 | w=5
  2441. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, global, severe
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, global, severe | rel=r_associated | relid=0 | w=5
  2442. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, mild
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, mild | rel=r_associated | relid=0 | w=5
  2443. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, mild, transient
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, mild, transient | rel=r_associated | relid=0 | w=5
  2444. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, neonatal (> 90%)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, neonatal (> 90%) | rel=r_associated | relid=0 | w=5
  2445. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, poor moro reflex
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, poor moro reflex | rel=r_associated | relid=0 | w=5
  2446. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, profound muscular (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, profound muscular (in some patients) | rel=r_associated | relid=0 | w=5
  2447. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, proximal, severe
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, proximal, severe | rel=r_associated | relid=0 | w=5
  2448. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonia, severe (rare)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonia, severe (rare) | rel=r_associated | relid=0 | w=5
  2449. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonic
    n1=hyperaldostéronisme secondaire | n2=en:hypotonic | rel=r_associated | relid=0 | w=5
  2450. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:hypotonic seizures | rel=r_associated | relid=0 | w=5
  2451. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotonicity (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypotonicity (in some patients) | rel=r_associated | relid=0 | w=5
  2452. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypotrophic brainstem
    n1=hyperaldostéronisme secondaire | n2=en:hypotrophic brainstem | rel=r_associated | relid=0 | w=5
  2453. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypoxic convulsions
    n1=hyperaldostéronisme secondaire | n2=en:hypoxic convulsions | rel=r_associated | relid=0 | w=5
  2454. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:hypperreflexia | rel=r_associated | relid=0 | w=5
  2455. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypsarrhythmia
    n1=hyperaldostéronisme secondaire | n2=en:hypsarrhythmia | rel=r_associated | relid=0 | w=5
  2456. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypsarrhythmia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:hypsarrhythmia (1 patient) | rel=r_associated | relid=0 | w=5
  2457. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypsarrhythmia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:hypsarrhythmia (in some patients) | rel=r_associated | relid=0 | w=5
  2458. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg
    n1=hyperaldostéronisme secondaire | n2=en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg | rel=r_associated | relid=0 | w=5
  2459. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:hypsarrhythmia seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:hypsarrhythmia seen on eeg | rel=r_associated | relid=0 | w=5
  2460. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg showed partial seizures with frontal lobe origin
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg showed partial seizures with frontal lobe origin | rel=r_associated | relid=0 | w=5
  2461. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg shows diffuse slow delta and theta activity
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg shows diffuse slow delta and theta activity | rel=r_associated | relid=0 | w=5
  2462. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg shows focal onset in central, parietal, or temporal regions
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg shows focal onset in central, parietal, or temporal regions | rel=r_associated | relid=0 | w=5
  2463. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg shows focal onset, often posterior region of brain
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg shows focal onset, often posterior region of brain | rel=r_associated | relid=0 | w=5
  2464. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude | rel=r_associated | relid=0 | w=5
  2465. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ictal eeg with bisynchronous spike waves
    n1=hyperaldostéronisme secondaire | n2=en:ictal eeg with bisynchronous spike waves | rel=r_associated | relid=0 | w=5
  2466. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:idiopathic generalized epilepsy in childhood (homozygous patient)
    n1=hyperaldostéronisme secondaire | n2=en:idiopathic generalized epilepsy in childhood (homozygous patient) | rel=r_associated | relid=0 | w=5
  2467. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:idiopathic torsion dystonia
    n1=hyperaldostéronisme secondaire | n2=en:idiopathic torsion dystonia | rel=r_associated | relid=0 | w=5
  2468. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:illegible handwriting
    n1=hyperaldostéronisme secondaire | n2=en:illegible handwriting | rel=r_associated | relid=0 | w=5
  2469. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter
    n1=hyperaldostéronisme secondaire | n2=en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter | rel=r_associated | relid=0 | w=5
  2470. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:imaging shows signal abnormalities in basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:imaging shows signal abnormalities in basal ganglia | rel=r_associated | relid=0 | w=5
  2471. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:imbalance
    n1=hyperaldostéronisme secondaire | n2=en:imbalance | rel=r_associated | relid=0 | w=5
  2472. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:immature brain with no gyral development
    n1=hyperaldostéronisme secondaire | n2=en:immature brain with no gyral development | rel=r_associated | relid=0 | w=5
  2473. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:immature myelination
    n1=hyperaldostéronisme secondaire | n2=en:immature myelination | rel=r_associated | relid=0 | w=5
  2474. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:immobile
    n1=hyperaldostéronisme secondaire | n2=en:immobile | rel=r_associated | relid=0 | w=5
  2475. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired ability to form peer relationships
    n1=hyperaldostéronisme secondaire | n2=en:impaired ability to form peer relationships | rel=r_associated | relid=0 | w=5
  2476. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired ambulation due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:impaired ambulation due to muscle weakness | rel=r_associated | relid=0 | w=5
  2477. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired attentional and executive function
    n1=hyperaldostéronisme secondaire | n2=en:impaired attentional and executive function | rel=r_associated | relid=0 | w=5
  2478. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired balance
    n1=hyperaldostéronisme secondaire | n2=en:impaired balance | rel=r_associated | relid=0 | w=5
  2479. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired balance (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:impaired balance (2 patients) | rel=r_associated | relid=0 | w=5
  2480. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired cognition (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:impaired cognition (in some patients) | rel=r_associated | relid=0 | w=5
  2481. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired executive function (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:impaired executive function (in some patients) | rel=r_associated | relid=0 | w=5
  2482. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired expression of language
    n1=hyperaldostéronisme secondaire | n2=en:impaired expression of language | rel=r_associated | relid=0 | w=5
  2483. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired expressive speech
    n1=hyperaldostéronisme secondaire | n2=en:impaired expressive speech | rel=r_associated | relid=0 | w=5
  2484. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired fine motor skills
    n1=hyperaldostéronisme secondaire | n2=en:impaired fine motor skills | rel=r_associated | relid=0 | w=5
  2485. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired gait due to peripheral neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:impaired gait due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  2486. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired language development
    n1=hyperaldostéronisme secondaire | n2=en:impaired language development | rel=r_associated | relid=0 | w=5
  2487. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired long-term verbal memory
    n1=hyperaldostéronisme secondaire | n2=en:impaired long-term verbal memory | rel=r_associated | relid=0 | w=5
  2488. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired motor control, mild
    n1=hyperaldostéronisme secondaire | n2=en:impaired motor control, mild | rel=r_associated | relid=0 | w=5
  2489. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired processing of language
    n1=hyperaldostéronisme secondaire | n2=en:impaired processing of language | rel=r_associated | relid=0 | w=5
  2490. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired proprioception
    n1=hyperaldostéronisme secondaire | n2=en:impaired proprioception | rel=r_associated | relid=0 | w=5
  2491. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:impaired psychomotor development | rel=r_associated | relid=0 | w=5
  2492. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired tandem gait
    n1=hyperaldostéronisme secondaire | n2=en:impaired tandem gait | rel=r_associated | relid=0 | w=5
  2493. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures
    n1=hyperaldostéronisme secondaire | n2=en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures | rel=r_associated | relid=0 | w=5
  2494. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired vertical visual pursuit
    n1=hyperaldostéronisme secondaire | n2=en:impaired vertical visual pursuit | rel=r_associated | relid=0 | w=5
  2495. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired vibration sensation at ankles
    n1=hyperaldostéronisme secondaire | n2=en:impaired vibration sensation at ankles | rel=r_associated | relid=0 | w=5
  2496. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired vibration sensation in the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:impaired vibration sensation in the lower limbs | rel=r_associated | relid=0 | w=5
  2497. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired visuospatial perception
    n1=hyperaldostéronisme secondaire | n2=en:impaired visuospatial perception | rel=r_associated | relid=0 | w=5
  2498. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired visuospatial skills
    n1=hyperaldostéronisme secondaire | n2=en:impaired visuospatial skills | rel=r_associated | relid=0 | w=5
  2499. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired voluntary movement
    n1=hyperaldostéronisme secondaire | n2=en:impaired voluntary movement | rel=r_associated | relid=0 | w=5
  2500. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impaired walking ability (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:impaired walking ability (in some patients) | rel=r_associated | relid=0 | w=5
  2501. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impairment of balance
    n1=hyperaldostéronisme secondaire | n2=en:impairment of balance | rel=r_associated | relid=0 | w=5
  2502. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impairment of gross and fine motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:impairment of gross and fine motor coordination | rel=r_associated | relid=0 | w=5
  2503. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:impulsive behavior
    n1=hyperaldostéronisme secondaire | n2=en:impulsive behavior | rel=r_associated | relid=0 | w=5
  2504. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to communicate
    n1=hyperaldostéronisme secondaire | n2=en:inability to communicate | rel=r_associated | relid=0 | w=5
  2505. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to generate syntactic grammar rules (i.e., tense, gender, number)
    n1=hyperaldostéronisme secondaire | n2=en:inability to generate syntactic grammar rules (i.e., tense, gender, number) | rel=r_associated | relid=0 | w=5
  2506. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to hold head
    n1=hyperaldostéronisme secondaire | n2=en:inability to hold head | rel=r_associated | relid=0 | w=5
  2507. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to hold head up
    n1=hyperaldostéronisme secondaire | n2=en:inability to hold head up | rel=r_associated | relid=0 | w=5
  2508. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to hold neck up ('limber neck') onset at 6 months
    n1=hyperaldostéronisme secondaire | n2=en:inability to hold neck up ('limber neck') onset at 6 months | rel=r_associated | relid=0 | w=5
  2509. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to reach
    n1=hyperaldostéronisme secondaire | n2=en:inability to reach | rel=r_associated | relid=0 | w=5
  2510. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to recognize someone familiar by the face alone
    n1=hyperaldostéronisme secondaire | n2=en:inability to recognize someone familiar by the face alone | rel=r_associated | relid=0 | w=5
  2511. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to run
    n1=hyperaldostéronisme secondaire | n2=en:inability to run | rel=r_associated | relid=0 | w=5
  2512. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to run (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:inability to run (in some patients) | rel=r_associated | relid=0 | w=5
  2513. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to sit
    n1=hyperaldostéronisme secondaire | n2=en:inability to sit | rel=r_associated | relid=0 | w=5
  2514. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to sit or control head
    n1=hyperaldostéronisme secondaire | n2=en:inability to sit or control head | rel=r_associated | relid=0 | w=5
  2515. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to sit or stand independently
    n1=hyperaldostéronisme secondaire | n2=en:inability to sit or stand independently | rel=r_associated | relid=0 | w=5
  2516. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to sit or walk independently
    n1=hyperaldostéronisme secondaire | n2=en:inability to sit or walk independently | rel=r_associated | relid=0 | w=5
  2517. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to stand on toes
    n1=hyperaldostéronisme secondaire | n2=en:inability to stand on toes | rel=r_associated | relid=0 | w=5
  2518. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to stand without assistance
    n1=hyperaldostéronisme secondaire | n2=en:inability to stand without assistance | rel=r_associated | relid=0 | w=5
  2519. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to walk independently
    n1=hyperaldostéronisme secondaire | n2=en:inability to walk independently | rel=r_associated | relid=0 | w=5
  2520. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to walk unaided
    n1=hyperaldostéronisme secondaire | n2=en:inability to walk unaided | rel=r_associated | relid=0 | w=5
  2521. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inability to walk unsupported
    n1=hyperaldostéronisme secondaire | n2=en:inability to walk unsupported | rel=r_associated | relid=0 | w=5
  2522. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate behavior
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate behavior | rel=r_associated | relid=0 | w=5
  2523. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate chewing behavior
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate chewing behavior | rel=r_associated | relid=0 | w=5
  2524. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate laughter
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate laughter | rel=r_associated | relid=0 | w=5
  2525. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate laughter (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate laughter (reported in 1 family) | rel=r_associated | relid=0 | w=5
  2526. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate laughter accompanying visual hallucinations (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate laughter accompanying visual hallucinations (in some patients) | rel=r_associated | relid=0 | w=5
  2527. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inappropriate sexual behavior
    n1=hyperaldostéronisme secondaire | n2=en:inappropriate sexual behavior | rel=r_associated | relid=0 | w=5
  2528. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inarticulate speech delayed gross motor skills
    n1=hyperaldostéronisme secondaire | n2=en:inarticulate speech delayed gross motor skills | rel=r_associated | relid=0 | w=5
  2529. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:incomplete myelination
    n1=hyperaldostéronisme secondaire | n2=en:incomplete myelination | rel=r_associated | relid=0 | w=5
  2530. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:incomprehensible speech
    n1=hyperaldostéronisme secondaire | n2=en:incomprehensible speech | rel=r_associated | relid=0 | w=5
  2531. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:incoordination of the hands
    n1=hyperaldostéronisme secondaire | n2=en:incoordination of the hands | rel=r_associated | relid=0 | w=5
  2532. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:incoordination of trunk and limbs
    n1=hyperaldostéronisme secondaire | n2=en:incoordination of trunk and limbs | rel=r_associated | relid=0 | w=5
  2533. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased activity in the left posterior superior temporal cortex
    n1=hyperaldostéronisme secondaire | n2=en:increased activity in the left posterior superior temporal cortex | rel=r_associated | relid=0 | w=5
  2534. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased activity in the right inferior temporal cortex
    n1=hyperaldostéronisme secondaire | n2=en:increased activity in the right inferior temporal cortex | rel=r_associated | relid=0 | w=5
  2535. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased activity period
    n1=hyperaldostéronisme secondaire | n2=en:increased activity period | rel=r_associated | relid=0 | w=5
  2536. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased cerebral lactate
    n1=hyperaldostéronisme secondaire | n2=en:increased cerebral lactate | rel=r_associated | relid=0 | w=5
  2537. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased csf lactate
    n1=hyperaldostéronisme secondaire | n2=en:increased csf lactate | rel=r_associated | relid=0 | w=5
  2538. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased csf protein
    n1=hyperaldostéronisme secondaire | n2=en:increased csf protein | rel=r_associated | relid=0 | w=5
  2539. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased csf protein with normal cell count
    n1=hyperaldostéronisme secondaire | n2=en:increased csf protein with normal cell count | rel=r_associated | relid=0 | w=5
  2540. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased deep tendon reflexes (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:increased deep tendon reflexes (if left untreated) | rel=r_associated | relid=0 | w=5
  2541. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased falls
    n1=hyperaldostéronisme secondaire | n2=en:increased falls | rel=r_associated | relid=0 | w=5
  2542. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased intracranial pressure preoperatively (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:increased intracranial pressure preoperatively (in some patients) | rel=r_associated | relid=0 | w=5
  2543. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased iron deposition in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:increased iron deposition in the basal ganglia | rel=r_associated | relid=0 | w=5
  2544. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased iron deposition in the basal ganglia (40%)
    n1=hyperaldostéronisme secondaire | n2=en:increased iron deposition in the basal ganglia (40%) | rel=r_associated | relid=0 | w=5
  2545. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased lactate in the brain
    n1=hyperaldostéronisme secondaire | n2=en:increased lactate in the brain | rel=r_associated | relid=0 | w=5
  2546. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased muscle tone in the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:increased muscle tone in the lower limbs | rel=r_associated | relid=0 | w=5
  2547. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased neurologic sequelae of infections (rare)
    n1=hyperaldostéronisme secondaire | n2=en:increased neurologic sequelae of infections (rare) | rel=r_associated | relid=0 | w=5
  2548. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased phonologic processing
    n1=hyperaldostéronisme secondaire | n2=en:increased phonologic processing | rel=r_associated | relid=0 | w=5
  2549. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased risk of seizures in childhood or adulthood (11-16%)
    n1=hyperaldostéronisme secondaire | n2=en:increased risk of seizures in childhood or adulthood (11-16%) | rel=r_associated | relid=0 | w=5
  2550. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area
    n1=hyperaldostéronisme secondaire | n2=en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area | rel=r_associated | relid=0 | w=5
  2551. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased startle response
    n1=hyperaldostéronisme secondaire | n2=en:increased startle response | rel=r_associated | relid=0 | w=5
  2552. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased subdural space around frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:increased subdural space around frontal lobes | rel=r_associated | relid=0 | w=5
  2553. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased susceptibility to schizophrenia
    n1=hyperaldostéronisme secondaire | n2=en:increased susceptibility to schizophrenia | rel=r_associated | relid=0 | w=5
  2554. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased t2 signal intensities in the middle cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:increased t2 signal intensities in the middle cerebellar peduncles | rel=r_associated | relid=0 | w=5
  2555. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased tone in the upper limbs (occur later)
    n1=hyperaldostéronisme secondaire | n2=en:increased tone in the upper limbs (occur later) | rel=r_associated | relid=0 | w=5
  2556. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:increased white matter abnormalities on t2 signalling (in type iib)
    n1=hyperaldostéronisme secondaire | n2=en:increased white matter abnormalities on t2 signalling (in type iib) | rel=r_associated | relid=0 | w=5
  2557. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:independent walking never achieved
    n1=hyperaldostéronisme secondaire | n2=en:independent walking never achieved | rel=r_associated | relid=0 | w=5
  2558. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:individuals can stand or walk with support by 4 to 6 years of age
    n1=hyperaldostéronisme secondaire | n2=en:individuals can stand or walk with support by 4 to 6 years of age | rel=r_associated | relid=0 | w=5
  2559. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:individuals require less sleep in a 24-hour period compared to age-matched controls
    n1=hyperaldostéronisme secondaire | n2=en:individuals require less sleep in a 24-hour period compared to age-matched controls | rel=r_associated | relid=0 | w=5
  2560. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:indolence
    n1=hyperaldostéronisme secondaire | n2=en:indolence | rel=r_associated | relid=0 | w=5
  2561. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infant and newborn care
    n1=hyperaldostéronisme secondaire | n2=en:infant and newborn care | rel=r_associated | relid=0 | w=5
  2562. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infant and newborn development
    n1=hyperaldostéronisme secondaire | n2=en:infant and newborn development | rel=r_associated | relid=0 | w=5
  2563. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infant and newborn nutrition
    n1=hyperaldostéronisme secondaire | n2=en:infant and newborn nutrition | rel=r_associated | relid=0 | w=5
  2564. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infant irritability
    n1=hyperaldostéronisme secondaire | n2=en:infant irritability | rel=r_associated | relid=0 | w=5
  2565. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:infantile encephalopathy | rel=r_associated | relid=0 | w=5
  2566. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile encephalopathy, progressive
    n1=hyperaldostéronisme secondaire | n2=en:infantile encephalopathy, progressive | rel=r_associated | relid=0 | w=5
  2567. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile hemiplegias
    n1=hyperaldostéronisme secondaire | n2=en:infantile hemiplegias | rel=r_associated | relid=0 | w=5
  2568. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile irritability (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:infantile irritability (if left untreated) | rel=r_associated | relid=0 | w=5
  2569. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile muscular hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:infantile muscular hypotonia | rel=r_associated | relid=0 | w=5
  2570. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile seizures
    n1=hyperaldostéronisme secondaire | n2=en:infantile seizures | rel=r_associated | relid=0 | w=5
  2571. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile seizures (approximately 80% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:infantile seizures (approximately 80% of patients) | rel=r_associated | relid=0 | w=5
  2572. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients) | rel=r_associated | relid=0 | w=5
  2573. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infantile spasm
    n1=hyperaldostéronisme secondaire | n2=en:infantile spasm | rel=r_associated | relid=0 | w=5
  2574. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infarction
    n1=hyperaldostéronisme secondaire | n2=en:infarction | rel=r_associated | relid=0 | w=5
  2575. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inferior olivary nuclei show fetal pattern
    n1=hyperaldostéronisme secondaire | n2=en:inferior olivary nuclei show fetal pattern | rel=r_associated | relid=0 | w=5
  2576. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inferior vermis hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:inferior vermis hypoplasia | rel=r_associated | relid=0 | w=5
  2577. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:inflexible adherence to routines or rituals
    n1=hyperaldostéronisme secondaire | n2=en:inflexible adherence to routines or rituals | rel=r_associated | relid=0 | w=5
  2578. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:infrequent generalized seizures
    n1=hyperaldostéronisme secondaire | n2=en:infrequent generalized seizures | rel=r_associated | relid=0 | w=5
  2579. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:initial hypotonia, followed by spasticity
    n1=hyperaldostéronisme secondaire | n2=en:initial hypotonia, followed by spasticity | rel=r_associated | relid=0 | w=5
  2580. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:initial normal development
    n1=hyperaldostéronisme secondaire | n2=en:initial normal development | rel=r_associated | relid=0 | w=5
  2581. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:insomnia
    n1=hyperaldostéronisme secondaire | n2=en:insomnia | rel=r_associated | relid=0 | w=5
  2582. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:insomnia (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:insomnia (hcp) | rel=r_associated | relid=0 | w=5
  2583. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:insomnia, refractory
    n1=hyperaldostéronisme secondaire | n2=en:insomnia, refractory | rel=r_associated | relid=0 | w=5
  2584. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellect high (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellect high (in some patients) | rel=r_associated | relid=0 | w=5
  2585. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual delay
    n1=hyperaldostéronisme secondaire | n2=en:intellectual delay | rel=r_associated | relid=0 | w=5
  2586. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disabilities (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disabilities (in 1 family) | rel=r_associated | relid=0 | w=5
  2587. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability | rel=r_associated | relid=0 | w=5
  2588. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability (in 1 ashkenazi patient)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability (in 1 ashkenazi patient) | rel=r_associated | relid=0 | w=5
  2589. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability (in most patients) | rel=r_associated | relid=0 | w=5
  2590. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability (in some patients) | rel=r_associated | relid=0 | w=5
  2591. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild (1 patient) | rel=r_associated | relid=0 | w=5
  2592. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild (in some patients) | rel=r_associated | relid=0 | w=5
  2593. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild (uncommon) | rel=r_associated | relid=0 | w=5
  2594. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild to moderate | rel=r_associated | relid=0 | w=5
  2595. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild to moderate (in homozygotes)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild to moderate (in homozygotes) | rel=r_associated | relid=0 | w=5
  2596. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, mild to severe
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, mild to severe | rel=r_associated | relid=0 | w=5
  2597. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, moderate (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, moderate (in some patients) | rel=r_associated | relid=0 | w=5
  2598. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, moderate to severe
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, moderate to severe | rel=r_associated | relid=0 | w=5
  2599. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual disability, progressive
    n1=hyperaldostéronisme secondaire | n2=en:intellectual disability, progressive | rel=r_associated | relid=0 | w=5
  2600. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual function may be high in milder cases
    n1=hyperaldostéronisme secondaire | n2=en:intellectual function may be high in milder cases | rel=r_associated | relid=0 | w=5
  2601. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual impairment (rare)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual impairment (rare) | rel=r_associated | relid=0 | w=5
  2602. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual impairment, mild
    n1=hyperaldostéronisme secondaire | n2=en:intellectual impairment, mild | rel=r_associated | relid=0 | w=5
  2603. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intellectual impairment, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intellectual impairment, mild (in some patients) | rel=r_associated | relid=0 | w=5
  2604. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intention tremor (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:intention tremor (1 patient) | rel=r_associated | relid=0 | w=5
  2605. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intention tremor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intention tremor (in some patients) | rel=r_associated | relid=0 | w=5
  2606. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intention tremor in those who survive
    n1=hyperaldostéronisme secondaire | n2=en:intention tremor in those who survive | rel=r_associated | relid=0 | w=5
  2607. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interhemispheric cysts
    n1=hyperaldostéronisme secondaire | n2=en:interhemispheric cysts | rel=r_associated | relid=0 | w=5
  2608. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interhemispheric lipoma
    n1=hyperaldostéronisme secondaire | n2=en:interhemispheric lipoma | rel=r_associated | relid=0 | w=5
  2609. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal ataxia may occur later in disease course
    n1=hyperaldostéronisme secondaire | n2=en:interictal ataxia may occur later in disease course | rel=r_associated | relid=0 | w=5
  2610. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal dystonia may occur later in disease course
    n1=hyperaldostéronisme secondaire | n2=en:interictal dystonia may occur later in disease course | rel=r_associated | relid=0 | w=5
  2611. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal eeg is usually normal
    n1=hyperaldostéronisme secondaire | n2=en:interictal eeg is usually normal | rel=r_associated | relid=0 | w=5
  2612. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal eeg may be normal or abnormal
    n1=hyperaldostéronisme secondaire | n2=en:interictal eeg may be normal or abnormal | rel=r_associated | relid=0 | w=5
  2613. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal eeg may show nonspecific changes in 15 to 20%
    n1=hyperaldostéronisme secondaire | n2=en:interictal eeg may show nonspecific changes in 15 to 20% | rel=r_associated | relid=0 | w=5
  2614. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal eeg shows 3-4 hz general spike-wave complexes
    n1=hyperaldostéronisme secondaire | n2=en:interictal eeg shows 3-4 hz general spike-wave complexes | rel=r_associated | relid=0 | w=5
  2615. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal neurologic impairment
    n1=hyperaldostéronisme secondaire | n2=en:interictal neurologic impairment | rel=r_associated | relid=0 | w=5
  2616. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interictal periods of normal health
    n1=hyperaldostéronisme secondaire | n2=en:interictal periods of normal health | rel=r_associated | relid=0 | w=5
  2617. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intermittent episodes associated with lethargy, vomiting
    n1=hyperaldostéronisme secondaire | n2=en:intermittent episodes associated with lethargy, vomiting | rel=r_associated | relid=0 | w=5
  2618. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intermittent migraine headaches
    n1=hyperaldostéronisme secondaire | n2=en:intermittent migraine headaches | rel=r_associated | relid=0 | w=5
  2619. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intermittent wheelchair dependence (stage 3)
    n1=hyperaldostéronisme secondaire | n2=en:intermittent wheelchair dependence (stage 3) | rel=r_associated | relid=0 | w=5
  2620. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intermittent, transient episodes of worsening of ataxia
    n1=hyperaldostéronisme secondaire | n2=en:intermittent, transient episodes of worsening of ataxia | rel=r_associated | relid=0 | w=5
  2621. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:internet safety
    n1=hyperaldostéronisme secondaire | n2=en:internet safety | rel=r_associated | relid=0 | w=5
  2622. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interosseus muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:interosseus muscle atrophy | rel=r_associated | relid=0 | w=5
  2623. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:interventricular cysts
    n1=hyperaldostéronisme secondaire | n2=en:interventricular cysts | rel=r_associated | relid=0 | w=5
  2624. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis
    n1=hyperaldostéronisme secondaire | n2=en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=5
  2625. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis
    n1=hyperaldostéronisme secondaire | n2=en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=5
  2626. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis
    n1=hyperaldostéronisme secondaire | n2=en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=5
  2627. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracellular lewy bodies
    n1=hyperaldostéronisme secondaire | n2=en:intracellular lewy bodies | rel=r_associated | relid=0 | w=5
  2628. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies)
    n1=hyperaldostéronisme secondaire | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) | rel=r_associated | relid=0 | w=5
  2629. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracerebral calcifications (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intracerebral calcifications (in some patients) | rel=r_associated | relid=0 | w=5
  2630. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracerebral cysts (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intracerebral cysts (in some patients) | rel=r_associated | relid=0 | w=5
  2631. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracerebral periventricular calcifications
    n1=hyperaldostéronisme secondaire | n2=en:intracerebral periventricular calcifications | rel=r_associated | relid=0 | w=5
  2632. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial bleeding (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:intracranial bleeding (1 patient) | rel=r_associated | relid=0 | w=5
  2633. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcification affecting the basal ganglia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcification affecting the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=5
  2634. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcification by x-ray or ct
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcification by x-ray or ct | rel=r_associated | relid=0 | w=5
  2635. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcifications (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcifications (1 patient) | rel=r_associated | relid=0 | w=5
  2636. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcifications (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcifications (in some patients) | rel=r_associated | relid=0 | w=5
  2637. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcifications in the anterior mesial temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcifications in the anterior mesial temporal lobes | rel=r_associated | relid=0 | w=5
  2638. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus
    n1=hyperaldostéronisme secondaire | n2=en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus | rel=r_associated | relid=0 | w=5
  2639. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial cysts
    n1=hyperaldostéronisme secondaire | n2=en:intracranial cysts | rel=r_associated | relid=0 | w=5
  2640. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:intracranial hemorrhage | rel=r_associated | relid=0 | w=5
  2641. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial hypertension
    n1=hyperaldostéronisme secondaire | n2=en:intracranial hypertension | rel=r_associated | relid=0 | w=5
  2642. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial lipoma (cerebello-pontine)
    n1=hyperaldostéronisme secondaire | n2=en:intracranial lipoma (cerebello-pontine) | rel=r_associated | relid=0 | w=5
  2643. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intracranial thin-walled sinusoidal vessel (cavernous) malformations
    n1=hyperaldostéronisme secondaire | n2=en:intracranial thin-walled sinusoidal vessel (cavernous) malformations | rel=r_associated | relid=0 | w=5
  2644. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intractable epilepsy
    n1=hyperaldostéronisme secondaire | n2=en:intractable epilepsy | rel=r_associated | relid=0 | w=5
  2645. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intraneuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:intraneuronal inclusions | rel=r_associated | relid=0 | w=5
  2646. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intraparenchymal brain hemorrhage, multifocal
    n1=hyperaldostéronisme secondaire | n2=en:intraparenchymal brain hemorrhage, multifocal | rel=r_associated | relid=0 | w=5
  2647. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:intraspinal neoplasm
    n1=hyperaldostéronisme secondaire | n2=en:intraspinal neoplasm | rel=r_associated | relid=0 | w=5
  2648. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary and nonvolitional phenomenon
    n1=hyperaldostéronisme secondaire | n2=en:involuntary and nonvolitional phenomenon | rel=r_associated | relid=0 | w=5
  2649. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary dystonic or choreiform movements
    n1=hyperaldostéronisme secondaire | n2=en:involuntary dystonic or choreiform movements | rel=r_associated | relid=0 | w=5
  2650. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary jerking movements
    n1=hyperaldostéronisme secondaire | n2=en:involuntary jerking movements | rel=r_associated | relid=0 | w=5
  2651. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary movement and habit disorder
    n1=hyperaldostéronisme secondaire | n2=en:involuntary movement and habit disorder | rel=r_associated | relid=0 | w=5
  2652. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary movements
    n1=hyperaldostéronisme secondaire | n2=en:involuntary movements | rel=r_associated | relid=0 | w=5
  2653. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary movements may be precipitated by exertion or anxiety
    n1=hyperaldostéronisme secondaire | n2=en:involuntary movements may be precipitated by exertion or anxiety | rel=r_associated | relid=0 | w=5
  2654. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary movements of extremities, neck, trunk, and/or face
    n1=hyperaldostéronisme secondaire | n2=en:involuntary movements of extremities, neck, trunk, and/or face | rel=r_associated | relid=0 | w=5
  2655. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary movements, asymmetric
    n1=hyperaldostéronisme secondaire | n2=en:involuntary movements, asymmetric | rel=r_associated | relid=0 | w=5
  2656. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary repetitive movements
    n1=hyperaldostéronisme secondaire | n2=en:involuntary repetitive movements | rel=r_associated | relid=0 | w=5
  2657. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers
    n1=hyperaldostéronisme secondaire | n2=en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers | rel=r_associated | relid=0 | w=5
  2658. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities
    n1=hyperaldostéronisme secondaire | n2=en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities | rel=r_associated | relid=0 | w=5
  2659. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:involuntary writhing movements
    n1=hyperaldostéronisme secondaire | n2=en:involuntary writhing movements | rel=r_associated | relid=0 | w=5
  2660. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ipsilateral brain hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:ipsilateral brain hypoplasia | rel=r_associated | relid=0 | w=5
  2661. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ipsilateral cranial nerve hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:ipsilateral cranial nerve hypoplasia | rel=r_associated | relid=0 | w=5
  2662. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iq 85-115 (female)
    n1=hyperaldostéronisme secondaire | n2=en:iq 85-115 (female) | rel=r_associated | relid=0 | w=5
  2663. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron accumulation in the basal ganglia seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:iron accumulation in the basal ganglia seen on mri | rel=r_associated | relid=0 | w=5
  2664. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron accumulation in the globus pallidus and substantia nigra seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:iron accumulation in the globus pallidus and substantia nigra seen on mri | rel=r_associated | relid=0 | w=5
  2665. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron deposition in pallidal nuclei
    n1=hyperaldostéronisme secondaire | n2=en:iron deposition in pallidal nuclei | rel=r_associated | relid=0 | w=5
  2666. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron deposition in the basal ganglia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:iron deposition in the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=5
  2667. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron deposition in the globus pallidus (variable)
    n1=hyperaldostéronisme secondaire | n2=en:iron deposition in the globus pallidus (variable) | rel=r_associated | relid=0 | w=5
  2668. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron deposition in the globus pallidus and substantia nigra seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:iron deposition in the globus pallidus and substantia nigra seen on mri | rel=r_associated | relid=0 | w=5
  2669. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron deposits in the globus pallidus, caudate, and substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:iron deposits in the globus pallidus, caudate, and substantia nigra | rel=r_associated | relid=0 | w=5
  2670. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iron-containing deposits in various brain regions
    n1=hyperaldostéronisme secondaire | n2=en:iron-containing deposits in various brain regions | rel=r_associated | relid=0 | w=5
  2671. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irregular cortical ribbon
    n1=hyperaldostéronisme secondaire | n2=en:irregular cortical ribbon | rel=r_associated | relid=0 | w=5
  2672. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irregular folding of the cortex
    n1=hyperaldostéronisme secondaire | n2=en:irregular folding of the cortex | rel=r_associated | relid=0 | w=5
  2673. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irregular spike and slow waves
    n1=hyperaldostéronisme secondaire | n2=en:irregular spike and slow waves | rel=r_associated | relid=0 | w=5
  2674. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irresistible desire to move the legs
    n1=hyperaldostéronisme secondaire | n2=en:irresistible desire to move the legs | rel=r_associated | relid=0 | w=5
  2675. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irritability (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:irritability (in 1 family) | rel=r_associated | relid=0 | w=5
  2676. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irritability beginning at puberty
    n1=hyperaldostéronisme secondaire | n2=en:irritability beginning at puberty | rel=r_associated | relid=0 | w=5
  2677. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:irritation
    n1=hyperaldostéronisme secondaire | n2=en:irritation | rel=r_associated | relid=0 | w=5
  2678. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic cerebrovascular accident
    n1=hyperaldostéronisme secondaire | n2=en:ischemic cerebrovascular accident | rel=r_associated | relid=0 | w=5
  2679. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic infarct of brain
    n1=hyperaldostéronisme secondaire | n2=en:ischemic infarct of brain | rel=r_associated | relid=0 | w=5
  2680. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic infarction (rare)
    n1=hyperaldostéronisme secondaire | n2=en:ischemic infarction (rare) | rel=r_associated | relid=0 | w=5
  2681. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic necrotic lesions
    n1=hyperaldostéronisme secondaire | n2=en:ischemic necrotic lesions | rel=r_associated | relid=0 | w=5
  2682. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic stroke (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ischemic stroke (in some patients) | rel=r_associated | relid=0 | w=5
  2683. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ischemic stroke in the basal ganglia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:ischemic stroke in the basal ganglia (rare) | rel=r_associated | relid=0 | w=5
  2684. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:isolated absence of pain sensation
    n1=hyperaldostéronisme secondaire | n2=en:isolated absence of pain sensation | rel=r_associated | relid=0 | w=5
  2685. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:isolated focal dystonia may occur
    n1=hyperaldostéronisme secondaire | n2=en:isolated focal dystonia may occur | rel=r_associated | relid=0 | w=5
  2686. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:iterations
    n1=hyperaldostéronisme secondaire | n2=en:iterations | rel=r_associated | relid=0 | w=5
  2687. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jacksonian seizure
    n1=hyperaldostéronisme secondaire | n2=en:jacksonian seizure | rel=r_associated | relid=0 | w=5
  2688. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerk-locked premyoclonus spikes
    n1=hyperaldostéronisme secondaire | n2=en:jerk-locked premyoclonus spikes | rel=r_associated | relid=0 | w=5
  2689. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like
    n1=hyperaldostéronisme secondaire | n2=en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like | rel=r_associated | relid=0 | w=5
  2690. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerking movements
    n1=hyperaldostéronisme secondaire | n2=en:jerking movements | rel=r_associated | relid=0 | w=5
  2691. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerky head movements
    n1=hyperaldostéronisme secondaire | n2=en:jerky head movements | rel=r_associated | relid=0 | w=5
  2692. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerky limb movements
    n1=hyperaldostéronisme secondaire | n2=en:jerky limb movements | rel=r_associated | relid=0 | w=5
  2693. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:jerky movements in infancy
    n1=hyperaldostéronisme secondaire | n2=en:jerky movements in infancy | rel=r_associated | relid=0 | w=5
  2694. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:joubert syndrome
    n1=hyperaldostéronisme secondaire | n2=en:joubert syndrome | rel=r_associated | relid=0 | w=5
  2695. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:juvenile rheumatoid arthritis
    n1=hyperaldostéronisme secondaire | n2=en:juvenile rheumatoid arthritis | rel=r_associated | relid=0 | w=5
  2696. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:kearns-sayre syndrome (530000), in a subset of patients
    n1=hyperaldostéronisme secondaire | n2=en:kearns-sayre syndrome (530000), in a subset of patients | rel=r_associated | relid=0 | w=5
  2697. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:kernicterus
    n1=hyperaldostéronisme secondaire | n2=en:kernicterus | rel=r_associated | relid=0 | w=5
  2698. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:kluver-bucy syndrome
    n1=hyperaldostéronisme secondaire | n2=en:kluver-bucy syndrome | rel=r_associated | relid=0 | w=5
  2699. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:knee and ankle clonus
    n1=hyperaldostéronisme secondaire | n2=en:knee and ankle clonus | rel=r_associated | relid=0 | w=5
  2700. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of bunina bodies
    n1=hyperaldostéronisme secondaire | n2=en:lack of bunina bodies | rel=r_associated | relid=0 | w=5
  2701. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of communication
    n1=hyperaldostéronisme secondaire | n2=en:lack of communication | rel=r_associated | relid=0 | w=5
  2702. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of development
    n1=hyperaldostéronisme secondaire | n2=en:lack of development | rel=r_associated | relid=0 | w=5
  2703. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of developmental development
    n1=hyperaldostéronisme secondaire | n2=en:lack of developmental development | rel=r_associated | relid=0 | w=5
  2704. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of developmental milestones
    n1=hyperaldostéronisme secondaire | n2=en:lack of developmental milestones | rel=r_associated | relid=0 | w=5
  2705. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of ependymal cells
    n1=hyperaldostéronisme secondaire | n2=en:lack of ependymal cells | rel=r_associated | relid=0 | w=5
  2706. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of expressive speech
    n1=hyperaldostéronisme secondaire | n2=en:lack of expressive speech | rel=r_associated | relid=0 | w=5
  2707. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of head control
    n1=hyperaldostéronisme secondaire | n2=en:lack of head control | rel=r_associated | relid=0 | w=5
  2708. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of head or postural control (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:lack of head or postural control (in severe cases) | rel=r_associated | relid=0 | w=5
  2709. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of independent ambulation
    n1=hyperaldostéronisme secondaire | n2=en:lack of independent ambulation | rel=r_associated | relid=0 | w=5
  2710. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of independent ambulation (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:lack of independent ambulation (1 patient) | rel=r_associated | relid=0 | w=5
  2711. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of independent sitting or walking
    n1=hyperaldostéronisme secondaire | n2=en:lack of independent sitting or walking | rel=r_associated | relid=0 | w=5
  2712. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of independent walking (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:lack of independent walking (in some patients) | rel=r_associated | relid=0 | w=5
  2713. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of inflammatory infiltrate
    n1=hyperaldostéronisme secondaire | n2=en:lack of inflammatory infiltrate | rel=r_associated | relid=0 | w=5
  2714. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of insight
    n1=hyperaldostéronisme secondaire | n2=en:lack of insight | rel=r_associated | relid=0 | w=5
  2715. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of motor development
    n1=hyperaldostéronisme secondaire | n2=en:lack of motor development | rel=r_associated | relid=0 | w=5
  2716. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of motor development (wws)
    n1=hyperaldostéronisme secondaire | n2=en:lack of motor development (wws) | rel=r_associated | relid=0 | w=5
  2717. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of motor milestones
    n1=hyperaldostéronisme secondaire | n2=en:lack of motor milestones | rel=r_associated | relid=0 | w=5
  2718. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of neurologic development
    n1=hyperaldostéronisme secondaire | n2=en:lack of neurologic development | rel=r_associated | relid=0 | w=5
  2719. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of peer relationships
    n1=hyperaldostéronisme secondaire | n2=en:lack of peer relationships | rel=r_associated | relid=0 | w=5
  2720. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of psychomotor development (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:lack of psychomotor development (1 patient) | rel=r_associated | relid=0 | w=5
  2721. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of psychomotor development (severe connatal form)
    n1=hyperaldostéronisme secondaire | n2=en:lack of psychomotor development (severe connatal form) | rel=r_associated | relid=0 | w=5
  2722. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of skein-like inclusions
    n1=hyperaldostéronisme secondaire | n2=en:lack of skein-like inclusions | rel=r_associated | relid=0 | w=5
  2723. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech (in severe cases) | rel=r_associated | relid=0 | w=5
  2724. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech acquisition
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech acquisition | rel=r_associated | relid=0 | w=5
  2725. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech development
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech development | rel=r_associated | relid=0 | w=5
  2726. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech development (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech development (some patients) | rel=r_associated | relid=0 | w=5
  2727. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech or only a few words
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech or only a few words | rel=r_associated | relid=0 | w=5
  2728. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of speech or poor speech
    n1=hyperaldostéronisme secondaire | n2=en:lack of speech or poor speech | rel=r_associated | relid=0 | w=5
  2729. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of spontaneous movement
    n1=hyperaldostéronisme secondaire | n2=en:lack of spontaneous movement | rel=r_associated | relid=0 | w=5
  2730. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of spontaneous play
    n1=hyperaldostéronisme secondaire | n2=en:lack of spontaneous play | rel=r_associated | relid=0 | w=5
  2731. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of upper motor neuron signs
    n1=hyperaldostéronisme secondaire | n2=en:lack of upper motor neuron signs | rel=r_associated | relid=0 | w=5
  2732. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of verbal communication
    n1=hyperaldostéronisme secondaire | n2=en:lack of verbal communication | rel=r_associated | relid=0 | w=5
  2733. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lack of volitional movement
    n1=hyperaldostéronisme secondaire | n2=en:lack of volitional movement | rel=r_associated | relid=0 | w=5
  2734. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lacunar infarcts develop after age 40 years
    n1=hyperaldostéronisme secondaire | n2=en:lacunar infarcts develop after age 40 years | rel=r_associated | relid=0 | w=5
  2735. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging
    n1=hyperaldostéronisme secondaire | n2=en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging | rel=r_associated | relid=0 | w=5
  2736. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:laminar necrosis
    n1=hyperaldostéronisme secondaire | n2=en:laminar necrosis | rel=r_associated | relid=0 | w=5
  2737. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language acquisition difficulties (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:language acquisition difficulties (in some patients) | rel=r_associated | relid=0 | w=5
  2738. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language delay
    n1=hyperaldostéronisme secondaire | n2=en:language delay | rel=r_associated | relid=0 | w=5
  2739. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language delay (55%)
    n1=hyperaldostéronisme secondaire | n2=en:language delay (55%) | rel=r_associated | relid=0 | w=5
  2740. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language delay/disorder
    n1=hyperaldostéronisme secondaire | n2=en:language delay/disorder | rel=r_associated | relid=0 | w=5
  2741. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language development limited to a few words
    n1=hyperaldostéronisme secondaire | n2=en:language development limited to a few words | rel=r_associated | relid=0 | w=5
  2742. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:language disorder
    n1=hyperaldostéronisme secondaire | n2=en:language disorder | rel=r_associated | relid=0 | w=5
  2743. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:large basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:large basal ganglia | rel=r_associated | relid=0 | w=5
  2744. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:large cavum vergae
    n1=hyperaldostéronisme secondaire | n2=en:large cavum vergae | rel=r_associated | relid=0 | w=5
  2745. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:large cerebellum, progressive
    n1=hyperaldostéronisme secondaire | n2=en:large cerebellum, progressive | rel=r_associated | relid=0 | w=5
  2746. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:large sella turcica
    n1=hyperaldostéronisme secondaire | n2=en:large sella turcica | rel=r_associated | relid=0 | w=5
  2747. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:large subcortical cysts in frontal and temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:large subcortical cysts in frontal and temporal lobes | rel=r_associated | relid=0 | w=5
  2748. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:late ambulation
    n1=hyperaldostéronisme secondaire | n2=en:late ambulation | rel=r_associated | relid=0 | w=5
  2749. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:late diaphragmatic involvement
    n1=hyperaldostéronisme secondaire | n2=en:late diaphragmatic involvement | rel=r_associated | relid=0 | w=5
  2750. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:late-onset spinocerebellar degeneration
    n1=hyperaldostéronisme secondaire | n2=en:late-onset spinocerebellar degeneration | rel=r_associated | relid=0 | w=5
  2751. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lateral corticospinal tracts show atrophy, pallor, and degeneration
    n1=hyperaldostéronisme secondaire | n2=en:lateral corticospinal tracts show atrophy, pallor, and degeneration | rel=r_associated | relid=0 | w=5
  2752. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lead poisoning
    n1=hyperaldostéronisme secondaire | n2=en:lead poisoning | rel=r_associated | relid=0 | w=5
  2753. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning and developmental delay (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:learning and developmental delay (in some patients) | rel=r_associated | relid=0 | w=5
  2754. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties | rel=r_associated | relid=0 | w=5
  2755. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties (in 1 patient) | rel=r_associated | relid=0 | w=5
  2756. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties (in some patients) | rel=r_associated | relid=0 | w=5
  2757. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties (less common)
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties (less common) | rel=r_associated | relid=0 | w=5
  2758. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties (seen in recessive form)
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties (seen in recessive form) | rel=r_associated | relid=0 | w=5
  2759. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties in affected females
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties in affected females | rel=r_associated | relid=0 | w=5
  2760. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning difficulties, mild (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:learning difficulties, mild (1 family) | rel=r_associated | relid=0 | w=5
  2761. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities | rel=r_associated | relid=0 | w=5
  2762. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (1 family) | rel=r_associated | relid=0 | w=5
  2763. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (30%)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (30%) | rel=r_associated | relid=0 | w=5
  2764. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (in females)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (in females) | rel=r_associated | relid=0 | w=5
  2765. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (in some patients) | rel=r_associated | relid=0 | w=5
  2766. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (in some)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (in some) | rel=r_associated | relid=0 | w=5
  2767. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities (major)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities (major) | rel=r_associated | relid=0 | w=5
  2768. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disabilities, mild (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:learning disabilities, mild (some patients) | rel=r_associated | relid=0 | w=5
  2769. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disability (90% patients)
    n1=hyperaldostéronisme secondaire | n2=en:learning disability (90% patients) | rel=r_associated | relid=0 | w=5
  2770. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disability (early in life)
    n1=hyperaldostéronisme secondaire | n2=en:learning disability (early in life) | rel=r_associated | relid=0 | w=5
  2771. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning disorder
    n1=hyperaldostéronisme secondaire | n2=en:learning disorder | rel=r_associated | relid=0 | w=5
  2772. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:learning problems
    n1=hyperaldostéronisme secondaire | n2=en:learning problems | rel=r_associated | relid=0 | w=5
  2773. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leg cramp
    n1=hyperaldostéronisme secondaire | n2=en:leg cramp | rel=r_associated | relid=0 | w=5
  2774. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leg pain
    n1=hyperaldostéronisme secondaire | n2=en:leg pain | rel=r_associated | relid=0 | w=5
  2775. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leg stiffness
    n1=hyperaldostéronisme secondaire | n2=en:leg stiffness | rel=r_associated | relid=0 | w=5
  2776. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leigh disease
    n1=hyperaldostéronisme secondaire | n2=en:leigh disease | rel=r_associated | relid=0 | w=5
  2777. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leigh syndrome (245000), in a subset of patients
    n1=hyperaldostéronisme secondaire | n2=en:leigh syndrome (245000), in a subset of patients | rel=r_associated | relid=0 | w=5
  2778. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leigh syndrome (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:leigh syndrome (in some patients) | rel=r_associated | relid=0 | w=5
  2779. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leptomeningeal melanocytosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:leptomeningeal melanocytosis (in some patients) | rel=r_associated | relid=0 | w=5
  2780. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leptomeningeal thickening
    n1=hyperaldostéronisme secondaire | n2=en:leptomeningeal thickening | rel=r_associated | relid=0 | w=5
  2781. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions are symmetrical
    n1=hyperaldostéronisme secondaire | n2=en:lesions are symmetrical | rel=r_associated | relid=0 | w=5
  2782. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation
    n1=hyperaldostéronisme secondaire | n2=en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | rel=r_associated | relid=0 | w=5
  2783. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord | rel=r_associated | relid=0 | w=5
  2784. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation
    n1=hyperaldostéronisme secondaire | n2=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | rel=r_associated | relid=0 | w=5
  2785. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in the anterior pituitary (less common)
    n1=hyperaldostéronisme secondaire | n2=en:lesions in the anterior pituitary (less common) | rel=r_associated | relid=0 | w=5
  2786. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:lesions in the basal ganglia | rel=r_associated | relid=0 | w=5
  2787. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in the caudate and putamen
    n1=hyperaldostéronisme secondaire | n2=en:lesions in the caudate and putamen | rel=r_associated | relid=0 | w=5
  2788. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in the caudate and putamen seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:lesions in the caudate and putamen seen on mri | rel=r_associated | relid=0 | w=5
  2789. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions in the internal capsule after age 40 years
    n1=hyperaldostéronisme secondaire | n2=en:lesions in the internal capsule after age 40 years | rel=r_associated | relid=0 | w=5
  2790. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lesions show signal increase on t2- and signal decrease on t1-weighted images
    n1=hyperaldostéronisme secondaire | n2=en:lesions show signal increase on t2- and signal decrease on t1-weighted images | rel=r_associated | relid=0 | w=5
  2791. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lethargy
    n1=hyperaldostéronisme secondaire | n2=en:lethargy | rel=r_associated | relid=0 | w=5
  2792. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lethargy (when taken off of medication)
    n1=hyperaldostéronisme secondaire | n2=en:lethargy (when taken off of medication) | rel=r_associated | relid=0 | w=5
  2793. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lethargy associated with hypoglycemia
    n1=hyperaldostéronisme secondaire | n2=en:lethargy associated with hypoglycemia | rel=r_associated | relid=0 | w=5
  2794. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lethargy, neonatal
    n1=hyperaldostéronisme secondaire | n2=en:lethargy, neonatal | rel=r_associated | relid=0 | w=5
  2795. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoaraiosis
    n1=hyperaldostéronisme secondaire | n2=en:leukoaraiosis | rel=r_associated | relid=0 | w=5
  2796. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy | rel=r_associated | relid=0 | w=5
  2797. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy (in 1 of 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
  2798. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy (in some patients) | rel=r_associated | relid=0 | w=5
  2799. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy and white matter changes, which improve with age
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy and white matter changes, which improve with age | rel=r_associated | relid=0 | w=5
  2800. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy, demyelinating
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy, demyelinating | rel=r_associated | relid=0 | w=5
  2801. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukodystrophy, hypomyelinating
    n1=hyperaldostéronisme secondaire | n2=en:leukodystrophy, hypomyelinating | rel=r_associated | relid=0 | w=5
  2802. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:leukoencephalopathy | rel=r_associated | relid=0 | w=5
  2803. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoencephalopathy in the frontal and parietal lobes (later)
    n1=hyperaldostéronisme secondaire | n2=en:leukoencephalopathy in the frontal and parietal lobes (later) | rel=r_associated | relid=0 | w=5
  2804. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts
    n1=hyperaldostéronisme secondaire | n2=en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts | rel=r_associated | relid=0 | w=5
  2805. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoencephalopathy on ct and mri
    n1=hyperaldostéronisme secondaire | n2=en:leukoencephalopathy on ct and mri | rel=r_associated | relid=0 | w=5
  2806. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukoencephalopathy, severe
    n1=hyperaldostéronisme secondaire | n2=en:leukoencephalopathy, severe | rel=r_associated | relid=0 | w=5
  2807. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:leukomalacia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:leukomalacia (rare) | rel=r_associated | relid=0 | w=5
  2808. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lewy bodies
    n1=hyperaldostéronisme secondaire | n2=en:lewy bodies | rel=r_associated | relid=0 | w=5
  2809. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lewy bodies (not always present)
    n1=hyperaldostéronisme secondaire | n2=en:lewy bodies (not always present) | rel=r_associated | relid=0 | w=5
  2810. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lewy bodies in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:lewy bodies in the substantia nigra | rel=r_associated | relid=0 | w=5
  2811. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lewy bodies throughout the brain
    n1=hyperaldostéronisme secondaire | n2=en:lewy bodies throughout the brain | rel=r_associated | relid=0 | w=5
  2812. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lewy body dementia
    n1=hyperaldostéronisme secondaire | n2=en:lewy body dementia | rel=r_associated | relid=0 | w=5
  2813. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:light-induced sneezing
    n1=hyperaldostéronisme secondaire | n2=en:light-induced sneezing | rel=r_associated | relid=0 | w=5
  2814. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lightheadedness
    n1=hyperaldostéronisme secondaire | n2=en:lightheadedness | rel=r_associated | relid=0 | w=5
  2815. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb ataxia, progressive
    n1=hyperaldostéronisme secondaire | n2=en:limb ataxia, progressive | rel=r_associated | relid=0 | w=5
  2816. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb dysmetria
    n1=hyperaldostéronisme secondaire | n2=en:limb dysmetria | rel=r_associated | relid=0 | w=5
  2817. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb dystonia
    n1=hyperaldostéronisme secondaire | n2=en:limb dystonia | rel=r_associated | relid=0 | w=5
  2818. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb dystonia (18%)
    n1=hyperaldostéronisme secondaire | n2=en:limb dystonia (18%) | rel=r_associated | relid=0 | w=5
  2819. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb fasciculations
    n1=hyperaldostéronisme secondaire | n2=en:limb fasciculations | rel=r_associated | relid=0 | w=5
  2820. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:limb hypertonia | rel=r_associated | relid=0 | w=5
  2821. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb hypertonia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:limb hypertonia (in some patients) | rel=r_associated | relid=0 | w=5
  2822. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb incoordination (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:limb incoordination (in some patients) | rel=r_associated | relid=0 | w=5
  2823. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb muscle stiffness is often asymmetric
    n1=hyperaldostéronisme secondaire | n2=en:limb muscle stiffness is often asymmetric | rel=r_associated | relid=0 | w=5
  2824. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb muscle weakness (distal greater than proximal)
    n1=hyperaldostéronisme secondaire | n2=en:limb muscle weakness (distal greater than proximal) | rel=r_associated | relid=0 | w=5
  2825. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb posturing (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:limb posturing (if left untreated) | rel=r_associated | relid=0 | w=5
  2826. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limb spasticity
    n1=hyperaldostéronisme secondaire | n2=en:limb spasticity | rel=r_associated | relid=0 | w=5
  2827. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limbic malformations
    n1=hyperaldostéronisme secondaire | n2=en:limbic malformations | rel=r_associated | relid=0 | w=5
  2828. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limited expressive language
    n1=hyperaldostéronisme secondaire | n2=en:limited expressive language | rel=r_associated | relid=0 | w=5
  2829. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limited memory, attention, language
    n1=hyperaldostéronisme secondaire | n2=en:limited memory, attention, language | rel=r_associated | relid=0 | w=5
  2830. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limited social interactions
    n1=hyperaldostéronisme secondaire | n2=en:limited social interactions | rel=r_associated | relid=0 | w=5
  2831. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limited verbal comprehension
    n1=hyperaldostéronisme secondaire | n2=en:limited verbal comprehension | rel=r_associated | relid=0 | w=5
  2832. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:limited walking ability
    n1=hyperaldostéronisme secondaire | n2=en:limited walking ability | rel=r_associated | relid=0 | w=5
  2833. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lingual-facial-buccal dyskinesia
    n1=hyperaldostéronisme secondaire | n2=en:lingual-facial-buccal dyskinesia | rel=r_associated | relid=0 | w=5
  2834. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lipoma, anterior sacral
    n1=hyperaldostéronisme secondaire | n2=en:lipoma, anterior sacral | rel=r_associated | relid=0 | w=5
  2835. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lipomyelocystoceles
    n1=hyperaldostéronisme secondaire | n2=en:lipomyelocystoceles | rel=r_associated | relid=0 | w=5
  2836. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lissencephaly
    n1=hyperaldostéronisme secondaire | n2=en:lissencephaly | rel=r_associated | relid=0 | w=5
  2837. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions)
    n1=hyperaldostéronisme secondaire | n2=en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions) | rel=r_associated | relid=0 | w=5
  2838. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions)
    n1=hyperaldostéronisme secondaire | n2=en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions) | rel=r_associated | relid=0 | w=5
  2839. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lissencephaly (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:lissencephaly (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  2840. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lissencephaly, posterior to anterior gradient
    n1=hyperaldostéronisme secondaire | n2=en:lissencephaly, posterior to anterior gradient | rel=r_associated | relid=0 | w=5
  2841. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:little or no speech acquisition
    n1=hyperaldostéronisme secondaire | n2=en:little or no speech acquisition | rel=r_associated | relid=0 | w=5
  2842. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:little polarity in remaining neurons
    n1=hyperaldostéronisme secondaire | n2=en:little polarity in remaining neurons | rel=r_associated | relid=0 | w=5
  2843. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:little spontaneous limb movement
    n1=hyperaldostéronisme secondaire | n2=en:little spontaneous limb movement | rel=r_associated | relid=0 | w=5
  2844. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:little spontaneous movement
    n1=hyperaldostéronisme secondaire | n2=en:little spontaneous movement | rel=r_associated | relid=0 | w=5
  2845. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lobar holoprosencephalies
    n1=hyperaldostéronisme secondaire | n2=en:lobar holoprosencephalies | rel=r_associated | relid=0 | w=5
  2846. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles
    n1=hyperaldostéronisme secondaire | n2=en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles | rel=r_associated | relid=0 | w=5
  2847. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:locomotor delay (early-onset form)
    n1=hyperaldostéronisme secondaire | n2=en:locomotor delay (early-onset form) | rel=r_associated | relid=0 | w=5
  2848. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:long perforating arteries of the brain are affected
    n1=hyperaldostéronisme secondaire | n2=en:long perforating arteries of the brain are affected | rel=r_associated | relid=0 | w=5
  2849. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:long-tract signs
    n1=hyperaldostéronisme secondaire | n2=en:long-tract signs | rel=r_associated | relid=0 | w=5
  2850. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:long, thickened cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:long, thickened cerebellar peduncles | rel=r_associated | relid=0 | w=5
  2851. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of ability to walk
    n1=hyperaldostéronisme secondaire | n2=en:loss of ability to walk | rel=r_associated | relid=0 | w=5
  2852. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of ability to walk in first decade
    n1=hyperaldostéronisme secondaire | n2=en:loss of ability to walk in first decade | rel=r_associated | relid=0 | w=5
  2853. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of ability to walk later
    n1=hyperaldostéronisme secondaire | n2=en:loss of ability to walk later | rel=r_associated | relid=0 | w=5
  2854. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of ambulation
    n1=hyperaldostéronisme secondaire | n2=en:loss of ambulation | rel=r_associated | relid=0 | w=5
  2855. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of ankle reflexes
    n1=hyperaldostéronisme secondaire | n2=en:loss of ankle reflexes | rel=r_associated | relid=0 | w=5
  2856. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of anterior horn cells and gliosis in the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:loss of anterior horn cells and gliosis in the spinal cord | rel=r_associated | relid=0 | w=5
  2857. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of any acquired abilities in early childhood
    n1=hyperaldostéronisme secondaire | n2=en:loss of any acquired abilities in early childhood | rel=r_associated | relid=0 | w=5
  2858. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of attention
    n1=hyperaldostéronisme secondaire | n2=en:loss of attention | rel=r_associated | relid=0 | w=5
  2859. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of balance may occur
    n1=hyperaldostéronisme secondaire | n2=en:loss of balance may occur | rel=r_associated | relid=0 | w=5
  2860. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of cerebellar granular cells
    n1=hyperaldostéronisme secondaire | n2=en:loss of cerebellar granular cells | rel=r_associated | relid=0 | w=5
  2861. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of cerebellar purkinje cells
    n1=hyperaldostéronisme secondaire | n2=en:loss of cerebellar purkinje cells | rel=r_associated | relid=0 | w=5
  2862. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of cerebral white matter (in 1 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:loss of cerebral white matter (in 1 of 3 patients) | rel=r_associated | relid=0 | w=5
  2863. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of consciousness
    n1=hyperaldostéronisme secondaire | n2=en:loss of consciousness | rel=r_associated | relid=0 | w=5
  2864. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of consciousness (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:loss of consciousness (1 patient) | rel=r_associated | relid=0 | w=5
  2865. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of coordination
    n1=hyperaldostéronisme secondaire | n2=en:loss of coordination | rel=r_associated | relid=0 | w=5
  2866. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of deep tendon reflexes (later)
    n1=hyperaldostéronisme secondaire | n2=en:loss of deep tendon reflexes (later) | rel=r_associated | relid=0 | w=5
  2867. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of developmental milestones
    n1=hyperaldostéronisme secondaire | n2=en:loss of developmental milestones | rel=r_associated | relid=0 | w=5
  2868. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of dopaminergic neurons
    n1=hyperaldostéronisme secondaire | n2=en:loss of dopaminergic neurons | rel=r_associated | relid=0 | w=5
  2869. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of dopaminergic neurons in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:loss of dopaminergic neurons in the substantia nigra | rel=r_associated | relid=0 | w=5
  2870. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of dorsal root ganglion cells
    n1=hyperaldostéronisme secondaire | n2=en:loss of dorsal root ganglion cells | rel=r_associated | relid=0 | w=5
  2871. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of executive functions
    n1=hyperaldostéronisme secondaire | n2=en:loss of executive functions | rel=r_associated | relid=0 | w=5
  2872. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of fine motor skills
    n1=hyperaldostéronisme secondaire | n2=en:loss of fine motor skills | rel=r_associated | relid=0 | w=5
  2873. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of gait (in some)
    n1=hyperaldostéronisme secondaire | n2=en:loss of gait (in some) | rel=r_associated | relid=0 | w=5
  2874. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus
    n1=hyperaldostéronisme secondaire | n2=en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus | rel=r_associated | relid=0 | w=5
  2875. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of independent ambulation
    n1=hyperaldostéronisme secondaire | n2=en:loss of independent ambulation | rel=r_associated | relid=0 | w=5
  2876. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of independent ambulation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:loss of independent ambulation (in some patients) | rel=r_associated | relid=0 | w=5
  2877. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of independent ambulation approximately 30 years after onset
    n1=hyperaldostéronisme secondaire | n2=en:loss of independent ambulation approximately 30 years after onset | rel=r_associated | relid=0 | w=5
  2878. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of independent ambulation by age 10 years
    n1=hyperaldostéronisme secondaire | n2=en:loss of independent ambulation by age 10 years | rel=r_associated | relid=0 | w=5
  2879. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of independent ambulation within a few years
    n1=hyperaldostéronisme secondaire | n2=en:loss of independent ambulation within a few years | rel=r_associated | relid=0 | w=5
  2880. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of judgement
    n1=hyperaldostéronisme secondaire | n2=en:loss of judgement | rel=r_associated | relid=0 | w=5
  2881. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of language ability
    n1=hyperaldostéronisme secondaire | n2=en:loss of language ability | rel=r_associated | relid=0 | w=5
  2882. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem
    n1=hyperaldostéronisme secondaire | n2=en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem | rel=r_associated | relid=0 | w=5
  2883. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of motor functions
    n1=hyperaldostéronisme secondaire | n2=en:loss of motor functions | rel=r_associated | relid=0 | w=5
  2884. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of motor milestones
    n1=hyperaldostéronisme secondaire | n2=en:loss of motor milestones | rel=r_associated | relid=0 | w=5
  2885. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of motor neurons in the anterior horn of the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:loss of motor neurons in the anterior horn of the spinal cord | rel=r_associated | relid=0 | w=5
  2886. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of motor neurons in the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:loss of motor neurons in the spinal cord | rel=r_associated | relid=0 | w=5
  2887. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of motor skills
    n1=hyperaldostéronisme secondaire | n2=en:loss of motor skills | rel=r_associated | relid=0 | w=5
  2888. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelin
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelin | rel=r_associated | relid=0 | w=5
  2889. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelin and oligodendroglia
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelin and oligodendroglia | rel=r_associated | relid=0 | w=5
  2890. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelin in the cerebral and cerebellar white matter
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelin in the cerebral and cerebellar white matter | rel=r_associated | relid=0 | w=5
  2891. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelin in the descending lateral spinal cord tracts
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelin in the descending lateral spinal cord tracts | rel=r_associated | relid=0 | w=5
  2892. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelin in the pyramidal tracts
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelin in the pyramidal tracts | rel=r_associated | relid=0 | w=5
  2893. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelinated fibers in spinal cord roots
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelinated fibers in spinal cord roots | rel=r_associated | relid=0 | w=5
  2894. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of myelinated fibers with regenerative clusters on biopsy
    n1=hyperaldostéronisme secondaire | n2=en:loss of myelinated fibers with regenerative clusters on biopsy | rel=r_associated | relid=0 | w=5
  2895. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of neurons affecting all cortical layers
    n1=hyperaldostéronisme secondaire | n2=en:loss of neurons affecting all cortical layers | rel=r_associated | relid=0 | w=5
  2896. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord | rel=r_associated | relid=0 | w=5
  2897. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of pain and temperature in a cape-like distribution
    n1=hyperaldostéronisme secondaire | n2=en:loss of pain and temperature in a cape-like distribution | rel=r_associated | relid=0 | w=5
  2898. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of pigmented neurons in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:loss of pigmented neurons in the substantia nigra | rel=r_associated | relid=0 | w=5
  2899. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of postural tone
    n1=hyperaldostéronisme secondaire | n2=en:loss of postural tone | rel=r_associated | relid=0 | w=5
  2900. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of primary reflexes
    n1=hyperaldostéronisme secondaire | n2=en:loss of primary reflexes | rel=r_associated | relid=0 | w=5
  2901. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of purkinje cells
    n1=hyperaldostéronisme secondaire | n2=en:loss of purkinje cells | rel=r_associated | relid=0 | w=5
  2902. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of purkinje cells in the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:loss of purkinje cells in the cerebellar vermis | rel=r_associated | relid=0 | w=5
  2903. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of purkinje cells in the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:loss of purkinje cells in the cerebellum | rel=r_associated | relid=0 | w=5
  2904. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of purposeful hand movements
    n1=hyperaldostéronisme secondaire | n2=en:loss of purposeful hand movements | rel=r_associated | relid=0 | w=5
  2905. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of reflexes due to myopathy
    n1=hyperaldostéronisme secondaire | n2=en:loss of reflexes due to myopathy | rel=r_associated | relid=0 | w=5
  2906. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of speech
    n1=hyperaldostéronisme secondaire | n2=en:loss of speech | rel=r_associated | relid=0 | w=5
  2907. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of speech (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:loss of speech (1 patient) | rel=r_associated | relid=0 | w=5
  2908. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of speech development
    n1=hyperaldostéronisme secondaire | n2=en:loss of speech development | rel=r_associated | relid=0 | w=5
  2909. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of spontaneous movements
    n1=hyperaldostéronisme secondaire | n2=en:loss of spontaneous movements | rel=r_associated | relid=0 | w=5
  2910. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of very early milestones
    n1=hyperaldostéronisme secondaire | n2=en:loss of very early milestones | rel=r_associated | relid=0 | w=5
  2911. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:loss of white matter
    n1=hyperaldostéronisme secondaire | n2=en:loss of white matter | rel=r_associated | relid=0 | w=5
  2912. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low apparent diffusion coefficient (adc) values
    n1=hyperaldostéronisme secondaire | n2=en:low apparent diffusion coefficient (adc) values | rel=r_associated | relid=0 | w=5
  2913. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low densities in the basal ganglia similar to leigh syndrome (256000)
    n1=hyperaldostéronisme secondaire | n2=en:low densities in the basal ganglia similar to leigh syndrome (256000) | rel=r_associated | relid=0 | w=5
  2914. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low density white matter on ct scan
    n1=hyperaldostéronisme secondaire | n2=en:low density white matter on ct scan | rel=r_associated | relid=0 | w=5
  2915. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low frustration tolerance
    n1=hyperaldostéronisme secondaire | n2=en:low frustration tolerance | rel=r_associated | relid=0 | w=5
  2916. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low iq
    n1=hyperaldostéronisme secondaire | n2=en:low iq | rel=r_associated | relid=0 | w=5
  2917. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low-lying cerebellar tonsils
    n1=hyperaldostéronisme secondaire | n2=en:low-lying cerebellar tonsils | rel=r_associated | relid=0 | w=5
  2918. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low-normal intelligence
    n1=hyperaldostéronisme secondaire | n2=en:low-normal intelligence | rel=r_associated | relid=0 | w=5
  2919. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:low-normal iq
    n1=hyperaldostéronisme secondaire | n2=en:low-normal iq | rel=r_associated | relid=0 | w=5
  2920. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower extremity weakness with febrile episodes (rare)
    n1=hyperaldostéronisme secondaire | n2=en:lower extremity weakness with febrile episodes (rare) | rel=r_associated | relid=0 | w=5
  2921. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb atrophy
    n1=hyperaldostéronisme secondaire | n2=en:lower limb atrophy | rel=r_associated | relid=0 | w=5
  2922. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb dystonia
    n1=hyperaldostéronisme secondaire | n2=en:lower limb dystonia | rel=r_associated | relid=0 | w=5
  2923. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb hyperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:lower limb hyperreflexia | rel=r_associated | relid=0 | w=5
  2924. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb hyperreflexia (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:lower limb hyperreflexia (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  2925. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:lower limb hypertonia | rel=r_associated | relid=0 | w=5
  2926. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb hypotrophy
    n1=hyperaldostéronisme secondaire | n2=en:lower limb hypotrophy | rel=r_associated | relid=0 | w=5
  2927. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:lower limb muscle atrophy | rel=r_associated | relid=0 | w=5
  2928. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb muscle weakness (occurs later)
    n1=hyperaldostéronisme secondaire | n2=en:lower limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=5
  2929. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb spasticity
    n1=hyperaldostéronisme secondaire | n2=en:lower limb spasticity | rel=r_associated | relid=0 | w=5
  2930. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb spasticity, mild
    n1=hyperaldostéronisme secondaire | n2=en:lower limb spasticity, mild | rel=r_associated | relid=0 | w=5
  2931. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limb weakness, proximal
    n1=hyperaldostéronisme secondaire | n2=en:lower limb weakness, proximal | rel=r_associated | relid=0 | w=5
  2932. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limbs affected before upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:lower limbs affected before upper limbs | rel=r_associated | relid=0 | w=5
  2933. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower limbs weakness and atrophy, distal
    n1=hyperaldostéronisme secondaire | n2=en:lower limbs weakness and atrophy, distal | rel=r_associated | relid=0 | w=5
  2934. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron degeneration
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron degeneration | rel=r_associated | relid=0 | w=5
  2935. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron disease affecting upper and lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron disease affecting upper and lower limbs | rel=r_associated | relid=0 | w=5
  2936. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron dysfunction | rel=r_associated | relid=0 | w=5
  2937. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron dysfunction involving upper and lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron dysfunction involving upper and lower limbs | rel=r_associated | relid=0 | w=5
  2938. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron involvement after long disease duration
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron involvement after long disease duration | rel=r_associated | relid=0 | w=5
  2939. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron involvement, mild, seen on emg (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron involvement, mild, seen on emg (in some patients) | rel=r_associated | relid=0 | w=5
  2940. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron signs, later
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron signs, later | rel=r_associated | relid=0 | w=5
  2941. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor neuron symptoms
    n1=hyperaldostéronisme secondaire | n2=en:lower motor neuron symptoms | rel=r_associated | relid=0 | w=5
  2942. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lower motor signs
    n1=hyperaldostéronisme secondaire | n2=en:lower motor signs | rel=r_associated | relid=0 | w=5
  2943. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis
    n1=hyperaldostéronisme secondaire | n2=en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis | rel=r_associated | relid=0 | w=5
  2944. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lumbosacral meningocele
    n1=hyperaldostéronisme secondaire | n2=en:lumbosacral meningocele | rel=r_associated | relid=0 | w=5
  2945. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:lymphocytic infiltration of the brain
    n1=hyperaldostéronisme secondaire | n2=en:lymphocytic infiltration of the brain | rel=r_associated | relid=0 | w=5
  2946. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:macrocephaly (due to dandy-walker malformation)
    n1=hyperaldostéronisme secondaire | n2=en:macrocephaly (due to dandy-walker malformation) | rel=r_associated | relid=0 | w=5
  2947. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:macroencephaly
    n1=hyperaldostéronisme secondaire | n2=en:macroencephaly | rel=r_associated | relid=0 | w=5
  2948. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter
    n1=hyperaldostéronisme secondaire | n2=en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter | rel=r_associated | relid=0 | w=5
  2949. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system | rel=r_associated | relid=0 | w=5
  2950. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:magnetic resonance spectroscopy shows increased lactate in white matter
    n1=hyperaldostéronisme secondaire | n2=en:magnetic resonance spectroscopy shows increased lactate in white matter | rel=r_associated | relid=0 | w=5
  2951. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:major depression (rare)
    n1=hyperaldostéronisme secondaire | n2=en:major depression (rare) | rel=r_associated | relid=0 | w=5
  2952. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:major developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:major developmental delay | rel=r_associated | relid=0 | w=5
  2953. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:major developmental milestones are not attained
    n1=hyperaldostéronisme secondaire | n2=en:major developmental milestones are not attained | rel=r_associated | relid=0 | w=5
  2954. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:male circumcision
    n1=hyperaldostéronisme secondaire | n2=en:male circumcision | rel=r_associated | relid=0 | w=5
  2955. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:malformation of the insula
    n1=hyperaldostéronisme secondaire | n2=en:malformation of the insula | rel=r_associated | relid=0 | w=5
  2956. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:malformation, cerebral arteriovenous
    n1=hyperaldostéronisme secondaire | n2=en:malformation, cerebral arteriovenous | rel=r_associated | relid=0 | w=5
  2957. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:malformations of cortical development
    n1=hyperaldostéronisme secondaire | n2=en:malformations of cortical development | rel=r_associated | relid=0 | w=5
  2958. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:malformations of cortical development, variable
    n1=hyperaldostéronisme secondaire | n2=en:malformations of cortical development, variable | rel=r_associated | relid=0 | w=5
  2959. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:malformations of the mid- and hindbrain
    n1=hyperaldostéronisme secondaire | n2=en:malformations of the mid- and hindbrain | rel=r_associated | relid=0 | w=5
  2960. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:markedly delayed nerve conduction velocities
    n1=hyperaldostéronisme secondaire | n2=en:markedly delayed nerve conduction velocities | rel=r_associated | relid=0 | w=5
  2961. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mask-like facies
    n1=hyperaldostéronisme secondaire | n2=en:mask-like facies | rel=r_associated | relid=0 | w=5
  2962. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mbd
    n1=hyperaldostéronisme secondaire | n2=en:mbd | rel=r_associated | relid=0 | w=5
  2963. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mean sleep latency is less than 5 to 8 minutes
    n1=hyperaldostéronisme secondaire | n2=en:mean sleep latency is less than 5 to 8 minutes | rel=r_associated | relid=0 | w=5
  2964. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:measles
    n1=hyperaldostéronisme secondaire | n2=en:measles | rel=r_associated | relid=0 | w=5
  2965. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:medicines and children
    n1=hyperaldostéronisme secondaire | n2=en:medicines and children | rel=r_associated | relid=0 | w=5
  2966. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:medulloblastoma
    n1=hyperaldostéronisme secondaire | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=5
  2967. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mega cisterna magna
    n1=hyperaldostéronisme secondaire | n2=en:mega cisterna magna | rel=r_associated | relid=0 | w=5
  2968. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:megacisterna magna (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:megacisterna magna (in some patients) | rel=r_associated | relid=0 | w=5
  2969. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:megacisterna magna (rare)
    n1=hyperaldostéronisme secondaire | n2=en:megacisterna magna (rare) | rel=r_associated | relid=0 | w=5
  2970. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory
    n1=hyperaldostéronisme secondaire | n2=en:memory | rel=r_associated | relid=0 | w=5
  2971. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory defects
    n1=hyperaldostéronisme secondaire | n2=en:memory defects | rel=r_associated | relid=0 | w=5
  2972. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory difficulties
    n1=hyperaldostéronisme secondaire | n2=en:memory difficulties | rel=r_associated | relid=0 | w=5
  2973. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory impairment
    n1=hyperaldostéronisme secondaire | n2=en:memory impairment | rel=r_associated | relid=0 | w=5
  2974. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory impairment, progressive
    n1=hyperaldostéronisme secondaire | n2=en:memory impairment, progressive | rel=r_associated | relid=0 | w=5
  2975. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:memory loss
    n1=hyperaldostéronisme secondaire | n2=en:memory loss | rel=r_associated | relid=0 | w=5
  2976. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meninges
    n1=hyperaldostéronisme secondaire | n2=en:meninges | rel=r_associated | relid=0 | w=5
  2977. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningioma
    n1=hyperaldostéronisme secondaire | n2=en:meningioma | rel=r_associated | relid=0 | w=5
  2978. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningioma (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:meningioma (in some patients) | rel=r_associated | relid=0 | w=5
  2979. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningitis
    n1=hyperaldostéronisme secondaire | n2=en:meningitis | rel=r_associated | relid=0 | w=5
  2980. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningoceles, multiple, lateral
    n1=hyperaldostéronisme secondaire | n2=en:meningoceles, multiple, lateral | rel=r_associated | relid=0 | w=5
  2981. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningoencephalitis
    n1=hyperaldostéronisme secondaire | n2=en:meningoencephalitis | rel=r_associated | relid=0 | w=5
  2982. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:meningoencephalocele (wws)
    n1=hyperaldostéronisme secondaire | n2=en:meningoencephalocele (wws) | rel=r_associated | relid=0 | w=5
  2983. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental and behavioural disorders
    n1=hyperaldostéronisme secondaire | n2=en:mental and behavioural disorders | rel=r_associated | relid=0 | w=5
  2984. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental and behavioural disorders due to psychoactive substance use
    n1=hyperaldostéronisme secondaire | n2=en:mental and behavioural disorders due to psychoactive substance use | rel=r_associated | relid=0 | w=5
  2985. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental deficiency
    n1=hyperaldostéronisme secondaire | n2=en:mental deficiency | rel=r_associated | relid=0 | w=5
  2986. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental delay or retardation (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:mental delay or retardation (uncommon) | rel=r_associated | relid=0 | w=5
  2987. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental deterioration
    n1=hyperaldostéronisme secondaire | n2=en:mental deterioration | rel=r_associated | relid=0 | w=5
  2988. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental deterioration beginning 2 to 5 years after onset of seizures
    n1=hyperaldostéronisme secondaire | n2=en:mental deterioration beginning 2 to 5 years after onset of seizures | rel=r_associated | relid=0 | w=5
  2989. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental deterioration in a subset of patients
    n1=hyperaldostéronisme secondaire | n2=en:mental deterioration in a subset of patients | rel=r_associated | relid=0 | w=5
  2990. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental deterioration in childhood
    n1=hyperaldostéronisme secondaire | n2=en:mental deterioration in childhood | rel=r_associated | relid=0 | w=5
  2991. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental disorder in adolescence
    n1=hyperaldostéronisme secondaire | n2=en:mental disorder in adolescence | rel=r_associated | relid=0 | w=5
  2992. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental disorder in infancy
    n1=hyperaldostéronisme secondaire | n2=en:mental disorder in infancy | rel=r_associated | relid=0 | w=5
  2993. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental disorder of infancy, childhood or adolescence
    n1=hyperaldostéronisme secondaire | n2=en:mental disorder of infancy, childhood or adolescence | rel=r_associated | relid=0 | w=5
  2994. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental handicap
    n1=hyperaldostéronisme secondaire | n2=en:mental handicap | rel=r_associated | relid=0 | w=5
  2995. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental health
    n1=hyperaldostéronisme secondaire | n2=en:mental health | rel=r_associated | relid=0 | w=5
  2996. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental health.behavior
    n1=hyperaldostéronisme secondaire | n2=en:mental health.behavior | rel=r_associated | relid=0 | w=5
  2997. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental impairment
    n1=hyperaldostéronisme secondaire | n2=en:mental impairment | rel=r_associated | relid=0 | w=5
  2998. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental impairment may develop with repeated acute episodes
    n1=hyperaldostéronisme secondaire | n2=en:mental impairment may develop with repeated acute episodes | rel=r_associated | relid=0 | w=5
  2999. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental impairment, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:mental impairment, mild to moderate | rel=r_associated | relid=0 | w=5
  3000. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental lethargy
    n1=hyperaldostéronisme secondaire | n2=en:mental lethargy | rel=r_associated | relid=0 | w=5
  3001. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation | rel=r_associated | relid=0 | w=5
  3002. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (1 family) | rel=r_associated | relid=0 | w=5
  3003. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (15%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (15%) | rel=r_associated | relid=0 | w=5
  3004. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (18% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (18% of patients) | rel=r_associated | relid=0 | w=5
  3005. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (2 patients) | rel=r_associated | relid=0 | w=5
  3006. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (2/3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (2/3 patients) | rel=r_associated | relid=0 | w=5
  3007. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (20%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (20%) | rel=r_associated | relid=0 | w=5
  3008. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (25%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (25%) | rel=r_associated | relid=0 | w=5
  3009. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (3 patients) | rel=r_associated | relid=0 | w=5
  3010. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (30%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (30%) | rel=r_associated | relid=0 | w=5
  3011. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (31%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (31%) | rel=r_associated | relid=0 | w=5
  3012. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (38%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (38%) | rel=r_associated | relid=0 | w=5
  3013. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (47%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (47%) | rel=r_associated | relid=0 | w=5
  3014. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (50% patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (50% patients) | rel=r_associated | relid=0 | w=5
  3015. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (6%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (6%) | rel=r_associated | relid=0 | w=5
  3016. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (7%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (7%) | rel=r_associated | relid=0 | w=5
  3017. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (70%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (70%) | rel=r_associated | relid=0 | w=5
  3018. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (about 40%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (about 40%) | rel=r_associated | relid=0 | w=5
  3019. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (average iq 51)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (average iq 51) | rel=r_associated | relid=0 | w=5
  3020. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (average iq 56)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (average iq 56) | rel=r_associated | relid=0 | w=5
  3021. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (cvs+) | rel=r_associated | relid=0 | w=5
  3022. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (develops later)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (develops later) | rel=r_associated | relid=0 | w=5
  3023. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (early-onset form)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (early-onset form) | rel=r_associated | relid=0 | w=5
  3024. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (if left untreated) | rel=r_associated | relid=0 | w=5
  3025. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (if untreated in infancy)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (if untreated in infancy) | rel=r_associated | relid=0 | w=5
  3026. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in 2 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in 2 of 6 patients) | rel=r_associated | relid=0 | w=5
  3027. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in 2 patients) learning disability (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in 2 patients) learning disability (in 1 patient) | rel=r_associated | relid=0 | w=5
  3028. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in a subset of patients) | rel=r_associated | relid=0 | w=5
  3029. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in most patients) | rel=r_associated | relid=0 | w=5
  3030. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in most)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in most) | rel=r_associated | relid=0 | w=5
  3031. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in some cases)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in some cases) | rel=r_associated | relid=0 | w=5
  3032. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in some patients) | rel=r_associated | relid=0 | w=5
  3033. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in some)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in some) | rel=r_associated | relid=0 | w=5
  3034. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (in type iia)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (in type iia) | rel=r_associated | relid=0 | w=5
  3035. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (iq 20-78)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (iq 20-78) | rel=r_associated | relid=0 | w=5
  3036. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (iq 24-85) (variable)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (iq 24-85) (variable) | rel=r_associated | relid=0 | w=5
  3037. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (iq 45-75)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (iq 45-75) | rel=r_associated | relid=0 | w=5
  3038. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale) | rel=r_associated | relid=0 | w=5
  3039. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (less common)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (less common) | rel=r_associated | relid=0 | w=5
  3040. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (males)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (males) | rel=r_associated | relid=0 | w=5
  3041. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (moderate to severe in males)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (moderate to severe in males) | rel=r_associated | relid=0 | w=5
  3042. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (one patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (one patient) | rel=r_associated | relid=0 | w=5
  3043. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (one-third)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (one-third) | rel=r_associated | relid=0 | w=5
  3044. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (range mild to severe)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (range mild to severe) | rel=r_associated | relid=0 | w=5
  3045. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (rare less than 1% of cases)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (rare less than 1% of cases) | rel=r_associated | relid=0 | w=5
  3046. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (rare)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (rare) | rel=r_associated | relid=0 | w=5
  3047. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (rarely noted)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (rarely noted) | rel=r_associated | relid=0 | w=5
  3048. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (reported in 1 family) | rel=r_associated | relid=0 | w=5
  3049. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  3050. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (secondary to intracranial bleed)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (secondary to intracranial bleed) | rel=r_associated | relid=0 | w=5
  3051. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (seen in hhs variant)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (seen in hhs variant) | rel=r_associated | relid=0 | w=5
  3052. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (some)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (some) | rel=r_associated | relid=0 | w=5
  3053. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (sometimes)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (sometimes) | rel=r_associated | relid=0 | w=5
  3054. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (type i)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (type i) | rel=r_associated | relid=0 | w=5
  3055. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (uncommon) | rel=r_associated | relid=0 | w=5
  3056. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (untreated hypothyroidism)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (untreated hypothyroidism) | rel=r_associated | relid=0 | w=5
  3057. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation (variable expression)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation (variable expression) | rel=r_associated | relid=0 | w=5
  3058. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation by age 30 years
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation by age 30 years | rel=r_associated | relid=0 | w=5
  3059. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation by the age of 7 years
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation by the age of 7 years | rel=r_associated | relid=0 | w=5
  3060. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation can occur in patients with repeated episodes of dehydration
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation can occur in patients with repeated episodes of dehydration | rel=r_associated | relid=0 | w=5
  3061. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation due to repeated episodes of hypoglycemia
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation due to repeated episodes of hypoglycemia | rel=r_associated | relid=0 | w=5
  3062. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation from rapid mental regression
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation from rapid mental regression | rel=r_associated | relid=0 | w=5
  3063. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation has been reported
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation has been reported | rel=r_associated | relid=0 | w=5
  3064. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation if untreated
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation if untreated | rel=r_associated | relid=0 | w=5
  3065. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation in 5-13%
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation in 5-13% | rel=r_associated | relid=0 | w=5
  3066. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation in 75%
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation in 75% | rel=r_associated | relid=0 | w=5
  3067. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation in survivors
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation in survivors | rel=r_associated | relid=0 | w=5
  3068. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation may occur
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation may occur | rel=r_associated | relid=0 | w=5
  3069. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, autosomal dominant 29
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, autosomal dominant 29 | rel=r_associated | relid=0 | w=5
  3070. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, borderline (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, borderline (1 patient) | rel=r_associated | relid=0 | w=5
  3071. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, borderline to severe
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, borderline to severe | rel=r_associated | relid=0 | w=5
  3072. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, borderline-mild in carrier females
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, borderline-mild in carrier females | rel=r_associated | relid=0 | w=5
  3073. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, in subgroup of patients
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, in subgroup of patients | rel=r_associated | relid=0 | w=5
  3074. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (1 family) | rel=r_associated | relid=0 | w=5
  3075. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (1 patient) | rel=r_associated | relid=0 | w=5
  3076. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (10%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (10%) | rel=r_associated | relid=0 | w=5
  3077. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (11%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (11%) | rel=r_associated | relid=0 | w=5
  3078. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (18%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (18%) | rel=r_associated | relid=0 | w=5
  3079. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (2 families)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (2 families) | rel=r_associated | relid=0 | w=5
  3080. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (20% have more severe mental retardation)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (20% have more severe mental retardation) | rel=r_associated | relid=0 | w=5
  3081. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (carrier females)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (carrier females) | rel=r_associated | relid=0 | w=5
  3082. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (in some females)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (in some females) | rel=r_associated | relid=0 | w=5
  3083. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (in some patients) | rel=r_associated | relid=0 | w=5
  3084. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (iq range from 50 to 70)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (iq range from 50 to 70) | rel=r_associated | relid=0 | w=5
  3085. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild (rare)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild (rare) | rel=r_associated | relid=0 | w=5
  3086. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to moderate | rel=r_associated | relid=0 | w=5
  3087. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to moderate (20% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to moderate (20% of patients) | rel=r_associated | relid=0 | w=5
  3088. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to moderate (in 12%)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to moderate (in 12%) | rel=r_associated | relid=0 | w=5
  3089. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to moderate (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to moderate (in some patients) | rel=r_associated | relid=0 | w=5
  3090. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to moderate (iq 30-76)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to moderate (iq 30-76) | rel=r_associated | relid=0 | w=5
  3091. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to profound
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to profound | rel=r_associated | relid=0 | w=5
  3092. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild to severe
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild to severe | rel=r_associated | relid=0 | w=5
  3093. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild-borderline, nonprogressive
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild-borderline, nonprogressive | rel=r_associated | relid=0 | w=5
  3094. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild-moderate (28%, usually in males)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild-moderate (28%, usually in males) | rel=r_associated | relid=0 | w=5
  3095. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild-moderate (some)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild-moderate (some) | rel=r_associated | relid=0 | w=5
  3096. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild, in most carrier females
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild, in most carrier females | rel=r_associated | relid=0 | w=5
  3097. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, mild, some patients (iq 70-80)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, mild, some patients (iq 70-80) | rel=r_associated | relid=0 | w=5
  3098. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate (apparent by age 4 years)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate (apparent by age 4 years) | rel=r_associated | relid=0 | w=5
  3099. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate (in 1 patient) | rel=r_associated | relid=0 | w=5
  3100. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate (in sister)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate (in sister) | rel=r_associated | relid=0 | w=5
  3101. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate (in some patients) | rel=r_associated | relid=0 | w=5
  3102. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to profound
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to profound | rel=r_associated | relid=0 | w=5
  3103. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe | rel=r_associated | relid=0 | w=5
  3104. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe (10-15% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe (10-15% of patients) | rel=r_associated | relid=0 | w=5
  3105. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe (in some patients) | rel=r_associated | relid=0 | w=5
  3106. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe (iq 35-50)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe (iq 35-50) | rel=r_associated | relid=0 | w=5
  3107. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe (iq 40 to 60)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe (iq 40 to 60) | rel=r_associated | relid=0 | w=5
  3108. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate to severe (type ii, infantile and juvenile)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate to severe (type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=5
  3109. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, moderate-severe (2p21del)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, moderate-severe (2p21del) | rel=r_associated | relid=0 | w=5
  3110. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, occasional
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, occasional | rel=r_associated | relid=0 | w=5
  3111. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, profound (wws)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, profound (wws) | rel=r_associated | relid=0 | w=5
  3112. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, progressive (50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, progressive (50% of patients) | rel=r_associated | relid=0 | w=5
  3113. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, residual mild-to-severe (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, residual mild-to-severe (in some patients) | rel=r_associated | relid=0 | w=5
  3114. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, severe (if untreated)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, severe (if untreated) | rel=r_associated | relid=0 | w=5
  3115. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, severe (meb)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, severe (meb) | rel=r_associated | relid=0 | w=5
  3116. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, severe in some patients
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, severe in some patients | rel=r_associated | relid=0 | w=5
  3117. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, severe to profound
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, severe to profound | rel=r_associated | relid=0 | w=5
  3118. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, severe, profound
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, severe, profound | rel=r_associated | relid=0 | w=5
  3119. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, variable (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, variable (in some patients) | rel=r_associated | relid=0 | w=5
  3120. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, variable degree (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, variable degree (in some patients) | rel=r_associated | relid=0 | w=5
  3121. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, variable severity
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, variable severity | rel=r_associated | relid=0 | w=5
  3122. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental retardation, x-linked 90 (disorder)
    n1=hyperaldostéronisme secondaire | n2=en:mental retardation, x-linked 90 (disorder) | rel=r_associated | relid=0 | w=5
  3123. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mental symptom
    n1=hyperaldostéronisme secondaire | n2=en:mental symptom | rel=r_associated | relid=0 | w=5
  3124. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mesial temporal brain malformations
    n1=hyperaldostéronisme secondaire | n2=en:mesial temporal brain malformations | rel=r_associated | relid=0 | w=5
  3125. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mesial temporal sclerosis (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mesial temporal sclerosis (in 1 patient) | rel=r_associated | relid=0 | w=5
  3126. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine | rel=r_associated | relid=0 | w=5
  3127. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride | rel=r_associated | relid=0 | w=5
  3128. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride 10 mg oral tablet
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride 10 mg oral tablet | rel=r_associated | relid=0 | w=5
  3129. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride 10mg m/r tablet
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride 10mg m/r tablet | rel=r_associated | relid=0 | w=5
  3130. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride 15mg m/r tablet
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride 15mg m/r tablet | rel=r_associated | relid=0 | w=5
  3131. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride 5mg m/r tablet
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride 5mg m/r tablet | rel=r_associated | relid=0 | w=5
  3132. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:methamphetamine hydrochloride 5mg tablet
    n1=hyperaldostéronisme secondaire | n2=en:methamphetamine hydrochloride 5mg tablet | rel=r_associated | relid=0 | w=5
  3133. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microbleeds
    n1=hyperaldostéronisme secondaire | n2=en:microbleeds | rel=r_associated | relid=0 | w=5
  3134. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microbleeds (most smaller than 5 mm) occur after age 40 years
    n1=hyperaldostéronisme secondaire | n2=en:microbleeds (most smaller than 5 mm) occur after age 40 years | rel=r_associated | relid=0 | w=5
  3135. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microcephaly
    n1=hyperaldostéronisme secondaire | n2=en:microcephaly | rel=r_associated | relid=0 | w=5
  3136. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microcystic degeneration
    n1=hyperaldostéronisme secondaire | n2=en:microcystic degeneration | rel=r_associated | relid=0 | w=5
  3137. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:micrographia
    n1=hyperaldostéronisme secondaire | n2=en:micrographia | rel=r_associated | relid=0 | w=5
  3138. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microgyria
    n1=hyperaldostéronisme secondaire | n2=en:microgyria | rel=r_associated | relid=0 | w=5
  3139. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microlissencephalies
    n1=hyperaldostéronisme secondaire | n2=en:microlissencephalies | rel=r_associated | relid=0 | w=5
  3140. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microvacuolation
    n1=hyperaldostéronisme secondaire | n2=en:microvacuolation | rel=r_associated | relid=0 | w=5
  3141. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:microvascular spaces, dilated
    n1=hyperaldostéronisme secondaire | n2=en:microvascular spaces, dilated | rel=r_associated | relid=0 | w=5
  3142. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:midbrain atrophy
    n1=hyperaldostéronisme secondaire | n2=en:midbrain atrophy | rel=r_associated | relid=0 | w=5
  3143. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:midline brain calcifications
    n1=hyperaldostéronisme secondaire | n2=en:midline brain calcifications | rel=r_associated | relid=0 | w=5
  3144. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:midline forebrain defects
    n1=hyperaldostéronisme secondaire | n2=en:midline forebrain defects | rel=r_associated | relid=0 | w=5
  3145. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine
    n1=hyperaldostéronisme secondaire | n2=en:migraine | rel=r_associated | relid=0 | w=5
  3146. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine (40% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:migraine (40% of patients) | rel=r_associated | relid=0 | w=5
  3147. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine (in affected males)
    n1=hyperaldostéronisme secondaire | n2=en:migraine (in affected males) | rel=r_associated | relid=0 | w=5
  3148. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:migraine (in some patients) | rel=r_associated | relid=0 | w=5
  3149. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:migraine (uncommon) | rel=r_associated | relid=0 | w=5
  3150. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine headache (less common)
    n1=hyperaldostéronisme secondaire | n2=en:migraine headache (less common) | rel=r_associated | relid=0 | w=5
  3151. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine headaches (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:migraine headaches (cvs+) | rel=r_associated | relid=0 | w=5
  3152. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine headaches (ipsilateral to facial hemangioma)
    n1=hyperaldostéronisme secondaire | n2=en:migraine headaches (ipsilateral to facial hemangioma) | rel=r_associated | relid=0 | w=5
  3153. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine headaches (onset in adolescence)
    n1=hyperaldostéronisme secondaire | n2=en:migraine headaches (onset in adolescence) | rel=r_associated | relid=0 | w=5
  3154. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine with aura
    n1=hyperaldostéronisme secondaire | n2=en:migraine with aura | rel=r_associated | relid=0 | w=5
  3155. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine with aura, usually visual (in 50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:migraine with aura, usually visual (in 50% of patients) | rel=r_associated | relid=0 | w=5
  3156. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine without aura
    n1=hyperaldostéronisme secondaire | n2=en:migraine without aura | rel=r_associated | relid=0 | w=5
  3157. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraine, with or without aura
    n1=hyperaldostéronisme secondaire | n2=en:migraine, with or without aura | rel=r_associated | relid=0 | w=5
  3158. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migraines (less common)
    n1=hyperaldostéronisme secondaire | n2=en:migraines (less common) | rel=r_associated | relid=0 | w=5
  3159. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migrating clonic jerks (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:migrating clonic jerks (in some patients) | rel=r_associated | relid=0 | w=5
  3160. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migrating discharges from one cortical region to another seen on eeg (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:migrating discharges from one cortical region to another seen on eeg (in some patients) | rel=r_associated | relid=0 | w=5
  3161. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migrating focal discharges from one cortical region to another seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:migrating focal discharges from one cortical region to another seen on eeg | rel=r_associated | relid=0 | w=5
  3162. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:migrating partial seizures
    n1=hyperaldostéronisme secondaire | n2=en:migrating partial seizures | rel=r_associated | relid=0 | w=5
  3163. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients) | rel=r_associated | relid=0 | w=5
  3164. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:mild cerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  3165. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive decline (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive decline (1 patient) | rel=r_associated | relid=0 | w=5
  3166. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive deterioration in adults
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive deterioration in adults | rel=r_associated | relid=0 | w=5
  3167. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive disorder
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive disorder | rel=r_associated | relid=0 | w=5
  3168. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive impairment (in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive impairment (in 2 patients) | rel=r_associated | relid=0 | w=5
  3169. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive impairment (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive impairment (in some patients) | rel=r_associated | relid=0 | w=5
  3170. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cognitive impairment (less common)
    n1=hyperaldostéronisme secondaire | n2=en:mild cognitive impairment (less common) | rel=r_associated | relid=0 | w=5
  3171. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cortical atrophy (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:mild cortical atrophy (in 1 patient) | rel=r_associated | relid=0 | w=5
  3172. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild cortical atrophy on ct or mri
    n1=hyperaldostéronisme secondaire | n2=en:mild cortical atrophy on ct or mri | rel=r_associated | relid=0 | w=5
  3173. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild distal sensory deficits
    n1=hyperaldostéronisme secondaire | n2=en:mild distal sensory deficits | rel=r_associated | relid=0 | w=5
  3174. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild global developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:mild global developmental delay | rel=r_associated | relid=0 | w=5
  3175. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild loss of neurons in the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:mild loss of neurons in the cerebellum | rel=r_associated | relid=0 | w=5
  3176. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild memory loss
    n1=hyperaldostéronisme secondaire | n2=en:mild memory loss | rel=r_associated | relid=0 | w=5
  3177. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental decline
    n1=hyperaldostéronisme secondaire | n2=en:mild mental decline | rel=r_associated | relid=0 | w=5
  3178. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental deterioration
    n1=hyperaldostéronisme secondaire | n2=en:mild mental deterioration | rel=r_associated | relid=0 | w=5
  3179. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:mild mental retardation | rel=r_associated | relid=0 | w=5
  3180. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental retardation (39%) feeding problems/weak suck (43%)
    n1=hyperaldostéronisme secondaire | n2=en:mild mental retardation (39%) feeding problems/weak suck (43%) | rel=r_associated | relid=0 | w=5
  3181. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental retardation (in 1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mild mental retardation (in 1/4 patients) | rel=r_associated | relid=0 | w=5
  3182. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild mental retardation (some)
    n1=hyperaldostéronisme secondaire | n2=en:mild mental retardation (some) | rel=r_associated | relid=0 | w=5
  3183. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild motor development delay
    n1=hyperaldostéronisme secondaire | n2=en:mild motor development delay | rel=r_associated | relid=0 | w=5
  3184. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild paraparesis
    n1=hyperaldostéronisme secondaire | n2=en:mild paraparesis | rel=r_associated | relid=0 | w=5
  3185. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild psychomotor delay
    n1=hyperaldostéronisme secondaire | n2=en:mild psychomotor delay | rel=r_associated | relid=0 | w=5
  3186. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild pyramidal signs (variable expression)
    n1=hyperaldostéronisme secondaire | n2=en:mild pyramidal signs (variable expression) | rel=r_associated | relid=0 | w=5
  3187. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild sensorimotor neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:mild sensorimotor neuropathy | rel=r_associated | relid=0 | w=5
  3188. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild spasticity
    n1=hyperaldostéronisme secondaire | n2=en:mild spasticity | rel=r_associated | relid=0 | w=5
  3189. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild structural abnormalities seen mri (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mild structural abnormalities seen mri (in some patients) | rel=r_associated | relid=0 | w=5
  3190. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild to moderate learning difficulties
    n1=hyperaldostéronisme secondaire | n2=en:mild to moderate learning difficulties | rel=r_associated | relid=0 | w=5
  3191. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild to severe mental retardation (24%)
    n1=hyperaldostéronisme secondaire | n2=en:mild to severe mental retardation (24%) | rel=r_associated | relid=0 | w=5
  3192. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild upper limb involvement
    n1=hyperaldostéronisme secondaire | n2=en:mild upper limb involvement | rel=r_associated | relid=0 | w=5
  3193. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild-moderate mental retardation (80% affected males)
    n1=hyperaldostéronisme secondaire | n2=en:mild-moderate mental retardation (80% affected males) | rel=r_associated | relid=0 | w=5
  3194. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild-moderate ventricular dilatation
    n1=hyperaldostéronisme secondaire | n2=en:mild-moderate ventricular dilatation | rel=r_associated | relid=0 | w=5
  3195. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mild-severe mental retardation (20%)
    n1=hyperaldostéronisme secondaire | n2=en:mild-severe mental retardation (20%) | rel=r_associated | relid=0 | w=5
  3196. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy
    n1=hyperaldostéronisme secondaire | n2=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | rel=r_associated | relid=0 | w=5
  3197. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly decreased intelligence has been reported
    n1=hyperaldostéronisme secondaire | n2=en:mildly decreased intelligence has been reported | rel=r_associated | relid=0 | w=5
  3198. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly delayed developmental milestones
    n1=hyperaldostéronisme secondaire | n2=en:mildly delayed developmental milestones | rel=r_associated | relid=0 | w=5
  3199. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly delayed motor development
    n1=hyperaldostéronisme secondaire | n2=en:mildly delayed motor development | rel=r_associated | relid=0 | w=5
  3200. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly delayed motor development due to vestibular dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:mildly delayed motor development due to vestibular dysfunction | rel=r_associated | relid=0 | w=5
  3201. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly enlarged ventricles
    n1=hyperaldostéronisme secondaire | n2=en:mildly enlarged ventricles | rel=r_associated | relid=0 | w=5
  3202. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mildly thin corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:mildly thin corpus callosum | rel=r_associated | relid=0 | w=5
  3203. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:minimal brain dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:minimal brain dysfunction | rel=r_associated | relid=0 | w=5
  3204. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:minimal gliosis
    n1=hyperaldostéronisme secondaire | n2=en:minimal gliosis | rel=r_associated | relid=0 | w=5
  3205. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:minimal or lack of speech
    n1=hyperaldostéronisme secondaire | n2=en:minimal or lack of speech | rel=r_associated | relid=0 | w=5
  3206. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:minimal to absent speech
    n1=hyperaldostéronisme secondaire | n2=en:minimal to absent speech | rel=r_associated | relid=0 | w=5
  3207. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:minor motor impairment (stage 2)
    n1=hyperaldostéronisme secondaire | n2=en:minor motor impairment (stage 2) | rel=r_associated | relid=0 | w=5
  3208. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mirror hand movements (bimanual synkinesis, in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:mirror hand movements (bimanual synkinesis, in some patients) | rel=r_associated | relid=0 | w=5
  3209. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mirror movements disorder
    n1=hyperaldostéronisme secondaire | n2=en:mirror movements disorder | rel=r_associated | relid=0 | w=5
  3210. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mirror movements, involuntary, affecting the hand and fingers
    n1=hyperaldostéronisme secondaire | n2=en:mirror movements, involuntary, affecting the hand and fingers | rel=r_associated | relid=0 | w=5
  3211. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mirror movements, involuntary, usually of the upper limb and hand
    n1=hyperaldostéronisme secondaire | n2=en:mirror movements, involuntary, usually of the upper limb and hand | rel=r_associated | relid=0 | w=5
  3212. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:misorientation of pyramidal fibers
    n1=hyperaldostéronisme secondaire | n2=en:misorientation of pyramidal fibers | rel=r_associated | relid=0 | w=5
  3213. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:misshapen posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:misshapen posterior fossa | rel=r_associated | relid=0 | w=5
  3214. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mitochondrial dna depletion in brain tissue
    n1=hyperaldostéronisme secondaire | n2=en:mitochondrial dna depletion in brain tissue | rel=r_associated | relid=0 | w=5
  3215. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mitochondrial encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:mitochondrial encephalopathy | rel=r_associated | relid=0 | w=5
  3216. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mixed cerebellar/pseudobulbar dysarthria
    n1=hyperaldostéronisme secondaire | n2=en:mixed cerebellar/pseudobulbar dysarthria | rel=r_associated | relid=0 | w=5
  3217. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mixed disorder of conduct and emotions, unspecified
    n1=hyperaldostéronisme secondaire | n2=en:mixed disorder of conduct and emotions, unspecified | rel=r_associated | relid=0 | w=5
  3218. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mobility poor
    n1=hyperaldostéronisme secondaire | n2=en:mobility poor | rel=r_associated | relid=0 | w=5
  3219. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moderate cortical atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:moderate cortical atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  3220. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moderate learning difficulties
    n1=hyperaldostéronisme secondaire | n2=en:moderate learning difficulties | rel=r_associated | relid=0 | w=5
  3221. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moderate mental retardation (i.q. 35-49)
    n1=hyperaldostéronisme secondaire | n2=en:moderate mental retardation (i.q. 35-49) | rel=r_associated | relid=0 | w=5
  3222. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moderate to severe hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:moderate to severe hypotonia | rel=r_associated | relid=0 | w=5
  3223. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moderately thickened cortex
    n1=hyperaldostéronisme secondaire | n2=en:moderately thickened cortex | rel=r_associated | relid=0 | w=5
  3224. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:molar tooth sign on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:molar tooth sign on brain mri | rel=r_associated | relid=0 | w=5
  3225. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:molar tooth sign on brain mri (subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:molar tooth sign on brain mri (subset of patients) | rel=r_associated | relid=0 | w=5
  3226. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:molar tooth sign on mri
    n1=hyperaldostéronisme secondaire | n2=en:molar tooth sign on mri | rel=r_associated | relid=0 | w=5
  3227. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:molar tooth sign seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:molar tooth sign seen on mri | rel=r_associated | relid=0 | w=5
  3228. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:monopareses
    n1=hyperaldostéronisme secondaire | n2=en:monopareses | rel=r_associated | relid=0 | w=5
  3229. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:monotone speech
    n1=hyperaldostéronisme secondaire | n2=en:monotone speech | rel=r_associated | relid=0 | w=5
  3230. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:monotonous speech
    n1=hyperaldostéronisme secondaire | n2=en:monotonous speech | rel=r_associated | relid=0 | w=5
  3231. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mood alteration
    n1=hyperaldostéronisme secondaire | n2=en:mood alteration | rel=r_associated | relid=0 | w=5
  3232. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mood disorder
    n1=hyperaldostéronisme secondaire | n2=en:mood disorder | rel=r_associated | relid=0 | w=5
  3233. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mood instability
    n1=hyperaldostéronisme secondaire | n2=en:mood instability | rel=r_associated | relid=0 | w=5
  3234. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mood lability
    n1=hyperaldostéronisme secondaire | n2=en:mood lability | rel=r_associated | relid=0 | w=5
  3235. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:morning myoclonic jerks
    n1=hyperaldostéronisme secondaire | n2=en:morning myoclonic jerks | rel=r_associated | relid=0 | w=5
  3236. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moro reflex absent
    n1=hyperaldostéronisme secondaire | n2=en:moro reflex absent | rel=r_associated | relid=0 | w=5
  3237. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:most never acquire independent ambulation
    n1=hyperaldostéronisme secondaire | n2=en:most never acquire independent ambulation | rel=r_associated | relid=0 | w=5
  3238. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:most patients achieve walking with aid
    n1=hyperaldostéronisme secondaire | n2=en:most patients achieve walking with aid | rel=r_associated | relid=0 | w=5
  3239. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:most patients are wheelchair-bound
    n1=hyperaldostéronisme secondaire | n2=en:most patients are wheelchair-bound | rel=r_associated | relid=0 | w=5
  3240. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:most patients do not achieve independent sitting or walking
    n1=hyperaldostéronisme secondaire | n2=en:most patients do not achieve independent sitting or walking | rel=r_associated | relid=0 | w=5
  3241. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:most patients remain stable or improve in years after the abrupt onset of symptoms
    n1=hyperaldostéronisme secondaire | n2=en:most patients remain stable or improve in years after the abrupt onset of symptoms | rel=r_associated | relid=0 | w=5
  3242. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mosy patients become wheelchair-bound after 10 years
    n1=hyperaldostéronisme secondaire | n2=en:mosy patients become wheelchair-bound after 10 years | rel=r_associated | relid=0 | w=5
  3243. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:motor abnormalities | rel=r_associated | relid=0 | w=5
  3244. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor and intellectual disability, severe
    n1=hyperaldostéronisme secondaire | n2=en:motor and intellectual disability, severe | rel=r_associated | relid=0 | w=5
  3245. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor and vocal tics
    n1=hyperaldostéronisme secondaire | n2=en:motor and vocal tics | rel=r_associated | relid=0 | w=5
  3246. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor automatisms
    n1=hyperaldostéronisme secondaire | n2=en:motor automatisms | rel=r_associated | relid=0 | w=5
  3247. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor delay (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:motor delay (in one patient) | rel=r_associated | relid=0 | w=5
  3248. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor deterioration
    n1=hyperaldostéronisme secondaire | n2=en:motor deterioration | rel=r_associated | relid=0 | w=5
  3249. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor deterioration in second decade
    n1=hyperaldostéronisme secondaire | n2=en:motor deterioration in second decade | rel=r_associated | relid=0 | w=5
  3250. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor development delay (83%)
    n1=hyperaldostéronisme secondaire | n2=en:motor development delay (83%) | rel=r_associated | relid=0 | w=5
  3251. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor development delayed (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:motor development delayed (in some patients) | rel=r_associated | relid=0 | w=5
  3252. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:motor developmental delay | rel=r_associated | relid=0 | w=5
  3253. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor developmental delay, severe
    n1=hyperaldostéronisme secondaire | n2=en:motor developmental delay, severe | rel=r_associated | relid=0 | w=5
  3254. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor disturbances
    n1=hyperaldostéronisme secondaire | n2=en:motor disturbances | rel=r_associated | relid=0 | w=5
  3255. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:motor dysfunction | rel=r_associated | relid=0 | w=5
  3256. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor dyspraxia
    n1=hyperaldostéronisme secondaire | n2=en:motor dyspraxia | rel=r_associated | relid=0 | w=5
  3257. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor incoordination
    n1=hyperaldostéronisme secondaire | n2=en:motor incoordination | rel=r_associated | relid=0 | w=5
  3258. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor neuron disease
    n1=hyperaldostéronisme secondaire | n2=en:motor neuron disease | rel=r_associated | relid=0 | w=5
  3259. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor neuron disease (less common)
    n1=hyperaldostéronisme secondaire | n2=en:motor neuron disease (less common) | rel=r_associated | relid=0 | w=5
  3260. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor neuron disease, lower
    n1=hyperaldostéronisme secondaire | n2=en:motor neuron disease, lower | rel=r_associated | relid=0 | w=5
  3261. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor regression
    n1=hyperaldostéronisme secondaire | n2=en:motor regression | rel=r_associated | relid=0 | w=5
  3262. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor retardation, mild
    n1=hyperaldostéronisme secondaire | n2=en:motor retardation, mild | rel=r_associated | relid=0 | w=5
  3263. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening
    n1=hyperaldostéronisme secondaire | n2=en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening | rel=r_associated | relid=0 | w=5
  3264. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor stereotypy
    n1=hyperaldostéronisme secondaire | n2=en:motor stereotypy | rel=r_associated | relid=0 | w=5
  3265. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor symptoms may be present
    n1=hyperaldostéronisme secondaire | n2=en:motor symptoms may be present | rel=r_associated | relid=0 | w=5
  3266. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:motor tic
    n1=hyperaldostéronisme secondaire | n2=en:motor tic | rel=r_associated | relid=0 | w=5
  3267. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mouth movements
    n1=hyperaldostéronisme secondaire | n2=en:mouth movements | rel=r_associated | relid=0 | w=5
  3268. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:movement abnormalities of the extremities
    n1=hyperaldostéronisme secondaire | n2=en:movement abnormalities of the extremities | rel=r_associated | relid=0 | w=5
  3269. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:movement disorder
    n1=hyperaldostéronisme secondaire | n2=en:movement disorder | rel=r_associated | relid=0 | w=5
  3270. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:movements ('tremors') characterized by 8 to 10-hz discharges
    n1=hyperaldostéronisme secondaire | n2=en:movements ('tremors') characterized by 8 to 10-hz discharges | rel=r_associated | relid=0 | w=5
  3271. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:movements are exacerbated by anxiety
    n1=hyperaldostéronisme secondaire | n2=en:movements are exacerbated by anxiety | rel=r_associated | relid=0 | w=5
  3272. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:moyamoya disease
    n1=hyperaldostéronisme secondaire | n2=en:moyamoya disease | rel=r_associated | relid=0 | w=5
  3273. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mr spectroscopy shows decreased n-acetyl aspartate
    n1=hyperaldostéronisme secondaire | n2=en:mr spectroscopy shows decreased n-acetyl aspartate | rel=r_associated | relid=0 | w=5
  3274. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri - diffuse or focal cerebral and cerebellar white matter disease
    n1=hyperaldostéronisme secondaire | n2=en:mri - diffuse or focal cerebral and cerebellar white matter disease | rel=r_associated | relid=0 | w=5
  3275. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri imaging shows cavitation of the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:mri imaging shows cavitation of the basal ganglia | rel=r_associated | relid=0 | w=5
  3276. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri is best imaging modality to detect lesions
    n1=hyperaldostéronisme secondaire | n2=en:mri is best imaging modality to detect lesions | rel=r_associated | relid=0 | w=5
  3277. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri may be normal, especially in type iib
    n1=hyperaldostéronisme secondaire | n2=en:mri may be normal, especially in type iib | rel=r_associated | relid=0 | w=5
  3278. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri may show atrophy of the cerebrum
    n1=hyperaldostéronisme secondaire | n2=en:mri may show atrophy of the cerebrum | rel=r_associated | relid=0 | w=5
  3279. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri may show lesions in basal ganglia, thalamus, and white matter
    n1=hyperaldostéronisme secondaire | n2=en:mri may show lesions in basal ganglia, thalamus, and white matter | rel=r_associated | relid=0 | w=5
  3280. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows absence of the facial nerve
    n1=hyperaldostéronisme secondaire | n2=en:mri shows absence of the facial nerve | rel=r_associated | relid=0 | w=5
  3281. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows atretic occipital cephalocele with bony skull defect
    n1=hyperaldostéronisme secondaire | n2=en:mri shows atretic occipital cephalocele with bony skull defect | rel=r_associated | relid=0 | w=5
  3282. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows brain asymmetry
    n1=hyperaldostéronisme secondaire | n2=en:mri shows brain asymmetry | rel=r_associated | relid=0 | w=5
  3283. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows brainstem hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:mri shows brainstem hypoplasia | rel=r_associated | relid=0 | w=5
  3284. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows cerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:mri shows cerebellar atrophy | rel=r_associated | relid=0 | w=5
  3285. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows cerebral atrophy
    n1=hyperaldostéronisme secondaire | n2=en:mri shows cerebral atrophy | rel=r_associated | relid=0 | w=5
  3286. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows congenital abnormalities of the posterior fossa
    n1=hyperaldostéronisme secondaire | n2=en:mri shows congenital abnormalities of the posterior fossa | rel=r_associated | relid=0 | w=5
  3287. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows decreased signal intensities in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:mri shows decreased signal intensities in the basal ganglia | rel=r_associated | relid=0 | w=5
  3288. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign)
    n1=hyperaldostéronisme secondaire | n2=en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign) | rel=r_associated | relid=0 | w=5
  3289. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows defects of the corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:mri shows defects of the corpus callosum | rel=r_associated | relid=0 | w=5
  3290. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows delayed myelination (1 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:mri shows delayed myelination (1 of 6 patients) | rel=r_associated | relid=0 | w=5
  3291. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows diffuse white matter hyperintensities on t2-weighted imaging
    n1=hyperaldostéronisme secondaire | n2=en:mri shows diffuse white matter hyperintensities on t2-weighted imaging | rel=r_associated | relid=0 | w=5
  3292. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows dysmyelination
    n1=hyperaldostéronisme secondaire | n2=en:mri shows dysmyelination | rel=r_associated | relid=0 | w=5
  3293. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows frontal and temporal cortical atrophy
    n1=hyperaldostéronisme secondaire | n2=en:mri shows frontal and temporal cortical atrophy | rel=r_associated | relid=0 | w=5
  3294. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows generalized atrophy
    n1=hyperaldostéronisme secondaire | n2=en:mri shows generalized atrophy | rel=r_associated | relid=0 | w=5
  3295. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows global lack of myelination in the cerebral hemispheres
    n1=hyperaldostéronisme secondaire | n2=en:mri shows global lack of myelination in the cerebral hemispheres | rel=r_associated | relid=0 | w=5
  3296. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows globus pallidus signal abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:mri shows globus pallidus signal abnormalities | rel=r_associated | relid=0 | w=5
  3297. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows high signal intensity of the white matter later
    n1=hyperaldostéronisme secondaire | n2=en:mri shows high signal intensity of the white matter later | rel=r_associated | relid=0 | w=5
  3298. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows hypointensity of the thalami early-on
    n1=hyperaldostéronisme secondaire | n2=en:mri shows hypointensity of the thalami early-on | rel=r_associated | relid=0 | w=5
  3299. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows increased t2-weighted signals in the globus pallidi
    n1=hyperaldostéronisme secondaire | n2=en:mri shows increased t2-weighted signals in the globus pallidi | rel=r_associated | relid=0 | w=5
  3300. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:mri shows leukoencephalopathy | rel=r_associated | relid=0 | w=5
  3301. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows no normal myelination
    n1=hyperaldostéronisme secondaire | n2=en:mri shows no normal myelination | rel=r_associated | relid=0 | w=5
  3302. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows short, thick corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:mri shows short, thick corpus callosum | rel=r_associated | relid=0 | w=5
  3303. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows subcortical leukoencephalopathy with cavitation
    n1=hyperaldostéronisme secondaire | n2=en:mri shows subcortical leukoencephalopathy with cavitation | rel=r_associated | relid=0 | w=5
  3304. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen)
    n1=hyperaldostéronisme secondaire | n2=en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen) | rel=r_associated | relid=0 | w=5
  3305. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows symmetric, diffuse lesions with csf-like signal intensity
    n1=hyperaldostéronisme secondaire | n2=en:mri shows symmetric, diffuse lesions with csf-like signal intensity | rel=r_associated | relid=0 | w=5
  3306. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows t2-weighted signals in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:mri shows t2-weighted signals in the basal ganglia | rel=r_associated | relid=0 | w=5
  3307. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mri shows white matter lesions
    n1=hyperaldostéronisme secondaire | n2=en:mri shows white matter lesions | rel=r_associated | relid=0 | w=5
  3308. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mrs shows decreased choline in affected white matter
    n1=hyperaldostéronisme secondaire | n2=en:mrs shows decreased choline in affected white matter | rel=r_associated | relid=0 | w=5
  3309. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mrs shows decreased creatine in white matter
    n1=hyperaldostéronisme secondaire | n2=en:mrs shows decreased creatine in white matter | rel=r_associated | relid=0 | w=5
  3310. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal areas of laminar dysmorphic neurons (in type iia)
    n1=hyperaldostéronisme secondaire | n2=en:multifocal areas of laminar dysmorphic neurons (in type iia) | rel=r_associated | relid=0 | w=5
  3311. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal cerebral white matter abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:multifocal cerebral white matter abnormalities | rel=r_associated | relid=0 | w=5
  3312. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal discharges
    n1=hyperaldostéronisme secondaire | n2=en:multifocal discharges | rel=r_associated | relid=0 | w=5
  3313. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal discharges associated with contralateral jerky movements
    n1=hyperaldostéronisme secondaire | n2=en:multifocal discharges associated with contralateral jerky movements | rel=r_associated | relid=0 | w=5
  3314. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal discharges seen on eeg (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:multifocal discharges seen on eeg (in some patients) | rel=r_associated | relid=0 | w=5
  3315. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal epileptic activity
    n1=hyperaldostéronisme secondaire | n2=en:multifocal epileptic activity | rel=r_associated | relid=0 | w=5
  3316. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal epileptiform discharges on diffuse slow background
    n1=hyperaldostéronisme secondaire | n2=en:multifocal epileptiform discharges on diffuse slow background | rel=r_associated | relid=0 | w=5
  3317. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal epileptiform spikes seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:multifocal epileptiform spikes seen on eeg | rel=r_associated | relid=0 | w=5
  3318. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal intractable seizures
    n1=hyperaldostéronisme secondaire | n2=en:multifocal intractable seizures | rel=r_associated | relid=0 | w=5
  3319. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal seizure
    n1=hyperaldostéronisme secondaire | n2=en:multifocal seizure | rel=r_associated | relid=0 | w=5
  3320. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal spike and wave activity
    n1=hyperaldostéronisme secondaire | n2=en:multifocal spike and wave activity | rel=r_associated | relid=0 | w=5
  3321. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal spike waves
    n1=hyperaldostéronisme secondaire | n2=en:multifocal spike waves | rel=r_associated | relid=0 | w=5
  3322. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal spikes
    n1=hyperaldostéronisme secondaire | n2=en:multifocal spikes | rel=r_associated | relid=0 | w=5
  3323. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal spikes and progressive slowing of background activity seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:multifocal spikes and progressive slowing of background activity seen on eeg | rel=r_associated | relid=0 | w=5
  3324. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multifocal white matter lesions
    n1=hyperaldostéronisme secondaire | n2=en:multifocal white matter lesions | rel=r_associated | relid=0 | w=5
  3325. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multiple aneurysms
    n1=hyperaldostéronisme secondaire | n2=en:multiple aneurysms | rel=r_associated | relid=0 | w=5
  3326. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multiple independent spike foci
    n1=hyperaldostéronisme secondaire | n2=en:multiple independent spike foci | rel=r_associated | relid=0 | w=5
  3327. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multiple lesions in the white matter
    n1=hyperaldostéronisme secondaire | n2=en:multiple lesions in the white matter | rel=r_associated | relid=0 | w=5
  3328. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multiple sclerosis
    n1=hyperaldostéronisme secondaire | n2=en:multiple sclerosis | rel=r_associated | relid=0 | w=5
  3329. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:multiple sclerosis-like illness (516003.0001)
    n1=hyperaldostéronisme secondaire | n2=en:multiple sclerosis-like illness (516003.0001) | rel=r_associated | relid=0 | w=5
  3330. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mumps
    n1=hyperaldostéronisme secondaire | n2=en:mumps | rel=r_associated | relid=0 | w=5
  3331. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:muscle atrophy | rel=r_associated | relid=0 | w=5
  3332. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle biopsy shows neurogenic changes
    n1=hyperaldostéronisme secondaire | n2=en:muscle biopsy shows neurogenic changes | rel=r_associated | relid=0 | w=5
  3333. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle cramp
    n1=hyperaldostéronisme secondaire | n2=en:muscle cramp | rel=r_associated | relid=0 | w=5
  3334. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle stiffness and rigidity, chronic, fluctuating
    n1=hyperaldostéronisme secondaire | n2=en:muscle stiffness and rigidity, chronic, fluctuating | rel=r_associated | relid=0 | w=5
  3335. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness | rel=r_associated | relid=0 | w=5
  3336. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness lower limb
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness lower limb | rel=r_associated | relid=0 | w=5
  3337. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness of limb
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness of limb | rel=r_associated | relid=0 | w=5
  3338. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy | rel=r_associated | relid=0 | w=5
  3339. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness, distal, upper and lower
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness, distal, upper and lower | rel=r_associated | relid=0 | w=5
  3340. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs | rel=r_associated | relid=0 | w=5
  3341. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy | rel=r_associated | relid=0 | w=5
  3342. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscle weakness, symmetric, proximal due to motor neuronopathy
    n1=hyperaldostéronisme secondaire | n2=en:muscle weakness, symmetric, proximal due to motor neuronopathy | rel=r_associated | relid=0 | w=5
  3343. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscular hypotonia of the trunk
    n1=hyperaldostéronisme secondaire | n2=en:muscular hypotonia of the trunk | rel=r_associated | relid=0 | w=5
  3344. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:muscular rigidity
    n1=hyperaldostéronisme secondaire | n2=en:muscular rigidity | rel=r_associated | relid=0 | w=5
  3345. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:musician's cramp
    n1=hyperaldostéronisme secondaire | n2=en:musician's cramp | rel=r_associated | relid=0 | w=5
  3346. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:mutism
    n1=hyperaldostéronisme secondaire | n2=en:mutism | rel=r_associated | relid=0 | w=5
  3347. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myasthenia gravis
    n1=hyperaldostéronisme secondaire | n2=en:myasthenia gravis | rel=r_associated | relid=0 | w=5
  3348. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myclonus (rare)
    n1=hyperaldostéronisme secondaire | n2=en:myclonus (rare) | rel=r_associated | relid=0 | w=5
  3349. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelin loss in the corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:myelin loss in the corticospinal tracts | rel=r_associated | relid=0 | w=5
  3350. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelin microvacuolation
    n1=hyperaldostéronisme secondaire | n2=en:myelin microvacuolation | rel=r_associated | relid=0 | w=5
  3351. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelin-like lamellar structures in schwann cells
    n1=hyperaldostéronisme secondaire | n2=en:myelin-like lamellar structures in schwann cells | rel=r_associated | relid=0 | w=5
  3352. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelination defect
    n1=hyperaldostéronisme secondaire | n2=en:myelination defect | rel=r_associated | relid=0 | w=5
  3353. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelination defects (type ii)
    n1=hyperaldostéronisme secondaire | n2=en:myelination defects (type ii) | rel=r_associated | relid=0 | w=5
  3354. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelomeningocele
    n1=hyperaldostéronisme secondaire | n2=en:myelomeningocele | rel=r_associated | relid=0 | w=5
  3355. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelomeningocele (less common)
    n1=hyperaldostéronisme secondaire | n2=en:myelomeningocele (less common) | rel=r_associated | relid=0 | w=5
  3356. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myelomeningocele (rare)
    n1=hyperaldostéronisme secondaire | n2=en:myelomeningocele (rare) | rel=r_associated | relid=0 | w=5
  3357. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic epilepsy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic epilepsy (1 patient) | rel=r_associated | relid=0 | w=5
  3358. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic jerk
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic jerk | rel=r_associated | relid=0 | w=5
  3359. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic jerks (less common)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic jerks (less common) | rel=r_associated | relid=0 | w=5
  3360. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic jerks (rare)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic jerks (rare) | rel=r_associated | relid=0 | w=5
  3361. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizure, refractory
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizure, refractory | rel=r_associated | relid=0 | w=5
  3362. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizures (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizures (1 patient) | rel=r_associated | relid=0 | w=5
  3363. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizures (subtype 3a)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizures (subtype 3a) | rel=r_associated | relid=0 | w=5
  3364. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizures may occur
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizures may occur | rel=r_associated | relid=0 | w=5
  3365. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizures, frequent, long-lasting (many hours)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizures, frequent, long-lasting (many hours) | rel=r_associated | relid=0 | w=5
  3366. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic seizures, progressive
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic seizures, progressive | rel=r_associated | relid=0 | w=5
  3367. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles) | rel=r_associated | relid=0 | w=5
  3368. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonic-astatic seizures
    n1=hyperaldostéronisme secondaire | n2=en:myoclonic-astatic seizures | rel=r_associated | relid=0 | w=5
  3369. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus (in 1 family) | rel=r_associated | relid=0 | w=5
  3370. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus (in a subset of patients) | rel=r_associated | relid=0 | w=5
  3371. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus (less common)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus (less common) | rel=r_associated | relid=0 | w=5
  3372. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus (subtype 3a)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus (subtype 3a) | rel=r_associated | relid=0 | w=5
  3373. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus (type i and type ii, infantile and juvenile)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus (type i and type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=5
  3374. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture)
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture) | rel=r_associated | relid=0 | w=5
  3375. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus, cortical, multifocal
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus, cortical, multifocal | rel=r_associated | relid=0 | w=5
  3376. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myoclonus, paroxysmal
    n1=hyperaldostéronisme secondaire | n2=en:myoclonus, paroxysmal | rel=r_associated | relid=0 | w=5
  3377. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myokymia
    n1=hyperaldostéronisme secondaire | n2=en:myokymia | rel=r_associated | relid=0 | w=5
  3378. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myokymia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:myokymia (in some patients) | rel=r_associated | relid=0 | w=5
  3379. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myokymia, especially facial
    n1=hyperaldostéronisme secondaire | n2=en:myokymia, especially facial | rel=r_associated | relid=0 | w=5
  3380. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myopathy
    n1=hyperaldostéronisme secondaire | n2=en:myopathy | rel=r_associated | relid=0 | w=5
  3381. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myotonia
    n1=hyperaldostéronisme secondaire | n2=en:myotonia | rel=r_associated | relid=0 | w=5
  3382. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myotonia (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:myotonia (in 1 patient) | rel=r_associated | relid=0 | w=5
  3383. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:myotonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:myotonic seizures | rel=r_associated | relid=0 | w=5
  3384. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:narcolepsy
    n1=hyperaldostéronisme secondaire | n2=en:narcolepsy | rel=r_associated | relid=0 | w=5
  3385. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neck drop
    n1=hyperaldostéronisme secondaire | n2=en:neck drop | rel=r_associated | relid=0 | w=5
  3386. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neck pain
    n1=hyperaldostéronisme secondaire | n2=en:neck pain | rel=r_associated | relid=0 | w=5
  3387. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:necrotic process
    n1=hyperaldostéronisme secondaire | n2=en:necrotic process | rel=r_associated | relid=0 | w=5
  3388. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:necrotic white matter lesions throughout the brain and brainstem
    n1=hyperaldostéronisme secondaire | n2=en:necrotic white matter lesions throughout the brain and brainstem | rel=r_associated | relid=0 | w=5
  3389. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neocortical atrophy
    n1=hyperaldostéronisme secondaire | n2=en:neocortical atrophy | rel=r_associated | relid=0 | w=5
  3390. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neocortical dysplasia (27%)
    n1=hyperaldostéronisme secondaire | n2=en:neocortical dysplasia (27%) | rel=r_associated | relid=0 | w=5
  3391. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal agitation
    n1=hyperaldostéronisme secondaire | n2=en:neonatal agitation | rel=r_associated | relid=0 | w=5
  3392. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal epileptic encephalopathy (nee)
    n1=hyperaldostéronisme secondaire | n2=en:neonatal epileptic encephalopathy (nee) | rel=r_associated | relid=0 | w=5
  3393. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:neonatal hypotonia | rel=r_associated | relid=0 | w=5
  3394. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal irresponsiveness
    n1=hyperaldostéronisme secondaire | n2=en:neonatal irresponsiveness | rel=r_associated | relid=0 | w=5
  3395. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal irritability
    n1=hyperaldostéronisme secondaire | n2=en:neonatal irritability | rel=r_associated | relid=0 | w=5
  3396. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neonatal/early-infantile onset encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:neonatal/early-infantile onset encephalopathy | rel=r_associated | relid=0 | w=5
  3397. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern
    n1=hyperaldostéronisme secondaire | n2=en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern | rel=r_associated | relid=0 | w=5
  3398. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nerve degeneration
    n1=hyperaldostéronisme secondaire | n2=en:nerve degeneration | rel=r_associated | relid=0 | w=5
  3399. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nerve paralysis
    n1=hyperaldostéronisme secondaire | n2=en:nerve paralysis | rel=r_associated | relid=0 | w=5
  3400. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nervous system disorder
    n1=hyperaldostéronisme secondaire | n2=en:nervous system disorder | rel=r_associated | relid=0 | w=5
  3401. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nervousness
    n1=hyperaldostéronisme secondaire | n2=en:nervousness | rel=r_associated | relid=0 | w=5
  3402. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neural tube defect
    n1=hyperaldostéronisme secondaire | n2=en:neural tube defect | rel=r_associated | relid=0 | w=5
  3403. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neural tube defect (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:neural tube defect (in some patients) | rel=r_associated | relid=0 | w=5
  3404. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neural tube defects (4%)
    n1=hyperaldostéronisme secondaire | n2=en:neural tube defects (4%) | rel=r_associated | relid=0 | w=5
  3405. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neural tube defects may occur
    n1=hyperaldostéronisme secondaire | n2=en:neural tube defects may occur | rel=r_associated | relid=0 | w=5
  3406. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuroaxonal abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:neuroaxonal abnormalities | rel=r_associated | relid=0 | w=5
  3407. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuroaxonal dystrophies
    n1=hyperaldostéronisme secondaire | n2=en:neuroaxonal dystrophies | rel=r_associated | relid=0 | w=5
  3408. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuroaxonal spheroids
    n1=hyperaldostéronisme secondaire | n2=en:neuroaxonal spheroids | rel=r_associated | relid=0 | w=5
  3409. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurobehavioral changes associated with hyperammonemia
    n1=hyperaldostéronisme secondaire | n2=en:neurobehavioral changes associated with hyperammonemia | rel=r_associated | relid=0 | w=5
  3410. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuroblastoma
    n1=hyperaldostéronisme secondaire | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=5
  3411. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurocognitive impairment, mild (homozygous patient)
    n1=hyperaldostéronisme secondaire | n2=en:neurocognitive impairment, mild (homozygous patient) | rel=r_associated | relid=0 | w=5
  3412. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodegeneration (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:neurodegeneration (patient a) | rel=r_associated | relid=0 | w=5
  3413. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodegeneration in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:neurodegeneration in the basal ganglia | rel=r_associated | relid=0 | w=5
  3414. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodegeneration in the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:neurodegeneration in the cerebellum | rel=r_associated | relid=0 | w=5
  3415. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodegeneration in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:neurodegeneration in the substantia nigra | rel=r_associated | relid=0 | w=5
  3416. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodegeneration leading to profound mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:neurodegeneration leading to profound mental retardation | rel=r_associated | relid=0 | w=5
  3417. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodevelopmental impairment (early-onset form)
    n1=hyperaldostéronisme secondaire | n2=en:neurodevelopmental impairment (early-onset form) | rel=r_associated | relid=0 | w=5
  3418. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurodevelopmental regression
    n1=hyperaldostéronisme secondaire | n2=en:neurodevelopmental regression | rel=r_associated | relid=0 | w=5
  3419. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibrillary degeneration (morphologic abnormality)
    n1=hyperaldostéronisme secondaire | n2=en:neurofibrillary degeneration (morphologic abnormality) | rel=r_associated | relid=0 | w=5
  3420. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibrillary mapt (tau)-positive tangles
    n1=hyperaldostéronisme secondaire | n2=en:neurofibrillary mapt (tau)-positive tangles | rel=r_associated | relid=0 | w=5
  3421. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibrillary tangles composed of disordered microtubules
    n1=hyperaldostéronisme secondaire | n2=en:neurofibrillary tangles composed of disordered microtubules | rel=r_associated | relid=0 | w=5
  3422. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibrillary tangles may be present
    n1=hyperaldostéronisme secondaire | n2=en:neurofibrillary tangles may be present | rel=r_associated | relid=0 | w=5
  3423. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels
    n1=hyperaldostéronisme secondaire | n2=en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels | rel=r_associated | relid=0 | w=5
  3424. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurofibromatosis
    n1=hyperaldostéronisme secondaire | n2=en:neurofibromatosis | rel=r_associated | relid=0 | w=5
  3425. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurogenic bladder
    n1=hyperaldostéronisme secondaire | n2=en:neurogenic bladder | rel=r_associated | relid=0 | w=5
  3426. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurogenic muscle atrophy, especially in the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:neurogenic muscle atrophy, especially in the lower limbs | rel=r_associated | relid=0 | w=5
  3427. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuroimaging shows cortical atrophy
    n1=hyperaldostéronisme secondaire | n2=en:neuroimaging shows cortical atrophy | rel=r_associated | relid=0 | w=5
  3428. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic abnormalities in about 7%
    n1=hyperaldostéronisme secondaire | n2=en:neurologic abnormalities in about 7% | rel=r_associated | relid=0 | w=5
  3429. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic crises with coma (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:neurologic crises with coma (in some patients) | rel=r_associated | relid=0 | w=5
  3430. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic decompensation
    n1=hyperaldostéronisme secondaire | n2=en:neurologic decompensation | rel=r_associated | relid=0 | w=5
  3431. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic degeneration
    n1=hyperaldostéronisme secondaire | n2=en:neurologic degeneration | rel=r_associated | relid=0 | w=5
  3432. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic deterioration in longterm survivors
    n1=hyperaldostéronisme secondaire | n2=en:neurologic deterioration in longterm survivors | rel=r_associated | relid=0 | w=5
  3433. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic dysfunction, progressive
    n1=hyperaldostéronisme secondaire | n2=en:neurologic dysfunction, progressive | rel=r_associated | relid=0 | w=5
  3434. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic involvement (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:neurologic involvement (in some patients) | rel=r_associated | relid=0 | w=5
  3435. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic involvement is rare
    n1=hyperaldostéronisme secondaire | n2=en:neurologic involvement is rare | rel=r_associated | relid=0 | w=5
  3436. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic regression
    n1=hyperaldostéronisme secondaire | n2=en:neurologic regression | rel=r_associated | relid=0 | w=5
  3437. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic regression after age 2 years
    n1=hyperaldostéronisme secondaire | n2=en:neurologic regression after age 2 years | rel=r_associated | relid=0 | w=5
  3438. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic regression after prolonged episodes
    n1=hyperaldostéronisme secondaire | n2=en:neurologic regression after prolonged episodes | rel=r_associated | relid=0 | w=5
  3439. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic regression around age 3 months
    n1=hyperaldostéronisme secondaire | n2=en:neurologic regression around age 3 months | rel=r_associated | relid=0 | w=5
  3440. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic regression following seizure onset
    n1=hyperaldostéronisme secondaire | n2=en:neurologic regression following seizure onset | rel=r_associated | relid=0 | w=5
  3441. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic sequelae not always present
    n1=hyperaldostéronisme secondaire | n2=en:neurologic sequelae not always present | rel=r_associated | relid=0 | w=5
  3442. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic sequelae of stroke
    n1=hyperaldostéronisme secondaire | n2=en:neurologic sequelae of stroke | rel=r_associated | relid=0 | w=5
  3443. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurologic symptoms, if present, usually result from associated syringomyelia
    n1=hyperaldostéronisme secondaire | n2=en:neurologic symptoms, if present, usually result from associated syringomyelia | rel=r_associated | relid=0 | w=5
  3444. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurological development terminology
    n1=hyperaldostéronisme secondaire | n2=en:neurological development terminology | rel=r_associated | relid=0 | w=5
  3445. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuromuscular diseases
    n1=hyperaldostéronisme secondaire | n2=en:neuromuscular diseases | rel=r_associated | relid=0 | w=5
  3446. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuromuscular disturbances, progressive
    n1=hyperaldostéronisme secondaire | n2=en:neuromuscular disturbances, progressive | rel=r_associated | relid=0 | w=5
  3447. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuron apoptotic process
    n1=hyperaldostéronisme secondaire | n2=en:neuron apoptotic process | rel=r_associated | relid=0 | w=5
  3448. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuron loss
    n1=hyperaldostéronisme secondaire | n2=en:neuron loss | rel=r_associated | relid=0 | w=5
  3449. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal and vascular calcifications
    n1=hyperaldostéronisme secondaire | n2=en:neuronal and vascular calcifications | rel=r_associated | relid=0 | w=5
  3450. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:neuronal heterotopia | rel=r_associated | relid=0 | w=5
  3451. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal inclusion bodies stain for neuroserpin
    n1=hyperaldostéronisme secondaire | n2=en:neuronal inclusion bodies stain for neuroserpin | rel=r_associated | relid=0 | w=5
  3452. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss (patient a) | rel=r_associated | relid=0 | w=5
  3453. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss and gliosis in caudate and putamen
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss and gliosis in caudate and putamen | rel=r_associated | relid=0 | w=5
  3454. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss and gliosis in the cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss and gliosis in the cerebral cortex | rel=r_associated | relid=0 | w=5
  3455. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss and gliosis in the dentate nucleus
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss and gliosis in the dentate nucleus | rel=r_associated | relid=0 | w=5
  3456. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss and gliosis in the inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss and gliosis in the inferior olives | rel=r_associated | relid=0 | w=5
  3457. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss and gliosis in the substantia nigra pars compacta
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss and gliosis in the substantia nigra pars compacta | rel=r_associated | relid=0 | w=5
  3458. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in basal ganglia | rel=r_associated | relid=0 | w=5
  3459. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in central nervous system | rel=r_associated | relid=0 | w=5
  3460. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the brainstem
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the brainstem | rel=r_associated | relid=0 | w=5
  3461. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the cerebral cortex | rel=r_associated | relid=0 | w=5
  3462. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the cerebrum and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the cerebrum and cerebellum | rel=r_associated | relid=0 | w=5
  3463. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the dentate nuclei
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the dentate nuclei | rel=r_associated | relid=0 | w=5
  3464. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the hippocampus
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the hippocampus | rel=r_associated | relid=0 | w=5
  3465. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the inferior olives | rel=r_associated | relid=0 | w=5
  3466. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the locus ceruleus
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the locus ceruleus | rel=r_associated | relid=0 | w=5
  3467. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the purkinje cell layer of the cerebellar vermis
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the purkinje cell layer of the cerebellar vermis | rel=r_associated | relid=0 | w=5
  3468. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients) | rel=r_associated | relid=0 | w=5
  3469. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives | rel=r_associated | relid=0 | w=5
  3470. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss in the substantia nigra | rel=r_associated | relid=0 | w=5
  3471. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss, diffuse
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss, diffuse | rel=r_associated | relid=0 | w=5
  3472. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal loss, particularly of cerebellar purkinje cells
    n1=hyperaldostéronisme secondaire | n2=en:neuronal loss, particularly of cerebellar purkinje cells | rel=r_associated | relid=0 | w=5
  3473. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal migration defect
    n1=hyperaldostéronisme secondaire | n2=en:neuronal migration defect | rel=r_associated | relid=0 | w=5
  3474. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuronal migration disorder
    n1=hyperaldostéronisme secondaire | n2=en:neuronal migration disorder | rel=r_associated | relid=0 | w=5
  3475. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathologic examination shows calcification of the small brain vessels
    n1=hyperaldostéronisme secondaire | n2=en:neuropathologic examination shows calcification of the small brain vessels | rel=r_associated | relid=0 | w=5
  3476. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathologic examination shows extensive spongiosis and gliosis
    n1=hyperaldostéronisme secondaire | n2=en:neuropathologic examination shows extensive spongiosis and gliosis | rel=r_associated | relid=0 | w=5
  3477. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathologic examination shows severe demyelination
    n1=hyperaldostéronisme secondaire | n2=en:neuropathologic examination shows severe demyelination | rel=r_associated | relid=0 | w=5
  3478. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially)
    n1=hyperaldostéronisme secondaire | n2=en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially) | rel=r_associated | relid=0 | w=5
  3479. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells | rel=r_associated | relid=0 | w=5
  3480. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows diffuse demyelination of the cerebral white matter
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows diffuse demyelination of the cerebral white matter | rel=r_associated | relid=0 | w=5
  3481. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes | rel=r_associated | relid=0 | w=5
  3482. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows neuronal degeneration
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows neuronal degeneration | rel=r_associated | relid=0 | w=5
  3483. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum | rel=r_associated | relid=0 | w=5
  3484. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum | rel=r_associated | relid=0 | w=5
  3485. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurophysiologic abnormalities (eeg, sep, vep)
    n1=hyperaldostéronisme secondaire | n2=en:neurophysiologic abnormalities (eeg, sep, vep) | rel=r_associated | relid=0 | w=5
  3486. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurophysiologic abnormalities (eeg, vep, sep)
    n1=hyperaldostéronisme secondaire | n2=en:neurophysiologic abnormalities (eeg, vep, sep) | rel=r_associated | relid=0 | w=5
  3487. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurophysiologic studies show evidence of denervation and renervation
    n1=hyperaldostéronisme secondaire | n2=en:neurophysiologic studies show evidence of denervation and renervation | rel=r_associated | relid=0 | w=5
  3488. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropil
    n1=hyperaldostéronisme secondaire | n2=en:neuropil | rel=r_associated | relid=0 | w=5
  3489. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropsychologic cognitive abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:neuropsychologic cognitive abnormalities | rel=r_associated | relid=0 | w=5
  3490. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neuropsychologic impairment
    n1=hyperaldostéronisme secondaire | n2=en:neuropsychologic impairment | rel=r_associated | relid=0 | w=5
  3491. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurosarcoidosis (5-16% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:neurosarcoidosis (5-16% of patients) | rel=r_associated | relid=0 | w=5
  3492. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurosis
    n1=hyperaldostéronisme secondaire | n2=en:neurosis | rel=r_associated | relid=0 | w=5
  3493. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurotic disorders, personality disorders, and other nonpsychotic mental disorders
    n1=hyperaldostéronisme secondaire | n2=en:neurotic disorders, personality disorders, and other nonpsychotic mental disorders | rel=r_associated | relid=0 | w=5
  3494. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurotic, personality, or other mental disorder
    n1=hyperaldostéronisme secondaire | n2=en:neurotic, personality, or other mental disorder | rel=r_associated | relid=0 | w=5
  3495. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:neurotic, stress-related and somatoform disorders
    n1=hyperaldostéronisme secondaire | n2=en:neurotic, stress-related and somatoform disorders | rel=r_associated | relid=0 | w=5
  3496. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:never able to walk
    n1=hyperaldostéronisme secondaire | n2=en:never able to walk | rel=r_associated | relid=0 | w=5
  3497. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:never learn to walk (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:never learn to walk (some patients) | rel=r_associated | relid=0 | w=5
  3498. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:newborn screening
    n1=hyperaldostéronisme secondaire | n2=en:newborn screening | rel=r_associated | relid=0 | w=5
  3499. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nigrostriatal degeneration
    n1=hyperaldostéronisme secondaire | n2=en:nigrostriatal degeneration | rel=r_associated | relid=0 | w=5
  3500. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no amyloid plaques
    n1=hyperaldostéronisme secondaire | n2=en:no amyloid plaques | rel=r_associated | relid=0 | w=5
  3501. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no autism
    n1=hyperaldostéronisme secondaire | n2=en:no autism | rel=r_associated | relid=0 | w=5
  3502. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no autistic features
    n1=hyperaldostéronisme secondaire | n2=en:no autistic features | rel=r_associated | relid=0 | w=5
  3503. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no bulbar involvement
    n1=hyperaldostéronisme secondaire | n2=en:no bulbar involvement | rel=r_associated | relid=0 | w=5
  3504. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no central nervous system abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:no central nervous system abnormalities | rel=r_associated | relid=0 | w=5
  3505. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no cerebellar signs
    n1=hyperaldostéronisme secondaire | n2=en:no cerebellar signs | rel=r_associated | relid=0 | w=5
  3506. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no cerebellar vermis aplasia/hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:no cerebellar vermis aplasia/hypoplasia | rel=r_associated | relid=0 | w=5
  3507. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no cognitive decline
    n1=hyperaldostéronisme secondaire | n2=en:no cognitive decline | rel=r_associated | relid=0 | w=5
  3508. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no dementia
    n1=hyperaldostéronisme secondaire | n2=en:no dementia | rel=r_associated | relid=0 | w=5
  3509. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no development
    n1=hyperaldostéronisme secondaire | n2=en:no development | rel=r_associated | relid=0 | w=5
  3510. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no developmental progress
    n1=hyperaldostéronisme secondaire | n2=en:no developmental progress | rel=r_associated | relid=0 | w=5
  3511. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no gaze contact
    n1=hyperaldostéronisme secondaire | n2=en:no gaze contact | rel=r_associated | relid=0 | w=5
  3512. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no head control
    n1=hyperaldostéronisme secondaire | n2=en:no head control | rel=r_associated | relid=0 | w=5
  3513. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no hippocampal sclerosis
    n1=hyperaldostéronisme secondaire | n2=en:no hippocampal sclerosis | rel=r_associated | relid=0 | w=5
  3514. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no hydrocephalus
    n1=hyperaldostéronisme secondaire | n2=en:no hydrocephalus | rel=r_associated | relid=0 | w=5
  3515. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no language
    n1=hyperaldostéronisme secondaire | n2=en:no language | rel=r_associated | relid=0 | w=5
  3516. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no language development
    n1=hyperaldostéronisme secondaire | n2=en:no language development | rel=r_associated | relid=0 | w=5
  3517. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no lewy bodies
    n1=hyperaldostéronisme secondaire | n2=en:no lewy bodies | rel=r_associated | relid=0 | w=5
  3518. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:no mental retardation | rel=r_associated | relid=0 | w=5
  3519. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no motor skills acquired (in some)
    n1=hyperaldostéronisme secondaire | n2=en:no motor skills acquired (in some) | rel=r_associated | relid=0 | w=5
  3520. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:no myoclonus | rel=r_associated | relid=0 | w=5
  3521. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no neurofibrillary tangles
    n1=hyperaldostéronisme secondaire | n2=en:no neurofibrillary tangles | rel=r_associated | relid=0 | w=5
  3522. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no neurofibromas
    n1=hyperaldostéronisme secondaire | n2=en:no neurofibromas | rel=r_associated | relid=0 | w=5
  3523. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no other neurologic deficits
    n1=hyperaldostéronisme secondaire | n2=en:no other neurologic deficits | rel=r_associated | relid=0 | w=5
  3524. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no other neurologic disorder
    n1=hyperaldostéronisme secondaire | n2=en:no other neurologic disorder | rel=r_associated | relid=0 | w=5
  3525. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no overt seizures
    n1=hyperaldostéronisme secondaire | n2=en:no overt seizures | rel=r_associated | relid=0 | w=5
  3526. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no pick bodies or lewy bodies
    n1=hyperaldostéronisme secondaire | n2=en:no pick bodies or lewy bodies | rel=r_associated | relid=0 | w=5
  3527. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no response to l-dopa treatment
    n1=hyperaldostéronisme secondaire | n2=en:no response to l-dopa treatment | rel=r_associated | relid=0 | w=5
  3528. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no seizures
    n1=hyperaldostéronisme secondaire | n2=en:no seizures | rel=r_associated | relid=0 | w=5
  3529. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no seizures (hcs)
    n1=hyperaldostéronisme secondaire | n2=en:no seizures (hcs) | rel=r_associated | relid=0 | w=5
  3530. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no sensory deficit
    n1=hyperaldostéronisme secondaire | n2=en:no sensory deficit | rel=r_associated | relid=0 | w=5
  3531. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no sensory symptoms
    n1=hyperaldostéronisme secondaire | n2=en:no sensory symptoms | rel=r_associated | relid=0 | w=5
  3532. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no social interaction
    n1=hyperaldostéronisme secondaire | n2=en:no social interaction | rel=r_associated | relid=0 | w=5
  3533. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no speech acquisition
    n1=hyperaldostéronisme secondaire | n2=en:no speech acquisition | rel=r_associated | relid=0 | w=5
  3534. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no speech development (in most patients)
    n1=hyperaldostéronisme secondaire | n2=en:no speech development (in most patients) | rel=r_associated | relid=0 | w=5
  3535. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no speech problem
    n1=hyperaldostéronisme secondaire | n2=en:no speech problem | rel=r_associated | relid=0 | w=5
  3536. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no spontaneous movements
    n1=hyperaldostéronisme secondaire | n2=en:no spontaneous movements | rel=r_associated | relid=0 | w=5
  3537. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no structural brain abnormalities seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:no structural brain abnormalities seen on mri | rel=r_associated | relid=0 | w=5
  3538. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no structural brain anomalies
    n1=hyperaldostéronisme secondaire | n2=en:no structural brain anomalies | rel=r_associated | relid=0 | w=5
  3539. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no tau pathology
    n1=hyperaldostéronisme secondaire | n2=en:no tau pathology | rel=r_associated | relid=0 | w=5
  3540. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no tremor
    n1=hyperaldostéronisme secondaire | n2=en:no tremor | rel=r_associated | relid=0 | w=5
  3541. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no verbal language development (in sister)
    n1=hyperaldostéronisme secondaire | n2=en:no verbal language development (in sister) | rel=r_associated | relid=0 | w=5
  3542. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no visual fixation
    n1=hyperaldostéronisme secondaire | n2=en:no visual fixation | rel=r_associated | relid=0 | w=5
  3543. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:no voluntary movement
    n1=hyperaldostéronisme secondaire | n2=en:no voluntary movement | rel=r_associated | relid=0 | w=5
  3544. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal enuresis
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal enuresis | rel=r_associated | relid=0 | w=5
  3545. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal occurrence
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal occurrence | rel=r_associated | relid=0 | w=5
  3546. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal occurrence, usually during light sleep
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal occurrence, usually during light sleep | rel=r_associated | relid=0 | w=5
  3547. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal seizures
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal seizures | rel=r_associated | relid=0 | w=5
  3548. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal seizures (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal seizures (in some patients) | rel=r_associated | relid=0 | w=5
  3549. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nocturnal sleep disruption
    n1=hyperaldostéronisme secondaire | n2=en:nocturnal sleep disruption | rel=r_associated | relid=0 | w=5
  3550. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodding of head
    n1=hyperaldostéronisme secondaire | n2=en:nodding of head | rel=r_associated | relid=0 | w=5
  3551. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodular heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:nodular heterotopia | rel=r_associated | relid=0 | w=5
  3552. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodular heterotopia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:nodular heterotopia (in some patients) | rel=r_associated | relid=0 | w=5
  3553. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodular heterotopia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:nodular heterotopia (less common) | rel=r_associated | relid=0 | w=5
  3554. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodular heterotopia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:nodular heterotopia (rare) | rel=r_associated | relid=0 | w=5
  3555. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nodular heterotopia of the grey matter
    n1=hyperaldostéronisme secondaire | n2=en:nodular heterotopia of the grey matter | rel=r_associated | relid=0 | w=5
  3556. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:non-febrile seizures later
    n1=hyperaldostéronisme secondaire | n2=en:non-febrile seizures later | rel=r_associated | relid=0 | w=5
  3557. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:non-purposeful arm movements, choreoathetoid-like
    n1=hyperaldostéronisme secondaire | n2=en:non-purposeful arm movements, choreoathetoid-like | rel=r_associated | relid=0 | w=5
  3558. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:non-stimulant drug therapy for attention deficit hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:non-stimulant drug therapy for attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=5
  3559. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nonprogressive cerebellar ataxia
    n1=hyperaldostéronisme secondaire | n2=en:nonprogressive cerebellar ataxia | rel=r_associated | relid=0 | w=5
  3560. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nonsensical speech accompanying visual hallucinations (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:nonsensical speech accompanying visual hallucinations (in some patients) | rel=r_associated | relid=0 | w=5
  3561. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nonspecific leukoencephalopathy (52%)
    n1=hyperaldostéronisme secondaire | n2=en:nonspecific leukoencephalopathy (52%) | rel=r_associated | relid=0 | w=5
  3562. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nonspecific spongiform degeneration
    n1=hyperaldostéronisme secondaire | n2=en:nonspecific spongiform degeneration | rel=r_associated | relid=0 | w=5
  3563. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nonverbal (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:nonverbal (in some patients) | rel=r_associated | relid=0 | w=5
  3564. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal brain mri or ct scan
    n1=hyperaldostéronisme secondaire | n2=en:normal brain mri or ct scan | rel=r_associated | relid=0 | w=5
  3565. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal cognition (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:normal cognition (1 patient) | rel=r_associated | relid=0 | w=5
  3566. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal cognition (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:normal cognition (in some patients) | rel=r_associated | relid=0 | w=5
  3567. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal cognition (reported in 1 patient who survived to age 20 years)
    n1=hyperaldostéronisme secondaire | n2=en:normal cognition (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=5
  3568. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal cognition (reported in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:normal cognition (reported in some patients) | rel=r_associated | relid=0 | w=5
  3569. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal cognition and intellectual function
    n1=hyperaldostéronisme secondaire | n2=en:normal cognition and intellectual function | rel=r_associated | relid=0 | w=5
  3570. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal development
    n1=hyperaldostéronisme secondaire | n2=en:normal development | rel=r_associated | relid=0 | w=5
  3571. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal development (in 2 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:normal development (in 2 of 6 patients) | rel=r_associated | relid=0 | w=5
  3572. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal development in some patients
    n1=hyperaldostéronisme secondaire | n2=en:normal development in some patients | rel=r_associated | relid=0 | w=5
  3573. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal development until 6-18 months
    n1=hyperaldostéronisme secondaire | n2=en:normal development until 6-18 months | rel=r_associated | relid=0 | w=5
  3574. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal early development
    n1=hyperaldostéronisme secondaire | n2=en:normal early development | rel=r_associated | relid=0 | w=5
  3575. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal early development, up to 8 to 15 months of age
    n1=hyperaldostéronisme secondaire | n2=en:normal early development, up to 8 to 15 months of age | rel=r_associated | relid=0 | w=5
  3576. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal early developmental milestones
    n1=hyperaldostéronisme secondaire | n2=en:normal early developmental milestones | rel=r_associated | relid=0 | w=5
  3577. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal early psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:normal early psychomotor development | rel=r_associated | relid=0 | w=5
  3578. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal fine motor activity
    n1=hyperaldostéronisme secondaire | n2=en:normal fine motor activity | rel=r_associated | relid=0 | w=5
  3579. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal initial psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:normal initial psychomotor development | rel=r_associated | relid=0 | w=5
  3580. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intellectual development
    n1=hyperaldostéronisme secondaire | n2=en:normal intellectual development | rel=r_associated | relid=0 | w=5
  3581. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intellectual function
    n1=hyperaldostéronisme secondaire | n2=en:normal intellectual function | rel=r_associated | relid=0 | w=5
  3582. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence (in some patients) | rel=r_associated | relid=0 | w=5
  3583. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence (majority)
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence (majority) | rel=r_associated | relid=0 | w=5
  3584. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence in carrier females
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence in carrier females | rel=r_associated | relid=0 | w=5
  3585. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence in iib
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence in iib | rel=r_associated | relid=0 | w=5
  3586. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence in majority
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence in majority | rel=r_associated | relid=0 | w=5
  3587. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence in most cases
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence in most cases | rel=r_associated | relid=0 | w=5
  3588. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal intelligence to mild or moderate mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:normal intelligence to mild or moderate mental retardation | rel=r_associated | relid=0 | w=5
  3589. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal interictal eeg
    n1=hyperaldostéronisme secondaire | n2=en:normal interictal eeg | rel=r_associated | relid=0 | w=5
  3590. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal interictal neurologic examination
    n1=hyperaldostéronisme secondaire | n2=en:normal interictal neurologic examination | rel=r_associated | relid=0 | w=5
  3591. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal iq in infancy, then iq drops with age
    n1=hyperaldostéronisme secondaire | n2=en:normal iq in infancy, then iq drops with age | rel=r_associated | relid=0 | w=5
  3592. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal mental development
    n1=hyperaldostéronisme secondaire | n2=en:normal mental development | rel=r_associated | relid=0 | w=5
  3593. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal motor conduction studies (initially)
    n1=hyperaldostéronisme secondaire | n2=en:normal motor conduction studies (initially) | rel=r_associated | relid=0 | w=5
  3594. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal motor development
    n1=hyperaldostéronisme secondaire | n2=en:normal motor development | rel=r_associated | relid=0 | w=5
  3595. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal muscle strength
    n1=hyperaldostéronisme secondaire | n2=en:normal muscle strength | rel=r_associated | relid=0 | w=5
  3596. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal neurologic development in most cases
    n1=hyperaldostéronisme secondaire | n2=en:normal neurologic development in most cases | rel=r_associated | relid=0 | w=5
  3597. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal neurological development is possible
    n1=hyperaldostéronisme secondaire | n2=en:normal neurological development is possible | rel=r_associated | relid=0 | w=5
  3598. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal neuromuscular studies
    n1=hyperaldostéronisme secondaire | n2=en:normal neuromuscular studies | rel=r_associated | relid=0 | w=5
  3599. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:normal psychomotor development | rel=r_associated | relid=0 | w=5
  3600. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal psychomotor development in most
    n1=hyperaldostéronisme secondaire | n2=en:normal psychomotor development in most | rel=r_associated | relid=0 | w=5
  3601. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal psychomotor development until age 2 to 3 years
    n1=hyperaldostéronisme secondaire | n2=en:normal psychomotor development until age 2 to 3 years | rel=r_associated | relid=0 | w=5
  3602. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal sleep-onset time (normal time of falling asleep)
    n1=hyperaldostéronisme secondaire | n2=en:normal sleep-onset time (normal time of falling asleep) | rel=r_associated | relid=0 | w=5
  3603. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal to mild mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:normal to mild mental retardation | rel=r_associated | relid=0 | w=5
  3604. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal to mildly delayed development
    n1=hyperaldostéronisme secondaire | n2=en:normal to mildly delayed development | rel=r_associated | relid=0 | w=5
  3605. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:normal, timely language development
    n1=hyperaldostéronisme secondaire | n2=en:normal, timely language development | rel=r_associated | relid=0 | w=5
  3606. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:notable friendly behavior
    n1=hyperaldostéronisme secondaire | n2=en:notable friendly behavior | rel=r_associated | relid=0 | w=5
  3607. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nuclear magnetic resonance imaging brain normal
    n1=hyperaldostéronisme secondaire | n2=en:nuclear magnetic resonance imaging brain normal | rel=r_associated | relid=0 | w=5
  3608. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:numbness
    n1=hyperaldostéronisme secondaire | n2=en:numbness | rel=r_associated | relid=0 | w=5
  3609. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nystagmus decreases on convergence
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus decreases on convergence | rel=r_associated | relid=0 | w=5
  3610. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit
    n1=hyperaldostéronisme secondaire | n2=en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit | rel=r_associated | relid=0 | w=5
  3611. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsession
    n1=hyperaldostéronisme secondaire | n2=en:obsession | rel=r_associated | relid=0 | w=5
  3612. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive behaviour (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:obsessive behaviour (in some patients) | rel=r_associated | relid=0 | w=5
  3613. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive compulsive behavior
    n1=hyperaldostéronisme secondaire | n2=en:obsessive compulsive behavior | rel=r_associated | relid=0 | w=5
  3614. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive compulsive behavior (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:obsessive compulsive behavior (1 patient) | rel=r_associated | relid=0 | w=5
  3615. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive compulsive disorder
    n1=hyperaldostéronisme secondaire | n2=en:obsessive compulsive disorder | rel=r_associated | relid=0 | w=5
  3616. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive features
    n1=hyperaldostéronisme secondaire | n2=en:obsessive features | rel=r_associated | relid=0 | w=5
  3617. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive tendencies
    n1=hyperaldostéronisme secondaire | n2=en:obsessive tendencies | rel=r_associated | relid=0 | w=5
  3618. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obsessive-compulsive trait
    n1=hyperaldostéronisme secondaire | n2=en:obsessive-compulsive trait | rel=r_associated | relid=0 | w=5
  3619. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obstruction of the foramen of monro (variable)
    n1=hyperaldostéronisme secondaire | n2=en:obstruction of the foramen of monro (variable) | rel=r_associated | relid=0 | w=5
  3620. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:obtundation
    n1=hyperaldostéronisme secondaire | n2=en:obtundation | rel=r_associated | relid=0 | w=5
  3621. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occasional degeneration of the globus pallidus
    n1=hyperaldostéronisme secondaire | n2=en:occasional degeneration of the globus pallidus | rel=r_associated | relid=0 | w=5
  3622. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital dermal sinus tract
    n1=hyperaldostéronisme secondaire | n2=en:occipital dermal sinus tract | rel=r_associated | relid=0 | w=5
  3623. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital encephalocele (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:occipital encephalocele (in some patients) | rel=r_associated | relid=0 | w=5
  3624. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital encephalocele (wws)
    n1=hyperaldostéronisme secondaire | n2=en:occipital encephalocele (wws) | rel=r_associated | relid=0 | w=5
  3625. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital encephaloceles
    n1=hyperaldostéronisme secondaire | n2=en:occipital encephaloceles | rel=r_associated | relid=0 | w=5
  3626. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital headache
    n1=hyperaldostéronisme secondaire | n2=en:occipital headache | rel=r_associated | relid=0 | w=5
  3627. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital lobe atrophy
    n1=hyperaldostéronisme secondaire | n2=en:occipital lobe atrophy | rel=r_associated | relid=0 | w=5
  3628. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital lobe infarct (rare)
    n1=hyperaldostéronisme secondaire | n2=en:occipital lobe infarct (rare) | rel=r_associated | relid=0 | w=5
  3629. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital meningocele
    n1=hyperaldostéronisme secondaire | n2=en:occipital meningocele | rel=r_associated | relid=0 | w=5
  3630. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital meningocele (less common)
    n1=hyperaldostéronisme secondaire | n2=en:occipital meningocele (less common) | rel=r_associated | relid=0 | w=5
  3631. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital myelomeningocele (less common)
    n1=hyperaldostéronisme secondaire | n2=en:occipital myelomeningocele (less common) | rel=r_associated | relid=0 | w=5
  3632. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occipital neural tube defects
    n1=hyperaldostéronisme secondaire | n2=en:occipital neural tube defects | rel=r_associated | relid=0 | w=5
  3633. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occlusive hydrocephalus, congenital
    n1=hyperaldostéronisme secondaire | n2=en:occlusive hydrocephalus, congenital | rel=r_associated | relid=0 | w=5
  3634. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:occurs most often during the night or early morning
    n1=hyperaldostéronisme secondaire | n2=en:occurs most often during the night or early morning | rel=r_associated | relid=0 | w=5
  3635. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ocular motility spared
    n1=hyperaldostéronisme secondaire | n2=en:ocular motility spared | rel=r_associated | relid=0 | w=5
  3636. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ocular muscle abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:ocular muscle abnormalities | rel=r_associated | relid=0 | w=5
  3637. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ocular palsies
    n1=hyperaldostéronisme secondaire | n2=en:ocular palsies | rel=r_associated | relid=0 | w=5
  3638. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:olfactory lobe agenesis
    n1=hyperaldostéronisme secondaire | n2=en:olfactory lobe agenesis | rel=r_associated | relid=0 | w=5
  3639. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:olfactory or auditory hallucinations
    n1=hyperaldostéronisme secondaire | n2=en:olfactory or auditory hallucinations | rel=r_associated | relid=0 | w=5
  3640. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:oligodendrocytes with foamy cytoplasm
    n1=hyperaldostéronisme secondaire | n2=en:oligodendrocytes with foamy cytoplasm | rel=r_associated | relid=0 | w=5
  3641. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:olivopontocerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:olivopontocerebellar atrophy | rel=r_associated | relid=0 | w=5
  3642. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:olivopontocerebellar hypoplasia, fetal-onset
    n1=hyperaldostéronisme secondaire | n2=en:olivopontocerebellar hypoplasia, fetal-onset | rel=r_associated | relid=0 | w=5
  3643. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:olivopontocerebellar hypoplasia, severe
    n1=hyperaldostéronisme secondaire | n2=en:olivopontocerebellar hypoplasia, severe | rel=r_associated | relid=0 | w=5
  3644. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:only some achieve rolling or sitting
    n1=hyperaldostéronisme secondaire | n2=en:only some achieve rolling or sitting | rel=r_associated | relid=0 | w=5
  3645. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:only walking achieved
    n1=hyperaldostéronisme secondaire | n2=en:only walking achieved | rel=r_associated | relid=0 | w=5
  3646. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:onset may be triggered by emotional stress, fever, exercise, exposure to heat
    n1=hyperaldostéronisme secondaire | n2=en:onset may be triggered by emotional stress, fever, exercise, exposure to heat | rel=r_associated | relid=0 | w=5
  3647. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:onychotillomania
    n1=hyperaldostéronisme secondaire | n2=en:onychotillomania | rel=r_associated | relid=0 | w=5
  3648. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:open operculum
    n1=hyperaldostéronisme secondaire | n2=en:open operculum | rel=r_associated | relid=0 | w=5
  3649. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:open spina bifida (myelomeningocele, 182940)
    n1=hyperaldostéronisme secondaire | n2=en:open spina bifida (myelomeningocele, 182940) | rel=r_associated | relid=0 | w=5
  3650. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:open sylvian fissures
    n1=hyperaldostéronisme secondaire | n2=en:open sylvian fissures | rel=r_associated | relid=0 | w=5
  3651. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:opisthotonic posturing
    n1=hyperaldostéronisme secondaire | n2=en:opisthotonic posturing | rel=r_associated | relid=0 | w=5
  3652. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:opisthotonos (type ii)
    n1=hyperaldostéronisme secondaire | n2=en:opisthotonos (type ii) | rel=r_associated | relid=0 | w=5
  3653. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:opisthotonus
    n1=hyperaldostéronisme secondaire | n2=en:opisthotonus | rel=r_associated | relid=0 | w=5
  3654. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:oppositional defiant disorder
    n1=hyperaldostéronisme secondaire | n2=en:oppositional defiant disorder | rel=r_associated | relid=0 | w=5
  3655. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:opsoclonus
    n1=hyperaldostéronisme secondaire | n2=en:opsoclonus | rel=r_associated | relid=0 | w=5
  3656. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:optic ataxia (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:optic ataxia (in a subset of patients) | rel=r_associated | relid=0 | w=5
  3657. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:optic tract agenesis
    n1=hyperaldostéronisme secondaire | n2=en:optic tract agenesis | rel=r_associated | relid=0 | w=5
  3658. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:optic tract and chiasm hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:optic tract and chiasm hypoplasia | rel=r_associated | relid=0 | w=5
  3659. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:oral behavior
    n1=hyperaldostéronisme secondaire | n2=en:oral behavior | rel=r_associated | relid=0 | w=5
  3660. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:organic writer's cramp
    n1=hyperaldostéronisme secondaire | n2=en:organic writer's cramp | rel=r_associated | relid=0 | w=5
  3661. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:organic, including symptomatic, mental disorders
    n1=hyperaldostéronisme secondaire | n2=en:organic, including symptomatic, mental disorders | rel=r_associated | relid=0 | w=5
  3662. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:orofacial dyspraxia, linguistic and nonlinguistic
    n1=hyperaldostéronisme secondaire | n2=en:orofacial dyspraxia, linguistic and nonlinguistic | rel=r_associated | relid=0 | w=5
  3663. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:orofacial dystonia
    n1=hyperaldostéronisme secondaire | n2=en:orofacial dystonia | rel=r_associated | relid=0 | w=5
  3664. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:oromandibular dystonia
    n1=hyperaldostéronisme secondaire | n2=en:oromandibular dystonia | rel=r_associated | relid=0 | w=5
  3665. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:orthostatic hypotension
    n1=hyperaldostéronisme secondaire | n2=en:orthostatic hypotension | rel=r_associated | relid=0 | w=5
  3666. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ossification of the faux cerebri (less common)
    n1=hyperaldostéronisme secondaire | n2=en:ossification of the faux cerebri (less common) | rel=r_associated | relid=0 | w=5
  3667. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other auras may occur
    n1=hyperaldostéronisme secondaire | n2=en:other auras may occur | rel=r_associated | relid=0 | w=5
  3668. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
    n1=hyperaldostéronisme secondaire | n2=en:other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | rel=r_associated | relid=0 | w=5
  3669. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other cranial nerves may be involved
    n1=hyperaldostéronisme secondaire | n2=en:other cranial nerves may be involved | rel=r_associated | relid=0 | w=5
  3670. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other hyperkinetic disorders
    n1=hyperaldostéronisme secondaire | n2=en:other hyperkinetic disorders | rel=r_associated | relid=0 | w=5
  3671. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other seizure types (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:other seizure types (in some patients) | rel=r_associated | relid=0 | w=5
  3672. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:other specified manifestations of hyperkinetic syndrome
    n1=hyperaldostéronisme secondaire | n2=en:other specified manifestations of hyperkinetic syndrome | rel=r_associated | relid=0 | w=5
  3673. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:outbursts
    n1=hyperaldostéronisme secondaire | n2=en:outbursts | rel=r_associated | relid=0 | w=5
  3674. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:over time, white matter vanishes and is replaced by csf
    n1=hyperaldostéronisme secondaire | n2=en:over time, white matter vanishes and is replaced by csf | rel=r_associated | relid=0 | w=5
  3675. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:overaction of oculomotor muscle
    n1=hyperaldostéronisme secondaire | n2=en:overaction of oculomotor muscle | rel=r_associated | relid=0 | w=5
  3676. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:overactive bladder (OAB)
    n1=hyperaldostéronisme secondaire | n2=en:overactive bladder (OAB) | rel=r_associated | relid=0 | w=5
  3677. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:overactive child
    n1=hyperaldostéronisme secondaire | n2=en:overactive child | rel=r_associated | relid=0 | w=5
  3678. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:overactivity/inattention behavior management
    n1=hyperaldostéronisme secondaire | n2=en:overactivity/inattention behavior management | rel=r_associated | relid=0 | w=5
  3679. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:overconcern with weight and body shape
    n1=hyperaldostéronisme secondaire | n2=en:overconcern with weight and body shape | rel=r_associated | relid=0 | w=5
  3680. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria (1 patient) | rel=r_associated | relid=0 | w=5
  3681. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria (less common)
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria (less common) | rel=r_associated | relid=0 | w=5
  3682. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria (posterior-to-anterior gradient)
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria (posterior-to-anterior gradient) | rel=r_associated | relid=0 | w=5
  3683. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria (rare)
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria (rare) | rel=r_associated | relid=0 | w=5
  3684. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria with preferential frontoparietal involvement (meb)
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria with preferential frontoparietal involvement (meb) | rel=r_associated | relid=0 | w=5
  3685. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria, bilateral frontotemporal
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria, bilateral frontotemporal | rel=r_associated | relid=0 | w=5
  3686. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria, frontoparietal
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria, frontoparietal | rel=r_associated | relid=0 | w=5
  3687. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria, most prominent in the frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria, most prominent in the frontal lobes | rel=r_associated | relid=0 | w=5
  3688. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria, occipital
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria, occipital | rel=r_associated | relid=0 | w=5
  3689. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyria, usually posterior
    n1=hyperaldostéronisme secondaire | n2=en:pachygyria, usually posterior | rel=r_associated | relid=0 | w=5
  3690. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachygyrias
    n1=hyperaldostéronisme secondaire | n2=en:pachygyrias | rel=r_associated | relid=0 | w=5
  3691. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachymacrogyria
    n1=hyperaldostéronisme secondaire | n2=en:pachymacrogyria | rel=r_associated | relid=0 | w=5
  3692. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pachymeningitis cervicalis (cervical cord compression due to thickened dura)
    n1=hyperaldostéronisme secondaire | n2=en:pachymeningitis cervicalis (cervical cord compression due to thickened dura) | rel=r_associated | relid=0 | w=5
  3693. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pain (sharp, boring, drilling, piercing)
    n1=hyperaldostéronisme secondaire | n2=en:pain (sharp, boring, drilling, piercing) | rel=r_associated | relid=0 | w=5
  3694. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pain affects upper body
    n1=hyperaldostéronisme secondaire | n2=en:pain affects upper body | rel=r_associated | relid=0 | w=5
  3695. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pain, episodic
    n1=hyperaldostéronisme secondaire | n2=en:pain, episodic | rel=r_associated | relid=0 | w=5
  3696. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:palatal myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:palatal myoclonus | rel=r_associated | relid=0 | w=5
  3697. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pallidal degeneration
    n1=hyperaldostéronisme secondaire | n2=en:pallidal degeneration | rel=r_associated | relid=0 | w=5
  3698. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pallor of dorsal columns of the spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:pallor of dorsal columns of the spinal cord | rel=r_associated | relid=0 | w=5
  3699. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:panic attack
    n1=hyperaldostéronisme secondaire | n2=en:panic attack | rel=r_associated | relid=0 | w=5
  3700. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:panic disorder
    n1=hyperaldostéronisme secondaire | n2=en:panic disorder | rel=r_associated | relid=0 | w=5
  3701. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paradoxical cerebral emboli
    n1=hyperaldostéronisme secondaire | n2=en:paradoxical cerebral emboli | rel=r_associated | relid=0 | w=5
  3702. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parakinesis
    n1=hyperaldostéronisme secondaire | n2=en:parakinesis | rel=r_associated | relid=0 | w=5
  3703. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paralysis
    n1=hyperaldostéronisme secondaire | n2=en:paralysis | rel=r_associated | relid=0 | w=5
  3704. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paralysis, episodic, after strenuous exercise
    n1=hyperaldostéronisme secondaire | n2=en:paralysis, episodic, after strenuous exercise | rel=r_associated | relid=0 | w=5
  3705. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraneoplastic syndrome
    n1=hyperaldostéronisme secondaire | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=5
  3706. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paranoia
    n1=hyperaldostéronisme secondaire | n2=en:paranoia | rel=r_associated | relid=0 | w=5
  3707. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paranoia (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:paranoia (hcp) | rel=r_associated | relid=0 | w=5
  3708. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraparesis
    n1=hyperaldostéronisme secondaire | n2=en:paraparesis | rel=r_associated | relid=0 | w=5
  3709. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraparesis, spastic
    n1=hyperaldostéronisme secondaire | n2=en:paraparesis, spastic | rel=r_associated | relid=0 | w=5
  3710. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraplegia
    n1=hyperaldostéronisme secondaire | n2=en:paraplegia | rel=r_associated | relid=0 | w=5
  3711. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraplegia secondary to spinal cord compression due to severe kyphosis
    n1=hyperaldostéronisme secondaire | n2=en:paraplegia secondary to spinal cord compression due to severe kyphosis | rel=r_associated | relid=0 | w=5
  3712. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraspinal masses
    n1=hyperaldostéronisme secondaire | n2=en:paraspinal masses | rel=r_associated | relid=0 | w=5
  3713. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parathyroid hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:parathyroid hyperplasia | rel=r_associated | relid=0 | w=5
  3714. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paraventricular cysts
    n1=hyperaldostéronisme secondaire | n2=en:paraventricular cysts | rel=r_associated | relid=0 | w=5
  3715. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parenchymal neuromelanosis
    n1=hyperaldostéronisme secondaire | n2=en:parenchymal neuromelanosis | rel=r_associated | relid=0 | w=5
  3716. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parenting behavior
    n1=hyperaldostéronisme secondaire | n2=en:parenting behavior | rel=r_associated | relid=0 | w=5
  3717. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paresis (hcp)
    n1=hyperaldostéronisme secondaire | n2=en:paresis (hcp) | rel=r_associated | relid=0 | w=5
  3718. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paresis of extensor muscles of the big toe is presenting symptom
    n1=hyperaldostéronisme secondaire | n2=en:paresis of extensor muscles of the big toe is presenting symptom | rel=r_associated | relid=0 | w=5
  3719. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paresthesia
    n1=hyperaldostéronisme secondaire | n2=en:paresthesia | rel=r_associated | relid=0 | w=5
  3720. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parietal lobe epilepsy
    n1=hyperaldostéronisme secondaire | n2=en:parietal lobe epilepsy | rel=r_associated | relid=0 | w=5
  3721. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinson's disease
    n1=hyperaldostéronisme secondaire | n2=en:parkinson's disease | rel=r_associated | relid=0 | w=5
  3722. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism | rel=r_associated | relid=0 | w=5
  3723. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism (in some patients) | rel=r_associated | relid=0 | w=5
  3724. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism (in some)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism (in some) | rel=r_associated | relid=0 | w=5
  3725. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism (later onset)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism (later onset) | rel=r_associated | relid=0 | w=5
  3726. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism (later)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism (later) | rel=r_associated | relid=0 | w=5
  3727. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism (less common)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism (less common) | rel=r_associated | relid=0 | w=5
  3728. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism has been described in 1 family
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism has been described in 1 family | rel=r_associated | relid=0 | w=5
  3729. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism may occur
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism may occur | rel=r_associated | relid=0 | w=5
  3730. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism, early-onset
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism, early-onset | rel=r_associated | relid=0 | w=5
  3731. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism, l-dopa responsive
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism, l-dopa responsive | rel=r_associated | relid=0 | w=5
  3732. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms)
    n1=hyperaldostéronisme secondaire | n2=en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms) | rel=r_associated | relid=0 | w=5
  3733. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal bursts of laughter
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal bursts of laughter | rel=r_associated | relid=0 | w=5
  3734. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal choreoathetosis
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal choreoathetosis | rel=r_associated | relid=0 | w=5
  3735. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal dystonia
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal dystonia | rel=r_associated | relid=0 | w=5
  3736. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal lethargy
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal lethargy | rel=r_associated | relid=0 | w=5
  3737. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal nonkinesigenic dyskinesia
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal nonkinesigenic dyskinesia | rel=r_associated | relid=0 | w=5
  3738. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paroxysmal oculogyric crises
    n1=hyperaldostéronisme secondaire | n2=en:paroxysmal oculogyric crises | rel=r_associated | relid=0 | w=5
  3739. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial absence of the corpus callosum (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:partial absence of the corpus callosum (in one patient) | rel=r_associated | relid=0 | w=5
  3740. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial agenesis of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:partial agenesis of corpus callosum | rel=r_associated | relid=0 | w=5
  3741. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial agenesis of corpus callosum (rare, in males)
    n1=hyperaldostéronisme secondaire | n2=en:partial agenesis of corpus callosum (rare, in males) | rel=r_associated | relid=0 | w=5
  3742. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial agenesis of the corpus callosum (in 1 of 2 sibs)
    n1=hyperaldostéronisme secondaire | n2=en:partial agenesis of the corpus callosum (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=5
  3743. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial agenesis of the corpus callosum (rare)
    n1=hyperaldostéronisme secondaire | n2=en:partial agenesis of the corpus callosum (rare) | rel=r_associated | relid=0 | w=5
  3744. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial empty sella turcica
    n1=hyperaldostéronisme secondaire | n2=en:partial empty sella turcica | rel=r_associated | relid=0 | w=5
  3745. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial epilepsy
    n1=hyperaldostéronisme secondaire | n2=en:partial epilepsy | rel=r_associated | relid=0 | w=5
  3746. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial migrating seizures seen on eeg (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:partial migrating seizures seen on eeg (in some patients) | rel=r_associated | relid=0 | w=5
  3747. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation
    n1=hyperaldostéronisme secondaire | n2=en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation | rel=r_associated | relid=0 | w=5
  3748. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial or complete agenesis of corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:partial or complete agenesis of corpus callosum | rel=r_associated | relid=0 | w=5
  3749. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial or total agenesis of the corpus callosum (33%)
    n1=hyperaldostéronisme secondaire | n2=en:partial or total agenesis of the corpus callosum (33%) | rel=r_associated | relid=0 | w=5
  3750. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial pachygyria
    n1=hyperaldostéronisme secondaire | n2=en:partial pachygyria | rel=r_associated | relid=0 | w=5
  3751. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial response to pyridoxine
    n1=hyperaldostéronisme secondaire | n2=en:partial response to pyridoxine | rel=r_associated | relid=0 | w=5
  3752. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial seizure
    n1=hyperaldostéronisme secondaire | n2=en:partial seizure | rel=r_associated | relid=0 | w=5
  3753. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:partial seizures, simple and complex
    n1=hyperaldostéronisme secondaire | n2=en:partial seizures, simple and complex | rel=r_associated | relid=0 | w=5
  3754. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:passive-aggressive traits
    n1=hyperaldostéronisme secondaire | n2=en:passive-aggressive traits | rel=r_associated | relid=0 | w=5
  3755. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patchy demyelination of subcortical white matter
    n1=hyperaldostéronisme secondaire | n2=en:patchy demyelination of subcortical white matter | rel=r_associated | relid=0 | w=5
  3756. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patchy diffuse hyperintensities on t2-weighted mri
    n1=hyperaldostéronisme secondaire | n2=en:patchy diffuse hyperintensities on t2-weighted mri | rel=r_associated | relid=0 | w=5
  3757. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patellar and ankle clonus
    n1=hyperaldostéronisme secondaire | n2=en:patellar and ankle clonus | rel=r_associated | relid=0 | w=5
  3758. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patellar tendon reflexes hyperactive
    n1=hyperaldostéronisme secondaire | n2=en:patellar tendon reflexes hyperactive | rel=r_associated | relid=0 | w=5
  3759. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pathologic calcification, calcified structure
    n1=hyperaldostéronisme secondaire | n2=en:pathologic calcification, calcified structure | rel=r_associated | relid=0 | w=5
  3760. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pathologic changes in anterior horn cells and lateral corticospinal tracts
    n1=hyperaldostéronisme secondaire | n2=en:pathologic changes in anterior horn cells and lateral corticospinal tracts | rel=r_associated | relid=0 | w=5
  3761. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pathological gambling
    n1=hyperaldostéronisme secondaire | n2=en:pathological gambling | rel=r_associated | relid=0 | w=5
  3762. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation
    n1=hyperaldostéronisme secondaire | n2=en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation | rel=r_associated | relid=0 | w=5
  3763. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes | rel=r_associated | relid=0 | w=5
  3764. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem
    n1=hyperaldostéronisme secondaire | n2=en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem | rel=r_associated | relid=0 | w=5
  3765. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients achieve ambulation
    n1=hyperaldostéronisme secondaire | n2=en:patients achieve ambulation | rel=r_associated | relid=0 | w=5
  3766. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients may develop a seizure disorder later in life
    n1=hyperaldostéronisme secondaire | n2=en:patients may develop a seizure disorder later in life | rel=r_associated | relid=0 | w=5
  3767. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients may have no structural abnormalities in the central nervous system
    n1=hyperaldostéronisme secondaire | n2=en:patients may have no structural abnormalities in the central nervous system | rel=r_associated | relid=0 | w=5
  3768. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients may only achieve sitting or walking
    n1=hyperaldostéronisme secondaire | n2=en:patients may only achieve sitting or walking | rel=r_associated | relid=0 | w=5
  3769. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds
    n1=hyperaldostéronisme secondaire | n2=en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds | rel=r_associated | relid=0 | w=5
  3770. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:patients show normal psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:patients show normal psychomotor development | rel=r_associated | relid=0 | w=5
  3771. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:paucity of anterior horn motor neurons
    n1=hyperaldostéronisme secondaire | n2=en:paucity of anterior horn motor neurons | rel=r_associated | relid=0 | w=5
  3772. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peak frequency of vomiting every 10 to 15 minutes
    n1=hyperaldostéronisme secondaire | n2=en:peak frequency of vomiting every 10 to 15 minutes | rel=r_associated | relid=0 | w=5
  3773. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peculiar gait (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:peculiar gait (if left untreated) | rel=r_associated | relid=0 | w=5
  3774. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peculiar stance and sitting posture (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:peculiar stance and sitting posture (if left untreated) | rel=r_associated | relid=0 | w=5
  3775. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pediatric psychiatric disorder
    n1=hyperaldostéronisme secondaire | n2=en:pediatric psychiatric disorder | rel=r_associated | relid=0 | w=5
  3776. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pericystic abnormal myelination
    n1=hyperaldostéronisme secondaire | n2=en:pericystic abnormal myelination | rel=r_associated | relid=0 | w=5
  3777. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periodic paralysis (finding)
    n1=hyperaldostéronisme secondaire | n2=en:periodic paralysis (finding) | rel=r_associated | relid=0 | w=5
  3778. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periodic paralysis, usually hypokalemic
    n1=hyperaldostéronisme secondaire | n2=en:periodic paralysis, usually hypokalemic | rel=r_associated | relid=0 | w=5
  3779. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periodic stiffness
    n1=hyperaldostéronisme secondaire | n2=en:periodic stiffness | rel=r_associated | relid=0 | w=5
  3780. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peripheral hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:peripheral hypertonia | rel=r_associated | relid=0 | w=5
  3781. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peripheral motor neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:peripheral motor neuropathy | rel=r_associated | relid=0 | w=5
  3782. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peripheral nervous system disorder
    n1=hyperaldostéronisme secondaire | n2=en:peripheral nervous system disorder | rel=r_associated | relid=0 | w=5
  3783. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peripheral neuropathy, axonal and demyelinating
    n1=hyperaldostéronisme secondaire | n2=en:peripheral neuropathy, axonal and demyelinating | rel=r_associated | relid=0 | w=5
  3784. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:peripheral sensory neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:peripheral sensory neuropathy | rel=r_associated | relid=0 | w=5
  3785. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:perisylvian polymicrogyria
    n1=hyperaldostéronisme secondaire | n2=en:perisylvian polymicrogyria | rel=r_associated | relid=0 | w=5
  3786. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:perivascular spaces
    n1=hyperaldostéronisme secondaire | n2=en:perivascular spaces | rel=r_associated | relid=0 | w=5
  3787. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular and subcortical white matter abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:periventricular and subcortical white matter abnormalities | rel=r_associated | relid=0 | w=5
  3788. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular calcifications
    n1=hyperaldostéronisme secondaire | n2=en:periventricular calcifications | rel=r_associated | relid=0 | w=5
  3789. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular cysts
    n1=hyperaldostéronisme secondaire | n2=en:periventricular cysts | rel=r_associated | relid=0 | w=5
  3790. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular gray matter heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:periventricular gray matter heterotopia | rel=r_associated | relid=0 | w=5
  3791. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular hemorrhagic infarction
    n1=hyperaldostéronisme secondaire | n2=en:periventricular hemorrhagic infarction | rel=r_associated | relid=0 | w=5
  3792. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular leukomalacia
    n1=hyperaldostéronisme secondaire | n2=en:periventricular leukomalacia | rel=r_associated | relid=0 | w=5
  3793. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular leukomalacia (reported in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:periventricular leukomalacia (reported in 2 patients) | rel=r_associated | relid=0 | w=5
  3794. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular nodular heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:periventricular nodular heterotopia | rel=r_associated | relid=0 | w=5
  3795. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular nodular heterotopia seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:periventricular nodular heterotopia seen on mri | rel=r_associated | relid=0 | w=5
  3796. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter abnormalities | rel=r_associated | relid=0 | w=5
  3797. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter abnormalities (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter abnormalities (in some patients) | rel=r_associated | relid=0 | w=5
  3798. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter changes
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter changes | rel=r_associated | relid=0 | w=5
  3799. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter changes (meb)
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter changes (meb) | rel=r_associated | relid=0 | w=5
  3800. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter gliosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter gliosis (in some patients) | rel=r_associated | relid=0 | w=5
  3801. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter hyperintensities, bilateral
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter hyperintensities, bilateral | rel=r_associated | relid=0 | w=5
  3802. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:periventricular white matter lesions
    n1=hyperaldostéronisme secondaire | n2=en:periventricular white matter lesions | rel=r_associated | relid=0 | w=5
  3803. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:perseveration
    n1=hyperaldostéronisme secondaire | n2=en:perseveration | rel=r_associated | relid=0 | w=5
  3804. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:persistent cavum septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:persistent cavum septum pellucidum | rel=r_associated | relid=0 | w=5
  3805. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:persistent cavus septum pellucidum
    n1=hyperaldostéronisme secondaire | n2=en:persistent cavus septum pellucidum | rel=r_associated | relid=0 | w=5
  3806. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:persistent falcine venous sinus
    n1=hyperaldostéronisme secondaire | n2=en:persistent falcine venous sinus | rel=r_associated | relid=0 | w=5
  3807. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:personality change
    n1=hyperaldostéronisme secondaire | n2=en:personality change | rel=r_associated | relid=0 | w=5
  3808. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:personality disorder
    n1=hyperaldostéronisme secondaire | n2=en:personality disorder | rel=r_associated | relid=0 | w=5
  3809. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:personality disorder (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:personality disorder (in some patients) | rel=r_associated | relid=0 | w=5
  3810. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pervasive developmental disorder
    n1=hyperaldostéronisme secondaire | n2=en:pervasive developmental disorder | rel=r_associated | relid=0 | w=5
  3811. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pervasive developmental disorder (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:pervasive developmental disorder (cvs+) | rel=r_associated | relid=0 | w=5
  3812. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:petit mal epilepsy
    n1=hyperaldostéronisme secondaire | n2=en:petit mal epilepsy | rel=r_associated | relid=0 | w=5
  3813. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pharyngeal gag reflex negative
    n1=hyperaldostéronisme secondaire | n2=en:pharyngeal gag reflex negative | rel=r_associated | relid=0 | w=5
  3814. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:phenylketonuria
    n1=hyperaldostéronisme secondaire | n2=en:phenylketonuria | rel=r_associated | relid=0 | w=5
  3815. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:phobia
    n1=hyperaldostéronisme secondaire | n2=en:phobia | rel=r_associated | relid=0 | w=5
  3816. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:phonology deficits
    n1=hyperaldostéronisme secondaire | n2=en:phonology deficits | rel=r_associated | relid=0 | w=5
  3817. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:phonophobia
    n1=hyperaldostéronisme secondaire | n2=en:phonophobia | rel=r_associated | relid=0 | w=5
  3818. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:photoparoxysmal and photomyoclonic responses
    n1=hyperaldostéronisme secondaire | n2=en:photoparoxysmal and photomyoclonic responses | rel=r_associated | relid=0 | w=5
  3819. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:photoparoxysmal response (in some)
    n1=hyperaldostéronisme secondaire | n2=en:photoparoxysmal response (in some) | rel=r_associated | relid=0 | w=5
  3820. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:photosensitive tonic-clonic seizures
    n1=hyperaldostéronisme secondaire | n2=en:photosensitive tonic-clonic seizures | rel=r_associated | relid=0 | w=5
  3821. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:photosensitivity in one-third of patients
    n1=hyperaldostéronisme secondaire | n2=en:photosensitivity in one-third of patients | rel=r_associated | relid=0 | w=5
  3822. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:physiological malfunction arising from mental factor
    n1=hyperaldostéronisme secondaire | n2=en:physiological malfunction arising from mental factor | rel=r_associated | relid=0 | w=5
  3823. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pica eating disorder
    n1=hyperaldostéronisme secondaire | n2=en:pica eating disorder | rel=r_associated | relid=0 | w=5
  3824. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus
    n1=hyperaldostéronisme secondaire | n2=en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus | rel=r_associated | relid=0 | w=5
  3825. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:piercing and tattoos
    n1=hyperaldostéronisme secondaire | n2=en:piercing and tattoos | rel=r_associated | relid=0 | w=5
  3826. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pigmentary loss in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:pigmentary loss in the substantia nigra | rel=r_associated | relid=0 | w=5
  3827. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pineal gland
    n1=hyperaldostéronisme secondaire | n2=en:pineal gland | rel=r_associated | relid=0 | w=5
  3828. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pineal hypertrophy
    n1=hyperaldostéronisme secondaire | n2=en:pineal hypertrophy | rel=r_associated | relid=0 | w=5
  3829. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pituitary agenesis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:pituitary agenesis (rare) | rel=r_associated | relid=0 | w=5
  3830. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pituitary aplasia or dysplasia
    n1=hyperaldostéronisme secondaire | n2=en:pituitary aplasia or dysplasia | rel=r_associated | relid=0 | w=5
  3831. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pituitary gland disorder
    n1=hyperaldostéronisme secondaire | n2=en:pituitary gland disorder | rel=r_associated | relid=0 | w=5
  3832. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pituitary gland hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:pituitary gland hypoplasia | rel=r_associated | relid=0 | w=5
  3833. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:placid affect
    n1=hyperaldostéronisme secondaire | n2=en:placid affect | rel=r_associated | relid=0 | w=5
  3834. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:plaque, amyloid
    n1=hyperaldostéronisme secondaire | n2=en:plaque, amyloid | rel=r_associated | relid=0 | w=5
  3835. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:platybasia
    n1=hyperaldostéronisme secondaire | n2=en:platybasia | rel=r_associated | relid=0 | w=5
  3836. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polio and post-polio syndrome
    n1=hyperaldostéronisme secondaire | n2=en:polio and post-polio syndrome | rel=r_associated | relid=0 | w=5
  3837. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polyembolokoilamania (insertion of foreign bodies into body orifices)
    n1=hyperaldostéronisme secondaire | n2=en:polyembolokoilamania (insertion of foreign bodies into body orifices) | rel=r_associated | relid=0 | w=5
  3838. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes
    n1=hyperaldostéronisme secondaire | n2=en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes | rel=r_associated | relid=0 | w=5
  3839. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polygyria
    n1=hyperaldostéronisme secondaire | n2=en:polygyria | rel=r_associated | relid=0 | w=5
  3840. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria | rel=r_associated | relid=0 | w=5
  3841. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria (64%)
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria (64%) | rel=r_associated | relid=0 | w=5
  3842. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria (meb)
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria (meb) | rel=r_associated | relid=0 | w=5
  3843. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria (rare)
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria (rare) | rel=r_associated | relid=0 | w=5
  3844. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  3845. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, anterior to posterior gradient
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, anterior to posterior gradient | rel=r_associated | relid=0 | w=5
  3846. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, asymmetric or symmetric
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, asymmetric or symmetric | rel=r_associated | relid=0 | w=5
  3847. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, bilateral frontoparietal
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, bilateral frontoparietal | rel=r_associated | relid=0 | w=5
  3848. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, diffuse, asymmetric
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, diffuse, asymmetric | rel=r_associated | relid=0 | w=5
  3849. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, frontal
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, frontal | rel=r_associated | relid=0 | w=5
  3850. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, most severe in the frontoparietal regions
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, most severe in the frontoparietal regions | rel=r_associated | relid=0 | w=5
  3851. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, occipital
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, occipital | rel=r_associated | relid=0 | w=5
  3852. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, predominantly frontal and perisylvian
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, predominantly frontal and perisylvian | rel=r_associated | relid=0 | w=5
  3853. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, temporo-occipital
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, temporo-occipital | rel=r_associated | relid=0 | w=5
  3854. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polymicrogyria, usually frontal (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:polymicrogyria, usually frontal (in some patients) | rel=r_associated | relid=0 | w=5
  3855. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polyneuropathies, motor
    n1=hyperaldostéronisme secondaire | n2=en:polyneuropathies, motor | rel=r_associated | relid=0 | w=5
  3856. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:polyneuropathy
    n1=hyperaldostéronisme secondaire | n2=en:polyneuropathy | rel=r_associated | relid=0 | w=5
  3857. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pons damage
    n1=hyperaldostéronisme secondaire | n2=en:pons damage | rel=r_associated | relid=0 | w=5
  3858. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontine atrophy
    n1=hyperaldostéronisme secondaire | n2=en:pontine atrophy | rel=r_associated | relid=0 | w=5
  3859. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontine dysraphia
    n1=hyperaldostéronisme secondaire | n2=en:pontine dysraphia | rel=r_associated | relid=0 | w=5
  3860. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontine hypoplasia (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:pontine hypoplasia (1 family) | rel=r_associated | relid=0 | w=5
  3861. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontine hypoplasia, mild
    n1=hyperaldostéronisme secondaire | n2=en:pontine hypoplasia, mild | rel=r_associated | relid=0 | w=5
  3862. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontocerebellar arachnoid cyst (reported in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:pontocerebellar arachnoid cyst (reported in 2 patients) | rel=r_associated | relid=0 | w=5
  3863. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontocerebellar atrophy
    n1=hyperaldostéronisme secondaire | n2=en:pontocerebellar atrophy | rel=r_associated | relid=0 | w=5
  3864. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pontoneocerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:pontoneocerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  3865. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor adaptive skills
    n1=hyperaldostéronisme secondaire | n2=en:poor adaptive skills | rel=r_associated | relid=0 | w=5
  3866. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor balance (finding)
    n1=hyperaldostéronisme secondaire | n2=en:poor balance (finding) | rel=r_associated | relid=0 | w=5
  3867. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor cognition
    n1=hyperaldostéronisme secondaire | n2=en:poor cognition | rel=r_associated | relid=0 | w=5
  3868. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor communication
    n1=hyperaldostéronisme secondaire | n2=en:poor communication | rel=r_associated | relid=0 | w=5
  3869. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor concentration
    n1=hyperaldostéronisme secondaire | n2=en:poor concentration | rel=r_associated | relid=0 | w=5
  3870. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor coordination | rel=r_associated | relid=0 | w=5
  3871. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor coordination (83%)
    n1=hyperaldostéronisme secondaire | n2=en:poor coordination (83%) | rel=r_associated | relid=0 | w=5
  3872. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor delineation of cerebral cortical regions
    n1=hyperaldostéronisme secondaire | n2=en:poor delineation of cerebral cortical regions | rel=r_associated | relid=0 | w=5
  3873. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor dendritic maturation
    n1=hyperaldostéronisme secondaire | n2=en:poor dendritic maturation | rel=r_associated | relid=0 | w=5
  3874. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor differentiation of gray and white matter on t2-weighted mri
    n1=hyperaldostéronisme secondaire | n2=en:poor differentiation of gray and white matter on t2-weighted mri | rel=r_associated | relid=0 | w=5
  3875. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor feeding (congenital form form)
    n1=hyperaldostéronisme secondaire | n2=en:poor feeding (congenital form form) | rel=r_associated | relid=0 | w=5
  3876. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor fine and gross motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor fine and gross motor coordination | rel=r_associated | relid=0 | w=5
  3877. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor fine motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor fine motor coordination | rel=r_associated | relid=0 | w=5
  3878. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor fine motor skills
    n1=hyperaldostéronisme secondaire | n2=en:poor fine motor skills | rel=r_associated | relid=0 | w=5
  3879. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor gross motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor gross motor coordination | rel=r_associated | relid=0 | w=5
  3880. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor hand-eye coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor hand-eye coordination | rel=r_associated | relid=0 | w=5
  3881. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor head and trunk control in infancy
    n1=hyperaldostéronisme secondaire | n2=en:poor head and trunk control in infancy | rel=r_associated | relid=0 | w=5
  3882. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor head control
    n1=hyperaldostéronisme secondaire | n2=en:poor head control | rel=r_associated | relid=0 | w=5
  3883. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor judgement
    n1=hyperaldostéronisme secondaire | n2=en:poor judgement | rel=r_associated | relid=0 | w=5
  3884. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor language
    n1=hyperaldostéronisme secondaire | n2=en:poor language | rel=r_associated | relid=0 | w=5
  3885. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor language and speech development
    n1=hyperaldostéronisme secondaire | n2=en:poor language and speech development | rel=r_associated | relid=0 | w=5
  3886. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor motor coordination
    n1=hyperaldostéronisme secondaire | n2=en:poor motor coordination | rel=r_associated | relid=0 | w=5
  3887. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor motor development
    n1=hyperaldostéronisme secondaire | n2=en:poor motor development | rel=r_associated | relid=0 | w=5
  3888. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor myelination
    n1=hyperaldostéronisme secondaire | n2=en:poor myelination | rel=r_associated | relid=0 | w=5
  3889. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor neonatal suck and swallow reflexes
    n1=hyperaldostéronisme secondaire | n2=en:poor neonatal suck and swallow reflexes | rel=r_associated | relid=0 | w=5
  3890. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor or absent independent walking
    n1=hyperaldostéronisme secondaire | n2=en:poor or absent independent walking | rel=r_associated | relid=0 | w=5
  3891. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor or absent smooth pursuit
    n1=hyperaldostéronisme secondaire | n2=en:poor or absent smooth pursuit | rel=r_associated | relid=0 | w=5
  3892. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor or absent speech
    n1=hyperaldostéronisme secondaire | n2=en:poor or absent speech | rel=r_associated | relid=0 | w=5
  3893. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor or absent speech acquisition
    n1=hyperaldostéronisme secondaire | n2=en:poor or absent speech acquisition | rel=r_associated | relid=0 | w=5
  3894. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor or absent speech development
    n1=hyperaldostéronisme secondaire | n2=en:poor or absent speech development | rel=r_associated | relid=0 | w=5
  3895. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor responsiveness
    n1=hyperaldostéronisme secondaire | n2=en:poor responsiveness | rel=r_associated | relid=0 | w=5
  3896. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor school performance
    n1=hyperaldostéronisme secondaire | n2=en:poor school performance | rel=r_associated | relid=0 | w=5
  3897. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor speech
    n1=hyperaldostéronisme secondaire | n2=en:poor speech | rel=r_associated | relid=0 | w=5
  3898. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor speech or lack of speech development
    n1=hyperaldostéronisme secondaire | n2=en:poor speech or lack of speech development | rel=r_associated | relid=0 | w=5
  3899. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor speech or no speech
    n1=hyperaldostéronisme secondaire | n2=en:poor speech or no speech | rel=r_associated | relid=0 | w=5
  3900. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor spontaneous movements
    n1=hyperaldostéronisme secondaire | n2=en:poor spontaneous movements | rel=r_associated | relid=0 | w=5
  3901. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor vestibuloocular reflex
    n1=hyperaldostéronisme secondaire | n2=en:poor vestibuloocular reflex | rel=r_associated | relid=0 | w=5
  3902. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor visual-motor integration (range 41-80)
    n1=hyperaldostéronisme secondaire | n2=en:poor visual-motor integration (range 41-80) | rel=r_associated | relid=0 | w=5
  3903. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor visual-spatial construction
    n1=hyperaldostéronisme secondaire | n2=en:poor visual-spatial construction | rel=r_associated | relid=0 | w=5
  3904. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:poor-absent neurologic development
    n1=hyperaldostéronisme secondaire | n2=en:poor-absent neurologic development | rel=r_associated | relid=0 | w=5
  3905. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:porencephalic changes
    n1=hyperaldostéronisme secondaire | n2=en:porencephalic changes | rel=r_associated | relid=0 | w=5
  3906. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:porencephalic cyst
    n1=hyperaldostéronisme secondaire | n2=en:porencephalic cyst | rel=r_associated | relid=0 | w=5
  3907. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:porencephaly (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:porencephaly (in some patients) | rel=r_associated | relid=0 | w=5
  3908. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:post-traumatic stress disorder
    n1=hyperaldostéronisme secondaire | n2=en:post-traumatic stress disorder | rel=r_associated | relid=0 | w=5
  3909. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior column degeneration
    n1=hyperaldostéronisme secondaire | n2=en:posterior column degeneration | rel=r_associated | relid=0 | w=5
  3910. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior column sensory loss
    n1=hyperaldostéronisme secondaire | n2=en:posterior column sensory loss | rel=r_associated | relid=0 | w=5
  3911. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa abnormalities (rare)
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa abnormalities (rare) | rel=r_associated | relid=0 | w=5
  3912. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa arachnoid cyst
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa arachnoid cyst | rel=r_associated | relid=0 | w=5
  3913. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa compression syndrome
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa compression syndrome | rel=r_associated | relid=0 | w=5
  3914. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa crowding, progressive
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa crowding, progressive | rel=r_associated | relid=0 | w=5
  3915. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa cyst
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa cyst | rel=r_associated | relid=0 | w=5
  3916. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa cyst (in 1 of 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa cyst (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
  3917. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa cyst continuous with the fourth ventricle
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa cyst continuous with the fourth ventricle | rel=r_associated | relid=0 | w=5
  3918. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa cysts (wws)
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa cysts (wws) | rel=r_associated | relid=0 | w=5
  3919. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior fossa malformations
    n1=hyperaldostéronisme secondaire | n2=en:posterior fossa malformations | rel=r_associated | relid=0 | w=5
  3920. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior pachygyria
    n1=hyperaldostéronisme secondaire | n2=en:posterior pachygyria | rel=r_associated | relid=0 | w=5
  3921. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posterior slow-wave activity on eeg
    n1=hyperaldostéronisme secondaire | n2=en:posterior slow-wave activity on eeg | rel=r_associated | relid=0 | w=5
  3922. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postnatal development of hypertonic extremities
    n1=hyperaldostéronisme secondaire | n2=en:postnatal development of hypertonic extremities | rel=r_associated | relid=0 | w=5
  3923. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postpartum depression
    n1=hyperaldostéronisme secondaire | n2=en:postpartum depression | rel=r_associated | relid=0 | w=5
  3924. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia)
    n1=hyperaldostéronisme secondaire | n2=en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia) | rel=r_associated | relid=0 | w=5
  3925. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural hand tremor
    n1=hyperaldostéronisme secondaire | n2=en:postural hand tremor | rel=r_associated | relid=0 | w=5
  3926. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural instability
    n1=hyperaldostéronisme secondaire | n2=en:postural instability | rel=r_associated | relid=0 | w=5
  3927. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural instability (63%)
    n1=hyperaldostéronisme secondaire | n2=en:postural instability (63%) | rel=r_associated | relid=0 | w=5
  3928. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural tremor (later onset, spreads to all limbs and neck)
    n1=hyperaldostéronisme secondaire | n2=en:postural tremor (later onset, spreads to all limbs and neck) | rel=r_associated | relid=0 | w=5
  3929. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:postural tremor, slow, irregular (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:postural tremor, slow, irregular (in some patients) | rel=r_associated | relid=0 | w=5
  3930. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:posturing
    n1=hyperaldostéronisme secondaire | n2=en:posturing | rel=r_associated | relid=0 | w=5
  3931. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prader-willi syndrome
    n1=hyperaldostéronisme secondaire | n2=en:prader-willi syndrome | rel=r_associated | relid=0 | w=5
  3932. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:praxis
    n1=hyperaldostéronisme secondaire | n2=en:praxis | rel=r_associated | relid=0 | w=5
  3933. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pre-senile dementia
    n1=hyperaldostéronisme secondaire | n2=en:pre-senile dementia | rel=r_associated | relid=0 | w=5
  3934. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:premature stroke
    n1=hyperaldostéronisme secondaire | n2=en:premature stroke | rel=r_associated | relid=0 | w=5
  3935. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments)
    n1=hyperaldostéronisme secondaire | n2=en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments) | rel=r_associated | relid=0 | w=5
  3936. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:presenile and senile dementia
    n1=hyperaldostéronisme secondaire | n2=en:presenile and senile dementia | rel=r_associated | relid=0 | w=5
  3937. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:preservation of u fibers
    n1=hyperaldostéronisme secondaire | n2=en:preservation of u fibers | rel=r_associated | relid=0 | w=5
  3938. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:preterm infant
    n1=hyperaldostéronisme secondaire | n2=en:preterm infant | rel=r_associated | relid=0 | w=5
  3939. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primarily affects distal lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:primarily affects distal lower limbs | rel=r_associated | relid=0 | w=5
  3940. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primary aldosteronism
    n1=hyperaldostéronisme secondaire | n2=en:primary aldosteronism | rel=r_associated | relid=0 | w=5
  3941. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primitive reflex
    n1=hyperaldostéronisme secondaire | n2=en:primitive reflex | rel=r_associated | relid=0 | w=5
  3942. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primitive reflexes (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:primitive reflexes (in some patients) | rel=r_associated | relid=0 | w=5
  3943. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primitive reflexes (palmomental, snout, glabellar)
    n1=hyperaldostéronisme secondaire | n2=en:primitive reflexes (palmomental, snout, glabellar) | rel=r_associated | relid=0 | w=5
  3944. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:primitive sylvian fissures
    n1=hyperaldostéronisme secondaire | n2=en:primitive sylvian fissures | rel=r_associated | relid=0 | w=5
  3945. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prion protein-positive senile plaques
    n1=hyperaldostéronisme secondaire | n2=en:prion protein-positive senile plaques | rel=r_associated | relid=0 | w=5
  3946. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients) | rel=r_associated | relid=0 | w=5
  3947. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:profound global developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:profound global developmental delay | rel=r_associated | relid=0 | w=5
  3948. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:profound intellectual disabilities
    n1=hyperaldostéronisme secondaire | n2=en:profound intellectual disabilities | rel=r_associated | relid=0 | w=5
  3949. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:profound mental retardation and hypotonia in survivors
    n1=hyperaldostéronisme secondaire | n2=en:profound mental retardation and hypotonia in survivors | rel=r_associated | relid=0 | w=5
  3950. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progression to paralysis and atrophy of distal lower limb muscles
    n1=hyperaldostéronisme secondaire | n2=en:progression to paralysis and atrophy of distal lower limb muscles | rel=r_associated | relid=0 | w=5
  3951. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progression to tetraplegia and decerebrate state
    n1=hyperaldostéronisme secondaire | n2=en:progression to tetraplegia and decerebrate state | rel=r_associated | relid=0 | w=5
  3952. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive ataxia (onset second year of life)
    n1=hyperaldostéronisme secondaire | n2=en:progressive ataxia (onset second year of life) | rel=r_associated | relid=0 | w=5
  3953. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive bulbar palsy
    n1=hyperaldostéronisme secondaire | n2=en:progressive bulbar palsy | rel=r_associated | relid=0 | w=5
  3954. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive cerebellar ataxia
    n1=hyperaldostéronisme secondaire | n2=en:progressive cerebellar ataxia | rel=r_associated | relid=0 | w=5
  3955. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive cerebellar degeneration
    n1=hyperaldostéronisme secondaire | n2=en:progressive cerebellar degeneration | rel=r_associated | relid=0 | w=5
  3956. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive cerebral atrophy seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:progressive cerebral atrophy seen on mri | rel=r_associated | relid=0 | w=5
  3957. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive choreoathetosis
    n1=hyperaldostéronisme secondaire | n2=en:progressive choreoathetosis | rel=r_associated | relid=0 | w=5
  3958. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive cns degeneration
    n1=hyperaldostéronisme secondaire | n2=en:progressive cns degeneration | rel=r_associated | relid=0 | w=5
  3959. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive cognitive decline following normal development in childhood (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:progressive cognitive decline following normal development in childhood (in some patients) | rel=r_associated | relid=0 | w=5
  3960. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:progressive encephalopathy | rel=r_associated | relid=0 | w=5
  3961. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive extrapyramidal movement disorder
    n1=hyperaldostéronisme secondaire | n2=en:progressive extrapyramidal movement disorder | rel=r_associated | relid=0 | w=5
  3962. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive forgetfulness
    n1=hyperaldostéronisme secondaire | n2=en:progressive forgetfulness | rel=r_associated | relid=0 | w=5
  3963. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive gait ataxia
    n1=hyperaldostéronisme secondaire | n2=en:progressive gait ataxia | rel=r_associated | relid=0 | w=5
  3964. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive impairment of gait
    n1=hyperaldostéronisme secondaire | n2=en:progressive impairment of gait | rel=r_associated | relid=0 | w=5
  3965. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive inability to walk
    n1=hyperaldostéronisme secondaire | n2=en:progressive inability to walk | rel=r_associated | relid=0 | w=5
  3966. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive intellectual decline
    n1=hyperaldostéronisme secondaire | n2=en:progressive intellectual decline | rel=r_associated | relid=0 | w=5
  3967. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive language deterioration
    n1=hyperaldostéronisme secondaire | n2=en:progressive language deterioration | rel=r_associated | relid=0 | w=5
  3968. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive leukoencephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:progressive leukoencephalopathy | rel=r_associated | relid=0 | w=5
  3969. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive loss of movement control
    n1=hyperaldostéronisme secondaire | n2=en:progressive loss of movement control | rel=r_associated | relid=0 | w=5
  3970. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive myoclonus epilepsy
    n1=hyperaldostéronisme secondaire | n2=en:progressive myoclonus epilepsy | rel=r_associated | relid=0 | w=5
  3971. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive neurologic deterioration
    n1=hyperaldostéronisme secondaire | n2=en:progressive neurologic deterioration | rel=r_associated | relid=0 | w=5
  3972. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive psychomotor deterioration
    n1=hyperaldostéronisme secondaire | n2=en:progressive psychomotor deterioration | rel=r_associated | relid=0 | w=5
  3973. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive pyramidal and cerebellar signs
    n1=hyperaldostéronisme secondaire | n2=en:progressive pyramidal and cerebellar signs | rel=r_associated | relid=0 | w=5
  3974. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive spastic diplegia to quadriplegia
    n1=hyperaldostéronisme secondaire | n2=en:progressive spastic diplegia to quadriplegia | rel=r_associated | relid=0 | w=5
  3975. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive spastic paraplegia
    n1=hyperaldostéronisme secondaire | n2=en:progressive spastic paraplegia | rel=r_associated | relid=0 | w=5
  3976. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive spastic quadriplegia
    n1=hyperaldostéronisme secondaire | n2=en:progressive spastic quadriplegia | rel=r_associated | relid=0 | w=5
  3977. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive spasticity
    n1=hyperaldostéronisme secondaire | n2=en:progressive spasticity | rel=r_associated | relid=0 | w=5
  3978. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive supranuclear palsy
    n1=hyperaldostéronisme secondaire | n2=en:progressive supranuclear palsy | rel=r_associated | relid=0 | w=5
  3979. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive truncal ataxia
    n1=hyperaldostéronisme secondaire | n2=en:progressive truncal ataxia | rel=r_associated | relid=0 | w=5
  3980. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive ventriculomegaly
    n1=hyperaldostéronisme secondaire | n2=en:progressive ventriculomegaly | rel=r_associated | relid=0 | w=5
  3981. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive white matter lesions in the brain
    n1=hyperaldostéronisme secondaire | n2=en:progressive white matter lesions in the brain | rel=r_associated | relid=0 | w=5
  3982. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:progressive, symmetric degeneration of the caudate and putamen
    n1=hyperaldostéronisme secondaire | n2=en:progressive, symmetric degeneration of the caudate and putamen | rel=r_associated | relid=0 | w=5
  3983. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prolonged seizure
    n1=hyperaldostéronisme secondaire | n2=en:prolonged seizure | rel=r_associated | relid=0 | w=5
  3984. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prolonged somatosensory evoked potentials (seps)
    n1=hyperaldostéronisme secondaire | n2=en:prolonged somatosensory evoked potentials (seps) | rel=r_associated | relid=0 | w=5
  3985. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent cortical sulci
    n1=hyperaldostéronisme secondaire | n2=en:prominent cortical sulci | rel=r_associated | relid=0 | w=5
  3986. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent csf spaces (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:prominent csf spaces (in some patients) | rel=r_associated | relid=0 | w=5
  3987. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent perivascular spaces
    n1=hyperaldostéronisme secondaire | n2=en:prominent perivascular spaces | rel=r_associated | relid=0 | w=5
  3988. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent perivascular spaces with surrounding gliosis in periatrial white matter
    n1=hyperaldostéronisme secondaire | n2=en:prominent perivascular spaces with surrounding gliosis in periatrial white matter | rel=r_associated | relid=0 | w=5
  3989. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent sulci
    n1=hyperaldostéronisme secondaire | n2=en:prominent sulci | rel=r_associated | relid=0 | w=5
  3990. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent trigone and occipital horns
    n1=hyperaldostéronisme secondaire | n2=en:prominent trigone and occipital horns | rel=r_associated | relid=0 | w=5
  3991. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prominent ventricles (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:prominent ventricles (in some patients) | rel=r_associated | relid=0 | w=5
  3992. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal amyotrophy
    n1=hyperaldostéronisme secondaire | n2=en:proximal amyotrophy | rel=r_associated | relid=0 | w=5
  3993. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal limb muscle stiffness
    n1=hyperaldostéronisme secondaire | n2=en:proximal limb muscle stiffness | rel=r_associated | relid=0 | w=5
  3994. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:proximal muscle weakness | rel=r_associated | relid=0 | w=5
  3995. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal muscle weakness in lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:proximal muscle weakness in lower limbs | rel=r_associated | relid=0 | w=5
  3996. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal weakness occurs first
    n1=hyperaldostéronisme secondaire | n2=en:proximal weakness occurs first | rel=r_associated | relid=0 | w=5
  3997. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal weakness occurs later
    n1=hyperaldostéronisme secondaire | n2=en:proximal weakness occurs later | rel=r_associated | relid=0 | w=5
  3998. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:proximal weakness of the lower extremities
    n1=hyperaldostéronisme secondaire | n2=en:proximal weakness of the lower extremities | rel=r_associated | relid=0 | w=5
  3999. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:prp immunoreactivity limited to cerebellum and putamen
    n1=hyperaldostéronisme secondaire | n2=en:prp immunoreactivity limited to cerebellum and putamen | rel=r_associated | relid=0 | w=5
  4000. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudobulbar palsy
    n1=hyperaldostéronisme secondaire | n2=en:pseudobulbar palsy | rel=r_associated | relid=0 | w=5
  4001. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudobulbar palsy (e.g. involuntary weeping or laughter)
    n1=hyperaldostéronisme secondaire | n2=en:pseudobulbar palsy (e.g. involuntary weeping or laughter) | rel=r_associated | relid=0 | w=5
  4002. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudobulbar signs
    n1=hyperaldostéronisme secondaire | n2=en:pseudobulbar signs | rel=r_associated | relid=0 | w=5
  4003. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudobulbar symptoms (uncontrolled laughter, weeping)
    n1=hyperaldostéronisme secondaire | n2=en:pseudobulbar symptoms (uncontrolled laughter, weeping) | rel=r_associated | relid=0 | w=5
  4004. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudolaminar spongiform changes
    n1=hyperaldostéronisme secondaire | n2=en:pseudolaminar spongiform changes | rel=r_associated | relid=0 | w=5
  4005. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudotumor
    n1=hyperaldostéronisme secondaire | n2=en:pseudotumor | rel=r_associated | relid=0 | w=5
  4006. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pseudotumor cerebri
    n1=hyperaldostéronisme secondaire | n2=en:pseudotumor cerebri | rel=r_associated | relid=0 | w=5
  4007. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric abnormalities | rel=r_associated | relid=0 | w=5
  4008. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric abnormalities (more common in patients with atypical disease and slow progression)
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric abnormalities (more common in patients with atypical disease and slow progression) | rel=r_associated | relid=0 | w=5
  4009. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric abnormalities (more common presentation in variant cjd)
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric abnormalities (more common presentation in variant cjd) | rel=r_associated | relid=0 | w=5
  4010. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric disorder
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric disorder | rel=r_associated | relid=0 | w=5
  4011. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric disturbances (25%)
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric disturbances (25%) | rel=r_associated | relid=0 | w=5
  4012. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric disturbances (9% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric disturbances (9% of patients) | rel=r_associated | relid=0 | w=5
  4013. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric manifestations more common with adult-onset of disease
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric manifestations more common with adult-onset of disease | rel=r_associated | relid=0 | w=5
  4014. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychiatric symptoms (delusions, hallucinations)
    n1=hyperaldostéronisme secondaire | n2=en:psychiatric symptoms (delusions, hallucinations) | rel=r_associated | relid=0 | w=5
  4015. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychic factors associated with diseases classified elsewhere
    n1=hyperaldostéronisme secondaire | n2=en:psychic factors associated with diseases classified elsewhere | rel=r_associated | relid=0 | w=5
  4016. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor agitation
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor agitation | rel=r_associated | relid=0 | w=5
  4017. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor agitation accompanying visual hallucinations (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor agitation accompanying visual hallucinations (in some patients) | rel=r_associated | relid=0 | w=5
  4018. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor arrest and regression
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor arrest and regression | rel=r_associated | relid=0 | w=5
  4019. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay (evident at 3 months)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay (evident at 3 months) | rel=r_associated | relid=0 | w=5
  4020. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay (in one family) | rel=r_associated | relid=0 | w=5
  4021. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay (rare)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay (rare) | rel=r_associated | relid=0 | w=5
  4022. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay after second year
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay after second year | rel=r_associated | relid=0 | w=5
  4023. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay, mild to moderate | rel=r_associated | relid=0 | w=5
  4024. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor delay, severe
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor delay, severe | rel=r_associated | relid=0 | w=5
  4025. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor deterioration
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor deterioration | rel=r_associated | relid=0 | w=5
  4026. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor deterioration (classical form)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor deterioration (classical form) | rel=r_associated | relid=0 | w=5
  4027. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor disturbances during acute psychotic outbursts
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor disturbances during acute psychotic outbursts | rel=r_associated | relid=0 | w=5
  4028. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor impairments
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor impairments | rel=r_associated | relid=0 | w=5
  4029. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression | rel=r_associated | relid=0 | w=5
  4030. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression (in milder cases)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression (in milder cases) | rel=r_associated | relid=0 | w=5
  4031. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression (in some patients) | rel=r_associated | relid=0 | w=5
  4032. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression (in some)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression (in some) | rel=r_associated | relid=0 | w=5
  4033. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression (onset within first year of life)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression (onset within first year of life) | rel=r_associated | relid=0 | w=5
  4034. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression beginning in infancy
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression beginning in infancy | rel=r_associated | relid=0 | w=5
  4035. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression in infants
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression in infants | rel=r_associated | relid=0 | w=5
  4036. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression may occur
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression may occur | rel=r_associated | relid=0 | w=5
  4037. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression, episodic, often associated with common childhood infections
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression, episodic, often associated with common childhood infections | rel=r_associated | relid=0 | w=5
  4038. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression, progressive
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression, progressive | rel=r_associated | relid=0 | w=5
  4039. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor regression, severe
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor regression, severe | rel=r_associated | relid=0 | w=5
  4040. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation | rel=r_associated | relid=0 | w=5
  4041. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation (2/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation (2/4 patients) | rel=r_associated | relid=0 | w=5
  4042. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation (in 1 patient) | rel=r_associated | relid=0 | w=5
  4043. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation (in some patients) | rel=r_associated | relid=0 | w=5
  4044. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation in those that survive
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation in those that survive | rel=r_associated | relid=0 | w=5
  4045. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, mild
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, mild | rel=r_associated | relid=0 | w=5
  4046. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, mild to moderate
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, mild to moderate | rel=r_associated | relid=0 | w=5
  4047. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, moderate
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, moderate | rel=r_associated | relid=0 | w=5
  4048. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, profound
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, profound | rel=r_associated | relid=0 | w=5
  4049. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, profound, in those who survive
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, profound, in those who survive | rel=r_associated | relid=0 | w=5
  4050. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, severe to profound
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, severe to profound | rel=r_associated | relid=0 | w=5
  4051. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychomotor retardation, variable
    n1=hyperaldostéronisme secondaire | n2=en:psychomotor retardation, variable | rel=r_associated | relid=0 | w=5
  4052. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychophysiologic disorders
    n1=hyperaldostéronisme secondaire | n2=en:psychophysiologic disorders | rel=r_associated | relid=0 | w=5
  4053. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosexual disorders
    n1=hyperaldostéronisme secondaire | n2=en:psychosexual disorders | rel=r_associated | relid=0 | w=5
  4054. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis
    n1=hyperaldostéronisme secondaire | n2=en:psychosis | rel=r_associated | relid=0 | w=5
  4055. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (1 family) | rel=r_associated | relid=0 | w=5
  4056. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (1 patient) | rel=r_associated | relid=0 | w=5
  4057. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (25% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (25% of patients) | rel=r_associated | relid=0 | w=5
  4058. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (if left untreated) | rel=r_associated | relid=0 | w=5
  4059. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (in some patients) | rel=r_associated | relid=0 | w=5
  4060. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:psychosis (rare) | rel=r_associated | relid=0 | w=5
  4061. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychosis in older patients
    n1=hyperaldostéronisme secondaire | n2=en:psychosis in older patients | rel=r_associated | relid=0 | w=5
  4062. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychotic episodes
    n1=hyperaldostéronisme secondaire | n2=en:psychotic episodes | rel=r_associated | relid=0 | w=5
  4063. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychotic episodes have been rarely reported
    n1=hyperaldostéronisme secondaire | n2=en:psychotic episodes have been rarely reported | rel=r_associated | relid=0 | w=5
  4064. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychotic illness
    n1=hyperaldostéronisme secondaire | n2=en:psychotic illness | rel=r_associated | relid=0 | w=5
  4065. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:psychoticism
    n1=hyperaldostéronisme secondaire | n2=en:psychoticism | rel=r_associated | relid=0 | w=5
  4066. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:puberty
    n1=hyperaldostéronisme secondaire | n2=en:puberty | rel=r_associated | relid=0 | w=5
  4067. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pulsating quality
    n1=hyperaldostéronisme secondaire | n2=en:pulsating quality | rel=r_associated | relid=0 | w=5
  4068. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:purposeless movements (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:purposeless movements (if left untreated) | rel=r_associated | relid=0 | w=5
  4069. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:putamen atrophy
    n1=hyperaldostéronisme secondaire | n2=en:putamen atrophy | rel=r_associated | relid=0 | w=5
  4070. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal features (rare)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal features (rare) | rel=r_associated | relid=0 | w=5
  4071. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal hypertonia | rel=r_associated | relid=0 | w=5
  4072. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal sign
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal sign | rel=r_associated | relid=0 | w=5
  4073. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (1 family) | rel=r_associated | relid=0 | w=5
  4074. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (1 patient) | rel=r_associated | relid=0 | w=5
  4075. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (21% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (21% of patients) | rel=r_associated | relid=0 | w=5
  4076. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (in some patients) | rel=r_associated | relid=0 | w=5
  4077. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (in some)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (in some) | rel=r_associated | relid=0 | w=5
  4078. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs (less common)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs (less common) | rel=r_associated | relid=0 | w=5
  4079. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs, mild
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs, mild | rel=r_associated | relid=0 | w=5
  4080. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal signs, mild (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal signs, mild (uncommon) | rel=r_associated | relid=0 | w=5
  4081. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal symptoms
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal symptoms | rel=r_associated | relid=0 | w=5
  4082. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal syndrome
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal syndrome | rel=r_associated | relid=0 | w=5
  4083. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal syndrome of the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal syndrome of the lower limbs | rel=r_associated | relid=0 | w=5
  4084. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal system
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal system | rel=r_associated | relid=0 | w=5
  4085. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal tetraparesis
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal tetraparesis | rel=r_associated | relid=0 | w=5
  4086. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal tract dysfunction (juvenile-onset, less common)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal tract dysfunction (juvenile-onset, less common) | rel=r_associated | relid=0 | w=5
  4087. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal tract involvement
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal tract involvement | rel=r_associated | relid=0 | w=5
  4088. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:pyramidal tract signs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:pyramidal tract signs (in some patients) | rel=r_associated | relid=0 | w=5
  4089. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadriparesis
    n1=hyperaldostéronisme secondaire | n2=en:quadriparesis | rel=r_associated | relid=0 | w=5
  4090. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadriplegia
    n1=hyperaldostéronisme secondaire | n2=en:quadriplegia | rel=r_associated | relid=0 | w=5
  4091. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadriplegia, episodic
    n1=hyperaldostéronisme secondaire | n2=en:quadriplegia, episodic | rel=r_associated | relid=0 | w=5
  4092. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadriplegia, flaccid
    n1=hyperaldostéronisme secondaire | n2=en:quadriplegia, flaccid | rel=r_associated | relid=0 | w=5
  4093. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadriplegic dyskinesia
    n1=hyperaldostéronisme secondaire | n2=en:quadriplegic dyskinesia | rel=r_associated | relid=0 | w=5
  4094. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadrupedal gait
    n1=hyperaldostéronisme secondaire | n2=en:quadrupedal gait | rel=r_associated | relid=0 | w=5
  4095. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadrupedal gait (in some)
    n1=hyperaldostéronisme secondaire | n2=en:quadrupedal gait (in some) | rel=r_associated | relid=0 | w=5
  4096. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadrupedal gait (palm of hands, legs straight) with diagonal walking
    n1=hyperaldostéronisme secondaire | n2=en:quadrupedal gait (palm of hands, legs straight) with diagonal walking | rel=r_associated | relid=0 | w=5
  4097. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:quadrupedal locomotion (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:quadrupedal locomotion (in some patients) | rel=r_associated | relid=0 | w=5
  4098. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid complete resolution of symptoms
    n1=hyperaldostéronisme secondaire | n2=en:rapid complete resolution of symptoms | rel=r_associated | relid=0 | w=5
  4099. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid initial onset of symptoms (hours to weeks)
    n1=hyperaldostéronisme secondaire | n2=en:rapid initial onset of symptoms (hours to weeks) | rel=r_associated | relid=0 | w=5
  4100. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid onset
    n1=hyperaldostéronisme secondaire | n2=en:rapid onset | rel=r_associated | relid=0 | w=5
  4101. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid regression
    n1=hyperaldostéronisme secondaire | n2=en:rapid regression | rel=r_associated | relid=0 | w=5
  4102. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid, instantaneous neurologic decline may occur after fright
    n1=hyperaldostéronisme secondaire | n2=en:rapid, instantaneous neurologic decline may occur after fright | rel=r_associated | relid=0 | w=5
  4103. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapid, jerky movements
    n1=hyperaldostéronisme secondaire | n2=en:rapid, jerky movements | rel=r_associated | relid=0 | w=5
  4104. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rapidly progressive brainstem degeneration
    n1=hyperaldostéronisme secondaire | n2=en:rapidly progressive brainstem degeneration | rel=r_associated | relid=0 | w=5
  4105. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rare dementia
    n1=hyperaldostéronisme secondaire | n2=en:rare dementia | rel=r_associated | relid=0 | w=5
  4106. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rare secondary generalization
    n1=hyperaldostéronisme secondaire | n2=en:rare secondary generalization | rel=r_associated | relid=0 | w=5
  4107. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reactive gliosis
    n1=hyperaldostéronisme secondaire | n2=en:reactive gliosis | rel=r_associated | relid=0 | w=5
  4108. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reading at level beyond mental age
    n1=hyperaldostéronisme secondaire | n2=en:reading at level beyond mental age | rel=r_associated | relid=0 | w=5
  4109. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reading comprehension on par with verbal abilities
    n1=hyperaldostéronisme secondaire | n2=en:reading comprehension on par with verbal abilities | rel=r_associated | relid=0 | w=5
  4110. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reclusive
    n1=hyperaldostéronisme secondaire | n2=en:reclusive | rel=r_associated | relid=0 | w=5
  4111. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent bacterial meningitis
    n1=hyperaldostéronisme secondaire | n2=en:recurrent bacterial meningitis | rel=r_associated | relid=0 | w=5
  4112. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:recurrent encephalopathy | rel=r_associated | relid=0 | w=5
  4113. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent episodes of binge eating
    n1=hyperaldostéronisme secondaire | n2=en:recurrent episodes of binge eating | rel=r_associated | relid=0 | w=5
  4114. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent inappropriate conpensatory behavior to prevent weight gain, including self-induced vomiting, laxative or diuretic abuse, fasting, excessive exercise
    n1=hyperaldostéronisme secondaire | n2=en:recurrent inappropriate conpensatory behavior to prevent weight gain, including self-induced vomiting, laxative or diuretic abuse, fasting, excessive exercise | rel=r_associated | relid=0 | w=5
  4115. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent meningitis
    n1=hyperaldostéronisme secondaire | n2=en:recurrent meningitis | rel=r_associated | relid=0 | w=5
  4116. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent muscle twitches (symptom)
    n1=hyperaldostéronisme secondaire | n2=en:recurrent muscle twitches (symptom) | rel=r_associated | relid=0 | w=5
  4117. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent seizures nos
    n1=hyperaldostéronisme secondaire | n2=en:recurrent seizures nos | rel=r_associated | relid=0 | w=5
  4118. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:recurrent subcortical infarcts (strokes)
    n1=hyperaldostéronisme secondaire | n2=en:recurrent subcortical infarcts (strokes) | rel=r_associated | relid=0 | w=5
  4119. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced brain gyri
    n1=hyperaldostéronisme secondaire | n2=en:reduced brain gyri | rel=r_associated | relid=0 | w=5
  4120. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced brain size
    n1=hyperaldostéronisme secondaire | n2=en:reduced brain size | rel=r_associated | relid=0 | w=5
  4121. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced cerebral white matter
    n1=hyperaldostéronisme secondaire | n2=en:reduced cerebral white matter | rel=r_associated | relid=0 | w=5
  4122. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced concentration span
    n1=hyperaldostéronisme secondaire | n2=en:reduced concentration span | rel=r_associated | relid=0 | w=5
  4123. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced consciousness
    n1=hyperaldostéronisme secondaire | n2=en:reduced consciousness | rel=r_associated | relid=0 | w=5
  4124. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced consciousness, hypoglycemia-related
    n1=hyperaldostéronisme secondaire | n2=en:reduced consciousness, hypoglycemia-related | rel=r_associated | relid=0 | w=5
  4125. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced numbers of neurons
    n1=hyperaldostéronisme secondaire | n2=en:reduced numbers of neurons | rel=r_associated | relid=0 | w=5
  4126. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced posterior white matter volume (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:reduced posterior white matter volume (in some patients) | rel=r_associated | relid=0 | w=5
  4127. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced size of the pituitary gland
    n1=hyperaldostéronisme secondaire | n2=en:reduced size of the pituitary gland | rel=r_associated | relid=0 | w=5
  4128. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced sleep latency
    n1=hyperaldostéronisme secondaire | n2=en:reduced sleep latency | rel=r_associated | relid=0 | w=5
  4129. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced tendon reflexes
    n1=hyperaldostéronisme secondaire | n2=en:reduced tendon reflexes | rel=r_associated | relid=0 | w=5
  4130. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced white matter
    n1=hyperaldostéronisme secondaire | n2=en:reduced white matter | rel=r_associated | relid=0 | w=5
  4131. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduced white matter volume
    n1=hyperaldostéronisme secondaire | n2=en:reduced white matter volume | rel=r_associated | relid=0 | w=5
  4132. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduction of white matter, generalized
    n1=hyperaldostéronisme secondaire | n2=en:reduction of white matter, generalized | rel=r_associated | relid=0 | w=5
  4133. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reduction or loss of acquired skills (e.g., purposeful hand use, speech)
    n1=hyperaldostéronisme secondaire | n2=en:reduction or loss of acquired skills (e.g., purposeful hand use, speech) | rel=r_associated | relid=0 | w=5
  4134. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reflex epilepsy, photosensitive
    n1=hyperaldostéronisme secondaire | n2=en:reflex epilepsy, photosensitive | rel=r_associated | relid=0 | w=5
  4135. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reflex, deep tendon, absent
    n1=hyperaldostéronisme secondaire | n2=en:reflex, deep tendon, absent | rel=r_associated | relid=0 | w=5
  4136. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:regression of development
    n1=hyperaldostéronisme secondaire | n2=en:regression of development | rel=r_associated | relid=0 | w=5
  4137. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:regression of early motor skills
    n1=hyperaldostéronisme secondaire | n2=en:regression of early motor skills | rel=r_associated | relid=0 | w=5
  4138. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:regression of motor development
    n1=hyperaldostéronisme secondaire | n2=en:regression of motor development | rel=r_associated | relid=0 | w=5
  4139. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relative preservation of purkinje cells, but they are deformed and disaligned
    n1=hyperaldostéronisme secondaire | n2=en:relative preservation of purkinje cells, but they are deformed and disaligned | rel=r_associated | relid=0 | w=5
  4140. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relative preservation of the cerebellar folia
    n1=hyperaldostéronisme secondaire | n2=en:relative preservation of the cerebellar folia | rel=r_associated | relid=0 | w=5
  4141. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relative preservation of the cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:relative preservation of the cerebellum | rel=r_associated | relid=0 | w=5
  4142. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relative sparing of language
    n1=hyperaldostéronisme secondaire | n2=en:relative sparing of language | rel=r_associated | relid=0 | w=5
  4143. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relatively higher cognitive abilities than classic autism
    n1=hyperaldostéronisme secondaire | n2=en:relatively higher cognitive abilities than classic autism | rel=r_associated | relid=0 | w=5
  4144. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relatively higher cognitive abilities than classic autism (608636)
    n1=hyperaldostéronisme secondaire | n2=en:relatively higher cognitive abilities than classic autism (608636) | rel=r_associated | relid=0 | w=5
  4145. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:relief with motor activation
    n1=hyperaldostéronisme secondaire | n2=en:relief with motor activation | rel=r_associated | relid=0 | w=5
  4146. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rem sleep behavior disorder
    n1=hyperaldostéronisme secondaire | n2=en:rem sleep behavior disorder | rel=r_associated | relid=0 | w=5
  4147. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:repetitive behavior
    n1=hyperaldostéronisme secondaire | n2=en:repetitive behavior | rel=r_associated | relid=0 | w=5
  4148. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:repetitive compulsive behavior
    n1=hyperaldostéronisme secondaire | n2=en:repetitive compulsive behavior | rel=r_associated | relid=0 | w=5
  4149. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:repetitive compulsive movements (rare)
    n1=hyperaldostéronisme secondaire | n2=en:repetitive compulsive movements (rare) | rel=r_associated | relid=0 | w=5
  4150. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:repetitive movements
    n1=hyperaldostéronisme secondaire | n2=en:repetitive movements | rel=r_associated | relid=0 | w=5
  4151. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:repetitive, self-stimulatory behavior using upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:repetitive, self-stimulatory behavior using upper limbs | rel=r_associated | relid=0 | w=5
  4152. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:residual ataxia
    n1=hyperaldostéronisme secondaire | n2=en:residual ataxia | rel=r_associated | relid=0 | w=5
  4153. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:respiratory syncytial virus infection
    n1=hyperaldostéronisme secondaire | n2=en:respiratory syncytial virus infection | rel=r_associated | relid=0 | w=5
  4154. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:response to pyridoxal phosphate
    n1=hyperaldostéronisme secondaire | n2=en:response to pyridoxal phosphate | rel=r_associated | relid=0 | w=5
  4155. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:resting myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:resting myoclonus | rel=r_associated | relid=0 | w=5
  4156. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:resting tremor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:resting tremor (in some patients) | rel=r_associated | relid=0 | w=5
  4157. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:resting tremors
    n1=hyperaldostéronisme secondaire | n2=en:resting tremors | rel=r_associated | relid=0 | w=5
  4158. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:restless leg syndrome
    n1=hyperaldostéronisme secondaire | n2=en:restless leg syndrome | rel=r_associated | relid=0 | w=5
  4159. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:restlessness
    n1=hyperaldostéronisme secondaire | n2=en:restlessness | rel=r_associated | relid=0 | w=5
  4160. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:restlessness at birth
    n1=hyperaldostéronisme secondaire | n2=en:restlessness at birth | rel=r_associated | relid=0 | w=5
  4161. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:restlessness, agitation, crying under stress
    n1=hyperaldostéronisme secondaire | n2=en:restlessness, agitation, crying under stress | rel=r_associated | relid=0 | w=5
  4162. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:restrictive behavior, interests, and activities
    n1=hyperaldostéronisme secondaire | n2=en:restrictive behavior, interests, and activities | rel=r_associated | relid=0 | w=5
  4163. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:results in nocturnal insomnia and chronic sleep deprivation
    n1=hyperaldostéronisme secondaire | n2=en:results in nocturnal insomnia and chronic sleep deprivation | rel=r_associated | relid=0 | w=5
  4164. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:retrocerebellar cyst
    n1=hyperaldostéronisme secondaire | n2=en:retrocerebellar cyst | rel=r_associated | relid=0 | w=5
  4165. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:retrocerebellar cyst (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:retrocerebellar cyst (in some patients) | rel=r_associated | relid=0 | w=5
  4166. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:retrocerebellar cyst (rare)
    n1=hyperaldostéronisme secondaire | n2=en:retrocerebellar cyst (rare) | rel=r_associated | relid=0 | w=5
  4167. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:retrocollis
    n1=hyperaldostéronisme secondaire | n2=en:retrocollis | rel=r_associated | relid=0 | w=5
  4168. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:retroflexion of the neck
    n1=hyperaldostéronisme secondaire | n2=en:retroflexion of the neck | rel=r_associated | relid=0 | w=5
  4169. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rett syndrome
    n1=hyperaldostéronisme secondaire | n2=en:rett syndrome | rel=r_associated | relid=0 | w=5
  4170. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:reye syndrome
    n1=hyperaldostéronisme secondaire | n2=en:reye syndrome | rel=r_associated | relid=0 | w=5
  4171. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rhombencephalosynapsis
    n1=hyperaldostéronisme secondaire | n2=en:rhombencephalosynapsis | rel=r_associated | relid=0 | w=5
  4172. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rigidity (juvenile form)
    n1=hyperaldostéronisme secondaire | n2=en:rigidity (juvenile form) | rel=r_associated | relid=0 | w=5
  4173. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rigidity (later)
    n1=hyperaldostéronisme secondaire | n2=en:rigidity (later) | rel=r_associated | relid=0 | w=5
  4174. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rigidity during seizures
    n1=hyperaldostéronisme secondaire | n2=en:rigidity during seizures | rel=r_associated | relid=0 | w=5
  4175. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rigidity of limbs
    n1=hyperaldostéronisme secondaire | n2=en:rigidity of limbs | rel=r_associated | relid=0 | w=5
  4176. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rigidity, axial and limb
    n1=hyperaldostéronisme secondaire | n2=en:rigidity, axial and limb | rel=r_associated | relid=0 | w=5
  4177. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:romberg's sign positive
    n1=hyperaldostéronisme secondaire | n2=en:romberg's sign positive | rel=r_associated | relid=0 | w=5
  4178. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rotary head movements ('rolling,' 'tremor')
    n1=hyperaldostéronisme secondaire | n2=en:rotary head movements ('rolling,' 'tremor') | rel=r_associated | relid=0 | w=5
  4179. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:roving eye movements (infancy)
    n1=hyperaldostéronisme secondaire | n2=en:roving eye movements (infancy) | rel=r_associated | relid=0 | w=5
  4180. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rubella infection
    n1=hyperaldostéronisme secondaire | n2=en:rubella infection | rel=r_associated | relid=0 | w=5
  4181. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rudimentary white matter
    n1=hyperaldostéronisme secondaire | n2=en:rudimentary white matter | rel=r_associated | relid=0 | w=5
  4182. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:rumination disorder
    n1=hyperaldostéronisme secondaire | n2=en:rumination disorder | rel=r_associated | relid=0 | w=5
  4183. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sagittal sinus thrombosis
    n1=hyperaldostéronisme secondaire | n2=en:sagittal sinus thrombosis | rel=r_associated | relid=0 | w=5
  4184. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:salaam seizures
    n1=hyperaldostéronisme secondaire | n2=en:salaam seizures | rel=r_associated | relid=0 | w=5
  4185. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:scanning speech
    n1=hyperaldostéronisme secondaire | n2=en:scanning speech | rel=r_associated | relid=0 | w=5
  4186. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:scant iron deposition in the brain (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:scant iron deposition in the brain (1 family) | rel=r_associated | relid=0 | w=5
  4187. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:scattered cns demyelination
    n1=hyperaldostéronisme secondaire | n2=en:scattered cns demyelination | rel=r_associated | relid=0 | w=5
  4188. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schilbach-rott syndrome
    n1=hyperaldostéronisme secondaire | n2=en:schilbach-rott syndrome | rel=r_associated | relid=0 | w=5
  4189. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizencephaly
    n1=hyperaldostéronisme secondaire | n2=en:schizencephaly | rel=r_associated | relid=0 | w=5
  4190. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia | rel=r_associated | relid=0 | w=5
  4191. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia (22% of adults)
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia (22% of adults) | rel=r_associated | relid=0 | w=5
  4192. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia (in some patients) | rel=r_associated | relid=0 | w=5
  4193. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia (rare) | rel=r_associated | relid=0 | w=5
  4194. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia-like symptoms (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia-like symptoms (uncommon) | rel=r_associated | relid=0 | w=5
  4195. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenia, schizotypal and delusional disorders
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenia, schizotypal and delusional disorders | rel=r_associated | relid=0 | w=5
  4196. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:schizophrenic symptoms (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:schizophrenic symptoms (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  4197. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:school problem (finding)
    n1=hyperaldostéronisme secondaire | n2=en:school problem (finding) | rel=r_associated | relid=0 | w=5
  4198. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sciatica
    n1=hyperaldostéronisme secondaire | n2=en:sciatica | rel=r_associated | relid=0 | w=5
  4199. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:scissoring
    n1=hyperaldostéronisme secondaire | n2=en:scissoring | rel=r_associated | relid=0 | w=5
  4200. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:scissors gait
    n1=hyperaldostéronisme secondaire | n2=en:scissors gait | rel=r_associated | relid=0 | w=5
  4201. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seasonal affective disorder
    n1=hyperaldostéronisme secondaire | n2=en:seasonal affective disorder | rel=r_associated | relid=0 | w=5
  4202. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary generalization
    n1=hyperaldostéronisme secondaire | n2=en:secondary generalization | rel=r_associated | relid=0 | w=5
  4203. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary generalization may occur
    n1=hyperaldostéronisme secondaire | n2=en:secondary generalization may occur | rel=r_associated | relid=0 | w=5
  4204. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary generalization occurs in about 33% of patients
    n1=hyperaldostéronisme secondaire | n2=en:secondary generalization occurs in about 33% of patients | rel=r_associated | relid=0 | w=5
  4205. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary generalized tonic-clonic seizures may occur
    n1=hyperaldostéronisme secondaire | n2=en:secondary generalized tonic-clonic seizures may occur | rel=r_associated | relid=0 | w=5
  4206. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles
    n1=hyperaldostéronisme secondaire | n2=en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles | rel=r_associated | relid=0 | w=5
  4207. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary hypertonia
    n1=hyperaldostéronisme secondaire | n2=en:secondary hypertonia | rel=r_associated | relid=0 | w=5
  4208. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary involvement of proximal and trunk muscles
    n1=hyperaldostéronisme secondaire | n2=en:secondary involvement of proximal and trunk muscles | rel=r_associated | relid=0 | w=5
  4209. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary motor complications develop in 50% of those on levodopa therapy
    n1=hyperaldostéronisme secondaire | n2=en:secondary motor complications develop in 50% of those on levodopa therapy | rel=r_associated | relid=0 | w=5
  4210. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary seizures (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:secondary seizures (in some patients) | rel=r_associated | relid=0 | w=5
  4211. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:secondary spinal cord compression may occur
    n1=hyperaldostéronisme secondaire | n2=en:secondary spinal cord compression may occur | rel=r_associated | relid=0 | w=5
  4212. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:see juvenile myoclonic epilepsy (606904)
    n1=hyperaldostéronisme secondaire | n2=en:see juvenile myoclonic epilepsy (606904) | rel=r_associated | relid=0 | w=5
  4213. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:see spg5a (270800)
    n1=hyperaldostéronisme secondaire | n2=en:see spg5a (270800) | rel=r_associated | relid=0 | w=5
  4214. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:segmental callosal hypoplasia, mild
    n1=hyperaldostéronisme secondaire | n2=en:segmental callosal hypoplasia, mild | rel=r_associated | relid=0 | w=5
  4215. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:segmental sensory loss, especially of pain and temperature
    n1=hyperaldostéronisme secondaire | n2=en:segmental sensory loss, especially of pain and temperature | rel=r_associated | relid=0 | w=5
  4216. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure (in a subset of patients in infancy)
    n1=hyperaldostéronisme secondaire | n2=en:seizure (in a subset of patients in infancy) | rel=r_associated | relid=0 | w=5
  4217. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure disorder
    n1=hyperaldostéronisme secondaire | n2=en:seizure disorder | rel=r_associated | relid=0 | w=5
  4218. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure disorder (homozygote)
    n1=hyperaldostéronisme secondaire | n2=en:seizure disorder (homozygote) | rel=r_associated | relid=0 | w=5
  4219. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure including seizure-like activity in utero starting around 18 weeks gestation
    n1=hyperaldostéronisme secondaire | n2=en:seizure including seizure-like activity in utero starting around 18 weeks gestation | rel=r_associated | relid=0 | w=5
  4220. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure, febrile (2/3 children)
    n1=hyperaldostéronisme secondaire | n2=en:seizure, febrile (2/3 children) | rel=r_associated | relid=0 | w=5
  4221. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizure, focal or multifocal onset
    n1=hyperaldostéronisme secondaire | n2=en:seizure, focal or multifocal onset | rel=r_associated | relid=0 | w=5
  4222. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (> 90%)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (> 90%) | rel=r_associated | relid=0 | w=5
  4223. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (1 family) | rel=r_associated | relid=0 | w=5
  4224. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (1 patient) | rel=r_associated | relid=0 | w=5
  4225. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (2-10% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (2-10% of patients) | rel=r_associated | relid=0 | w=5
  4226. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (3 patients) | rel=r_associated | relid=0 | w=5
  4227. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (40%)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (40%) | rel=r_associated | relid=0 | w=5
  4228. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (50% of patients) | rel=r_associated | relid=0 | w=5
  4229. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (50%)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (50%) | rel=r_associated | relid=0 | w=5
  4230. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (about 50% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (about 50% of patients) | rel=r_associated | relid=0 | w=5
  4231. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (adult)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (adult) | rel=r_associated | relid=0 | w=5
  4232. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (cvs+)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (cvs+) | rel=r_associated | relid=0 | w=5
  4233. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (eclampsia)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (eclampsia) | rel=r_associated | relid=0 | w=5
  4234. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (if left untreated) | rel=r_associated | relid=0 | w=5
  4235. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in 1 of 2 sibs)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=5
  4236. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in 1 of 3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in 1 of 3 patients) | rel=r_associated | relid=0 | w=5
  4237. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in 2 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in 2 of 6 patients) | rel=r_associated | relid=0 | w=5
  4238. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in 2 of 9 patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in 2 of 9 patients) | rel=r_associated | relid=0 | w=5
  4239. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in 35%)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in 35%) | rel=r_associated | relid=0 | w=5
  4240. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in one patient) | rel=r_associated | relid=0 | w=5
  4241. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in some patients) | rel=r_associated | relid=0 | w=5
  4242. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (in some)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (in some) | rel=r_associated | relid=0 | w=5
  4243. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (juvenile form)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (juvenile form) | rel=r_associated | relid=0 | w=5
  4244. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (less common)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (less common) | rel=r_associated | relid=0 | w=5
  4245. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (may be difficult to control)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (may be difficult to control) | rel=r_associated | relid=0 | w=5
  4246. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (mean onset 4-5 months)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (mean onset 4-5 months) | rel=r_associated | relid=0 | w=5
  4247. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (meb)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (meb) | rel=r_associated | relid=0 | w=5
  4248. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (onset <2 years)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (onset <2 years) | rel=r_associated | relid=0 | w=5
  4249. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (rare, in males)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (rare, in males) | rel=r_associated | relid=0 | w=5
  4250. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (rare)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (rare) | rel=r_associated | relid=0 | w=5
  4251. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (reported in 1 family) | rel=r_associated | relid=0 | w=5
  4252. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (reported in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (reported in 2 patients) | rel=r_associated | relid=0 | w=5
  4253. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (tetany)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (tetany) | rel=r_associated | relid=0 | w=5
  4254. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (type i and type ii, juvenile)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (type i and type ii, juvenile) | rel=r_associated | relid=0 | w=5
  4255. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (uncommon) | rel=r_associated | relid=0 | w=5
  4256. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures (variable)
    n1=hyperaldostéronisme secondaire | n2=en:seizures (variable) | rel=r_associated | relid=0 | w=5
  4257. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures affect the vocal cords, lips, mouth, and face
    n1=hyperaldostéronisme secondaire | n2=en:seizures affect the vocal cords, lips, mouth, and face | rel=r_associated | relid=0 | w=5
  4258. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures are poorly controlled
    n1=hyperaldostéronisme secondaire | n2=en:seizures are poorly controlled | rel=r_associated | relid=0 | w=5
  4259. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures in 15-30%
    n1=hyperaldostéronisme secondaire | n2=en:seizures in 15-30% | rel=r_associated | relid=0 | w=5
  4260. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures in the newborn, refractory
    n1=hyperaldostéronisme secondaire | n2=en:seizures in the newborn, refractory | rel=r_associated | relid=0 | w=5
  4261. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures may occur during hypotensive episodes
    n1=hyperaldostéronisme secondaire | n2=en:seizures may occur during hypotensive episodes | rel=r_associated | relid=0 | w=5
  4262. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause
    n1=hyperaldostéronisme secondaire | n2=en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause | rel=r_associated | relid=0 | w=5
  4263. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures occur in clusters
    n1=hyperaldostéronisme secondaire | n2=en:seizures occur in clusters | rel=r_associated | relid=0 | w=5
  4264. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures occur in clusters over 1 or several days
    n1=hyperaldostéronisme secondaire | n2=en:seizures occur in clusters over 1 or several days | rel=r_associated | relid=0 | w=5
  4265. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures occur multiple times per day
    n1=hyperaldostéronisme secondaire | n2=en:seizures occur multiple times per day | rel=r_associated | relid=0 | w=5
  4266. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures often associated with infections
    n1=hyperaldostéronisme secondaire | n2=en:seizures often associated with infections | rel=r_associated | relid=0 | w=5
  4267. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures often begin focally with head and eye deviation
    n1=hyperaldostéronisme secondaire | n2=en:seizures often begin focally with head and eye deviation | rel=r_associated | relid=0 | w=5
  4268. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures often begin with head and eye deviation
    n1=hyperaldostéronisme secondaire | n2=en:seizures often begin with head and eye deviation | rel=r_associated | relid=0 | w=5
  4269. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures provoked by tactile stimulation or extreme emotion
    n1=hyperaldostéronisme secondaire | n2=en:seizures provoked by tactile stimulation or extreme emotion | rel=r_associated | relid=0 | w=5
  4270. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures recur in 33% of patients
    n1=hyperaldostéronisme secondaire | n2=en:seizures recur in 33% of patients | rel=r_associated | relid=0 | w=5
  4271. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes)
    n1=hyperaldostéronisme secondaire | n2=en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes) | rel=r_associated | relid=0 | w=5
  4272. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures usually last less than 15 minutes
    n1=hyperaldostéronisme secondaire | n2=en:seizures usually last less than 15 minutes | rel=r_associated | relid=0 | w=5
  4273. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures usually occur less than 3 times
    n1=hyperaldostéronisme secondaire | n2=en:seizures usually occur less than 3 times | rel=r_associated | relid=0 | w=5
  4274. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, complex partial, episodic
    n1=hyperaldostéronisme secondaire | n2=en:seizures, complex partial, episodic | rel=r_associated | relid=0 | w=5
  4275. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, complex, myoclonic
    n1=hyperaldostéronisme secondaire | n2=en:seizures, complex, myoclonic | rel=r_associated | relid=0 | w=5
  4276. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, continuous, refractory
    n1=hyperaldostéronisme secondaire | n2=en:seizures, continuous, refractory | rel=r_associated | relid=0 | w=5
  4277. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, diurnal partial, rare (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, diurnal partial, rare (in some patients) | rel=r_associated | relid=0 | w=5
  4278. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, early onset
    n1=hyperaldostéronisme secondaire | n2=en:seizures, early onset | rel=r_associated | relid=0 | w=5
  4279. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, early-onset (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, early-onset (1 family) | rel=r_associated | relid=0 | w=5
  4280. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, febrile (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, febrile (1 family) | rel=r_associated | relid=0 | w=5
  4281. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, focal, partial, motor
    n1=hyperaldostéronisme secondaire | n2=en:seizures, focal, partial, motor | rel=r_associated | relid=0 | w=5
  4282. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients) | rel=r_associated | relid=0 | w=5
  4283. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, generalized, afebrile
    n1=hyperaldostéronisme secondaire | n2=en:seizures, generalized, afebrile | rel=r_associated | relid=0 | w=5
  4284. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, generalized, may occur
    n1=hyperaldostéronisme secondaire | n2=en:seizures, generalized, may occur | rel=r_associated | relid=0 | w=5
  4285. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, hypoglycemic (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, hypoglycemic (in some patients) | rel=r_associated | relid=0 | w=5
  4286. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, infantile-onset
    n1=hyperaldostéronisme secondaire | n2=en:seizures, infantile-onset | rel=r_associated | relid=0 | w=5
  4287. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, intractable
    n1=hyperaldostéronisme secondaire | n2=en:seizures, intractable | rel=r_associated | relid=0 | w=5
  4288. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, intractable (in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, intractable (in 1 family) | rel=r_associated | relid=0 | w=5
  4289. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, juvenile myoclonic
    n1=hyperaldostéronisme secondaire | n2=en:seizures, juvenile myoclonic | rel=r_associated | relid=0 | w=5
  4290. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, mild
    n1=hyperaldostéronisme secondaire | n2=en:seizures, mild | rel=r_associated | relid=0 | w=5
  4291. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, multiple types
    n1=hyperaldostéronisme secondaire | n2=en:seizures, multiple types | rel=r_associated | relid=0 | w=5
  4292. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, neonatal (2p21del)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, neonatal (2p21del) | rel=r_associated | relid=0 | w=5
  4293. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, nocturnal, usually occur in daily clusters
    n1=hyperaldostéronisme secondaire | n2=en:seizures, nocturnal, usually occur in daily clusters | rel=r_associated | relid=0 | w=5
  4294. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, onset age 5 to 10 years
    n1=hyperaldostéronisme secondaire | n2=en:seizures, onset age 5 to 10 years | rel=r_associated | relid=0 | w=5
  4295. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, partial complex (rare)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, partial complex (rare) | rel=r_associated | relid=0 | w=5
  4296. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, partial with secondary generalization, focal at onset, usually motor
    n1=hyperaldostéronisme secondaire | n2=en:seizures, partial with secondary generalization, focal at onset, usually motor | rel=r_associated | relid=0 | w=5
  4297. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, partial, often hemifacial
    n1=hyperaldostéronisme secondaire | n2=en:seizures, partial, often hemifacial | rel=r_associated | relid=0 | w=5
  4298. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, partial, unilateral
    n1=hyperaldostéronisme secondaire | n2=en:seizures, partial, unilateral | rel=r_associated | relid=0 | w=5
  4299. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, particularly absence (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, particularly absence (in some patients) | rel=r_associated | relid=0 | w=5
  4300. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, poorly controlled
    n1=hyperaldostéronisme secondaire | n2=en:seizures, poorly controlled | rel=r_associated | relid=0 | w=5
  4301. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, recurrent, refractory
    n1=hyperaldostéronisme secondaire | n2=en:seizures, recurrent, refractory | rel=r_associated | relid=0 | w=5
  4302. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, refractory
    n1=hyperaldostéronisme secondaire | n2=en:seizures, refractory | rel=r_associated | relid=0 | w=5
  4303. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, refractory to treatment
    n1=hyperaldostéronisme secondaire | n2=en:seizures, refractory to treatment | rel=r_associated | relid=0 | w=5
  4304. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, refractory, infantile-onset
    n1=hyperaldostéronisme secondaire | n2=en:seizures, refractory, infantile-onset | rel=r_associated | relid=0 | w=5
  4305. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, severe, drug-resistant, intractable
    n1=hyperaldostéronisme secondaire | n2=en:seizures, severe, drug-resistant, intractable | rel=r_associated | relid=0 | w=5
  4306. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, severe, intractable
    n1=hyperaldostéronisme secondaire | n2=en:seizures, severe, intractable | rel=r_associated | relid=0 | w=5
  4307. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, sudden-onset, drug-resistant
    n1=hyperaldostéronisme secondaire | n2=en:seizures, sudden-onset, drug-resistant | rel=r_associated | relid=0 | w=5
  4308. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, tonic-clonic (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, tonic-clonic (1 patient) | rel=r_associated | relid=0 | w=5
  4309. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, tonic-clonic (rare)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, tonic-clonic (rare) | rel=r_associated | relid=0 | w=5
  4310. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, tonic-clonic or absence (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:seizures, tonic-clonic or absence (in some patients) | rel=r_associated | relid=0 | w=5
  4311. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, tonic, clonic, focal
    n1=hyperaldostéronisme secondaire | n2=en:seizures, tonic, clonic, focal | rel=r_associated | relid=0 | w=5
  4312. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:seizures, tonic, hyperekplectic
    n1=hyperaldostéronisme secondaire | n2=en:seizures, tonic, hyperekplectic | rel=r_associated | relid=0 | w=5
  4313. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:selective loss of cerebellar purkinje cells
    n1=hyperaldostéronisme secondaire | n2=en:selective loss of cerebellar purkinje cells | rel=r_associated | relid=0 | w=5
  4314. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:selective mutism
    n1=hyperaldostéronisme secondaire | n2=en:selective mutism | rel=r_associated | relid=0 | w=5
  4315. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self abuse
    n1=hyperaldostéronisme secondaire | n2=en:self abuse | rel=r_associated | relid=0 | w=5
  4316. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self mutilation
    n1=hyperaldostéronisme secondaire | n2=en:self mutilation | rel=r_associated | relid=0 | w=5
  4317. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self mutilation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:self mutilation (in some patients) | rel=r_associated | relid=0 | w=5
  4318. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-absorbed
    n1=hyperaldostéronisme secondaire | n2=en:self-absorbed | rel=r_associated | relid=0 | w=5
  4319. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-harming behaviors
    n1=hyperaldostéronisme secondaire | n2=en:self-harming behaviors | rel=r_associated | relid=0 | w=5
  4320. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-injurious behavior
    n1=hyperaldostéronisme secondaire | n2=en:self-injurious behavior | rel=r_associated | relid=0 | w=5
  4321. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-injurious behavior (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:self-injurious behavior (in some patients) | rel=r_associated | relid=0 | w=5
  4322. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-injurious behavior, median onset age 2 years
    n1=hyperaldostéronisme secondaire | n2=en:self-injurious behavior, median onset age 2 years | rel=r_associated | relid=0 | w=5
  4323. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-mutilation (if left untreated)
    n1=hyperaldostéronisme secondaire | n2=en:self-mutilation (if left untreated) | rel=r_associated | relid=0 | w=5
  4324. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-mutilation of tongue and lips due to involuntary movements
    n1=hyperaldostéronisme secondaire | n2=en:self-mutilation of tongue and lips due to involuntary movements | rel=r_associated | relid=0 | w=5
  4325. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:self-stimulating behavior (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:self-stimulating behavior (in some patients) | rel=r_associated | relid=0 | w=5
  4326. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:semilobar holoprosencephalies
    n1=hyperaldostéronisme secondaire | n2=en:semilobar holoprosencephalies | rel=r_associated | relid=0 | w=5
  4327. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle
    n1=hyperaldostéronisme secondaire | n2=en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle | rel=r_associated | relid=0 | w=5
  4328. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sensitivity to neuroleptic medication
    n1=hyperaldostéronisme secondaire | n2=en:sensitivity to neuroleptic medication | rel=r_associated | relid=0 | w=5
  4329. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sensory ataxia (less common)
    n1=hyperaldostéronisme secondaire | n2=en:sensory ataxia (less common) | rel=r_associated | relid=0 | w=5
  4330. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sensory aura may occur
    n1=hyperaldostéronisme secondaire | n2=en:sensory aura may occur | rel=r_associated | relid=0 | w=5
  4331. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:separation anxiety disorder
    n1=hyperaldostéronisme secondaire | n2=en:separation anxiety disorder | rel=r_associated | relid=0 | w=5
  4332. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:septum pellucidum deficient or cavum
    n1=hyperaldostéronisme secondaire | n2=en:septum pellucidum deficient or cavum | rel=r_associated | relid=0 | w=5
  4333. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe behavioral problems at age 3-4
    n1=hyperaldostéronisme secondaire | n2=en:severe behavioral problems at age 3-4 | rel=r_associated | relid=0 | w=5
  4334. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe behavioral problems at age 3-4 years
    n1=hyperaldostéronisme secondaire | n2=en:severe behavioral problems at age 3-4 years | rel=r_associated | relid=0 | w=5
  4335. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe behavioral problems beginning at 3 to 4 years of age
    n1=hyperaldostéronisme secondaire | n2=en:severe behavioral problems beginning at 3 to 4 years of age | rel=r_associated | relid=0 | w=5
  4336. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe brain damage
    n1=hyperaldostéronisme secondaire | n2=en:severe brain damage | rel=r_associated | relid=0 | w=5
  4337. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe cognitive deficits (develop later)
    n1=hyperaldostéronisme secondaire | n2=en:severe cognitive deficits (develop later) | rel=r_associated | relid=0 | w=5
  4338. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe cognitive impairment
    n1=hyperaldostéronisme secondaire | n2=en:severe cognitive impairment | rel=r_associated | relid=0 | w=5
  4339. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe delay in myelination
    n1=hyperaldostéronisme secondaire | n2=en:severe delay in myelination | rel=r_associated | relid=0 | w=5
  4340. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe demyelination of the white matter
    n1=hyperaldostéronisme secondaire | n2=en:severe demyelination of the white matter | rel=r_associated | relid=0 | w=5
  4341. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe developmental delay in survivors
    n1=hyperaldostéronisme secondaire | n2=en:severe developmental delay in survivors | rel=r_associated | relid=0 | w=5
  4342. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe expressive language delay
    n1=hyperaldostéronisme secondaire | n2=en:severe expressive language delay | rel=r_associated | relid=0 | w=5
  4343. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe expressive speech delay
    n1=hyperaldostéronisme secondaire | n2=en:severe expressive speech delay | rel=r_associated | relid=0 | w=5
  4344. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe form may never achieve sitting or walking
    n1=hyperaldostéronisme secondaire | n2=en:severe form may never achieve sitting or walking | rel=r_associated | relid=0 | w=5
  4345. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe global developmental delay
    n1=hyperaldostéronisme secondaire | n2=en:severe global developmental delay | rel=r_associated | relid=0 | w=5
  4346. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe hydrocephalus
    n1=hyperaldostéronisme secondaire | n2=en:severe hydrocephalus | rel=r_associated | relid=0 | w=5
  4347. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe involvement of globus pallidus
    n1=hyperaldostéronisme secondaire | n2=en:severe involvement of globus pallidus | rel=r_associated | relid=0 | w=5
  4348. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe mental retardation (congenital form)
    n1=hyperaldostéronisme secondaire | n2=en:severe mental retardation (congenital form) | rel=r_associated | relid=0 | w=5
  4349. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe mental retardation (i.q. 20-34)
    n1=hyperaldostéronisme secondaire | n2=en:severe mental retardation (i.q. 20-34) | rel=r_associated | relid=0 | w=5
  4350. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe mental retardation (iq 10-40)
    n1=hyperaldostéronisme secondaire | n2=en:severe mental retardation (iq 10-40) | rel=r_associated | relid=0 | w=5
  4351. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe muscular hypotonia
    n1=hyperaldostéronisme secondaire | n2=en:severe muscular hypotonia | rel=r_associated | relid=0 | w=5
  4352. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe neonatal hypotonia improving with age
    n1=hyperaldostéronisme secondaire | n2=en:severe neonatal hypotonia improving with age | rel=r_associated | relid=0 | w=5
  4353. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe prenatal onset hydrocephalus
    n1=hyperaldostéronisme secondaire | n2=en:severe prenatal onset hydrocephalus | rel=r_associated | relid=0 | w=5
  4354. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe psychomotor retardation
    n1=hyperaldostéronisme secondaire | n2=en:severe psychomotor retardation | rel=r_associated | relid=0 | w=5
  4355. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe psychomotor retardation (iq 35-65)
    n1=hyperaldostéronisme secondaire | n2=en:severe psychomotor retardation (iq 35-65) | rel=r_associated | relid=0 | w=5
  4356. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe psychomotor retardation from birth
    n1=hyperaldostéronisme secondaire | n2=en:severe psychomotor retardation from birth | rel=r_associated | relid=0 | w=5
  4357. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe speech delay
    n1=hyperaldostéronisme secondaire | n2=en:severe speech delay | rel=r_associated | relid=0 | w=5
  4358. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severe speech impairment
    n1=hyperaldostéronisme secondaire | n2=en:severe speech impairment | rel=r_associated | relid=0 | w=5
  4359. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severely delayed psychomotor development
    n1=hyperaldostéronisme secondaire | n2=en:severely delayed psychomotor development | rel=r_associated | relid=0 | w=5
  4360. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severely impaired or absent speech
    n1=hyperaldostéronisme secondaire | n2=en:severely impaired or absent speech | rel=r_associated | relid=0 | w=5
  4361. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:severity of symptoms peak in the second decade and do not progress
    n1=hyperaldostéronisme secondaire | n2=en:severity of symptoms peak in the second decade and do not progress | rel=r_associated | relid=0 | w=5
  4362. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sexual and gender identity disorders
    n1=hyperaldostéronisme secondaire | n2=en:sexual and gender identity disorders | rel=r_associated | relid=0 | w=5
  4363. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shivering sensation
    n1=hyperaldostéronisme secondaire | n2=en:shivering sensation | rel=r_associated | relid=0 | w=5
  4364. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:short circadian rhythm cycle (tau)
    n1=hyperaldostéronisme secondaire | n2=en:short circadian rhythm cycle (tau) | rel=r_associated | relid=0 | w=5
  4365. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:short pons
    n1=hyperaldostéronisme secondaire | n2=en:short pons | rel=r_associated | relid=0 | w=5
  4366. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shorter daily total sleep times compared to age-matched controls
    n1=hyperaldostéronisme secondaire | n2=en:shorter daily total sleep times compared to age-matched controls | rel=r_associated | relid=0 | w=5
  4367. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shrunken inferior olivary nuclei
    n1=hyperaldostéronisme secondaire | n2=en:shrunken inferior olivary nuclei | rel=r_associated | relid=0 | w=5
  4368. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shuffling gaits
    n1=hyperaldostéronisme secondaire | n2=en:shuffling gaits | rel=r_associated | relid=0 | w=5
  4369. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shy character
    n1=hyperaldostéronisme secondaire | n2=en:shy character | rel=r_associated | relid=0 | w=5
  4370. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shy character (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:shy character (1 family) | rel=r_associated | relid=0 | w=5
  4371. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:shyness
    n1=hyperaldostéronisme secondaire | n2=en:shyness | rel=r_associated | relid=0 | w=5
  4372. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri | rel=r_associated | relid=0 | w=5
  4373. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:signal changes in the caudate and putamen
    n1=hyperaldostéronisme secondaire | n2=en:signal changes in the caudate and putamen | rel=r_associated | relid=0 | w=5
  4374. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simple partial seizures
    n1=hyperaldostéronisme secondaire | n2=en:simple partial seizures | rel=r_associated | relid=0 | w=5
  4375. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simple partial seizures with secondary generalization
    n1=hyperaldostéronisme secondaire | n2=en:simple partial seizures with secondary generalization | rel=r_associated | relid=0 | w=5
  4376. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified cortical gyral pattern
    n1=hyperaldostéronisme secondaire | n2=en:simplified cortical gyral pattern | rel=r_associated | relid=0 | w=5
  4377. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified cortical gyration pattern
    n1=hyperaldostéronisme secondaire | n2=en:simplified cortical gyration pattern | rel=r_associated | relid=0 | w=5
  4378. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyral pattern (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyral pattern (1 patient) | rel=r_associated | relid=0 | w=5
  4379. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyral pattern (in 1 of 2 sibs)
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyral pattern (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=5
  4380. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyral pattern (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyral pattern (in one patient) | rel=r_associated | relid=0 | w=5
  4381. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyral pattern (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyral pattern (in some patients) | rel=r_associated | relid=0 | w=5
  4382. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyration in the frontal cortex (less common)
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyration in the frontal cortex (less common) | rel=r_associated | relid=0 | w=5
  4383. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:simplified gyration pattern
    n1=hyperaldostéronisme secondaire | n2=en:simplified gyration pattern | rel=r_associated | relid=0 | w=5
  4384. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sinus pericranii (rare)
    n1=hyperaldostéronisme secondaire | n2=en:sinus pericranii (rare) | rel=r_associated | relid=0 | w=5
  4385. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:sleep abnormalities | rel=r_associated | relid=0 | w=5
  4386. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep apnea
    n1=hyperaldostéronisme secondaire | n2=en:sleep apnea | rel=r_associated | relid=0 | w=5
  4387. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep apnea (in 1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:sleep apnea (in 1/4 patients) | rel=r_associated | relid=0 | w=5
  4388. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep benefit (31%)
    n1=hyperaldostéronisme secondaire | n2=en:sleep benefit (31%) | rel=r_associated | relid=0 | w=5
  4389. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disorder
    n1=hyperaldostéronisme secondaire | n2=en:sleep disorder | rel=r_associated | relid=0 | w=5
  4390. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disorder (rare)
    n1=hyperaldostéronisme secondaire | n2=en:sleep disorder (rare) | rel=r_associated | relid=0 | w=5
  4391. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disorder with severe insomnia (in adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:sleep disorder with severe insomnia (in adulthood) | rel=r_associated | relid=0 | w=5
  4392. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disturbances
    n1=hyperaldostéronisme secondaire | n2=en:sleep disturbances | rel=r_associated | relid=0 | w=5
  4393. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disturbances (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:sleep disturbances (in some patients) | rel=r_associated | relid=0 | w=5
  4394. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep disturbances common
    n1=hyperaldostéronisme secondaire | n2=en:sleep disturbances common | rel=r_associated | relid=0 | w=5
  4395. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep impairment, progressive
    n1=hyperaldostéronisme secondaire | n2=en:sleep impairment, progressive | rel=r_associated | relid=0 | w=5
  4396. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep paralysis at beginning or end of sleep period (in 60% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:sleep paralysis at beginning or end of sleep period (in 60% of patients) | rel=r_associated | relid=0 | w=5
  4397. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep pattern disturbance
    n1=hyperaldostéronisme secondaire | n2=en:sleep pattern disturbance | rel=r_associated | relid=0 | w=5
  4398. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep talking
    n1=hyperaldostéronisme secondaire | n2=en:sleep talking | rel=r_associated | relid=0 | w=5
  4399. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep-onset rem
    n1=hyperaldostéronisme secondaire | n2=en:sleep-onset rem | rel=r_associated | relid=0 | w=5
  4400. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleep-wake cycle disturbance
    n1=hyperaldostéronisme secondaire | n2=en:sleep-wake cycle disturbance | rel=r_associated | relid=0 | w=5
  4401. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sleepiness
    n1=hyperaldostéronisme secondaire | n2=en:sleepiness | rel=r_associated | relid=0 | w=5
  4402. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow gait
    n1=hyperaldostéronisme secondaire | n2=en:slow gait | rel=r_associated | relid=0 | w=5
  4403. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow gross motor activity
    n1=hyperaldostéronisme secondaire | n2=en:slow gross motor activity | rel=r_associated | relid=0 | w=5
  4404. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow paraparetic gait
    n1=hyperaldostéronisme secondaire | n2=en:slow paraparetic gait | rel=r_associated | relid=0 | w=5
  4405. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow reactions
    n1=hyperaldostéronisme secondaire | n2=en:slow reactions | rel=r_associated | relid=0 | w=5
  4406. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow speech
    n1=hyperaldostéronisme secondaire | n2=en:slow speech | rel=r_associated | relid=0 | w=5
  4407. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow spike-wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:slow spike-wave discharges | rel=r_associated | relid=0 | w=5
  4408. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slow, broad-based gait
    n1=hyperaldostéronisme secondaire | n2=en:slow, broad-based gait | rel=r_associated | relid=0 | w=5
  4409. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slowed background activity
    n1=hyperaldostéronisme secondaire | n2=en:slowed background activity | rel=r_associated | relid=0 | w=5
  4410. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slowing mental development by 1.5 to 3 years
    n1=hyperaldostéronisme secondaire | n2=en:slowing mental development by 1.5 to 3 years | rel=r_associated | relid=0 | w=5
  4411. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slowing mental development by 1.5 to 3 years of age
    n1=hyperaldostéronisme secondaire | n2=en:slowing mental development by 1.5 to 3 years of age | rel=r_associated | relid=0 | w=5
  4412. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slowly progressive neurologic deterioration
    n1=hyperaldostéronisme secondaire | n2=en:slowly progressive neurologic deterioration | rel=r_associated | relid=0 | w=5
  4413. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slurred speech
    n1=hyperaldostéronisme secondaire | n2=en:slurred speech | rel=r_associated | relid=0 | w=5
  4414. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:slurred speech, episodic
    n1=hyperaldostéronisme secondaire | n2=en:slurred speech, episodic | rel=r_associated | relid=0 | w=5
  4415. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration
    n1=hyperaldostéronisme secondaire | n2=en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration | rel=r_associated | relid=0 | w=5
  4416. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small anterior commissure
    n1=hyperaldostéronisme secondaire | n2=en:small anterior commissure | rel=r_associated | relid=0 | w=5
  4417. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small brain
    n1=hyperaldostéronisme secondaire | n2=en:small brain | rel=r_associated | relid=0 | w=5
  4418. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small brain size (some patients)
    n1=hyperaldostéronisme secondaire | n2=en:small brain size (some patients) | rel=r_associated | relid=0 | w=5
  4419. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small brain with no other malformation see on mri
    n1=hyperaldostéronisme secondaire | n2=en:small brain with no other malformation see on mri | rel=r_associated | relid=0 | w=5
  4420. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small but structurally normal cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:small but structurally normal cerebral cortex | rel=r_associated | relid=0 | w=5
  4421. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small caudate
    n1=hyperaldostéronisme secondaire | n2=en:small caudate | rel=r_associated | relid=0 | w=5
  4422. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small cavum septum
    n1=hyperaldostéronisme secondaire | n2=en:small cavum septum | rel=r_associated | relid=0 | w=5
  4423. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:small cerebellum | rel=r_associated | relid=0 | w=5
  4424. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small cerebellum (especially vermis)
    n1=hyperaldostéronisme secondaire | n2=en:small cerebellum (especially vermis) | rel=r_associated | relid=0 | w=5
  4425. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:small cerebral cortex | rel=r_associated | relid=0 | w=5
  4426. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small frontal lobes (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:small frontal lobes (in one patient) | rel=r_associated | relid=0 | w=5
  4427. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small hippocampi (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:small hippocampi (1 patient) | rel=r_associated | relid=0 | w=5
  4428. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small midbrain
    n1=hyperaldostéronisme secondaire | n2=en:small midbrain | rel=r_associated | relid=0 | w=5
  4429. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small pituitary gland (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:small pituitary gland (in some patients) | rel=r_associated | relid=0 | w=5
  4430. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small rotary component may be present
    n1=hyperaldostéronisme secondaire | n2=en:small rotary component may be present | rel=r_associated | relid=0 | w=5
  4431. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small sella
    n1=hyperaldostéronisme secondaire | n2=en:small sella | rel=r_associated | relid=0 | w=5
  4432. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small shrunken brain
    n1=hyperaldostéronisme secondaire | n2=en:small shrunken brain | rel=r_associated | relid=0 | w=5
  4433. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small size of the left hippocampus gyri
    n1=hyperaldostéronisme secondaire | n2=en:small size of the left hippocampus gyri | rel=r_associated | relid=0 | w=5
  4434. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small thalami
    n1=hyperaldostéronisme secondaire | n2=en:small thalami | rel=r_associated | relid=0 | w=5
  4435. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small, smooth cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:small, smooth cerebellum | rel=r_associated | relid=0 | w=5
  4436. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:small, thin cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:small, thin cerebellum | rel=r_associated | relid=0 | w=5
  4437. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:smoking and youth
    n1=hyperaldostéronisme secondaire | n2=en:smoking and youth | rel=r_associated | relid=0 | w=5
  4438. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:smooth brain surface
    n1=hyperaldostéronisme secondaire | n2=en:smooth brain surface | rel=r_associated | relid=0 | w=5
  4439. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:smooth, thin cortical mantle (wws)
    n1=hyperaldostéronisme secondaire | n2=en:smooth, thin cortical mantle (wws) | rel=r_associated | relid=0 | w=5
  4440. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:social and occupational deterioration
    n1=hyperaldostéronisme secondaire | n2=en:social and occupational deterioration | rel=r_associated | relid=0 | w=5
  4441. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:social communication disorder
    n1=hyperaldostéronisme secondaire | n2=en:social communication disorder | rel=r_associated | relid=0 | w=5
  4442. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:social difficulties
    n1=hyperaldostéronisme secondaire | n2=en:social difficulties | rel=r_associated | relid=0 | w=5
  4443. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:social sensitivity
    n1=hyperaldostéronisme secondaire | n2=en:social sensitivity | rel=r_associated | relid=0 | w=5
  4444. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:social withdrawal
    n1=hyperaldostéronisme secondaire | n2=en:social withdrawal | rel=r_associated | relid=0 | w=5
  4445. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:somatosensory evoked potentials show prolonged latency
    n1=hyperaldostéronisme secondaire | n2=en:somatosensory evoked potentials show prolonged latency | rel=r_associated | relid=0 | w=5
  4446. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some may not achieve ambulation
    n1=hyperaldostéronisme secondaire | n2=en:some may not achieve ambulation | rel=r_associated | relid=0 | w=5
  4447. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients do not achieve ability to walk
    n1=hyperaldostéronisme secondaire | n2=en:some patients do not achieve ability to walk | rel=r_associated | relid=0 | w=5
  4448. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients have neurologic involvement
    n1=hyperaldostéronisme secondaire | n2=en:some patients have neurologic involvement | rel=r_associated | relid=0 | w=5
  4449. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients have no structural brain abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:some patients have no structural brain abnormalities | rel=r_associated | relid=0 | w=5
  4450. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients have periodic wave complexes on eeg
    n1=hyperaldostéronisme secondaire | n2=en:some patients have periodic wave complexes on eeg | rel=r_associated | relid=0 | w=5
  4451. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients may develop afebrile seizures later in life
    n1=hyperaldostéronisme secondaire | n2=en:some patients may develop afebrile seizures later in life | rel=r_associated | relid=0 | w=5
  4452. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients may show normal early development
    n1=hyperaldostéronisme secondaire | n2=en:some patients may show normal early development | rel=r_associated | relid=0 | w=5
  4453. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients never achieve independent ambulation
    n1=hyperaldostéronisme secondaire | n2=en:some patients never achieve independent ambulation | rel=r_associated | relid=0 | w=5
  4454. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:some patients only achieve sitting
    n1=hyperaldostéronisme secondaire | n2=en:some patients only achieve sitting | rel=r_associated | relid=0 | w=5
  4455. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:somnolence
    n1=hyperaldostéronisme secondaire | n2=en:somnolence | rel=r_associated | relid=0 | w=5
  4456. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sparing of central white matter structures
    n1=hyperaldostéronisme secondaire | n2=en:sparing of central white matter structures | rel=r_associated | relid=0 | w=5
  4457. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sparing of optic tracts
    n1=hyperaldostéronisme secondaire | n2=en:sparing of optic tracts | rel=r_associated | relid=0 | w=5
  4458. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sparing of the inferior olives
    n1=hyperaldostéronisme secondaire | n2=en:sparing of the inferior olives | rel=r_associated | relid=0 | w=5
  4459. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasmodic dysphonia
    n1=hyperaldostéronisme secondaire | n2=en:spasmodic dysphonia | rel=r_associated | relid=0 | w=5
  4460. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasmodic torticollis
    n1=hyperaldostéronisme secondaire | n2=en:spasmodic torticollis | rel=r_associated | relid=0 | w=5
  4461. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic ataxia
    n1=hyperaldostéronisme secondaire | n2=en:spastic ataxia | rel=r_associated | relid=0 | w=5
  4462. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic cerebral palsy
    n1=hyperaldostéronisme secondaire | n2=en:spastic cerebral palsy | rel=r_associated | relid=0 | w=5
  4463. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic diplegia
    n1=hyperaldostéronisme secondaire | n2=en:spastic diplegia | rel=r_associated | relid=0 | w=5
  4464. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic diplegia (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:spastic diplegia (1 patient) | rel=r_associated | relid=0 | w=5
  4465. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic diplegia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spastic diplegia (in some patients) | rel=r_associated | relid=0 | w=5
  4466. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic diplegia, progressive
    n1=hyperaldostéronisme secondaire | n2=en:spastic diplegia, progressive | rel=r_associated | relid=0 | w=5
  4467. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic diplegia, symmetric
    n1=hyperaldostéronisme secondaire | n2=en:spastic diplegia, symmetric | rel=r_associated | relid=0 | w=5
  4468. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic dystonia
    n1=hyperaldostéronisme secondaire | n2=en:spastic dystonia | rel=r_associated | relid=0 | w=5
  4469. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic gait
    n1=hyperaldostéronisme secondaire | n2=en:spastic gait | rel=r_associated | relid=0 | w=5
  4470. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paralysis
    n1=hyperaldostéronisme secondaire | n2=en:spastic paralysis | rel=r_associated | relid=0 | w=5
  4471. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraparesis (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraparesis (1 patient) | rel=r_associated | relid=0 | w=5
  4472. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraparesis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraparesis (rare) | rel=r_associated | relid=0 | w=5
  4473. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia | rel=r_associated | relid=0 | w=5
  4474. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia (in some patients) | rel=r_associated | relid=0 | w=5
  4475. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia, later onset (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia, later onset (in one patient) | rel=r_associated | relid=0 | w=5
  4476. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia, pure
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia, pure | rel=r_associated | relid=0 | w=5
  4477. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia, severe
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia, severe | rel=r_associated | relid=0 | w=5
  4478. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic paraplegia, slowly progressive
    n1=hyperaldostéronisme secondaire | n2=en:spastic paraplegia, slowly progressive | rel=r_associated | relid=0 | w=5
  4479. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic quadriplegia
    n1=hyperaldostéronisme secondaire | n2=en:spastic quadriplegia | rel=r_associated | relid=0 | w=5
  4480. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic quadriplegia (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:spastic quadriplegia (in one patient) | rel=r_associated | relid=0 | w=5
  4481. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic quadriplegia, residual mild-to-severe (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spastic quadriplegia, residual mild-to-severe (in some patients) | rel=r_associated | relid=0 | w=5
  4482. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic quadriplegia, severe
    n1=hyperaldostéronisme secondaire | n2=en:spastic quadriplegia, severe | rel=r_associated | relid=0 | w=5
  4483. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic tetraparesis
    n1=hyperaldostéronisme secondaire | n2=en:spastic tetraparesis | rel=r_associated | relid=0 | w=5
  4484. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic tetraparesis (in severe cases)
    n1=hyperaldostéronisme secondaire | n2=en:spastic tetraparesis (in severe cases) | rel=r_associated | relid=0 | w=5
  4485. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic tetraplegia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spastic tetraplegia (in some patients) | rel=r_associated | relid=0 | w=5
  4486. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic tetraplegia (onset in the second decade)
    n1=hyperaldostéronisme secondaire | n2=en:spastic tetraplegia (onset in the second decade) | rel=r_associated | relid=0 | w=5
  4487. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic-ataxic gait
    n1=hyperaldostéronisme secondaire | n2=en:spastic-ataxic gait | rel=r_associated | relid=0 | w=5
  4488. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spastic-ataxic tetraparesis
    n1=hyperaldostéronisme secondaire | n2=en:spastic-ataxic tetraparesis | rel=r_associated | relid=0 | w=5
  4489. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity
    n1=hyperaldostéronisme secondaire | n2=en:spasticity | rel=r_associated | relid=0 | w=5
  4490. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (1 family) | rel=r_associated | relid=0 | w=5
  4491. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (1 of 4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (1 of 4 patients) | rel=r_associated | relid=0 | w=5
  4492. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (in some patients) | rel=r_associated | relid=0 | w=5
  4493. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (in some)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (in some) | rel=r_associated | relid=0 | w=5
  4494. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (later onset)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (later onset) | rel=r_associated | relid=0 | w=5
  4495. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (later)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (later) | rel=r_associated | relid=0 | w=5
  4496. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (less common)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (less common) | rel=r_associated | relid=0 | w=5
  4497. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (patient a) | rel=r_associated | relid=0 | w=5
  4498. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (rare)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (rare) | rel=r_associated | relid=0 | w=5
  4499. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (reported in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  4500. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity (type ii)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity (type ii) | rel=r_associated | relid=0 | w=5
  4501. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity in infancy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity in infancy (1 patient) | rel=r_associated | relid=0 | w=5
  4502. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity may be present
    n1=hyperaldostéronisme secondaire | n2=en:spasticity may be present | rel=r_associated | relid=0 | w=5
  4503. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity may occur
    n1=hyperaldostéronisme secondaire | n2=en:spasticity may occur | rel=r_associated | relid=0 | w=5
  4504. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity of facial muscles
    n1=hyperaldostéronisme secondaire | n2=en:spasticity of facial muscles | rel=r_associated | relid=0 | w=5
  4505. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity of lower and upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity of lower and upper limbs | rel=r_associated | relid=0 | w=5
  4506. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity of pharyngeal muscles
    n1=hyperaldostéronisme secondaire | n2=en:spasticity of pharyngeal muscles | rel=r_associated | relid=0 | w=5
  4507. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, distal
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, distal | rel=r_associated | relid=0 | w=5
  4508. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, hyperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, hyperreflexia | rel=r_associated | relid=0 | w=5
  4509. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, lower limbs greater than upper limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, lower limbs greater than upper limbs | rel=r_associated | relid=0 | w=5
  4510. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, mainly in the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, mainly in the lower limbs | rel=r_associated | relid=0 | w=5
  4511. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, mild (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, mild (in some patients) | rel=r_associated | relid=0 | w=5
  4512. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, more apparent in the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, more apparent in the lower limbs | rel=r_associated | relid=0 | w=5
  4513. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, primarily lower limbs, but upper limbs may be involved
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, primarily lower limbs, but upper limbs may be involved | rel=r_associated | relid=0 | w=5
  4514. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, progressive, develops in childhood
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, progressive, develops in childhood | rel=r_associated | relid=0 | w=5
  4515. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, severe
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, severe | rel=r_associated | relid=0 | w=5
  4516. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, severe, affecting lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, severe, affecting lower limbs | rel=r_associated | relid=0 | w=5
  4517. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity, usually of the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:spasticity, usually of the lower limbs | rel=r_associated | relid=0 | w=5
  4518. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spasticity/paresis (rare)
    n1=hyperaldostéronisme secondaire | n2=en:spasticity/paresis (rare) | rel=r_associated | relid=0 | w=5
  4519. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:special symptoms or syndromes, nec in icd9cm_2014
    n1=hyperaldostéronisme secondaire | n2=en:special symptoms or syndromes, nec in icd9cm_2014 | rel=r_associated | relid=0 | w=5
  4520. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:specific developmental disorder
    n1=hyperaldostéronisme secondaire | n2=en:specific developmental disorder | rel=r_associated | relid=0 | w=5
  4521. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:specific nonpsychotic mental disorders due to brain damage
    n1=hyperaldostéronisme secondaire | n2=en:specific nonpsychotic mental disorders due to brain damage | rel=r_associated | relid=0 | w=5
  4522. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:specific phobia
    n1=hyperaldostéronisme secondaire | n2=en:specific phobia | rel=r_associated | relid=0 | w=5
  4523. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:specific visual spatial processing defect
    n1=hyperaldostéronisme secondaire | n2=en:specific visual spatial processing defect | rel=r_associated | relid=0 | w=5
  4524. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spect scan may show hypermetabolism of the temporal lobe
    n1=hyperaldostéronisme secondaire | n2=en:spect scan may show hypermetabolism of the temporal lobe | rel=r_associated | relid=0 | w=5
  4525. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech abnormalities (palilalia)
    n1=hyperaldostéronisme secondaire | n2=en:speech abnormalities (palilalia) | rel=r_associated | relid=0 | w=5
  4526. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech absent or delayed
    n1=hyperaldostéronisme secondaire | n2=en:speech absent or delayed | rel=r_associated | relid=0 | w=5
  4527. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and communication disorders
    n1=hyperaldostéronisme secondaire | n2=en:speech and communication disorders | rel=r_associated | relid=0 | w=5
  4528. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and language delay (rare)
    n1=hyperaldostéronisme secondaire | n2=en:speech and language delay (rare) | rel=r_associated | relid=0 | w=5
  4529. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and language delay, severe
    n1=hyperaldostéronisme secondaire | n2=en:speech and language delay, severe | rel=r_associated | relid=0 | w=5
  4530. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and language disorder
    n1=hyperaldostéronisme secondaire | n2=en:speech and language disorder | rel=r_associated | relid=0 | w=5
  4531. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and language problems in children
    n1=hyperaldostéronisme secondaire | n2=en:speech and language problems in children | rel=r_associated | relid=0 | w=5
  4532. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech and language regression
    n1=hyperaldostéronisme secondaire | n2=en:speech and language regression | rel=r_associated | relid=0 | w=5
  4533. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech articulation defects
    n1=hyperaldostéronisme secondaire | n2=en:speech articulation defects | rel=r_associated | relid=0 | w=5
  4534. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech articulation problems
    n1=hyperaldostéronisme secondaire | n2=en:speech articulation problems | rel=r_associated | relid=0 | w=5
  4535. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech deficits
    n1=hyperaldostéronisme secondaire | n2=en:speech deficits | rel=r_associated | relid=0 | w=5
  4536. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay
    n1=hyperaldostéronisme secondaire | n2=en:speech delay | rel=r_associated | relid=0 | w=5
  4537. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:speech delay (1 patient) | rel=r_associated | relid=0 | w=5
  4538. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay (10%)
    n1=hyperaldostéronisme secondaire | n2=en:speech delay (10%) | rel=r_associated | relid=0 | w=5
  4539. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay (59%)
    n1=hyperaldostéronisme secondaire | n2=en:speech delay (59%) | rel=r_associated | relid=0 | w=5
  4540. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay (in all patients)
    n1=hyperaldostéronisme secondaire | n2=en:speech delay (in all patients) | rel=r_associated | relid=0 | w=5
  4541. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech delay (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:speech delay (in some patients) | rel=r_associated | relid=0 | w=5
  4542. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech deterioration
    n1=hyperaldostéronisme secondaire | n2=en:speech deterioration | rel=r_associated | relid=0 | w=5
  4543. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech development delayed (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:speech development delayed (in some patients) | rel=r_associated | relid=0 | w=5
  4544. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech difficulties (48%)
    n1=hyperaldostéronisme secondaire | n2=en:speech difficulties (48%) | rel=r_associated | relid=0 | w=5
  4545. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech difficulties due to hypoglossia
    n1=hyperaldostéronisme secondaire | n2=en:speech difficulties due to hypoglossia | rel=r_associated | relid=0 | w=5
  4546. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech disability
    n1=hyperaldostéronisme secondaire | n2=en:speech disability | rel=r_associated | relid=0 | w=5
  4547. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech disorder
    n1=hyperaldostéronisme secondaire | n2=en:speech disorder | rel=r_associated | relid=0 | w=5
  4548. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech disorder (in 1 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:speech disorder (in 1 of 6 patients) | rel=r_associated | relid=0 | w=5
  4549. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech disorders (rare)
    n1=hyperaldostéronisme secondaire | n2=en:speech disorders (rare) | rel=r_associated | relid=0 | w=5
  4550. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech hesitancy
    n1=hyperaldostéronisme secondaire | n2=en:speech hesitancy | rel=r_associated | relid=0 | w=5
  4551. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech impairment
    n1=hyperaldostéronisme secondaire | n2=en:speech impairment | rel=r_associated | relid=0 | w=5
  4552. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech limited
    n1=hyperaldostéronisme secondaire | n2=en:speech limited | rel=r_associated | relid=0 | w=5
  4553. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech limited to single word or no words
    n1=hyperaldostéronisme secondaire | n2=en:speech limited to single word or no words | rel=r_associated | relid=0 | w=5
  4554. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech never acquired
    n1=hyperaldostéronisme secondaire | n2=en:speech never acquired | rel=r_associated | relid=0 | w=5
  4555. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech severely limited or absent
    n1=hyperaldostéronisme secondaire | n2=en:speech severely limited or absent | rel=r_associated | relid=0 | w=5
  4556. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:speech, limited or nonverbal
    n1=hyperaldostéronisme secondaire | n2=en:speech, limited or nonverbal | rel=r_associated | relid=0 | w=5
  4557. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spheroids contain neurofilaments
    n1=hyperaldostéronisme secondaire | n2=en:spheroids contain neurofilaments | rel=r_associated | relid=0 | w=5
  4558. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spina bifida
    n1=hyperaldostéronisme secondaire | n2=en:spina bifida | rel=r_associated | relid=0 | w=5
  4559. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spina bifida (less common)
    n1=hyperaldostéronisme secondaire | n2=en:spina bifida (less common) | rel=r_associated | relid=0 | w=5
  4560. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spina bifida occulta
    n1=hyperaldostéronisme secondaire | n2=en:spina bifida occulta | rel=r_associated | relid=0 | w=5
  4561. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal arteriovenous malformation
    n1=hyperaldostéronisme secondaire | n2=en:spinal arteriovenous malformation | rel=r_associated | relid=0 | w=5
  4562. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord | rel=r_associated | relid=0 | w=5
  4563. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord atrophy (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord atrophy (1 family) | rel=r_associated | relid=0 | w=5
  4564. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord atrophy (rare)
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord atrophy (rare) | rel=r_associated | relid=0 | w=5
  4565. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord compression
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord compression | rel=r_associated | relid=0 | w=5
  4566. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord compression by tumor infiltration
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord compression by tumor infiltration | rel=r_associated | relid=0 | w=5
  4567. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord disorder
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord disorder | rel=r_associated | relid=0 | w=5
  4568. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord glial hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord glial hyperplasia | rel=r_associated | relid=0 | w=5
  4569. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord injury
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord injury | rel=r_associated | relid=0 | w=5
  4570. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord paresis
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord paresis | rel=r_associated | relid=0 | w=5
  4571. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cord syrinx (in 2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:spinal cord syrinx (in 2 patients) | rel=r_associated | relid=0 | w=5
  4572. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal cysts (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spinal cysts (in some patients) | rel=r_associated | relid=0 | w=5
  4573. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal muscular atrophy
    n1=hyperaldostéronisme secondaire | n2=en:spinal muscular atrophy | rel=r_associated | relid=0 | w=5
  4574. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal neurofibromas (64%)
    n1=hyperaldostéronisme secondaire | n2=en:spinal neurofibromas (64%) | rel=r_associated | relid=0 | w=5
  4575. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal neuropathy
    n1=hyperaldostéronisme secondaire | n2=en:spinal neuropathy | rel=r_associated | relid=0 | w=5
  4576. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal stenosis
    n1=hyperaldostéronisme secondaire | n2=en:spinal stenosis | rel=r_associated | relid=0 | w=5
  4577. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinal tract degeneration
    n1=hyperaldostéronisme secondaire | n2=en:spinal tract degeneration | rel=r_associated | relid=0 | w=5
  4578. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar ataxia
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar ataxia | rel=r_associated | relid=0 | w=5
  4579. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar ataxia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar ataxia (in some patients) | rel=r_associated | relid=0 | w=5
  4580. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar ataxia (upper and lower limb involvement)
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar ataxia (upper and lower limb involvement) | rel=r_associated | relid=0 | w=5
  4581. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar degeneration
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar degeneration | rel=r_associated | relid=0 | w=5
  4582. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar tract degeneration
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar tract degeneration | rel=r_associated | relid=0 | w=5
  4583. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spinocerebellar tract disease in lower limbs (in adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:spinocerebellar tract disease in lower limbs (in adulthood) | rel=r_associated | relid=0 | w=5
  4584. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spongiform changes are mild or may not be present
    n1=hyperaldostéronisme secondaire | n2=en:spongiform changes are mild or may not be present | rel=r_associated | relid=0 | w=5
  4585. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spongiform degeneration
    n1=hyperaldostéronisme secondaire | n2=en:spongiform degeneration | rel=r_associated | relid=0 | w=5
  4586. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spongiform encephalomyelopathy
    n1=hyperaldostéronisme secondaire | n2=en:spongiform encephalomyelopathy | rel=r_associated | relid=0 | w=5
  4587. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spongy degeneration
    n1=hyperaldostéronisme secondaire | n2=en:spongy degeneration | rel=r_associated | relid=0 | w=5
  4588. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:spongy gliosis
    n1=hyperaldostéronisme secondaire | n2=en:spongy gliosis | rel=r_associated | relid=0 | w=5
  4589. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stance ataxia
    n1=hyperaldostéronisme secondaire | n2=en:stance ataxia | rel=r_associated | relid=0 | w=5
  4590. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:staring episodes during seizures
    n1=hyperaldostéronisme secondaire | n2=en:staring episodes during seizures | rel=r_associated | relid=0 | w=5
  4591. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:staring spells
    n1=hyperaldostéronisme secondaire | n2=en:staring spells | rel=r_associated | relid=0 | w=5
  4592. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:start with tonic posturing
    n1=hyperaldostéronisme secondaire | n2=en:start with tonic posturing | rel=r_associated | relid=0 | w=5
  4593. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:startle myoclonus
    n1=hyperaldostéronisme secondaire | n2=en:startle myoclonus | rel=r_associated | relid=0 | w=5
  4594. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status dystonicus
    n1=hyperaldostéronisme secondaire | n2=en:status dystonicus | rel=r_associated | relid=0 | w=5
  4595. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus | rel=r_associated | relid=0 | w=5
  4596. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus (in 1 of 6 patients)
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus (in 1 of 6 patients) | rel=r_associated | relid=0 | w=5
  4597. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus (in some patients) | rel=r_associated | relid=0 | w=5
  4598. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus (in some)
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus (in some) | rel=r_associated | relid=0 | w=5
  4599. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus may occur
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus may occur | rel=r_associated | relid=0 | w=5
  4600. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:status epilepticus rarely occurs
    n1=hyperaldostéronisme secondaire | n2=en:status epilepticus rarely occurs | rel=r_associated | relid=0 | w=5
  4601. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stenosis of the aqueduct of sylvius (rare)
    n1=hyperaldostéronisme secondaire | n2=en:stenosis of the aqueduct of sylvius (rare) | rel=r_associated | relid=0 | w=5
  4602. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stenosis of the jugular foramen
    n1=hyperaldostéronisme secondaire | n2=en:stenosis of the jugular foramen | rel=r_associated | relid=0 | w=5
  4603. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic behavior (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic behavior (1 patient) | rel=r_associated | relid=0 | w=5
  4604. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic behaviors (hand-washing movements, head-banging)
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic behaviors (hand-washing movements, head-banging) | rel=r_associated | relid=0 | w=5
  4605. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic behaviors (tantrums, aggressiveness)
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic behaviors (tantrums, aggressiveness) | rel=r_associated | relid=0 | w=5
  4606. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic hand movements
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic hand movements | rel=r_associated | relid=0 | w=5
  4607. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic laughter
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic laughter | rel=r_associated | relid=0 | w=5
  4608. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic laughter (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic laughter (1 family) | rel=r_associated | relid=0 | w=5
  4609. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic movement disorder
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic movement disorder | rel=r_associated | relid=0 | w=5
  4610. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic movements
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic movements | rel=r_associated | relid=0 | w=5
  4611. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypic, repetitive movements
    n1=hyperaldostéronisme secondaire | n2=en:stereotypic, repetitive movements | rel=r_associated | relid=0 | w=5
  4612. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stereotypical hand movements
    n1=hyperaldostéronisme secondaire | n2=en:stereotypical hand movements | rel=r_associated | relid=0 | w=5
  4613. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sterotypical movements
    n1=hyperaldostéronisme secondaire | n2=en:sterotypical movements | rel=r_associated | relid=0 | w=5
  4614. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stiff gait
    n1=hyperaldostéronisme secondaire | n2=en:stiff gait | rel=r_associated | relid=0 | w=5
  4615. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stiff limbs
    n1=hyperaldostéronisme secondaire | n2=en:stiff limbs | rel=r_associated | relid=0 | w=5
  4616. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stiffness
    n1=hyperaldostéronisme secondaire | n2=en:stiffness | rel=r_associated | relid=0 | w=5
  4617. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stiffness of the lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:stiffness of the lower limbs | rel=r_associated | relid=0 | w=5
  4618. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stiffness while walking
    n1=hyperaldostéronisme secondaire | n2=en:stiffness while walking | rel=r_associated | relid=0 | w=5
  4619. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stimulant drug therapy for attention deficit hyperactivity disorder
    n1=hyperaldostéronisme secondaire | n2=en:stimulant drug therapy for attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=5
  4620. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stimulation sensitive generalized myoclonus (stage 3)
    n1=hyperaldostéronisme secondaire | n2=en:stimulation sensitive generalized myoclonus (stage 3) | rel=r_associated | relid=0 | w=5
  4621. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stimulation sensitive segmental myoclonus (stage 2)
    n1=hyperaldostéronisme secondaire | n2=en:stimulation sensitive segmental myoclonus (stage 2) | rel=r_associated | relid=0 | w=5
  4622. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stoke-like lesions
    n1=hyperaldostéronisme secondaire | n2=en:stoke-like lesions | rel=r_associated | relid=0 | w=5
  4623. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stress
    n1=hyperaldostéronisme secondaire | n2=en:stress | rel=r_associated | relid=0 | w=5
  4624. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stretched cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:stretched cerebellar peduncles | rel=r_associated | relid=0 | w=5
  4625. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:striatal atrophy
    n1=hyperaldostéronisme secondaire | n2=en:striatal atrophy | rel=r_associated | relid=0 | w=5
  4626. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:striatal lesions
    n1=hyperaldostéronisme secondaire | n2=en:striatal lesions | rel=r_associated | relid=0 | w=5
  4627. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:striatal necrosis
    n1=hyperaldostéronisme secondaire | n2=en:striatal necrosis | rel=r_associated | relid=0 | w=5
  4628. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:stroke (in some patients) | rel=r_associated | relid=0 | w=5
  4629. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke (rare)
    n1=hyperaldostéronisme secondaire | n2=en:stroke (rare) | rel=r_associated | relid=0 | w=5
  4630. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:stroke (uncommon) | rel=r_associated | relid=0 | w=5
  4631. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke rehabilitation
    n1=hyperaldostéronisme secondaire | n2=en:stroke rehabilitation | rel=r_associated | relid=0 | w=5
  4632. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke-like episodes
    n1=hyperaldostéronisme secondaire | n2=en:stroke-like episodes | rel=r_associated | relid=0 | w=5
  4633. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke-like episodes (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:stroke-like episodes (in some patients) | rel=r_associated | relid=0 | w=5
  4634. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stroke-like symptoms
    n1=hyperaldostéronisme secondaire | n2=en:stroke-like symptoms | rel=r_associated | relid=0 | w=5
  4635. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:strokes due to coagulopathy
    n1=hyperaldostéronisme secondaire | n2=en:strokes due to coagulopathy | rel=r_associated | relid=0 | w=5
  4636. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:strong attraction to music
    n1=hyperaldostéronisme secondaire | n2=en:strong attraction to music | rel=r_associated | relid=0 | w=5
  4637. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structural abnormalities in the basal ganglia (especially caudate)
    n1=hyperaldostéronisme secondaire | n2=en:structural abnormalities in the basal ganglia (especially caudate) | rel=r_associated | relid=0 | w=5
  4638. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structural abnormalities of cerebellum
    n1=hyperaldostéronisme secondaire | n2=en:structural abnormalities of cerebellum | rel=r_associated | relid=0 | w=5
  4639. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structural brain abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:structural brain abnormalities | rel=r_associated | relid=0 | w=5
  4640. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structural brain anomalies
    n1=hyperaldostéronisme secondaire | n2=en:structural brain anomalies | rel=r_associated | relid=0 | w=5
  4641. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structural changes in the temporal lobe
    n1=hyperaldostéronisme secondaire | n2=en:structural changes in the temporal lobe | rel=r_associated | relid=0 | w=5
  4642. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structure of central auditory system
    n1=hyperaldostéronisme secondaire | n2=en:structure of central auditory system | rel=r_associated | relid=0 | w=5
  4643. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structure of central sensory visual system
    n1=hyperaldostéronisme secondaire | n2=en:structure of central sensory visual system | rel=r_associated | relid=0 | w=5
  4644. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:structure of decussation of superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:structure of decussation of superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  4645. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stubbornness
    n1=hyperaldostéronisme secondaire | n2=en:stubbornness | rel=r_associated | relid=0 | w=5
  4646. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stuporous catatonia
    n1=hyperaldostéronisme secondaire | n2=en:stuporous catatonia | rel=r_associated | relid=0 | w=5
  4647. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sturge-weber syndrome
    n1=hyperaldostéronisme secondaire | n2=en:sturge-weber syndrome | rel=r_associated | relid=0 | w=5
  4648. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stutter
    n1=hyperaldostéronisme secondaire | n2=en:stutter | rel=r_associated | relid=0 | w=5
  4649. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:stuttering, severe (in brother)
    n1=hyperaldostéronisme secondaire | n2=en:stuttering, severe (in brother) | rel=r_associated | relid=0 | w=5
  4650. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subacute neurologic deterioration
    n1=hyperaldostéronisme secondaire | n2=en:subacute neurologic deterioration | rel=r_associated | relid=0 | w=5
  4651. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subarachnoid cyst
    n1=hyperaldostéronisme secondaire | n2=en:subarachnoid cyst | rel=r_associated | relid=0 | w=5
  4652. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subarachnoid hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:subarachnoid hemorrhage | rel=r_associated | relid=0 | w=5
  4653. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subarachnoid hemorrhage (rare)
    n1=hyperaldostéronisme secondaire | n2=en:subarachnoid hemorrhage (rare) | rel=r_associated | relid=0 | w=5
  4654. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subclinical absence seizures
    n1=hyperaldostéronisme secondaire | n2=en:subclinical absence seizures | rel=r_associated | relid=0 | w=5
  4655. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical and periventricular white matter abnormalities seen on mri (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:subcortical and periventricular white matter abnormalities seen on mri (in some patients) | rel=r_associated | relid=0 | w=5
  4656. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical atrophy (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:subcortical atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  4657. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical band or laminar heterotopia (in female carriers)
    n1=hyperaldostéronisme secondaire | n2=en:subcortical band or laminar heterotopia (in female carriers) | rel=r_associated | relid=0 | w=5
  4658. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical cysts in frontal and temporal lobes
    n1=hyperaldostéronisme secondaire | n2=en:subcortical cysts in frontal and temporal lobes | rel=r_associated | relid=0 | w=5
  4659. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical cysts may occur elsewhere
    n1=hyperaldostéronisme secondaire | n2=en:subcortical cysts may occur elsewhere | rel=r_associated | relid=0 | w=5
  4660. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical cysts temporal lobe
    n1=hyperaldostéronisme secondaire | n2=en:subcortical cysts temporal lobe | rel=r_associated | relid=0 | w=5
  4661. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical dementia, progressive (6% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:subcortical dementia, progressive (6% of patients) | rel=r_associated | relid=0 | w=5
  4662. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical focal lacunae
    n1=hyperaldostéronisme secondaire | n2=en:subcortical focal lacunae | rel=r_associated | relid=0 | w=5
  4663. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical gliosis
    n1=hyperaldostéronisme secondaire | n2=en:subcortical gliosis | rel=r_associated | relid=0 | w=5
  4664. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:subcortical heterotopia | rel=r_associated | relid=0 | w=5
  4665. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical hypomyelination
    n1=hyperaldostéronisme secondaire | n2=en:subcortical hypomyelination | rel=r_associated | relid=0 | w=5
  4666. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical lacunar lesions seen early in disease
    n1=hyperaldostéronisme secondaire | n2=en:subcortical lacunar lesions seen early in disease | rel=r_associated | relid=0 | w=5
  4667. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical lesions
    n1=hyperaldostéronisme secondaire | n2=en:subcortical lesions | rel=r_associated | relid=0 | w=5
  4668. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical lesions with edema
    n1=hyperaldostéronisme secondaire | n2=en:subcortical lesions with edema | rel=r_associated | relid=0 | w=5
  4669. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical leukodystrophy
    n1=hyperaldostéronisme secondaire | n2=en:subcortical leukodystrophy | rel=r_associated | relid=0 | w=5
  4670. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical nodular grey matter heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:subcortical nodular grey matter heterotopia | rel=r_associated | relid=0 | w=5
  4671. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical nodular lesions in perivascular white matter
    n1=hyperaldostéronisme secondaire | n2=en:subcortical nodular lesions in perivascular white matter | rel=r_associated | relid=0 | w=5
  4672. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical origin of the myoclonus based on neurophysiologic studies
    n1=hyperaldostéronisme secondaire | n2=en:subcortical origin of the myoclonus based on neurophysiologic studies | rel=r_associated | relid=0 | w=5
  4673. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical temporal white matter disease, moderate
    n1=hyperaldostéronisme secondaire | n2=en:subcortical temporal white matter disease, moderate | rel=r_associated | relid=0 | w=5
  4674. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical white matter abnormalities (rare)
    n1=hyperaldostéronisme secondaire | n2=en:subcortical white matter abnormalities (rare) | rel=r_associated | relid=0 | w=5
  4675. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical white matter abnormalities seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:subcortical white matter abnormalities seen on mri | rel=r_associated | relid=0 | w=5
  4676. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical white matter calcifications
    n1=hyperaldostéronisme secondaire | n2=en:subcortical white matter calcifications | rel=r_associated | relid=0 | w=5
  4677. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subcortical white matter lesions in the temporal lobes seen on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:subcortical white matter lesions in the temporal lobes seen on brain mri | rel=r_associated | relid=0 | w=5
  4678. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal calcifications
    n1=hyperaldostéronisme secondaire | n2=en:subependymal calcifications | rel=r_associated | relid=0 | w=5
  4679. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal hemorrhage
    n1=hyperaldostéronisme secondaire | n2=en:subependymal hemorrhage | rel=r_associated | relid=0 | w=5
  4680. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal heterotopias
    n1=hyperaldostéronisme secondaire | n2=en:subependymal heterotopias | rel=r_associated | relid=0 | w=5
  4681. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal heterotopic nodules
    n1=hyperaldostéronisme secondaire | n2=en:subependymal heterotopic nodules | rel=r_associated | relid=0 | w=5
  4682. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal nodules
    n1=hyperaldostéronisme secondaire | n2=en:subependymal nodules | rel=r_associated | relid=0 | w=5
  4683. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subependymal pseudocyst
    n1=hyperaldostéronisme secondaire | n2=en:subependymal pseudocyst | rel=r_associated | relid=0 | w=5
  4684. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subnormal cognition
    n1=hyperaldostéronisme secondaire | n2=en:subnormal cognition | rel=r_associated | relid=0 | w=5
  4685. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:subnormal intelligence (62%)
    n1=hyperaldostéronisme secondaire | n2=en:subnormal intelligence (62%) | rel=r_associated | relid=0 | w=5
  4686. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:substantia nigra gliosis
    n1=hyperaldostéronisme secondaire | n2=en:substantia nigra gliosis | rel=r_associated | relid=0 | w=5
  4687. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors)
    n1=hyperaldostéronisme secondaire | n2=en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors) | rel=r_associated | relid=0 | w=5
  4688. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sudden awakening
    n1=hyperaldostéronisme secondaire | n2=en:sudden awakening | rel=r_associated | relid=0 | w=5
  4689. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sudden infant death syndrome
    n1=hyperaldostéronisme secondaire | n2=en:sudden infant death syndrome | rel=r_associated | relid=0 | w=5
  4690. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sudden onset of neuropsychiatric symptoms
    n1=hyperaldostéronisme secondaire | n2=en:sudden onset of neuropsychiatric symptoms | rel=r_associated | relid=0 | w=5
  4691. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:suicide
    n1=hyperaldostéronisme secondaire | n2=en:suicide | rel=r_associated | relid=0 | w=5
  4692. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:superficial laminar spongiosis
    n1=hyperaldostéronisme secondaire | n2=en:superficial laminar spongiosis | rel=r_associated | relid=0 | w=5
  4693. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:suppression-burst pattern
    n1=hyperaldostéronisme secondaire | n2=en:suppression-burst pattern | rel=r_associated | relid=0 | w=5
  4694. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:suppression-burst pattern see on eeg
    n1=hyperaldostéronisme secondaire | n2=en:suppression-burst pattern see on eeg | rel=r_associated | relid=0 | w=5
  4695. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:supratentorial structures unformed or regressed
    n1=hyperaldostéronisme secondaire | n2=en:supratentorial structures unformed or regressed | rel=r_associated | relid=0 | w=5
  4696. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:susceptibility to rage in 50% of patients
    n1=hyperaldostéronisme secondaire | n2=en:susceptibility to rage in 50% of patients | rel=r_associated | relid=0 | w=5
  4697. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:sweating problem
    n1=hyperaldostéronisme secondaire | n2=en:sweating problem | rel=r_associated | relid=0 | w=5
  4698. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:swelling of the cerebral white matter
    n1=hyperaldostéronisme secondaire | n2=en:swelling of the cerebral white matter | rel=r_associated | relid=0 | w=5
  4699. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:swelling of the deep white matter seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:swelling of the deep white matter seen on mri | rel=r_associated | relid=0 | w=5
  4700. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:swollen achromatic cells (pick cells)
    n1=hyperaldostéronisme secondaire | n2=en:swollen achromatic cells (pick cells) | rel=r_associated | relid=0 | w=5
  4701. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients
    n1=hyperaldostéronisme secondaire | n2=en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients | rel=r_associated | relid=0 | w=5
  4702. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symmetric spinal nerve root neurofibromas
    n1=hyperaldostéronisme secondaire | n2=en:symmetric spinal nerve root neurofibromas | rel=r_associated | relid=0 | w=5
  4703. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symmetric ventriculomegaly
    n1=hyperaldostéronisme secondaire | n2=en:symmetric ventriculomegaly | rel=r_associated | relid=0 | w=5
  4704. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symmetrical progressive demyelination
    n1=hyperaldostéronisme secondaire | n2=en:symmetrical progressive demyelination | rel=r_associated | relid=0 | w=5
  4705. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symptoms are exacerbated during pregnancy
    n1=hyperaldostéronisme secondaire | n2=en:symptoms are exacerbated during pregnancy | rel=r_associated | relid=0 | w=5
  4706. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symptoms occur at rest
    n1=hyperaldostéronisme secondaire | n2=en:symptoms occur at rest | rel=r_associated | relid=0 | w=5
  4707. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symptoms of hypothalamic disturbances (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:symptoms of hypothalamic disturbances (in some patients) | rel=r_associated | relid=0 | w=5
  4708. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:symptoms stabilize within 4 weeks
    n1=hyperaldostéronisme secondaire | n2=en:symptoms stabilize within 4 weeks | rel=r_associated | relid=0 | w=5
  4709. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:syncope
    n1=hyperaldostéronisme secondaire | n2=en:syncope | rel=r_associated | relid=0 | w=5
  4710. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:syndrome screaming
    n1=hyperaldostéronisme secondaire | n2=en:syndrome screaming | rel=r_associated | relid=0 | w=5
  4711. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:synkinesia (rare)
    n1=hyperaldostéronisme secondaire | n2=en:synkinesia (rare) | rel=r_associated | relid=0 | w=5
  4712. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:synkinesis
    n1=hyperaldostéronisme secondaire | n2=en:synkinesis | rel=r_associated | relid=0 | w=5
  4713. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:syringomyelia
    n1=hyperaldostéronisme secondaire | n2=en:syringomyelia | rel=r_associated | relid=0 | w=5
  4714. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:syringomyelia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:syringomyelia (in some patients) | rel=r_associated | relid=0 | w=5
  4715. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:syringomyelia, noncommunicating (80% of cases)
    n1=hyperaldostéronisme secondaire | n2=en:syringomyelia, noncommunicating (80% of cases) | rel=r_associated | relid=0 | w=5
  4716. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra
    n1=hyperaldostéronisme secondaire | n2=en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra | rel=r_associated | relid=0 | w=5
  4717. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem | rel=r_associated | relid=0 | w=5
  4718. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in deep brain regions
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in deep brain regions | rel=r_associated | relid=0 | w=5
  4719. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim | rel=r_associated | relid=0 | w=5
  4720. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in subcortical brain regions seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in subcortical brain regions seen on mri | rel=r_associated | relid=0 | w=5
  4721. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the basal ganglia | rel=r_associated | relid=0 | w=5
  4722. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri | rel=r_associated | relid=0 | w=5
  4723. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri | rel=r_associated | relid=0 | w=5
  4724. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter | rel=r_associated | relid=0 | w=5
  4725. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the putamen and caudate nuclei
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the putamen and caudate nuclei | rel=r_associated | relid=0 | w=5
  4726. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri | rel=r_associated | relid=0 | w=5
  4727. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted hypodensities in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted hypodensities in the basal ganglia | rel=r_associated | relid=0 | w=5
  4728. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve)
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve) | rel=r_associated | relid=0 | w=5
  4729. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:t2-weighted signal abnormalities in the deep white matter
    n1=hyperaldostéronisme secondaire | n2=en:t2-weighted signal abnormalities in the deep white matter | rel=r_associated | relid=0 | w=5
  4730. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tau immunreactivity
    n1=hyperaldostéronisme secondaire | n2=en:tau immunreactivity | rel=r_associated | relid=0 | w=5
  4731. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tau inclusions are 'flame-shaped' or 'tuft-like'
    n1=hyperaldostéronisme secondaire | n2=en:tau inclusions are 'flame-shaped' or 'tuft-like' | rel=r_associated | relid=0 | w=5
  4732. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tau-containing inclusions
    n1=hyperaldostéronisme secondaire | n2=en:tau-containing inclusions | rel=r_associated | relid=0 | w=5
  4733. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tau-immunoreactive inclusions in neurons and astrocytes
    n1=hyperaldostéronisme secondaire | n2=en:tau-immunoreactive inclusions in neurons and astrocytes | rel=r_associated | relid=0 | w=5
  4734. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tau-positive inclusions may be found
    n1=hyperaldostéronisme secondaire | n2=en:tau-positive inclusions may be found | rel=r_associated | relid=0 | w=5
  4735. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tay-sachs disease
    n1=hyperaldostéronisme secondaire | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=5
  4736. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tbp- and 1c2-immunoreactive neuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:tbp- and 1c2-immunoreactive neuronal inclusions | rel=r_associated | relid=0 | w=5
  4737. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tdp43-positive inclusions
    n1=hyperaldostéronisme secondaire | n2=en:tdp43-positive inclusions | rel=r_associated | relid=0 | w=5
  4738. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tdp43-positive neuronal and glial cytoplasmic inclusions
    n1=hyperaldostéronisme secondaire | n2=en:tdp43-positive neuronal and glial cytoplasmic inclusions | rel=r_associated | relid=0 | w=5
  4739. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tdp43-positive neuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:tdp43-positive neuronal inclusions | rel=r_associated | relid=0 | w=5
  4740. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tectal enlargement
    n1=hyperaldostéronisme secondaire | n2=en:tectal enlargement | rel=r_associated | relid=0 | w=5
  4741. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teen development
    n1=hyperaldostéronisme secondaire | n2=en:teen development | rel=r_associated | relid=0 | w=5
  4742. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teen health
    n1=hyperaldostéronisme secondaire | n2=en:teen health | rel=r_associated | relid=0 | w=5
  4743. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teen mental health
    n1=hyperaldostéronisme secondaire | n2=en:teen mental health | rel=r_associated | relid=0 | w=5
  4744. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teen sexual health
    n1=hyperaldostéronisme secondaire | n2=en:teen sexual health | rel=r_associated | relid=0 | w=5
  4745. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teen violence
    n1=hyperaldostéronisme secondaire | n2=en:teen violence | rel=r_associated | relid=0 | w=5
  4746. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teenage pregnancy
    n1=hyperaldostéronisme secondaire | n2=en:teenage pregnancy | rel=r_associated | relid=0 | w=5
  4747. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:teens' page
    n1=hyperaldostéronisme secondaire | n2=en:teens' page | rel=r_associated | relid=0 | w=5
  4748. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temper tantrum
    n1=hyperaldostéronisme secondaire | n2=en:temper tantrum | rel=r_associated | relid=0 | w=5
  4749. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temporal epileptiform discharges seen on eeg
    n1=hyperaldostéronisme secondaire | n2=en:temporal epileptiform discharges seen on eeg | rel=r_associated | relid=0 | w=5
  4750. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temporal lobe epilepsy (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:temporal lobe epilepsy (1 patient) | rel=r_associated | relid=0 | w=5
  4751. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temporal lobe heterotopias
    n1=hyperaldostéronisme secondaire | n2=en:temporal lobe heterotopias | rel=r_associated | relid=0 | w=5
  4752. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temporal lobe infarct (rare)
    n1=hyperaldostéronisme secondaire | n2=en:temporal lobe infarct (rare) | rel=r_associated | relid=0 | w=5
  4753. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:temporal lobe seizures (in 1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:temporal lobe seizures (in 1 patient) | rel=r_associated | relid=0 | w=5
  4754. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tendency to walk on toes
    n1=hyperaldostéronisme secondaire | n2=en:tendency to walk on toes | rel=r_associated | relid=0 | w=5
  4755. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tends not to be sociable
    n1=hyperaldostéronisme secondaire | n2=en:tends not to be sociable | rel=r_associated | relid=0 | w=5
  4756. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tense affect
    n1=hyperaldostéronisme secondaire | n2=en:tense affect | rel=r_associated | relid=0 | w=5
  4757. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tetany
    n1=hyperaldostéronisme secondaire | n2=en:tetany | rel=r_associated | relid=0 | w=5
  4758. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tetany, hypocalcemic (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:tetany, hypocalcemic (in some patients) | rel=r_associated | relid=0 | w=5
  4759. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tetany, hypocalcemic, episodic
    n1=hyperaldostéronisme secondaire | n2=en:tetany, hypocalcemic, episodic | rel=r_associated | relid=0 | w=5
  4760. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tethered cord (rare)
    n1=hyperaldostéronisme secondaire | n2=en:tethered cord (rare) | rel=r_associated | relid=0 | w=5
  4761. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tethered cord (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:tethered cord (uncommon) | rel=r_associated | relid=0 | w=5
  4762. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tethered spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:tethered spinal cord | rel=r_associated | relid=0 | w=5
  4763. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tethered spinal cord syndrome
    n1=hyperaldostéronisme secondaire | n2=en:tethered spinal cord syndrome | rel=r_associated | relid=0 | w=5
  4764. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tetraplegic spasticity
    n1=hyperaldostéronisme secondaire | n2=en:tetraplegic spasticity | rel=r_associated | relid=0 | w=5
  4765. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons
    n1=hyperaldostéronisme secondaire | n2=en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons | rel=r_associated | relid=0 | w=5
  4766. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thalamic hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:thalamic hypoplasia | rel=r_associated | relid=0 | w=5
  4767. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thalamic lesions
    n1=hyperaldostéronisme secondaire | n2=en:thalamic lesions | rel=r_associated | relid=0 | w=5
  4768. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thalamic neuronal loss, especially in the medial dorsal nucleus
    n1=hyperaldostéronisme secondaire | n2=en:thalamic neuronal loss, especially in the medial dorsal nucleus | rel=r_associated | relid=0 | w=5
  4769. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thenar muscle atrophy
    n1=hyperaldostéronisme secondaire | n2=en:thenar muscle atrophy | rel=r_associated | relid=0 | w=5
  4770. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thenar muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:thenar muscle weakness | rel=r_associated | relid=0 | w=5
  4771. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thick and elongated superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:thick and elongated superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  4772. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thick corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:thick corpus callosum | rel=r_associated | relid=0 | w=5
  4773. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thick cortex
    n1=hyperaldostéronisme secondaire | n2=en:thick cortex | rel=r_associated | relid=0 | w=5
  4774. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thick, maloriented superior cerebellar peduncles
    n1=hyperaldostéronisme secondaire | n2=en:thick, maloriented superior cerebellar peduncles | rel=r_associated | relid=0 | w=5
  4775. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thick, short corpus callosum
    n1=hyperaldostéronisme secondaire | n2=en:thick, short corpus callosum | rel=r_associated | relid=0 | w=5
  4776. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thickened cortices
    n1=hyperaldostéronisme secondaire | n2=en:thickened cortices | rel=r_associated | relid=0 | w=5
  4777. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thickened frontal cortex
    n1=hyperaldostéronisme secondaire | n2=en:thickened frontal cortex | rel=r_associated | relid=0 | w=5
  4778. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thickened optic nerve sheath
    n1=hyperaldostéronisme secondaire | n2=en:thickened optic nerve sheath | rel=r_associated | relid=0 | w=5
  4779. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thickening of the skull (less common)
    n1=hyperaldostéronisme secondaire | n2=en:thickening of the skull (less common) | rel=r_associated | relid=0 | w=5
  4780. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin bony cortex
    n1=hyperaldostéronisme secondaire | n2=en:thin bony cortex | rel=r_associated | relid=0 | w=5
  4781. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin brainstem
    n1=hyperaldostéronisme secondaire | n2=en:thin brainstem | rel=r_associated | relid=0 | w=5
  4782. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin cerebral cortex
    n1=hyperaldostéronisme secondaire | n2=en:thin cerebral cortex | rel=r_associated | relid=0 | w=5
  4783. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin corpus callosum (1 family)
    n1=hyperaldostéronisme secondaire | n2=en:thin corpus callosum (1 family) | rel=r_associated | relid=0 | w=5
  4784. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin corpus callosum (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:thin corpus callosum (1 patient) | rel=r_associated | relid=0 | w=5
  4785. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin corpus callosum (1/4 patients)
    n1=hyperaldostéronisme secondaire | n2=en:thin corpus callosum (1/4 patients) | rel=r_associated | relid=0 | w=5
  4786. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin corpus callosum (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:thin corpus callosum (in some patients) | rel=r_associated | relid=0 | w=5
  4787. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin corpus callosum enlarged ventricles
    n1=hyperaldostéronisme secondaire | n2=en:thin corpus callosum enlarged ventricles | rel=r_associated | relid=0 | w=5
  4788. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin cortical mantle (wws)
    n1=hyperaldostéronisme secondaire | n2=en:thin cortical mantle (wws) | rel=r_associated | relid=0 | w=5
  4789. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin myelin sheaths
    n1=hyperaldostéronisme secondaire | n2=en:thin myelin sheaths | rel=r_associated | relid=0 | w=5
  4790. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thin optic chiasm
    n1=hyperaldostéronisme secondaire | n2=en:thin optic chiasm | rel=r_associated | relid=0 | w=5
  4791. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thinning of the cerebellopontine tracts
    n1=hyperaldostéronisme secondaire | n2=en:thinning of the cerebellopontine tracts | rel=r_associated | relid=0 | w=5
  4792. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:third ventricle subependymal focal gliosis
    n1=hyperaldostéronisme secondaire | n2=en:third ventricle subependymal focal gliosis | rel=r_associated | relid=0 | w=5
  4793. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thoracic outlet syndrome
    n1=hyperaldostéronisme secondaire | n2=en:thoracic outlet syndrome | rel=r_associated | relid=0 | w=5
  4794. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:thrombosis of cerebral veins
    n1=hyperaldostéronisme secondaire | n2=en:thrombosis of cerebral veins | rel=r_associated | relid=0 | w=5
  4795. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tic
    n1=hyperaldostéronisme secondaire | n2=en:tic | rel=r_associated | relid=0 | w=5
  4796. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tics or anxieties (rare)
    n1=hyperaldostéronisme secondaire | n2=en:tics or anxieties (rare) | rel=r_associated | relid=0 | w=5
  4797. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tip-toe gait
    n1=hyperaldostéronisme secondaire | n2=en:tip-toe gait | rel=r_associated | relid=0 | w=5
  4798. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toddler development
    n1=hyperaldostéronisme secondaire | n2=en:toddler development | rel=r_associated | relid=0 | w=5
  4799. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toddler health
    n1=hyperaldostéronisme secondaire | n2=en:toddler health | rel=r_associated | relid=0 | w=5
  4800. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toddler nutrition
    n1=hyperaldostéronisme secondaire | n2=en:toddler nutrition | rel=r_associated | relid=0 | w=5
  4801. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toe-walking gait
    n1=hyperaldostéronisme secondaire | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=5
  4802. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toe-walking in early childhood
    n1=hyperaldostéronisme secondaire | n2=en:toe-walking in early childhood | rel=r_associated | relid=0 | w=5
  4803. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:toilet training
    n1=hyperaldostéronisme secondaire | n2=en:toilet training | rel=r_associated | relid=0 | w=5
  4804. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tongue movements, protrusions
    n1=hyperaldostéronisme secondaire | n2=en:tongue movements, protrusions | rel=r_associated | relid=0 | w=5
  4805. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic clonic seizures, infrequent (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:tonic clonic seizures, infrequent (in one patient) | rel=r_associated | relid=0 | w=5
  4806. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic convulsion
    n1=hyperaldostéronisme secondaire | n2=en:tonic convulsion | rel=r_associated | relid=0 | w=5
  4807. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic head extension
    n1=hyperaldostéronisme secondaire | n2=en:tonic head extension | rel=r_associated | relid=0 | w=5
  4808. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic posturing
    n1=hyperaldostéronisme secondaire | n2=en:tonic posturing | rel=r_associated | relid=0 | w=5
  4809. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic seizures, refractory
    n1=hyperaldostéronisme secondaire | n2=en:tonic seizures, refractory | rel=r_associated | relid=0 | w=5
  4810. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic spasms
    n1=hyperaldostéronisme secondaire | n2=en:tonic spasms | rel=r_associated | relid=0 | w=5
  4811. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonic-clonic seizures (less common)
    n1=hyperaldostéronisme secondaire | n2=en:tonic-clonic seizures (less common) | rel=r_associated | relid=0 | w=5
  4812. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonsil and adenoid structure
    n1=hyperaldostéronisme secondaire | n2=en:tonsil and adenoid structure | rel=r_associated | relid=0 | w=5
  4813. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tonus dysregulation
    n1=hyperaldostéronisme secondaire | n2=en:tonus dysregulation | rel=r_associated | relid=0 | w=5
  4814. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing)
    n1=hyperaldostéronisme secondaire | n2=en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing) | rel=r_associated | relid=0 | w=5
  4815. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:torticollis
    n1=hyperaldostéronisme secondaire | n2=en:torticollis | rel=r_associated | relid=0 | w=5
  4816. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:total body paralysis, paroxysmal
    n1=hyperaldostéronisme secondaire | n2=en:total body paralysis, paroxysmal | rel=r_associated | relid=0 | w=5
  4817. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:touch, vibration, and limb position may or may not be affected
    n1=hyperaldostéronisme secondaire | n2=en:touch, vibration, and limb position may or may not be affected | rel=r_associated | relid=0 | w=5
  4818. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tourette syndrome
    n1=hyperaldostéronisme secondaire | n2=en:tourette syndrome | rel=r_associated | relid=0 | w=5
  4819. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tow-walking
    n1=hyperaldostéronisme secondaire | n2=en:tow-walking | rel=r_associated | relid=0 | w=5
  4820. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:transient ataxia
    n1=hyperaldostéronisme secondaire | n2=en:transient ataxia | rel=r_associated | relid=0 | w=5
  4821. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:transient ischemic attack
    n1=hyperaldostéronisme secondaire | n2=en:transient ischemic attack | rel=r_associated | relid=0 | w=5
  4822. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:transient mild dystonia may precede abrupt onset of disorder by several years
    n1=hyperaldostéronisme secondaire | n2=en:transient mild dystonia may precede abrupt onset of disorder by several years | rel=r_associated | relid=0 | w=5
  4823. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:transient, reversible neurologic deficits
    n1=hyperaldostéronisme secondaire | n2=en:transient, reversible neurologic deficits | rel=r_associated | relid=0 | w=5
  4824. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:transitional facial palsy (15%)
    n1=hyperaldostéronisme secondaire | n2=en:transitional facial palsy (15%) | rel=r_associated | relid=0 | w=5
  4825. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:traumatic encephalopathy
    n1=hyperaldostéronisme secondaire | n2=en:traumatic encephalopathy | rel=r_associated | relid=0 | w=5
  4826. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor
    n1=hyperaldostéronisme secondaire | n2=en:tremor | rel=r_associated | relid=0 | w=5
  4827. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (1 patient) | rel=r_associated | relid=0 | w=5
  4828. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (3 patients) | rel=r_associated | relid=0 | w=5
  4829. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (30%)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (30%) | rel=r_associated | relid=0 | w=5
  4830. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (57% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (57% of patients) | rel=r_associated | relid=0 | w=5
  4831. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (in some patients) | rel=r_associated | relid=0 | w=5
  4832. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (later-onset)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (later-onset) | rel=r_associated | relid=0 | w=5
  4833. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (less common)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (less common) | rel=r_associated | relid=0 | w=5
  4834. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor (rare)
    n1=hyperaldostéronisme secondaire | n2=en:tremor (rare) | rel=r_associated | relid=0 | w=5
  4835. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor due to hyperthyroidism
    n1=hyperaldostéronisme secondaire | n2=en:tremor due to hyperthyroidism | rel=r_associated | relid=0 | w=5
  4836. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor is exacerbated by stress and exercise
    n1=hyperaldostéronisme secondaire | n2=en:tremor is exacerbated by stress and exercise | rel=r_associated | relid=0 | w=5
  4837. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor of hands
    n1=hyperaldostéronisme secondaire | n2=en:tremor of hands | rel=r_associated | relid=0 | w=5
  4838. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor of palate
    n1=hyperaldostéronisme secondaire | n2=en:tremor of palate | rel=r_associated | relid=0 | w=5
  4839. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor of the upper limb
    n1=hyperaldostéronisme secondaire | n2=en:tremor of the upper limb | rel=r_associated | relid=0 | w=5
  4840. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor with febrile episodes (rare)
    n1=hyperaldostéronisme secondaire | n2=en:tremor with febrile episodes (rare) | rel=r_associated | relid=0 | w=5
  4841. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, action (arms, tongue, head, legs and trunk)
    n1=hyperaldostéronisme secondaire | n2=en:tremor, action (arms, tongue, head, legs and trunk) | rel=r_associated | relid=0 | w=5
  4842. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, action, progressive
    n1=hyperaldostéronisme secondaire | n2=en:tremor, action, progressive | rel=r_associated | relid=0 | w=5
  4843. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, mild
    n1=hyperaldostéronisme secondaire | n2=en:tremor, mild | rel=r_associated | relid=0 | w=5
  4844. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, postural (arms, tongue, head, legs and trunk)
    n1=hyperaldostéronisme secondaire | n2=en:tremor, postural (arms, tongue, head, legs and trunk) | rel=r_associated | relid=0 | w=5
  4845. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family)
    n1=hyperaldostéronisme secondaire | n2=en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family) | rel=r_associated | relid=0 | w=5
  4846. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, small-amplitude, high-frequency, restricted to the hands
    n1=hyperaldostéronisme secondaire | n2=en:tremor, small-amplitude, high-frequency, restricted to the hands | rel=r_associated | relid=0 | w=5
  4847. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, static
    n1=hyperaldostéronisme secondaire | n2=en:tremor, static | rel=r_associated | relid=0 | w=5
  4848. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremor, variable
    n1=hyperaldostéronisme secondaire | n2=en:tremor, variable | rel=r_associated | relid=0 | w=5
  4849. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremors, action
    n1=hyperaldostéronisme secondaire | n2=en:tremors, action | rel=r_associated | relid=0 | w=5
  4850. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tremors, limb
    n1=hyperaldostéronisme secondaire | n2=en:tremors, limb | rel=r_associated | relid=0 | w=5
  4851. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:trichotillomania
    n1=hyperaldostéronisme secondaire | n2=en:trichotillomania | rel=r_associated | relid=0 | w=5
  4852. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:trigeminal anesthesia
    n1=hyperaldostéronisme secondaire | n2=en:trigeminal anesthesia | rel=r_associated | relid=0 | w=5
  4853. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:trigeminal neuralgia
    n1=hyperaldostéronisme secondaire | n2=en:trigeminal neuralgia | rel=r_associated | relid=0 | w=5
  4854. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:trismus (rare)
    n1=hyperaldostéronisme secondaire | n2=en:trismus (rare) | rel=r_associated | relid=0 | w=5
  4855. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:truncal arching
    n1=hyperaldostéronisme secondaire | n2=en:truncal arching | rel=r_associated | relid=0 | w=5
  4856. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:truncal ataxia, mild
    n1=hyperaldostéronisme secondaire | n2=en:truncal ataxia, mild | rel=r_associated | relid=0 | w=5
  4857. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:truncal ataxia, severe
    n1=hyperaldostéronisme secondaire | n2=en:truncal ataxia, severe | rel=r_associated | relid=0 | w=5
  4858. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:truncal instability
    n1=hyperaldostéronisme secondaire | n2=en:truncal instability | rel=r_associated | relid=0 | w=5
  4859. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:truncal titubation
    n1=hyperaldostéronisme secondaire | n2=en:truncal titubation | rel=r_associated | relid=0 | w=5
  4860. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tuberous sclerosis
    n1=hyperaldostéronisme secondaire | n2=en:tuberous sclerosis | rel=r_associated | relid=0 | w=5
  4861. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:tussive syncopes
    n1=hyperaldostéronisme secondaire | n2=en:tussive syncopes | rel=r_associated | relid=0 | w=5
  4862. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:twins, triplets, multiple births
    n1=hyperaldostéronisme secondaire | n2=en:twins, triplets, multiple births | rel=r_associated | relid=0 | w=5
  4863. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:twitching of the fingers and toes
    n1=hyperaldostéronisme secondaire | n2=en:twitching of the fingers and toes | rel=r_associated | relid=0 | w=5
  4864. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:type i arnold chiari malformation
    n1=hyperaldostéronisme secondaire | n2=en:type i arnold chiari malformation | rel=r_associated | relid=0 | w=5
  4865. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:type i eeg response is occipital spikes
    n1=hyperaldostéronisme secondaire | n2=en:type i eeg response is occipital spikes | rel=r_associated | relid=0 | w=5
  4866. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves
    n1=hyperaldostéronisme secondaire | n2=en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves | rel=r_associated | relid=0 | w=5
  4867. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region
    n1=hyperaldostéronisme secondaire | n2=en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region | rel=r_associated | relid=0 | w=5
  4868. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:type iv eeg response is generalized spike-wave discharges
    n1=hyperaldostéronisme secondaire | n2=en:type iv eeg response is generalized spike-wave discharges | rel=r_associated | relid=0 | w=5
  4869. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions | rel=r_associated | relid=0 | w=5
  4870. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ubiquitin-positive inclusions
    n1=hyperaldostéronisme secondaire | n2=en:ubiquitin-positive inclusions | rel=r_associated | relid=0 | w=5
  4871. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ubiquitin-positive intranuclear neuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:ubiquitin-positive intranuclear neuronal inclusions | rel=r_associated | relid=0 | w=5
  4872. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons
    n1=hyperaldostéronisme secondaire | n2=en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons | rel=r_associated | relid=0 | w=5
  4873. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unable to grasp objects
    n1=hyperaldostéronisme secondaire | n2=en:unable to grasp objects | rel=r_associated | relid=0 | w=5
  4874. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unable to sit unsupported
    n1=hyperaldostéronisme secondaire | n2=en:unable to sit unsupported | rel=r_associated | relid=0 | w=5
  4875. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unable to stand
    n1=hyperaldostéronisme secondaire | n2=en:unable to stand | rel=r_associated | relid=0 | w=5
  4876. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unable to talk
    n1=hyperaldostéronisme secondaire | n2=en:unable to talk | rel=r_associated | relid=0 | w=5
  4877. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unable to walk
    n1=hyperaldostéronisme secondaire | n2=en:unable to walk | rel=r_associated | relid=0 | w=5
  4878. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unaggressive type unsocialized behavior disorder
    n1=hyperaldostéronisme secondaire | n2=en:unaggressive type unsocialized behavior disorder | rel=r_associated | relid=0 | w=5
  4879. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:uncommon infant and newborn problems
    n1=hyperaldostéronisme secondaire | n2=en:uncommon infant and newborn problems | rel=r_associated | relid=0 | w=5
  4880. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:uncontrolled rage
    n1=hyperaldostéronisme secondaire | n2=en:uncontrolled rage | rel=r_associated | relid=0 | w=5
  4881. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:uncoordinated movements
    n1=hyperaldostéronisme secondaire | n2=en:uncoordinated movements | rel=r_associated | relid=0 | w=5
  4882. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:underage drinking
    n1=hyperaldostéronisme secondaire | n2=en:underage drinking | rel=r_associated | relid=0 | w=5
  4883. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:underdeveloped corpus callosum (3 patients)
    n1=hyperaldostéronisme secondaire | n2=en:underdeveloped corpus callosum (3 patients) | rel=r_associated | relid=0 | w=5
  4884. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:undersulcation of the frontal lobes
    n1=hyperaldostéronisme secondaire | n2=en:undersulcation of the frontal lobes | rel=r_associated | relid=0 | w=5
  4885. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:undifferentiated type schizophrenia
    n1=hyperaldostéronisme secondaire | n2=en:undifferentiated type schizophrenia | rel=r_associated | relid=0 | w=5
  4886. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unidentified bright objects on brain mri
    n1=hyperaldostéronisme secondaire | n2=en:unidentified bright objects on brain mri | rel=r_associated | relid=0 | w=5
  4887. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unilateral cerebellar hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:unilateral cerebellar hypoplasia | rel=r_associated | relid=0 | w=5
  4888. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unilateral headache location
    n1=hyperaldostéronisme secondaire | n2=en:unilateral headache location | rel=r_associated | relid=0 | w=5
  4889. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unintelligible speech, vocalizations, grunting
    n1=hyperaldostéronisme secondaire | n2=en:unintelligible speech, vocalizations, grunting | rel=r_associated | relid=0 | w=5
  4890. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unresponsive to stimuli
    n1=hyperaldostéronisme secondaire | n2=en:unresponsive to stimuli | rel=r_associated | relid=0 | w=5
  4891. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unresponsiveness
    n1=hyperaldostéronisme secondaire | n2=en:unresponsiveness | rel=r_associated | relid=0 | w=5
  4892. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
    n1=hyperaldostéronisme secondaire | n2=en:unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence | rel=r_associated | relid=0 | w=5
  4893. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unspecified disorder of adult personality and behaviour
    n1=hyperaldostéronisme secondaire | n2=en:unspecified disorder of adult personality and behaviour | rel=r_associated | relid=0 | w=5
  4894. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unstable, ataxic gait
    n1=hyperaldostéronisme secondaire | n2=en:unstable, ataxic gait | rel=r_associated | relid=0 | w=5
  4895. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unsteadiness, episodic
    n1=hyperaldostéronisme secondaire | n2=en:unsteadiness, episodic | rel=r_associated | relid=0 | w=5
  4896. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unsteady gait due to muscle weakness
    n1=hyperaldostéronisme secondaire | n2=en:unsteady gait due to muscle weakness | rel=r_associated | relid=0 | w=5
  4897. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unsteady standing
    n1=hyperaldostéronisme secondaire | n2=en:unsteady standing | rel=r_associated | relid=0 | w=5
  4898. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo
    n1=hyperaldostéronisme secondaire | n2=en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo | rel=r_associated | relid=0 | w=5
  4899. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unusual behavior (2 patients)
    n1=hyperaldostéronisme secondaire | n2=en:unusual behavior (2 patients) | rel=r_associated | relid=0 | w=5
  4900. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:unusual fears
    n1=hyperaldostéronisme secondaire | n2=en:unusual fears | rel=r_associated | relid=0 | w=5
  4901. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upbeat central vestibular nystagmus
    n1=hyperaldostéronisme secondaire | n2=en:upbeat central vestibular nystagmus | rel=r_associated | relid=0 | w=5
  4902. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper and lower motor neuron degeneration
    n1=hyperaldostéronisme secondaire | n2=en:upper and lower motor neuron degeneration | rel=r_associated | relid=0 | w=5
  4903. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper and lower motor neuron disease
    n1=hyperaldostéronisme secondaire | n2=en:upper and lower motor neuron disease | rel=r_associated | relid=0 | w=5
  4904. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper and lower neuron manifestations
    n1=hyperaldostéronisme secondaire | n2=en:upper and lower neuron manifestations | rel=r_associated | relid=0 | w=5
  4905. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper body involvement
    n1=hyperaldostéronisme secondaire | n2=en:upper body involvement | rel=r_associated | relid=0 | w=5
  4906. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper extremities may be involved
    n1=hyperaldostéronisme secondaire | n2=en:upper extremities may be involved | rel=r_associated | relid=0 | w=5
  4907. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper extremity action tremor
    n1=hyperaldostéronisme secondaire | n2=en:upper extremity action tremor | rel=r_associated | relid=0 | w=5
  4908. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb ataxia
    n1=hyperaldostéronisme secondaire | n2=en:upper limb ataxia | rel=r_associated | relid=0 | w=5
  4909. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb dysmetria
    n1=hyperaldostéronisme secondaire | n2=en:upper limb dysmetria | rel=r_associated | relid=0 | w=5
  4910. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb dystonia
    n1=hyperaldostéronisme secondaire | n2=en:upper limb dystonia | rel=r_associated | relid=0 | w=5
  4911. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb hyperreflexia (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb hyperreflexia (in some patients) | rel=r_associated | relid=0 | w=5
  4912. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb hyperreflexia (some)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb hyperreflexia (some) | rel=r_associated | relid=0 | w=5
  4913. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb involvement
    n1=hyperaldostéronisme secondaire | n2=en:upper limb involvement | rel=r_associated | relid=0 | w=5
  4914. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb involvement (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb involvement (in some patients) | rel=r_associated | relid=0 | w=5
  4915. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb involvement (onset in the first decade)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb involvement (onset in the first decade) | rel=r_associated | relid=0 | w=5
  4916. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb involvement may occur
    n1=hyperaldostéronisme secondaire | n2=en:upper limb involvement may occur | rel=r_associated | relid=0 | w=5
  4917. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb spasticity
    n1=hyperaldostéronisme secondaire | n2=en:upper limb spasticity | rel=r_associated | relid=0 | w=5
  4918. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb spasticity (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb spasticity (in some patients) | rel=r_associated | relid=0 | w=5
  4919. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb spasticity (some)
    n1=hyperaldostéronisme secondaire | n2=en:upper limb spasticity (some) | rel=r_associated | relid=0 | w=5
  4920. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb spasticity, mild
    n1=hyperaldostéronisme secondaire | n2=en:upper limb spasticity, mild | rel=r_associated | relid=0 | w=5
  4921. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb weakness
    n1=hyperaldostéronisme secondaire | n2=en:upper limb weakness | rel=r_associated | relid=0 | w=5
  4922. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limb weakness may occur later
    n1=hyperaldostéronisme secondaire | n2=en:upper limb weakness may occur later | rel=r_associated | relid=0 | w=5
  4923. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limbs affected
    n1=hyperaldostéronisme secondaire | n2=en:upper limbs affected | rel=r_associated | relid=0 | w=5
  4924. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limbs may be affected
    n1=hyperaldostéronisme secondaire | n2=en:upper limbs may be affected | rel=r_associated | relid=0 | w=5
  4925. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limbs may show hyperreflexia
    n1=hyperaldostéronisme secondaire | n2=en:upper limbs may show hyperreflexia | rel=r_associated | relid=0 | w=5
  4926. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limbs may show mild involvement
    n1=hyperaldostéronisme secondaire | n2=en:upper limbs may show mild involvement | rel=r_associated | relid=0 | w=5
  4927. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper limbs more often affected than lower limbs
    n1=hyperaldostéronisme secondaire | n2=en:upper limbs more often affected than lower limbs | rel=r_associated | relid=0 | w=5
  4928. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor involvement (some patient)
    n1=hyperaldostéronisme secondaire | n2=en:upper motor involvement (some patient) | rel=r_associated | relid=0 | w=5
  4929. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor neuron degeneration
    n1=hyperaldostéronisme secondaire | n2=en:upper motor neuron degeneration | rel=r_associated | relid=0 | w=5
  4930. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor neuron dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:upper motor neuron dysfunction | rel=r_associated | relid=0 | w=5
  4931. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor neuron signs
    n1=hyperaldostéronisme secondaire | n2=en:upper motor neuron signs | rel=r_associated | relid=0 | w=5
  4932. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor neuron signs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:upper motor neuron signs (in some patients) | rel=r_associated | relid=0 | w=5
  4933. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor neuron signs, early
    n1=hyperaldostéronisme secondaire | n2=en:upper motor neuron signs, early | rel=r_associated | relid=0 | w=5
  4934. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor signs
    n1=hyperaldostéronisme secondaire | n2=en:upper motor signs | rel=r_associated | relid=0 | w=5
  4935. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:upper motor signs (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:upper motor signs (in some patients) | rel=r_associated | relid=0 | w=5
  4936. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:urea cycle metabolism disorder
    n1=hyperaldostéronisme secondaire | n2=en:urea cycle metabolism disorder | rel=r_associated | relid=0 | w=5
  4937. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:usually occurs at night
    n1=hyperaldostéronisme secondaire | n2=en:usually occurs at night | rel=r_associated | relid=0 | w=5
  4938. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vacuolated neurons
    n1=hyperaldostéronisme secondaire | n2=en:vacuolated neurons | rel=r_associated | relid=0 | w=5
  4939. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vacuolization (patient a)
    n1=hyperaldostéronisme secondaire | n2=en:vacuolization (patient a) | rel=r_associated | relid=0 | w=5
  4940. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vacuolizing myelinopathy
    n1=hyperaldostéronisme secondaire | n2=en:vacuolizing myelinopathy | rel=r_associated | relid=0 | w=5
  4941. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable delay (iq range 52-104)
    n1=hyperaldostéronisme secondaire | n2=en:variable delay (iq range 52-104) | rel=r_associated | relid=0 | w=5
  4942. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable intracranial abnormalities
    n1=hyperaldostéronisme secondaire | n2=en:variable intracranial abnormalities | rel=r_associated | relid=0 | w=5
  4943. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:variable mental retardation | rel=r_associated | relid=0 | w=5
  4944. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable mental retardation (40%)
    n1=hyperaldostéronisme secondaire | n2=en:variable mental retardation (40%) | rel=r_associated | relid=0 | w=5
  4945. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation | rel=r_associated | relid=0 | w=5
  4946. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable neurologic deterioration (likely result of hemophagocytic syndrome)
    n1=hyperaldostéronisme secondaire | n2=en:variable neurologic deterioration (likely result of hemophagocytic syndrome) | rel=r_associated | relid=0 | w=5
  4947. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:variable outcome after acute illness
    n1=hyperaldostéronisme secondaire | n2=en:variable outcome after acute illness | rel=r_associated | relid=0 | w=5
  4948. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:varying degree of mental retardation
    n1=hyperaldostéronisme secondaire | n2=en:varying degree of mental retardation | rel=r_associated | relid=0 | w=5
  4949. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vasculopathy of the small arteries penetrating the white matter
    n1=hyperaldostéronisme secondaire | n2=en:vasculopathy of the small arteries penetrating the white matter | rel=r_associated | relid=0 | w=5
  4950. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vasovagal syncope
    n1=hyperaldostéronisme secondaire | n2=en:vasovagal syncope | rel=r_associated | relid=0 | w=5
  4951. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vcp-positive inclusions
    n1=hyperaldostéronisme secondaire | n2=en:vcp-positive inclusions | rel=r_associated | relid=0 | w=5
  4952. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricles slightly enlarged
    n1=hyperaldostéronisme secondaire | n2=en:ventricles slightly enlarged | rel=r_associated | relid=0 | w=5
  4953. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular anomalies
    n1=hyperaldostéronisme secondaire | n2=en:ventricular anomalies | rel=r_associated | relid=0 | w=5
  4954. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular asymmetry
    n1=hyperaldostéronisme secondaire | n2=en:ventricular asymmetry | rel=r_associated | relid=0 | w=5
  4955. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular dilatation (29%)
    n1=hyperaldostéronisme secondaire | n2=en:ventricular dilatation (29%) | rel=r_associated | relid=0 | w=5
  4956. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular dilatation (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ventricular dilatation (in some patients) | rel=r_associated | relid=0 | w=5
  4957. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular dilatation (rare)
    n1=hyperaldostéronisme secondaire | n2=en:ventricular dilatation (rare) | rel=r_associated | relid=0 | w=5
  4958. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular enlargement
    n1=hyperaldostéronisme secondaire | n2=en:ventricular enlargement | rel=r_associated | relid=0 | w=5
  4959. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventricular enlargement, mild
    n1=hyperaldostéronisme secondaire | n2=en:ventricular enlargement, mild | rel=r_associated | relid=0 | w=5
  4960. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventriculomegaly (38%)
    n1=hyperaldostéronisme secondaire | n2=en:ventriculomegaly (38%) | rel=r_associated | relid=0 | w=5
  4961. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventriculomegaly (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:ventriculomegaly (in some patients) | rel=r_associated | relid=0 | w=5
  4962. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventriculomegaly (variable)
    n1=hyperaldostéronisme secondaire | n2=en:ventriculomegaly (variable) | rel=r_associated | relid=0 | w=5
  4963. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventriculomegaly, mild (rare)
    n1=hyperaldostéronisme secondaire | n2=en:ventriculomegaly, mild (rare) | rel=r_associated | relid=0 | w=5
  4964. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:ventriculomeglia
    n1=hyperaldostéronisme secondaire | n2=en:ventriculomeglia | rel=r_associated | relid=0 | w=5
  4965. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:verbal delay (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:verbal delay (in some patients) | rel=r_associated | relid=0 | w=5
  4966. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:verbal outbursts (in one patient)
    n1=hyperaldostéronisme secondaire | n2=en:verbal outbursts (in one patient) | rel=r_associated | relid=0 | w=5
  4967. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:verbal repetition
    n1=hyperaldostéronisme secondaire | n2=en:verbal repetition | rel=r_associated | relid=0 | w=5
  4968. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vermian hypoplasia
    n1=hyperaldostéronisme secondaire | n2=en:vermian hypoplasia | rel=r_associated | relid=0 | w=5
  4969. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vertical orientation of hippocampus
    n1=hyperaldostéronisme secondaire | n2=en:vertical orientation of hippocampus | rel=r_associated | relid=0 | w=5
  4970. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vertigo
    n1=hyperaldostéronisme secondaire | n2=en:vertigo | rel=r_associated | relid=0 | w=5
  4971. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vertigo, episodic (onset in second or third decade)
    n1=hyperaldostéronisme secondaire | n2=en:vertigo, episodic (onset in second or third decade) | rel=r_associated | relid=0 | w=5
  4972. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vertigo, mild
    n1=hyperaldostéronisme secondaire | n2=en:vertigo, mild | rel=r_associated | relid=0 | w=5
  4973. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:very poor expressive speech
    n1=hyperaldostéronisme secondaire | n2=en:very poor expressive speech | rel=r_associated | relid=0 | w=5
  4974. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vestibular anomalies (less common)
    n1=hyperaldostéronisme secondaire | n2=en:vestibular anomalies (less common) | rel=r_associated | relid=0 | w=5
  4975. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vestibular dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:vestibular dysfunction | rel=r_associated | relid=0 | w=5
  4976. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vestibular dysfunction, mild
    n1=hyperaldostéronisme secondaire | n2=en:vestibular dysfunction, mild | rel=r_associated | relid=0 | w=5
  4977. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade)
    n1=hyperaldostéronisme secondaire | n2=en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade) | rel=r_associated | relid=0 | w=5
  4978. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:violent behavior
    n1=hyperaldostéronisme secondaire | n2=en:violent behavior | rel=r_associated | relid=0 | w=5
  4979. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:virtual absence of pyramidal tracts (wws)
    n1=hyperaldostéronisme secondaire | n2=en:virtual absence of pyramidal tracts (wws) | rel=r_associated | relid=0 | w=5
  4980. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visceroautonomic dysfunction
    n1=hyperaldostéronisme secondaire | n2=en:visceroautonomic dysfunction | rel=r_associated | relid=0 | w=5
  4981. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual acuity is normal
    n1=hyperaldostéronisme secondaire | n2=en:visual acuity is normal | rel=r_associated | relid=0 | w=5
  4982. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual auras
    n1=hyperaldostéronisme secondaire | n2=en:visual auras | rel=r_associated | relid=0 | w=5
  4983. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual blackouts (stage 1)
    n1=hyperaldostéronisme secondaire | n2=en:visual blackouts (stage 1) | rel=r_associated | relid=0 | w=5
  4984. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual changes
    n1=hyperaldostéronisme secondaire | n2=en:visual changes | rel=r_associated | relid=0 | w=5
  4985. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual hallucination
    n1=hyperaldostéronisme secondaire | n2=en:visual hallucination | rel=r_associated | relid=0 | w=5
  4986. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual hallucinations may occur
    n1=hyperaldostéronisme secondaire | n2=en:visual hallucinations may occur | rel=r_associated | relid=0 | w=5
  4987. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visual symptoms (in 60% of patients)
    n1=hyperaldostéronisme secondaire | n2=en:visual symptoms (in 60% of patients) | rel=r_associated | relid=0 | w=5
  4988. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:visuospatial agnosia (in a subset of patients)
    n1=hyperaldostéronisme secondaire | n2=en:visuospatial agnosia (in a subset of patients) | rel=r_associated | relid=0 | w=5
  4989. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:vocalization (finding)
    n1=hyperaldostéronisme secondaire | n2=en:vocalization (finding) | rel=r_associated | relid=0 | w=5
  4990. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:waddling gait
    n1=hyperaldostéronisme secondaire | n2=en:waddling gait | rel=r_associated | relid=0 | w=5
  4991. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:walking delay
    n1=hyperaldostéronisme secondaire | n2=en:walking delay | rel=r_associated | relid=0 | w=5
  4992. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:walking during slow-wave sleep (sleepwalking)
    n1=hyperaldostéronisme secondaire | n2=en:walking during slow-wave sleep (sleepwalking) | rel=r_associated | relid=0 | w=5
  4993. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:walking impairment due to myoclonus late in disease
    n1=hyperaldostéronisme secondaire | n2=en:walking impairment due to myoclonus late in disease | rel=r_associated | relid=0 | w=5
  4994. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:walking independently at 2.5 years to 4 years of age
    n1=hyperaldostéronisme secondaire | n2=en:walking independently at 2.5 years to 4 years of age | rel=r_associated | relid=0 | w=5
  4995. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:warm and engaging personality
    n1=hyperaldostéronisme secondaire | n2=en:warm and engaging personality | rel=r_associated | relid=0 | w=5
  4996. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:weak or absent tendon reflexes of knees and ankles (in some patients)
    n1=hyperaldostéronisme secondaire | n2=en:weak or absent tendon reflexes of knees and ankles (in some patients) | rel=r_associated | relid=0 | w=5
  4997. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:weakness
    n1=hyperaldostéronisme secondaire | n2=en:weakness | rel=r_associated | relid=0 | w=5
  4998. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:weakness of hip and ankle flexion
    n1=hyperaldostéronisme secondaire | n2=en:weakness of hip and ankle flexion | rel=r_associated | relid=0 | w=5
  4999. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:wernicke-korsakoff syndrome
    n1=hyperaldostéronisme secondaire | n2=en:wernicke-korsakoff syndrome | rel=r_associated | relid=0 | w=5
  5000. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:west nile viral infection
    n1=hyperaldostéronisme secondaire | n2=en:west nile viral infection | rel=r_associated | relid=0 | w=5
  5001. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:west syndrome
    n1=hyperaldostéronisme secondaire | n2=en:west syndrome | rel=r_associated | relid=0 | w=5
  5002. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white mater abnormalities in the posterior periventricular region
    n1=hyperaldostéronisme secondaire | n2=en:white mater abnormalities in the posterior periventricular region | rel=r_associated | relid=0 | w=5
  5003. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter
    n1=hyperaldostéronisme secondaire | n2=en:white matter | rel=r_associated | relid=0 | w=5
  5004. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities (1 patient) | rel=r_associated | relid=0 | w=5
  5005. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities (in some)
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities (in some) | rel=r_associated | relid=0 | w=5
  5006. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities (rare)
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities (rare) | rel=r_associated | relid=0 | w=5
  5007. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities (uncommon)
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities (uncommon) | rel=r_associated | relid=0 | w=5
  5008. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities in the periventricular regions (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities in the periventricular regions (1 patient) | rel=r_associated | relid=0 | w=5
  5009. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities on mri
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities on mri | rel=r_associated | relid=0 | w=5
  5010. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities seen on mri | rel=r_associated | relid=0 | w=5
  5011. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter abnormalities seen on mri which resolve over time
    n1=hyperaldostéronisme secondaire | n2=en:white matter abnormalities seen on mri which resolve over time | rel=r_associated | relid=0 | w=5
  5012. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter alterations (in one family)
    n1=hyperaldostéronisme secondaire | n2=en:white matter alterations (in one family) | rel=r_associated | relid=0 | w=5
  5013. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter changes
    n1=hyperaldostéronisme secondaire | n2=en:white matter changes | rel=r_associated | relid=0 | w=5
  5014. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter changes may occur (in adulthood)
    n1=hyperaldostéronisme secondaire | n2=en:white matter changes may occur (in adulthood) | rel=r_associated | relid=0 | w=5
  5015. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter changes on brain imaging (less common)
    n1=hyperaldostéronisme secondaire | n2=en:white matter changes on brain imaging (less common) | rel=r_associated | relid=0 | w=5
  5016. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter degeneration
    n1=hyperaldostéronisme secondaire | n2=en:white matter degeneration | rel=r_associated | relid=0 | w=5
  5017. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter dysmyelination/demyelination (71%)
    n1=hyperaldostéronisme secondaire | n2=en:white matter dysmyelination/demyelination (71%) | rel=r_associated | relid=0 | w=5
  5018. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hyperintensities
    n1=hyperaldostéronisme secondaire | n2=en:white matter hyperintensities | rel=r_associated | relid=0 | w=5
  5019. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts
    n1=hyperaldostéronisme secondaire | n2=en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts | rel=r_associated | relid=0 | w=5
  5020. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hyperintensities in t2 imaging
    n1=hyperaldostéronisme secondaire | n2=en:white matter hyperintensities in t2 imaging | rel=r_associated | relid=0 | w=5
  5021. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hyperintensities in various brain regions
    n1=hyperaldostéronisme secondaire | n2=en:white matter hyperintensities in various brain regions | rel=r_associated | relid=0 | w=5
  5022. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hypodensities on brain imaging
    n1=hyperaldostéronisme secondaire | n2=en:white matter hypodensities on brain imaging | rel=r_associated | relid=0 | w=5
  5023. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter hypodensities seen on mri
    n1=hyperaldostéronisme secondaire | n2=en:white matter hypodensities seen on mri | rel=r_associated | relid=0 | w=5
  5024. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter immaturity
    n1=hyperaldostéronisme secondaire | n2=en:white matter immaturity | rel=r_associated | relid=0 | w=5
  5025. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lacks axons and myelin
    n1=hyperaldostéronisme secondaire | n2=en:white matter lacks axons and myelin | rel=r_associated | relid=0 | w=5
  5026. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesion
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesion | rel=r_associated | relid=0 | w=5
  5027. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions (1 patient)
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions (1 patient) | rel=r_associated | relid=0 | w=5
  5028. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions in the basal ganglia
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions in the basal ganglia | rel=r_associated | relid=0 | w=5
  5029. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions in the brainstem may occur
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions in the brainstem may occur | rel=r_associated | relid=0 | w=5
  5030. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord | rel=r_associated | relid=0 | w=5
  5031. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000)
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000) | rel=r_associated | relid=0 | w=5
  5032. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter lesions seen on brain imaging
    n1=hyperaldostéronisme secondaire | n2=en:white matter lesions seen on brain imaging | rel=r_associated | relid=0 | w=5
  5033. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter neuronal heterotopia
    n1=hyperaldostéronisme secondaire | n2=en:white matter neuronal heterotopia | rel=r_associated | relid=0 | w=5
  5034. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter rarefaction and cystic degeneration
    n1=hyperaldostéronisme secondaire | n2=en:white matter rarefaction and cystic degeneration | rel=r_associated | relid=0 | w=5
  5035. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter signal abnormalities in the deep white matter and periventricular regions
    n1=hyperaldostéronisme secondaire | n2=en:white matter signal abnormalities in the deep white matter and periventricular regions | rel=r_associated | relid=0 | w=5
  5036. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter signal abnormalities in various brain regions
    n1=hyperaldostéronisme secondaire | n2=en:white matter signal abnormalities in various brain regions | rel=r_associated | relid=0 | w=5
  5037. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter streaks
    n1=hyperaldostéronisme secondaire | n2=en:white matter streaks | rel=r_associated | relid=0 | w=5
  5038. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:white matter vacuolization
    n1=hyperaldostéronisme secondaire | n2=en:white matter vacuolization | rel=r_associated | relid=0 | w=5
  5039. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:whooping cough due to unspecified organism
    n1=hyperaldostéronisme secondaire | n2=en:whooping cough due to unspecified organism | rel=r_associated | relid=0 | w=5
  5040. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:wide subarachnoid spaces
    n1=hyperaldostéronisme secondaire | n2=en:wide subarachnoid spaces | rel=r_associated | relid=0 | w=5
  5041. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:wide sylvian fissures
    n1=hyperaldostéronisme secondaire | n2=en:wide sylvian fissures | rel=r_associated | relid=0 | w=5
  5042. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:wide sylvian fissures with incomplete opercularization
    n1=hyperaldostéronisme secondaire | n2=en:wide sylvian fissures with incomplete opercularization | rel=r_associated | relid=0 | w=5
  5043. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widened lateral ventricles
    n1=hyperaldostéronisme secondaire | n2=en:widened lateral ventricles | rel=r_associated | relid=0 | w=5
  5044. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widened subarachnoid spaces
    n1=hyperaldostéronisme secondaire | n2=en:widened subarachnoid spaces | rel=r_associated | relid=0 | w=5
  5045. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widening of cortical sulci
    n1=hyperaldostéronisme secondaire | n2=en:widening of cortical sulci | rel=r_associated | relid=0 | w=5
  5046. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widening of the operculum
    n1=hyperaldostéronisme secondaire | n2=en:widening of the operculum | rel=r_associated | relid=0 | w=5
  5047. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widening of the spinal canal
    n1=hyperaldostéronisme secondaire | n2=en:widening of the spinal canal | rel=r_associated | relid=0 | w=5
  5048. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widening of the ventricles
    n1=hyperaldostéronisme secondaire | n2=en:widening of the ventricles | rel=r_associated | relid=0 | w=5
  5049. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widespread brain atrophy
    n1=hyperaldostéronisme secondaire | n2=en:widespread brain atrophy | rel=r_associated | relid=0 | w=5
  5050. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widespread brain calcifications
    n1=hyperaldostéronisme secondaire | n2=en:widespread brain calcifications | rel=r_associated | relid=0 | w=5
  5051. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widespread neuronal loss
    n1=hyperaldostéronisme secondaire | n2=en:widespread neuronal loss | rel=r_associated | relid=0 | w=5
  5052. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:widespread tau (mapt)-positive glial and neuronal inclusions
    n1=hyperaldostéronisme secondaire | n2=en:widespread tau (mapt)-positive glial and neuronal inclusions | rel=r_associated | relid=0 | w=5
  5053. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:withdrawal
    n1=hyperaldostéronisme secondaire | n2=en:withdrawal | rel=r_associated | relid=0 | w=5
  5054. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:word finding difficulty (disorder)
    n1=hyperaldostéronisme secondaire | n2=en:word finding difficulty (disorder) | rel=r_associated | relid=0 | w=5
  5055. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:wrist-biting
    n1=hyperaldostéronisme secondaire | n2=en:wrist-biting | rel=r_associated | relid=0 | w=5
  5056. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:writing fatigability
    n1=hyperaldostéronisme secondaire | n2=en:writing fatigability | rel=r_associated | relid=0 | w=5
  5057. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:x-linked creatine transporter deficiency
    n1=hyperaldostéronisme secondaire | n2=en:x-linked creatine transporter deficiency | rel=r_associated | relid=0 | w=5
  5058. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> en:x-linked epilepsy with learning disability and behavior disorder syndrome
    n1=hyperaldostéronisme secondaire | n2=en:x-linked epilepsy with learning disability and behavior disorder syndrome | rel=r_associated | relid=0 | w=5
  5059. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> encéphalopathie hépatique
    n1=hyperaldostéronisme secondaire | n2=encéphalopathie hépatique | rel=r_associated | relid=0 | w=5
  5060. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> enfant hyperactif
    n1=hyperaldostéronisme secondaire | n2=enfant hyperactif | rel=r_associated | relid=0 | w=5
  5061. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> erreur innée du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=erreur innée du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5062. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> erreurs innées du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=erreurs innées du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5063. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> erreurs innées du métabolisme du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=erreurs innées du métabolisme du cycle de l'urée | rel=r_associated | relid=0 | w=5
  5064. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> génio-hyoïdien
    n1=hyperaldostéronisme secondaire | n2=génio-hyoïdien | rel=r_associated | relid=0 | w=5
  5065. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> HAD
    n1=hyperaldostéronisme secondaire | n2=HAD | rel=r_associated | relid=0 | w=5
  5066. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hamartome épidermique
    n1=hyperaldostéronisme secondaire | n2=hamartome épidermique | rel=r_associated | relid=0 | w=5
  5067. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> HDLémie
    n1=hyperaldostéronisme secondaire | n2=HDLémie | rel=r_associated | relid=0 | w=5
  5068. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyoïde
    n1=hyperaldostéronisme secondaire | n2=hyoïde | rel=r_associated | relid=0 | w=5
  5069. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> Hyper
    n1=hyperaldostéronisme secondaire | n2=Hyper | rel=r_associated | relid=0 | w=5
  5070. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyper-?-lipoprotéinémie
    n1=hyperaldostéronisme secondaire | n2=hyper-?-lipoprotéinémie | rel=r_associated | relid=0 | w=5
  5071. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperaction
    n1=hyperaldostéronisme secondaire | n2=hyperaction | rel=r_associated | relid=0 | w=5
  5072. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperactivité avec déficit de l'attention, type hyperactivité-impulsivité prédominante
    n1=hyperaldostéronisme secondaire | n2=hyperactivité avec déficit de l'attention, type hyperactivité-impulsivité prédominante | rel=r_associated | relid=0 | w=5
  5073. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperactivité avec déficit de l'attention, type mixte
    n1=hyperaldostéronisme secondaire | n2=hyperactivité avec déficit de l'attention, type mixte | rel=r_associated | relid=0 | w=5
  5074. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperaldostéronisme primaire à rénine basse
    n1=hyperaldostéronisme secondaire | n2=hyperaldostéronisme primaire à rénine basse | rel=r_associated | relid=0 | w=5
  5075. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperaldostéronismes
    n1=hyperaldostéronisme secondaire | n2=hyperaldostéronismes | rel=r_associated | relid=0 | w=5
  5076. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperammoniémies
    n1=hyperaldostéronisme secondaire | n2=hyperammoniémies | rel=r_associated | relid=0 | w=5
  5077. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hypercholestérolémie xanthomateuse familiale
    n1=hyperaldostéronisme secondaire | n2=hypercholestérolémie xanthomateuse familiale | rel=r_associated | relid=0 | w=5
  5078. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperkinétique (trouble)
    n1=hyperaldostéronisme secondaire | n2=hyperkinétique (trouble) | rel=r_associated | relid=0 | w=5
  5079. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperlipidémie
    n1=hyperaldostéronisme secondaire | n2=hyperlipidémie | rel=r_associated | relid=0 | w=5
  5080. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperlipoprotéinémie type II
    n1=hyperaldostéronisme secondaire | n2=hyperlipoprotéinémie type II | rel=r_associated | relid=0 | w=5
  5081. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperlysinémie
    n1=hyperaldostéronisme secondaire | n2=hyperlysinémie | rel=r_associated | relid=0 | w=5
  5082. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperréflexie vésicale
    n1=hyperaldostéronisme secondaire | n2=hyperréflexie vésicale | rel=r_associated | relid=0 | w=5
  5083. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> hyperuricémie
    n1=hyperaldostéronisme secondaire | n2=hyperuricémie | rel=r_associated | relid=0 | w=5
  5084. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> instabilité psychomotrice
    n1=hyperaldostéronisme secondaire | n2=instabilité psychomotrice | rel=r_associated | relid=0 | w=5
  5085. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> instabilité vésicale
    n1=hyperaldostéronisme secondaire | n2=instabilité vésicale | rel=r_associated | relid=0 | w=5
  5086. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> LDLémie
    n1=hyperaldostéronisme secondaire | n2=LDLémie | rel=r_associated | relid=0 | w=5
  5087. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> lésions
    n1=hyperaldostéronisme secondaire | n2=lésions | rel=r_associated | relid=0 | w=5
  5088. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> lipoprotéinémie
    n1=hyperaldostéronisme secondaire | n2=lipoprotéinémie | rel=r_associated | relid=0 | w=5
  5089. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> maladie
    (médecine, vétérinaire)
    n1=hyperaldostéronisme secondaire | n2=maladie
    (médecine, vétérinaire)
    | rel=r_associated | relid=0 | w=5
  5090. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> Médecine
    n1=hyperaldostéronisme secondaire | n2=Médecine | rel=r_associated | relid=0 | w=5
  5091. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> médecine
    (science)
    n1=hyperaldostéronisme secondaire | n2=médecine
    (science)
    | rel=r_associated | relid=0 | w=5
  5092. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> muscle
    n1=hyperaldostéronisme secondaire | n2=muscle | rel=r_associated | relid=0 | w=5
  5093. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> muscles
    n1=hyperaldostéronisme secondaire | n2=muscles | rel=r_associated | relid=0 | w=5
  5094. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> néphropathie tubulaire chronique
    n1=hyperaldostéronisme secondaire | n2=néphropathie tubulaire chronique | rel=r_associated | relid=0 | w=5
  5095. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> oculomoteur
    n1=hyperaldostéronisme secondaire | n2=oculomoteur | rel=r_associated | relid=0 | w=5
  5096. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> ornithine-carbamyltransférase
    n1=hyperaldostéronisme secondaire | n2=ornithine-carbamyltransférase | rel=r_associated | relid=0 | w=5
  5097. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> os
    n1=hyperaldostéronisme secondaire | n2=os | rel=r_associated | relid=0 | w=5
  5098. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> os hyoïde
    n1=hyperaldostéronisme secondaire | n2=os hyoïde | rel=r_associated | relid=0 | w=5
  5099. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> papillome
    n1=hyperaldostéronisme secondaire | n2=papillome | rel=r_associated | relid=0 | w=5
  5100. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> pathologie
    n1=hyperaldostéronisme secondaire | n2=pathologie | rel=r_associated | relid=0 | w=5
  5101. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> pyruvate décarboxylase
    n1=hyperaldostéronisme secondaire | n2=pyruvate décarboxylase | rel=r_associated | relid=0 | w=5
  5102. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> Russell (syndromes de)
    n1=hyperaldostéronisme secondaire | n2=Russell (syndromes de) | rel=r_associated | relid=0 | w=5
  5103. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> sang
    n1=hyperaldostéronisme secondaire | n2=sang | rel=r_associated | relid=0 | w=5
  5104. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> sang
    (hémoglobine)
    n1=hyperaldostéronisme secondaire | n2=sang
    (hémoglobine)
    | rel=r_associated | relid=0 | w=5
  5105. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> sections 6-a-b anomalies du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=sections 6-a-b anomalies du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5106. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> Sections 6-A-B Anomalies du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=Sections 6-A-B Anomalies du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5107. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> sous-hyoïdien
    n1=hyperaldostéronisme secondaire | n2=sous-hyoïdien | rel=r_associated | relid=0 | w=5
  5108. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> sterno-hyoïdien
    n1=hyperaldostéronisme secondaire | n2=sterno-hyoïdien | rel=r_associated | relid=0 | w=5
  5109. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome d'hyperactivité de l'enfant
    n1=hyperaldostéronisme secondaire | n2=syndrome d'hyperactivité de l'enfant | rel=r_associated | relid=0 | w=5
  5110. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome d'hyperkinésie
    n1=hyperaldostéronisme secondaire | n2=syndrome d'hyperkinésie | rel=r_associated | relid=0 | w=5
  5111. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome de Conn
    n1=hyperaldostéronisme secondaire | n2=syndrome de Conn | rel=r_associated | relid=0 | w=5
  5112. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome de conn
    n1=hyperaldostéronisme secondaire | n2=syndrome de conn | rel=r_associated | relid=0 | w=5
  5113. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome de Kramer Pollnow
    n1=hyperaldostéronisme secondaire | n2=syndrome de Kramer Pollnow | rel=r_associated | relid=0 | w=5
  5114. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome de l'enfant hyperactif
    n1=hyperaldostéronisme secondaire | n2=syndrome de l'enfant hyperactif | rel=r_associated | relid=0 | w=5
  5115. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome hyperkinétique
    n1=hyperaldostéronisme secondaire | n2=syndrome hyperkinétique | rel=r_associated | relid=0 | w=5
  5116. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome hyperkinétique de l'enfance
    n1=hyperaldostéronisme secondaire | n2=syndrome hyperkinétique de l'enfance | rel=r_associated | relid=0 | w=5
  5117. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> syndrome hyperkinétique de l'enfance non précisé
    n1=hyperaldostéronisme secondaire | n2=syndrome hyperkinétique de l'enfance non précisé | rel=r_associated | relid=0 | w=5
  5118. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble congénital du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=trouble congénital du cycle de l'urée | rel=r_associated | relid=0 | w=5
  5119. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble d'hyperactivité avec déficit de l'attention
    n1=hyperaldostéronisme secondaire | n2=trouble d'hyperactivité avec déficit de l'attention | rel=r_associated | relid=0 | w=5
  5120. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble de déficit de l'attention avec hyperactivité
    n1=hyperaldostéronisme secondaire | n2=trouble de déficit de l'attention avec hyperactivité | rel=r_associated | relid=0 | w=5
  5121. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble déficitaire de l'attention
    n1=hyperaldostéronisme secondaire | n2=trouble déficitaire de l'attention | rel=r_associated | relid=0 | w=5
  5122. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble déficitaire de l'attention avec hyperactivité
    n1=hyperaldostéronisme secondaire | n2=trouble déficitaire de l'attention avec hyperactivité | rel=r_associated | relid=0 | w=5
  5123. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble déficitaire de l'attention de l'enfance avec hyperactivité
    n1=hyperaldostéronisme secondaire | n2=trouble déficitaire de l'attention de l'enfance avec hyperactivité | rel=r_associated | relid=0 | w=5
  5124. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble des acides aminés
    n1=hyperaldostéronisme secondaire | n2=trouble des acides aminés | rel=r_associated | relid=0 | w=5
  5125. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble du cycle métabolique de l'urée
    n1=hyperaldostéronisme secondaire | n2=trouble du cycle métabolique de l'urée | rel=r_associated | relid=0 | w=5
  5126. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=trouble du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5127. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble hyperkinétique
    n1=hyperaldostéronisme secondaire | n2=trouble hyperkinétique | rel=r_associated | relid=0 | w=5
  5128. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble métabolique
    n1=hyperaldostéronisme secondaire | n2=trouble métabolique | rel=r_associated | relid=0 | w=5
  5129. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> trouble non précisé du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=trouble non précisé du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5130. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> troubles congénitaux du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=troubles congénitaux du cycle de l'urée | rel=r_associated | relid=0 | w=5
  5131. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> troubles du cycle de l'urée
    n1=hyperaldostéronisme secondaire | n2=troubles du cycle de l'urée | rel=r_associated | relid=0 | w=5
  5132. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> troubles du métabolisme du cycle uréique
    n1=hyperaldostéronisme secondaire | n2=troubles du métabolisme du cycle uréique | rel=r_associated | relid=0 | w=5
  5133. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> troubles du transport et du métabolisme des acides aminés
    n1=hyperaldostéronisme secondaire | n2=troubles du transport et du métabolisme des acides aminés | rel=r_associated | relid=0 | w=5
  5134. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> uréogénèse
    n1=hyperaldostéronisme secondaire | n2=uréogénèse | rel=r_associated | relid=0 | w=5
  5135. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> urgenturie
    n1=hyperaldostéronisme secondaire | n2=urgenturie | rel=r_associated | relid=0 | w=5
  5136. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> végétation
    n1=hyperaldostéronisme secondaire | n2=végétation | rel=r_associated | relid=0 | w=5
  5137. hyperaldostéronisme secondaire -- r_associated #0: 5 / 0.083 -> vésicale
    n1=hyperaldostéronisme secondaire | n2=vésicale | rel=r_associated | relid=0 | w=5
≈ 112 relations entrantes

  1. hyperaldostéronisme --- r_associated #0: 60 --> hyperaldostéronisme secondaire
    n1=hyperaldostéronisme | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=60
  2. hyperaldostéronisme primaire --- r_associated #0: 60 --> hyperaldostéronisme secondaire
    n1=hyperaldostéronisme primaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=60
  3. en:hyperaldosteronism --- r_associated #0: 57 --> hyperaldostéronisme secondaire
    n1=en:hyperaldosteronism | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=57
  4. hyodésoxycholique (acide) --- r_associated #0: 48 --> hyperaldostéronisme secondaire
    n1=hyodésoxycholique (acide) | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=48
  5. aldostérone --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=aldostérone | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  6. antialdostérones --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=antialdostérones | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  7. en:aldosterone --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=en:aldosterone | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  8. en:renovascular hypertension --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=en:renovascular hypertension | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  9. hypertension rénovasculaire --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=hypertension rénovasculaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  10. rénine angio tensine (système) --- r_associated #0: 40 --> hyperaldostéronisme secondaire
    n1=rénine angio tensine (système) | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=40
  11. en:primary hyperaldosteronism --- r_associated #0: 37 --> hyperaldostéronisme secondaire
    n1=en:primary hyperaldosteronism | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=37
  12. angiotensine (test à l') --- r_associated #0: 30 --> hyperaldostéronisme secondaire
    n1=angiotensine (test à l') | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=30
  13. processus pathologique --- r_associated #0: 30 --> hyperaldostéronisme secondaire
    n1=processus pathologique | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=30
  14. aldostéronisme secondaire --- r_associated #0: 28 --> hyperaldostéronisme secondaire
    n1=aldostéronisme secondaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=28
  15. en:secondary hyperaldosteronism --- r_associated #0: 28 --> hyperaldostéronisme secondaire
    n1=en:secondary hyperaldosteronism | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=28
  16. angio-oedème --- r_associated #0: 25 --> hyperaldostéronisme secondaire
    n1=angio-oedème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=25
  17. en:hyodeoxycholic acid --- r_associated #0: 25 --> hyperaldostéronisme secondaire
    n1=en:hyodeoxycholic acid | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=25
  18. en:angiotensin test --- r_associated #0: 23 --> hyperaldostéronisme secondaire
    n1=en:angiotensin test | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=23
  19. oedème angioneurotique --- r_associated #0: 20 --> hyperaldostéronisme secondaire
    n1=oedème angioneurotique | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=20
  20. oedème de Quincke --- r_associated #0: 20 --> hyperaldostéronisme secondaire
    n1=oedème de Quincke | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=20
  21. Hyper-HDLémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=Hyper-HDLémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  22. aldolase (déficit en) --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=aldolase (déficit en) | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  23. angioœdème --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioœdème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  24. angioœdème héréditaire --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioœdème héréditaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  25. angio-œdème --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angio-œdème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  26. angio-œdème --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angio-œdème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  27. angiooedème --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiooedème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  28. angiooedème de Quincke --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiooedème de Quincke | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  29. angiooedème héréditaire --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiooedème héréditaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  30. angiotensine 1-7 --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiotensine 1-7 | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  31. angiotensinogène --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiotensinogène | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  32. angiotensinogénase --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiotensinogénase | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  33. angiothérapie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiothérapie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  34. angiotonie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiotonie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  35. angiotrophique --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angiotrophique | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  36. angioventriculographie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioventriculographie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  37. angioœdème --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioœdème | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  38. angioœdème de Quincke --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioœdème de Quincke | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  39. angioœdème héréditaire --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angioœdème héréditaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  40. angle acromial --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle acromial | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  41. angle acétabulaire --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle acétabulaire | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  42. angle alpha --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle alpha | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  43. angle ano-rectal --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle ano-rectal | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  44. angle antérieur des côtes --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle antérieur des côtes | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  45. angle astragalocalcanéen --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle astragalocalcanéen | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  46. angle auriculaire de Broca --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle auriculaire de Broca | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  47. angle basal --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle basal | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  48. angle basal de Welcker --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=angle basal de Welcker | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  49. en:angioedema --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=en:angioedema | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  50. en:angiotensinogen --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=en:angiotensinogen | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  51. hyoïdien --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyoïdien | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  52. hyper-LDLémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyper-LDLémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  53. hyper-alpha-globulinémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyper-alpha-globulinémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  54. hyper-bêta-alaninémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyper-bêta-alaninémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  55. hyper-bêta-globulinémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyper-bêta-globulinémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  56. hyper-bêta-lipoprotéinémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyper-bêta-lipoprotéinémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  57. hyperabsorbant --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperabsorbant | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  58. hyperacanthose --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperacanthose | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  59. hyperaction d'un muscle oculomoteur --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperaction d'un muscle oculomoteur | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  60. hyperactivité avec déficit de l'attention --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperactivité avec déficit de l'attention | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  61. hyperactivité détrusorienne --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperactivité détrusorienne | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  62. hyperactivité vésicale --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperactivité vésicale | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  63. hyperalaninémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperalaninémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  64. hyperaminoacidurie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperaminoacidurie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  65. hyperaminoacidémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperaminoacidémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  66. hyperammoniémie --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperammoniémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  67. hyperammoniémie congénitale --- r_associated #0: 15 --> hyperaldostéronisme secondaire
    n1=hyperammoniémie congénitale | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
  68. Aldostérone --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=Aldostérone | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  69. Hyperaldostéronisme --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=Hyperaldostéronisme | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  70. angle antéro-inférieur de l'os pariétal --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=angle antéro-inférieur de l'os pariétal | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  71. angle antéro-supérieur de l'os frontal --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=angle antéro-supérieur de l'os frontal | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  72. antiacide gastrique (médicament) --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=antiacide gastrique (médicament) | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  73. en:ADHD --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:ADHD | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  74. en:Broca's auricular angle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:Broca's auricular angle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  75. en:Quincke's angioedema --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:Quincke's angioedema | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  76. en:Welcker's basal angle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:Welcker's basal angle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  77. en:acanthosis --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:acanthosis | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  78. en:acetabular angle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:acetabular angle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  79. en:aldostérone inhibitor --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:aldostérone inhibitor | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  80. en:alpha angle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:alpha angle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  81. en:angiotensin 1-7 --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angiotensin 1-7 | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  82. en:angiotensinogenase --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angiotensinogenase | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  83. en:angiotherapy --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angiotherapy | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  84. en:angiotonie --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angiotonie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  85. en:angiotrophic --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angiotrophic | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  86. en:angioventriculography --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angioventriculography | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  87. en:angulus acromia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:angulus acromia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  88. en:attention deficit hyperactivity disorder --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:attention deficit hyperactivity disorder | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  89. en:congenital hyperammonaemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:congenital hyperammonaemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  90. en:flexura anorectalis --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:flexura anorectalis | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  91. en:flexura perinealis --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:flexura perinealis | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  92. en:herÉdit.ary angioedema --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:herÉdit.ary angioedema | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  93. en:hyper attenuation --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyper attenuation | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  94. en:hyper-?-alaninemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyper-?-alaninemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  95. en:hyper-?-globulinaemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyper-?-globulinaemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  96. en:hyper-?-lipoproteinemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyper-?-lipoproteinemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  97. en:hyper-beta-alaninemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyper-beta-alaninemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  98. en:hyperHDLemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperHDLemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  99. en:hyperLDLemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperLDLemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  100. en:hyperacanthosis --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperacanthosis | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  101. en:hyperalaninemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperalaninemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  102. en:hyperalphaglobulinemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperalphaglobulinemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  103. en:hyperaminoacidaemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperaminoacidaemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  104. en:hyperaminoaciduria --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperaminoaciduria | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  105. en:hyperammoniaemia --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:hyperammoniaemia | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  106. en:overaction of oculomotor muscle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:overaction of oculomotor muscle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  107. en:talo-calcaneal angle --- r_associated #0: 10 --> hyperaldostéronisme secondaire
    n1=en:talo-calcaneal angle | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=10
  108. aldopentoses --- r_associated #0: 5 --> hyperaldostéronisme secondaire
    n1=aldopentoses | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=5
  109. aldose --- r_associated #0: 5 --> hyperaldostéronisme secondaire
    n1=aldose | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=5
  110. anti-aldostérones --- r_associated #0: 5 --> hyperaldostéronisme secondaire
    n1=anti-aldostérones | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=5
  111. déficit en aldolase --- r_associated #0: 5 --> hyperaldostéronisme secondaire
    n1=déficit en aldolase | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=5
  112. en:overactive bladder (OAB) --- r_associated #0: 5 --> hyperaldostéronisme secondaire
    n1=en:overactive bladder (OAB) | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr